var title_f24_9_24720="Mallory Weiss tear Endosc";
var content_f24_9_24720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F57049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F57049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mallory-Weiss tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 449px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic diagnosis and treatment of Mallory-Weiss tears. Left panel: A large esophageal laceration extending to the lower esophageal body. Right panel: A large esophageal laceration below the gastroesophageal junction seen by retroflexion of the tip of the gastroscope which also visualized a hiatal hernia; previous bleeding was controlled by multipolar electrocoagulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Moises Guelrud, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24720=[""].join("\n");
var outline_f24_9_24720=null;
var title_f24_9_24721="Blistering distal dactylitis";
var content_f24_9_24721=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Blistering distal dactylitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF7AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2AE80wtjBIFSN2HXP6VE/UjvXlHooikAx096rSDB571a6g5qtKMikXEr5GcfrTk5PJ9hUTnGRnmhST3oNWXIuerU9wODjNRRMMKQe/pUzgMtUjJ7mZdjg1lzH2rWugSp74rJuBg8dfepZ0QYsLc5FadqfxrJiJBHpWjbHJBqoiqG1CBjPTPrVuP6cYqnAOAOtXE5qjkZMp+U+p61HLHvGOce1SLuAODzTn5zxTIuZdyOTkDOe/asqdTvORj0rcuVBH0rHuPlJOSfwqDopsqo2GrUtpRxnjtWQCAx3c1etH6dRTRpNXRuwvjoce1W0bjOB68VnW7HaCatRtwKZySRcD5x+dG4Ek+9QA5HByKdn5R1/KmTYkJHrUTn059jQW4zimnjOfWpZSRHJxu7H0qA8Z46ipZDzxxUDHGCOuORUmkRGPHXA70M3T6UwnpnrSAjk0irEgI6Yp5GTxxxTF5OPxqdVOPc00IbHkdKsI20g4zTVXsP5U5QBxj9ataEMsoeAM1MpJGTg+9VUPT65qwp6DtVEPQd0NBHcU7sfpQoJPPpQTcaSQM96cMnoaUryMUuwjqMUCuITj69KjfJUjI4p7AsQRUbcAjqfWnYaKc3zK2fSs64GCcdSK05xgLk8/SqM8XXPTqOazkbQZjuuWP05qBW2cdOK0Zo+T61SnjznpxSWh0J3RUmfv1Jqs0mwnmpyT1PbioJY9x6DBrUY9XyQRT85/DvVX7p5PAqVXyM8YouFhxJqKQg5qTJ29uagkHIIAx9KTY0RSEcccVWdjzyMZxU0pIHt6VSmkwDgc9qm5qlchuJAuSRmsq6mzkjoat3LEk/rVCWMsPX6UnqbRVtTOmy7d6YIMnPWtJbc9+tSrb9CAMjrRGI5TsZaw7ucdfzpJIBjABFbC2wGT3pjw/LzjrWhi5GHJAST2qvLCeSBz1rblhG04HPtVOWLB5HXpTRLZjyRDGc/hRVm4XAPFFOxJ9HHpzUDDjnrmp3zuBHSom6c1izjRE3X2qCXjPoentU8mdp46VWl6c9T0qC0VJid/rjvikj4HzfWpZAOTkmolUbqZrfQsxfXgjNSlgFwOM/zqGPO0D9akJ4PFV0MXuVbkfI3r0rHuAASTWxdElW/pWVcAE98VLR0UyGL0FaVp94H8KzYwRjp7VpWhyRTiFTY2IASuB9KuIMYz1qnCcgYHWricEZOas42TqD9aUgCmKakPAHGaZFitOMoc8ViXgJJ/lW3MTWTdgNUM2pmUeHwatW7cjB5qu4O6p4RnGfu1J0vY1rZ845/OryMBwTzWbbgjgscdquo3H9arY5ZItBjwO1P3YHJyT2qAHj71KvJzz7UJk2JmYbeTxUbtgZ/KgEg8YH1oPHp60MEiOTgA1VdsAnNSysSSSOP61UmbAO4/hUmsAZsUsZLHjrVcE4+tTQkZPpQW9C7GMnJwe2asxLgYAJzUEKZHoO1Xo06+lXFGEmIUyeB+NDKVAJFWvLyOOPpQynbgCqsRzFU4BAHXFSBuRk4yKa8eBwMHNMjZmUErtbHIPagNy2jZOcdsHFPzznPy1VV+hxz61OknBxTM3oTrzzk0/bjAzkGokcj3qQsCBnjPf0p2IuyKQ7CR1FQyEgZHX0qdzhucVA2CeT1NIuJDIu4gHmoHUYPr9KtleSR0HQ0xgNuQeetI0TMyaPg46GqUsXA4/8Ar1tSKNox1PIqhMhPY8H1qTWMjEuYfQcVScYHNbkiBueM49Kz7iEkZzgUXOiLMqQ4OQKYWPrgDtVqSHHUCqrqRnjihmgok7mmyPnHB+lNKEk+lOSEluevfFAOyK0gL5yeaqtEcAHvzmtcQAnjFRSW5yOeOnBp2BVEYkkA3Z9eDTPIHXHbFbLWee2R2pDakAdOO9CRTqGULcbeB0qRYPbg1rLbEgZH1FL5IwMgYPAApoyc7mU0GFGR04qvLEBuOK2JYsZBqhOu36UxKRlzxDHp71nXGFHIrQvJgqkde9YF9dDGRjNNMoqX820EA9O1FZF7ccls+1FUQ2j6pccDHSoXB6Y71OQeR6VG6/Nj9awZzJlaTPXHFV5PXv8AyqzMDuyDx3qs5O7GaktER5bGP/r0wLyevPTFSAdx1p6qegx0ppFOQRj8qWTocc/Snhdoz6mhuQcDiqIKE3AIrNuRzxnj1rUnTJJPasy4IJbB6HBqZHRBlXPP6n3q9atgmqDcNVm3cZoW5UzdtHDADH51fjYHAWsm1YFRj0q+JAgBY4FWckkXUIPccU/dxnjH5VQa4YgbF4/vGo1hluJcs7FR0xwDTRFizPPGqn5wW+tZkzLIG2c888VcktthbysB8dabBAQrFjlj6cYpWuXFpGTLGQ4BGeM0RMoOCD+ArZEe3G1QW7nFV3gJcnCg9wKlqxoqj6kSXUSHljnHYVeiuYXUYkGazTbEsQOlQPZkO20nbjjHrTsKyZ0S+ufyNOyOxP0rlWkmtUykjBuh54qzba20J23IDcdVFSHs30OjDAjtTX78cVQttVtbnASQA+jVbLKyjacg9cU2RZ3IpXx161Rnb8zVqU8jrVNuW561JrATGTkHirlsvGOnpmqqD5hxV63Ufn2poJvQ0LdPlGfrV+GPHUcHpVS2Bxk/XitCIZGVPbvWqOSbHqjc8DGenrTinA7HrmnoDjJ9akIBXaD37imZXKMsQAz3qnMpDH071ryLwc1SmTg5pWNIyKDE59KcknJB4/GiQDPB4/lUIO1uOwoNbXRfSTAHapi5x6jtWYkzFiD+tW1k45NMxlElY8daY3A6e9NJyw6/nS/maQ0PUYGc59qVlxjaMChfuY7dcUj8evvmkMry5bHciqsq56dCKttwQPXrnrTZIwfpSNE7GVLEccD/AOvVaWLI6VsNEOw5HrVV4h+fakaKRjS2xIOR0FVHtTzkHFdA0YY9MY4prW4ZeBVJGntLHN/ZTkZGPSpUgAHPWtd7cLwAAajEIJ565poTqXKKQ5wNvNSi14BrQWFQeBzT/L4x71Rk5mWbf2/HFRm2xx0zWu0YBwelV5doGDSFzGa8ZAAI4PWq8qAEj8/ardxOoyc1k314qZIPB/WkaLUZdSbM1gajcAEEseORzRqF+uCAcCuV1PUMZ+bPNBtFW3JNRvRk/N0rnL6944qG7vdxyDWPPMzNx+FVFEymPubjdnDZootbRpmBIOM0VuqTZzuZ9hsxBGO9NkNOPLHPb9abIpxnArhEVX6H0qq4+bkHpVlx/LpUEucikWhi9QCeO9SR8EEdKjUY9SKnQEgE4FUNjmIGMikIyOeoNSEA5zTSBzwcGmSU7lSV+XIzWVcIPmIABY5PvW3KgAwMgfWsu4TKnI60mjaDMqTIOafE/wAw+lLMPTtU9pas3zkfQe1JLU2k0lqW7MyEjC8etaiQkMN2CfQ9qgiIjjUrgH0q5Cc9Tn3Na2OKVySOHgFmbaTjgdKlZn2sI0AHQE06OdQSTzjqAKZ54KkjAGaLpEpMWNOR5jdR81PkROqHAHXJ61XldyR8hA6imG4DMAeM9anmKUWSvj2z+lRSgnGAOTzimsG3DuKQMQcsRkd6LoqxG8bBmIBHtTZ1ZBgggHpRPNOwb5tqE5ZvaqJuH3gBxj+8TUuVikmyO7jc4bHHpis2VVYnIxnpW9GY2VZJC0gGcgngVm6pbp55MHKsAwqWuxrTlrymLLlGO0nPpUtvqFzCMI7Bv7rUs8QB+fP1qnLwCynLfzpXN+VM37XW1cKLjAJ/irQWRHXKOG/GuFLk4O3JHY1NFfSQyBoSVUfw54NVuQ6djuogSOnB71pWyBVA6+lcbYeIF3BZ/lz3rrtOuYrhQY3B4ppHNUTRqwjJAq8nC8CqUB4yeB7VdjwMkH860RyTLMZytPxxx1qFH3KCv+RU46EetMyYjAEZxkeoqvKox1P41ZzjrgelQSKWBwevNA4sz54+ORx2qpKvTaAT7VpOmRggiq00PIwKRtGRRwQwBp6sQ3XH4UjgjqOlNzgZNBe5YDZPX6YqaPt1qnG/r1zVlHO3k8dqCWmWhgc0jD06Y71GjDOQTj0pxY/nQIaVz2z70bcDgVKo9zSsgI/pU2C5VdCeowKgkU9gT+FW5PYn61CeBjJNBaIRHj6UhjGRg1KB70uCFyfwqkDZWaEHlsZx+VVpISfpWkU46HPpUEoznNArlE8Y9+hpjzbSS33adcMEHJrHu70BSN2MUFxjct3F4AMAjPUYrIu9QGCd1ZWo6iFz8361zd9q2M/NjqfrSudMKNjcvdUABIaud1DVhz83WsG/1fJIzxWFe6luB560JM0domrqGqdcE5+tc9eXpY/e61TuLksTg8VAqtKwB5NaxiYTqCs7SNgd6v2Ng0hB561Y07TyxBI6V1Wl6bgg45FdFOmctSqVtL0zpxn8KK7Cxsdqg4oroWhyObueylcfjTCMe4qdsZyeuKZjPGPxrxmjtIJIvlyPyqjKRkj+lasowtUZkOf60WKTKyduPzqymMetQhCGyTwamjB28CqRTHNhQcjI7UwtmpG9qjIoJTGuMjI49azbiM4JzWrsypx1xVHUG8mIsSMnoKllxdjICfvOMZ75qzCOhxkelRqhwpxljzmrUMYUFmq0rFt3JkYhjvXjHSp0kYxFkAyOMHvVWeYlAMbguTmrEeI0Bd1Vj2HpQ5WEoliFF3LubI7jNWI5OHEUUQjAyzy+lZEsq72AG9yT82cBfYVBdXMshLs+cY6HpWTmaRoOWo2W7leZirbQDxmrNq+HVXcYPOT0NZd3eNKyl9owMDHelS7lwqSHKr91SM/rWd7HU6DcdjcWRWLKoYjtzTZmc7RINvHGPSqFvcvu3AhPf+la8V2pGJIlYjnkcGtE7nNOm4PQx7iWZFKOwIPQD+tVbu4CpH5owzcHAxjFatyofL8c5+WnalHayWEISMO4XIx1z3oswTjG10YT3LKBt+6DzmpPN3oFD9BgcUqWzEBtpeNTkqeoqtfKYndoQ3k54z1FTdrVnRGMZPQe4Xy2OcovUkdKzb8jGVX8qHuJRuCOQrcMB0YelIyFlyCefWqvc09ny7mXvweSQ1IV3Z2n3FTTxEZO04wcVWiOMhvwNCG0MZuznr0NWLLU7jT5A8Ltx29aiuQduVxxzVIAtMoZwFbvVpmUoJo9H8PeL0uHWO5G1umTXeWk8UyBoiGyOfavn2R/ImZVcHHetvRvEt3YAYkLKD0PpWqaZxVcPfY9yCEnjPPerAAUda4nw74xtrwhJnCt3zXZ280cyq8bBhVWOCcXHcXv7elRkehyanwQeTTD3PtSITKzLnsKideOwqywx3qGUZHBxSKTM+ePBOelU5RitOYEjJ5qhMvOO3rQbRZVLBfvEjtUkcvQA9Kim64PNRqxzkZFSza1zRjkzx3q3Gdx645rLjYHhmq7C+Op5AoREkXhjj0qOVsHANIje1I5HSmQkRycj0qLHXI/WpyNw69qbtBJyMHvSLuMBI6nAprHrk8e9EjBAfpxVWW4VD14oBK5YaTaOT1qjc3C4OTiqN3f7QcP9awtQ1QBT82PapbNYUmy3qV8ADg9K5LUtTwW54qtqmrjBG7nrXHanqZYk5oWp1xpqCuXdU1XJI3AmuavNQLEnIqne3jMxJbOazHlLZHerjEU6hPcXLM2feqbMWzmgknNOjjLMMCtoxOaUxI4y5Cgn1rb0uw3YOOfel0vTy2Cynmuv0vTgNvy10U4dTknUE0vTsAEjnvXTWNlhQcc/SnWVrtxxx71sW8OAOOOtbI5XIbbW2MHGaKv4CjAH0opkneY3cjGf5UFccdc0KB2HfrUgHA6H3rx7XPQGFQcg8iq8sWTjPtV1VG7vyKGQHtzRYV7MymiwwyDzT1j+XpVyRACT1qtKCXyDxQVe4zjPOfpSrGBnpzTT09u1SJ15P50D2B1VFJJAAGSTXK39y13cgov7oHC57+9b2vTRwaYwY5L/KADXMWzu5VX+6oAHtSNIK6uXY87SBx0yandT5LMF4GDkmoF+RjGy/rRczOsP7tsFjz+HenKVlc0jC+hJcSiBf4CNxx7VnSaiDJtB6/L16Vn31w+1nbIUnAyec1kebmMlN27Pz8cVyubZ6tDCK12bU2oODhWGORu71JYFrnJIx71j2g8+QIFzk5zXYabZMsKiMZJ6jFOlHmZeIcaK5VuVRbLIuNhbFWYLUE4wOmMdxW3Fps7pvjRniTqQMEVdOk+TBEyFDIW6H7xrq9noebPFdEzBfTiItwHHoaYYJY7bfuBAbp3xXTpbkht42MPu+mKqXVuPLLHbyOtRKnYzjiG3YwJJF2CN1yQM7verCyCKAqELDqDnocVJdW6NbRMFKkZHTr71JbrGtkzNuY4wT6VKjuXKSauQWyC3SZ5SmSA5wfU0t1bKrZ2/I3NTTxRz26y28iyRCPaeOMiktiZrJVY7iF4/CqVmZXs7mLd6VGzhk49cDrUeou0VkUKKxGBkdh2/GtiF+dpPXpS3FmkyEEKxUZw1Xy3Whs6mq5jiNwlUeuPzqpNAcnZ930rob3RWVneHIz8233qmsO1CtypjcjvS5Tb2ieqOfkLrnI6VTncKO1bl3ENuFrGvbYYzv8AlI5xUtWLUkyFGjCscbs9vSmowTb/AHagRSr4UnFWNp24HOe9NMmSJVl2S5RiPTFdPofjC609wsjF06da5Ex7SAT1HbtUiJzkc1omc86ae57ZpHjO1uYlV3Ct710FvqMFwo2MOfevndXeLDKzAdeDWvYeI7q06OSB6mr0Zxyw6eqPeCwIyOO1QyH8q8107xwT/rWO7jNdFZeKoJvvOPxNKxg6MkdDJ044qpMmen40+K9hnGVkGccipNoJ680hrQzJosnj61C0Q4Jz+dajx9wKgaHAI4JpGqkUlADE4PpVpGwKZJGVBxUDuR3pFbmgs2OnQ1KrZNY73BUDmpY7sLj+tFxcpq569KY8gUH071RN2ABn61Ru9SUKRnGOaAUW2Wby6VFY5rnr/UVTIzxVHUtU4PzflXJ6pq3LDdz9elQ2dlKjbc1b/VvvcnPNcvqWsHBweDWRqGqMSQH4rAurxnyCeKajc2bUC9qGpswPzVhXN0zk4zUckhJPNREe5rVROaVS5GzHOSTSEc807GevSnKtapGDkNVPzrX02z3kcdar2VuZGBx3rr9IsfuttzW8ImE5FjSrDCoCMV1NjaAAZ4NQ6fa4UDHWt+1gIA4Fb7HI5MdbQqAKtDg4ApdoCY7mg4wBQZjT17E+9FNbjvRQB3sbZwe1SA8emD1quAQuce9SR9/Q149z0GiyoyPY1JjBApiHgADipDzkUEEEqgLxVKQnNXJ+hqnLjP40y4kR5OM1NGO4/E1Cv3qnTAUsDnikWzlvFNwJdUggU/6oZb61WgwY2296rTSi41Ce4kA5Y4x6CrCsMYXpikkdCjZJEsUnzMMcmmXWGikkVtrLgAY6k0zfmTI9elZd1eMLkAPtKnJz0BrKcuh10aTk9CtqroVRSczHkkdKzEdI4Zsk7yOAO5omnM12zO20qcgHvUF64a4AXq3XisFqz3aUOVKLOk8OQs8angE8816N4bsnnicGTbtI5A+8fQVxOjMixRqVPSvQfDVwImg85R5bfdYdM9Oa76KSR87mM3JuxvpYG2t3WIFmYZIY55qG+toTFCswZG6hge/pWszhTyRn0zWZqrFhHuGArbiTW8kkeNFu5jXpMchiZSAMbSeQaqagFEIxyu3nA71Jqk7SzqFHy5xmmRhZPMDjKRLvcjp7CsmdkFZJkt9bfaNDtncKHB2KR1x71S1XTkh0UiN8uFzgA4LelbdlbbrKJJo8M5wAD92m308CARswESDbuZfzqZWSJVWUXZdHc86gu7mHZaqAi5wVXrzWto/mrGI5+SCQD0OKr3zQSTtPEkSsDhCOp96I7lkKoTk7eSO1Y042O6f7xaIsoB5zAY4OBVvYVAIyRnrWXbSgsT1Iqxa6pG94LcjCnox9a2gKdKTWi2J5VyM45FZd9YrcKVIO70FbsqBskdaqSQMMsox+NaGEZWOOnshb5WcnB4XjmsjULQoC2M57etdtfwLKrBhlunNZj2S3FvIpZVmQfKGHWk43OhVOrOAnUKxPQjoaSKTaOQTWhqdsYmkVwNynkVlSvj6DsKw2OlO6LEOWapQWV+ORVa3fDc81akYMu4cAVaZEkI3fkCoJVJB29ccUGRXO0HIPep4UHQkVaZnKJTDMh9PXmrEdzIuWjYqPY02dQrZA49Kh+YY7CmmZtHQ6X4muYcI7k+9ddpvioMBvb615jwBxxUsFwy8AnrTtczlBHs1vr8bqORjtzV9NRikxyOPQ15DZ3bE4DfhmtWLUZYsHdzScTJ00ekvcREcMCc1UmdG5UiuLTWZAQc5wKlXWd3G41DViowNy5nC9f07VTlvCOSeR6VmTX6sp5qlPd/LnPHpSOiMDauNUCjG7kViX2rAAgGsu5u9xbk5rJu2d/utx396LXNlFIdquq5JGelcvf6gzE/zq9dW7uTnr0rMnsX3Hjj0q1AUqltjMnnZiSCaqOxYnJrQms2A6VWa3K9setaqNjllO5VI4pACeoqyYzTljJqlEybKwj44qaKIk4qdYjnFXLG33Nk+taRjczky7pVplhkEd67LS7YgA44rK0u2K7eOBXVWERAAx1FbpWOWbL1nAAorViTaoAGCKr2yjAAGf6Va9aoxY18Y4ppbHBpXOO3FRMcA46mgQkj4PA460VHIeRyAKKCjvjx9KkjOCoA4FNA4qRAM4zXjneyxFycY4pz5OApqOFuSBmpARnpQQ0RTNgZzyRVKfoCBmrkvvVKU9/ancuIwEZBPQ9qLuUQ2U8nQKhOaRTyM9RTNTGNLumxwIycetI0W5w8ByQevfmroyoGejVmwSfKC3I9KtJISynj8aDqtdk7KWAUkKpzljWRfWrTorth8oTnOOBW1Eok4OOfWquq2pSZoSw39fk5FYVI9Tsw0+WVjkZ1EZPOBnuagy4uFdjkBgeK1Lq0LqhP3iO9Z7fJgJ8xU8+1Y7HvQkpLQ7DT5QygA8Cuj0+9eKDyXbK9s9jXHaZJmFdn3u9dDbzb4gjL8g68V2U2rHh4mkrtHb2d0wSPdIXk6bs9RU+oaluj8gMC5J3bj/ACriYLuS3YCJjhuma2IRJLl3jDSAcEHoa3vc8uph1F8zNG8uR9j8sReW3948cU7SrWR7OWWJMxykI7FsZHtWZqs2IYfLZnlI+bI4q54fnuIrEqk27ex3Qnjj1FTfXUUoNU9Df3yRNFby5wzZVl5bgfyrndbtLiSHybJz9oeXGw9T71a1TWLNVW4gbbOpARR1X1zUnhjUIbsXtxJIwuZAVI28ADJyDUvllKxjGE4L2ljhL7aJxHtKyx/K6j+8OtTBWt7N5Jcb5AF56qKi0dPNv57mU5VWZh9c1Df3L3FwQw4BJ61nF3jdnqJPmUF03LNsxLA+taBs4pzG7DEiNkGsq2bsBkitmBzjJIHFawJqtp6F4sWALcccimuBs61AkgLH3qTcCeOMfrWiOFlK5UFjgjn+dUZIjEyyc471qXCgjIAz1NVJVXaQPyplJ2MDxBprS2q3SqSmDXnl0WSY7lwpPBr1a3dhI9q7HypOgPIrivFWn/Zrp1VgyeorKcTpoza91nPxuy49KtyAtGNoySOcVSaB1Ixg1dhHyAZGSKhG7ZHDGMvkHNSnOPlPNRxqyyYHKk9KlYKhIGQf5VSM2MPzcHqKU524P4UjEtwD9aickuMVaIaJDGzY5HNRTRmI5FSKxUj1NErbxg/pTRLEtnYgHOCO9X1mfIGTjuaxkdkcjHFXre4Ty+c5pktGzbMGXhuacw5OOh9KyUlO7INXkm4yTnFMknbd0zTSCQf50sMgxn1PNSEA5x0FK1x8zRmTQ8sTk1X8vBw2a2SnbrUM0OBx16UrFe0M3yt2d3eo3tQ2cj3q8RtyGHApAQeaaZMjFubAHPQmsyew2k/LyK6x41b2NU54RnBGT71sncxaORkswvJ601YAOxH4V0U9sp6CqbwbWxtNWjJmYsA9K09PtwCpPIpohyeK1bCEALxWkUZSNXT4gAAB1robJOMnrWXZRkYrbtlwR9K0OZluPCr6GnE89c0g/IUh60ECMcnryaic5Bx1px5JIqEt2oGNkbAwRmio3b5SD260UDPTtuMjFOAA/Kn7fTJprYAPFeNI7rjVwOfWpA3qajDdMA0m8c5pXE0LJwD03VTmPHFWJD6Y4qu4Oead7lxRGpJbimaqSNGvOcERE/WnxoQ5OOD0p2ppv0i6HYxN/Khl9UeZRMfJQjGT1q7CSzJhhmqEYXykx0I5FTtIBt2A8VJ2+RsRsrY5GPao5F2CSQH5scE96Zblcc9exouC21dpOR60T2Lp7mXd+ZGEDYKhSASOxrNe2xllGG6jPeti9jeRBuYsyABfcVV8ohEVmAbPX0rmadz1qNVJC6NMV4kA31vedlMBuSfwrnciOTd74JrRScbfk6VrTlbQitDnlzGxbliQdxJU/WuhOpxkDyI0gwmGAPU+tcpbkn5s7T2GanebeeetbxlZHBVoqb1NWW7B2MCQQeoPWqVpfXsdxMtvKuJWPJGSfpVNpmUhVA4pYp5beRZY/kZRuBxUSd9S40bRaJFgurj7Q4hcpCPnY9B9a6WfVLXRvDZs4Eme4uIwwOM7MjnmuHuNcuDa3ILkGeQF2zjdj2qtbajdy3CS+axVQUGeeKzjVSTUd2FTCynrPZHQWDrb6XIc8ucBT1/GssNljnv3qKW5cIFY5ycmkV+RmtI+ZUKbV5PdmrZ8kVqKwC89fesOC4jjI3Oo+pq6t7AwCrLHuPYGt47GFWDlsjQEmBnj86f5nzDHB71nCTIBpTLyOhPerORxL7ykDkjI9qryuOQO9V1mO05Hfj6VG0hIODnHWqSFyjLzhkcYGD1rL8WWom8ucAgOoODV+6YGEg1JrMS3Hhu3k85A8WUIJ5x60pLQd+Vpnl8z4kKnAI96kgJ2Alqg1JSLlieeTimQudpyQCvIBrnidbLjOVx3J/SlR2L5I/Wq4kRyMN/wGljwGzuPXpVkllyXOUxmmLuLYYfNmnIoOWGc9eKGJ3ZB5xQZsa5K4Pr60hbingeZwV59aSVDjgVaJI8hl4qNuFAbpQilT1INSTMpt9pUZ6UIl7j4J1EZ6VZtZ84GcGsmFQo4OfarcTBQDnmqC5psxBBBNTRzgDBOM8ZNU43MqdDxTopMZBxilYHY0lboc5zUo+bgVTjYgDkGrUL9MUIh6EcyDnPWqzJgE84FXjkt600LnOelArmc5Kgg/lUEh+Y88VfuIsgg9fWqUi9PQUx6EDLweKrugz3q2BnJz0pjr1xirUjOUSosXI71qWceMEiqsagNx6VpWw6AZHvXRBnLUVjUtFyAD9a1oF4zWZb84rRiPBHYe9anKyfPPJOaazepFNyCOOtM38nPbtQIV2+b/axUMhOCAetKxB+pp9za+RdRwTzxxlsbz1EeexpDKbtnv14op+qCdLpxdMrSKANy4wRjgj8KKYHrWMKaYy9MduaergDk01ux7147O25C2eT/AC7VGcZ7Y+lPdfqajPFQWhrDkH3qFj8xGakY9SfyqEg5zQUkOQEnHarEsZewnQEsWjYDP0qJCGHHartuM5HQGm2Dep4zbu0ZII+YMR17Va3KY+MKR1+tJr9q2na5dwMuAWJUex6VFFJy69c8kkZApnenfVGlac4DEc881bAEjYPIPf0rKtZh93jParqMV/75otcew28BSB1CFh/eHaqMpBCuzH0FaBclSB096zZ2G5sqQM8VhNHZSbGthxhWGe3FNT7TBKwmAK+1OhQPIQhyewx1p7x8ktlWHGKIo61O2hZgnyxy3GKmaToVJ4HrWK++MM8fbrSRXRcBHbBPHWtPIHRv7yL73UpZmXJGR+NbFjexyAQsm6V0Kgnp/wDrqDQhAtyftMSOkSn5S3DZq9AIXLpp1n5t065DknCH1pNXVjlrTi/dsc3qwS1QR8F9x+U/zqzo+rRxp5V1CrRj+EcZP1pmo6XJNI019OsZA6dOfQ1gwt5cjLv3bSQCK50veOiMYVYct9TeknWW4ZlUKhPyjsBTTOEDOxwFGazUuRjJzWT4j1IQWRjRzvl4A9u5rq2RpSoc0lEo6vq8k10zxswDHIyaTS9RmuNVto14O8dD6Vz80xP5Va8MB5tYidc7IzuLVKk76HrVYxjTa7I9eW6B4Bwe9SRz5PJH4ViJOMfSpBPg5U4rqR8pKnY2mmyBz+tRtIc9eDWcZz689vaj7RzmrTMnAu3Eu6PHTBq5qVsY/DQkcKrtkDPUVhyzbhg9DVzXL0SabKqOxgRQAD1zim2rGE4u6R5/qcqiYgDHqarR5bJyAccZpdQLBicZzVOCQiT5sfjXMtzsLBOxhjr+eKs2q+cZApO4DdiqcrDI5w3vRC7IxZSBnjIqzN6mlBIMEMeMcYpyyMrAkbgaqxscZH3SetThkyOSG7iglllWAbOdue1Okl+XgZpkmzeMEcDIqBpcHd69RVEsHzkE9KCQ/QACnM/y52ZGMVAGXzOARmmiRJBg/L+nWkZvmXOQfrSnIYnPHamMwDZJGOtUBp2UmPkJNS3Awc4xjpis21cpNkNkVenJcA80GZYtXLjB5q0hK9TWbC/lHHf1q8r5AbPzDtU3KaLkfzt7U5vlPU1USVgzDjmllk3EYJwOtUZssSjK5HWqTpkGr0OHBLHnt71XmTZ680WYXM5xjgU3jnP4VNIM+oxURU88cetUkLmEX739av2zjg+lZ+RwP50scxWTGOKuL5TOceZHS2zjAq/G2VxWBazjHf6VqRyjaMcZrojK5wzjYub+nHNRs/OSOajD/LkcE0xn/vHmrIHb8DIOD1+lacy29832ia1v1dxl1iTKufUHtmsZm5ycHnoa3NSj1CW7aS3vY1iYDaguQuwY6YzSY0Y2rztJeM7xNDhVVY26qoGBRVPUzNHcutzIJJQAWYPv+nNFNAe0LnAA/Ggjjg8U3Jx0waUAnivIO2w05OcVDIpwcH9Ks7cjIOKY6n5sf/rpNIpMoNx9aY2R9O9WJV5A54qqWO4/LUFksYxV+3OSKzomP0NXYCMDp60CkcJ8VLZ4tSsLuNTskQxs2O45FcaszBiF6NwRXr3i6wOp+HLuFQTKg3x465FeMq4ZF7MDg1SOzDy5o2NThduARjBNaMcm5RnrWHHduH2kA5GOmeKvwSlsHPFOxr6l9m4AzjnvUM6EqOQaSOUhXQ52t175pGPz/Kflx0qJRNYuzIYQUcgdemamBLKQQGA79xTAWwNjHGalGMZYdfSpUbG3Prczr47XAGQCO1VYQPMxggdR9auzxlpPvZA/Ss+7KxkNk5oeh2Up3XKakl4r2CogKybv3jYxgVNb63dadbySafJ5dyRtU9TXOnVZo2FvKuUPoKuI6SqZGAz/AAY9a53KV7ESjFL39hfPu5mnW9m86WU73djnBqndskbfIctV/wCSKIs/3u5zXL3F4GndgTtFXa25ph/ebaLmoaj9jtWlOGI6D1Ncje6g95N5k3XHAHamaxfNdShRxGvQH1rORyD6epqr3PVpwUFfqXlk3D3rb8LZimmk42YA/GsCziaWTjhe5rprDESKiYxVwWpz4mr7tjpFuOnbNTxz9T2rCFz/AHsVL9qwRzxXQmeNKJsLcY9aes+Rwcj0rGW49TxUqXA2k84NaIxkjVjl3TqgGXJ6GrPiXybTTFDH99I/IB6YqLQYmuHJQozOCMN/B7msPxVetNMsYZSsfHHrSnojlfvTS7GPqEwbABIqjvKkZQEHpVe5mLuQhOR15pIJMjn8s1gjZu5aJDNzggdjT49m4dQf7pqGAK4Yv09qcSd2EIx9Ku5LLiu23apyB2NTBhk5PPrVRX3EcD+VSByp4J49eaZBbWXaRz1p8smQMDrWe74AI5qWCbe2GXGBTQmi+Jt4VRwcVFIPnBPNRwEPJ9DTrj+L5qtEMY7c8U0hipB4PamIc5O7BFS5ytMm46BimMjOK10cSRdMcVj+aoJA7etWYZztwSOKq2hEix5eWz+dXkB2e3tWf5w3LgfTipEn7AYJNRYd2WgcHk98VLnAAqBGBbcRx6VJKRs4PPamSy9p5JJHYU+9QgbtvFZ9lcGOUKehOM1rSsssIbpjtVrYzejMQ43HFMk5BI7VJOu1zxgdaqO+QRzxTQ9xrHJyeooU55qMthgD3704MBxVJCLMMpVvf2rStrrJx2rE3YAA7mpopdvYfWqjoZTjc6NJwQMHFPLDPBBrEhuSMc1bS4BHWt0cso2ZpW91bwl/tNsLjI4BYrtpX1HTu+kr/wB/jWWXxnaevrUEzAevHYU7CJr+eOSZnt4BBGQMRht2PxoqtqESwAFbmCY8ZEZOVyM9/wClFFwPegMrjJqWMDIOOKjTGKsINwAI59a8k62xCmR0HNNMY4OOBVgqMYI6etDccNzUyFczblQPXJqjImCQa1p1Hf1qhMo3Y71BrFlRRg5q7ATtFVCNrg4znrU8TYxnpmguSuaMRzj8iK8V8c6adG1q4iVSIZX81M9s17PE3BA71zvxC0RdU0Tz4wPPtvnXjJI7imtC6E+WR49b3BYbg3frWpYy+ZIEDc9PxrBaVQzBcBs9h3q3BJ/GpweuDVo73qbjTlGdjxg4phkJXcTg1micMvbn17VY83CgnHpQ1cpaFmKXEgyMYq1BKdzN1X09KyjNhhkZx6U+W7Cr8vB70rWGXJWRCX465rGvp1Z8jOc9Kiub8KvLZrAvNSEjEJkP0HOahvXQ6Kb5TrdKji1Ga5ecqVEfzN0I+lJCPs9uqkhtvANc7Zu8SYVtpJyTVi91ElNqkcCrUUlqc75pysnoLq2qFQyr34rnnfKnnlqLmQyOSTmqjttrnldu56tC1OJXkt33ZYjimNbdhg+9StIMg0zzOc9TQkayxDLdufKQIvOKtxzkKMVlLIevFSCTA5NaI5ZzvqbAuCBjPFPW49+ayPNzjNSxyE960TMJM2YLoo+4du3rUqTbsBumeo7Vl5KMEbh+4rb8Pael1ia4YrAh+ckcVrG+xy1JJK5v27LpGiPI5PnSZypOMjtXD6nOrSswfcxGS3vWn4r1Tz7spCf3SgKue46Vy8zYRdxH9aU3fQ5o6avqRyMWY9TjrT42BIAzj2qI5VlY4IP8OetKjDcSCQOwrIvmL8LFc/Lx61LGwznOCeBVRG3J3zTwcDrn69qtCbLY3EngEAcmnqzY/DpUVrdeXazxbPnc/epiybcbgT+NN2uK9yxhtoOMYrfFrZRaQJmkBuCPug81zfmZbpx6GnlwcAnGKpPlIknIvxsV5AHtim7/AJmDLkVXEigHDcnjr1p7O20dM/WmAikAnjvmpWlUgAD8KaF3JuzjFRFhnIPI9qZDLDY2hqWCT5sHIqmJGP0zUhOMEHr6VpEze5qQoC+Tnb1znpV1EUEfzqjZ9iemKtuxymMmhITZbZTwV/OkyemeRU1pxHhjnHamvGdxYDFFhc3QrSIUOR16nFaFjIWTB7daoyuw4PFTWMmwnJ601uTLVEl6hHJrKkAD46GtW+m+THWshnLknjHTFUxIaxwcdqaG+b6UOeTnmoskjse1NaDJy2McUokx9OwqIEbQD1qNpB16fjVGbdy0JdpPPFWYbgccnNZLScc5BHakjn+bg9ulXFmc4nQCTcQAcZOMnpW7cWtpZS6jM9u8sVmEiRJScTSt347Vx0UxIA6k8AetdRqBkhsx9o1W4km0+WIOiqNkRb0J5YgVozGxk+IoY7XUWjgUojRpL5ZPKbhkr+FFUvEEctvqcqy3BuGfEqzHrIrDIP5UU0xH0an3TtGSOeaspkEZNVYieg78VbQ4615B0seMgHNHXntSBhjNKSCuT17YpaCIZhySRn2qjOvp+VaBAwapzrk5HUVDRpFmft+bJ4zT4jjoO/ekbJbnvQhCnHUCkal2HlTVtI1aJkbkMMc+lULZsngVowMD2oIeh8//ABF0OXw7r25FzazEuh6D3Fc5BcbslFOQc/T2r6P8aeHIfE2iPbv/AK+PLRP6H0r5rvLe4028uLeUMjRsVY4x0NXE9ChV54+ZcE5GOQM81ZSYop3EhvQ1z32pwdp5B596sxXB2fM24etVc2NqG6XJDsFIqrc3DPGSrk89vSqP2nkfT0oMjbcHO0jND1KTMu/vyNwOfYDmsmG9XduY5bqKv39lL9oaaBiQV+6azZLSQMWeFkb26Go5Wh+0T3L39qOerH8aGv2cEEj6Vhyqwkxz9c9Ka28AdzRZlwqLobLXIxx1qF7kHjNZDTN0zTfNPT+tLlLc2avnAgZXFMMgJrN80g4H86US4+tOyDnZpb8d6cJckZzWcJietPEvaixLkzTWXd7VKj4757YrPhbIGc1u6Fpkt9OpKMUz2HNVCLb0MZ1FFal3RrKS/laW4ZhAP9ZIR0rX1fUre3t/stiWFuFwQeCx9al1a8j0vTxZrIQu7Ig44PcnHeuPvLgXNwzxsxQdM8VtL3Fy9Tlcuf3nsEk3mMXI49CaqSHzHJ6Drk0SsGRizhWHbHWoF3YyegrBpjvcmiPHbNPwCQSDiogRuIU4P0qRnYIoLDAosFyVXG4YOMHvQ7hsgAfUVESCMk/WnQxvKzbV6e/SqswuSxsSOB361ZdjkZXBxVeLav3gwx6U5nG7v9aaQrol8z5iWqVZD0Kj3NV1GBl+QOlNyHb5cjPWgLluWQfLxj3p6PkcZIqusiiLBHNPD5XGeKpEllCdpOetM3DHvUSynkNnGajLncR2NUQ2TyS8YAGBQZN65z3yMVTnfggU6Et5ecnFWjM39NzIo5/CtcxhEGOTVbQIFNkHbhsZyfSpI3LSsG4WtLWIvcswTguFPSpJ5Qo68A1nyuoIwDjPNWkYOi8Z9qe4NWIXcsxJ4zxSrIQ3t3pZlAUlTkA81DbDzJSp69qLBfQluJN0ZyRz0FUs456fStC6iUKpI6VRkA2kg8HrTJuilPMSSM596aj5xg9PWmzqAxB/DFNiwoxzkUrDuSSyEcCoGmyepp1wCRnkcVReQgn0qiCd5c55NIkvze4qmZcUCQg+hpomRrwSkY29c5Hrmu3aR7m2uft2gao01yUabyRhXKjg88jPevNoJ9rruJIzzj0ruNRTUdSvTe6TqkP2EhTE32oR+SoA4ZSc5H61pcysY/iOS9lvWuL2zltFkASNGQhQqjAAz1wKK0tc1GK4stckN4k1rKYooU3ZLzrjfIq9l680VSFY+gbfOB2q0gyeTVWHGAQT+VToxXnNeSbPVk+d3J+lAyP89aYDk8GpAcH6UgI35GcYx2qKZc81aI7ntUT9wOfrSGmZkqgY64HeoCDnJ6+lXZ1A7ZxVGQHd8vFQbRehNAxDZHArSt2yARxWVESWGRz3q/bN8wGcVSFI1YD0rzL4xeEvOiOs2UO/aMXCqOo/vV6VEcEHHNWmVJEZHCsjLgqehpImFR05XR8Z3UZjdjGMqDnimowJAOV756V6J8VvB0nh7V/tdkpOn3BJUf8APNvSvOZMs45AbtnvWqsekp8yuizuHXkZpwYkEHPTmqsc2wcg46c09ZMg7sHP6VSsHMT8ocqQR3Bp+F8kg5yT8pFQCZeM+vWpUuo8jjHbjmrjYhu5l39gNrOGB9fX6VkTQ+g+YcV0F7cBxjjA4BxWPcrycHmolFdCozaMl15I71Gw9qsyLleRUDDsKlRNHVIjnHBozinHI6ilVNx6UcpPtRoJz2qzbwySsFXH41GqA9Tg1eiZ8oEIQL0PqapQIlWfQ1dJtbS2Znv23YHCeprc1HV5LONLO0jWJnUEMrZYjt9K5TackysznPp3pNxB3A59M1pzWVomLbbuzTurmW5n/wBLKhkG35e/19TVR3HIGcduKiD5xuH5US5SUByVI69+KxZSEJ3MckHtzTZx5Kjcc56FahZlJBGcUOxf5i2fxoSHclBOAadnc2RjHYVWL7j3x2qQSDjI2g/jTSFcsNgLk8jvzT4n28pkZ7VWHzSHptP6VMhAGCR7UxXLAcbcAZNSJhlAJxIefpVbGW96DlSMH6miwyVnZTgnIpquMliajWT5uGzRMQvBHNILlgODyCetSrIpIwMCqMXByfwqWKVUfc3OKtES1LbyDooOKik4GQScc1BJdbpOBgUv2gBCCOarQgYzZGM5zVmNmEYTPtVQPkZ/yKmjcu6Kp5Jql2JO10t9tuATxgfSobmVxLtiGe9EYMdmPmPI54rPN15c2RzmtH2J3Lb7+j5yelT20jIDn73Sqcc+6UEjAHSpZpOBg85yaFoMtSy5yM/U0WrYk5NVDJlTuwc8YpLS52yn2NNbky2Na5fO0n8aoXTKq4zx61LPIXI5471n3jnYBziqM+pA7ktz09ah8w7+lKjbicVXn+Ukjg0mirk8suVPNUJ3yuKa8uO9QOxx/WgkGbnk85oaTpUTHk+tIxxk9aaJZPG+ZFG7AJAz6Zr0C5bSbH+2I10K2kOmGIEyM26VCQCx/PivNkO4hRyzHAFd40iaZqIW88St9vt4hbyL9j81NvXYc/exnvVIhoyfFyRw60/kQxwwvFHJEiDGEZQRn39aKoeILkXWqzTC8e9DgEztH5eeOm3sB0oqrsR9Z24OB0BFWAP0NVoj8nvmrJPGK8o2ZIo64p6nJziolPTFSITg0CH7vYj1zTGp56k8Y/lUUhyT9KQFabH3e+KoS/Kea0JCN3aqUqgE5HFSaxIUJDE96t27Yxn86prkvnP6VagBz9aCnsasLdM9atxuN2OtZsTcA9qtxycZFIyaG65pttrOny2V7GHikHII6e4r5s8c+C7rw1euJEaWwY5ilA7e9fTIY59qo65plvrGny2t4gaJxj3H0pp2NqNTkdnsfHl0HhbI+ZD1I6GmJPkcf/qrufHXg268M3LCNWksnJw+Mha4OWEpy2MZ6rWyOt66ola46YAPqKjaY4IzjvVZm5wc5HQYwaiZiScjP14p2I5i27jAPOMetQPz6GofMC57Z9aC4K8EY9aaQnISRQV56elRSRDdnoKezgngjPpUbM1MV2MdAeccUmwqQSP/AK1S5U49RTQ4J+Y8ZxQIaGOQW5qUyk4wchemaiHzHoCB6mowwDZJOPr0oAuGZnABycGjewUgklB09qp+aMY54pVkUDa27PsetIC5uHy4br2IpjvleSTjgc1AHJUZbinMR/CTtHXiiw7ji5zgYGeKcuwH5wR9Krk4zyR9aA+T13Ae9CQ2x4HzEAnHvTlJHoaar4DE5JpoOD3H1p2JLJfaMBl9elIHJIJAI/Kqu8lvl5qcugiUIvzDrRa4XsWdxVAwP0FIZCRg4qo75zkEY55pdrCNX4INCQmy7C/yHcvI5od92HPJ+tVlkYqBnBNPjz3PHr70CbHZPekeQYwBwKRyApBOcVGGDA59KLCuSxZY5HSi6f5M88VCr7MjPWqskpMmDyKtWE2X7WQEHJOav6YplvAB0HesmNlCDsxrc0geSnmbvmq0luS2bl9cOiBA3bAArPgBdtxOD9KrTXRkck8Y6UtvMysCOB9etCd3cLWNbIiXJP40jvlwT93Gc1SknMjBFGWJFXLoAQ9AParFcnSULyQOeRUIcPNuB5HeqrMPKIz04z6VBESBnNCFI3DcKAOeaz7+fcKpNdjfziq9xNuOOc027kNWLFu5JJzUdzLnOKSE7U57Cqly53EUCBvmwTTHbA9qVW+UD0qCcjHWhIVxTJnrSu4+oqmHO4c8Zp5csCCMYPbuKpbEsmUjeuWwpPJ9B613HiC/sINUeKXQBelFULeSTOGuBtGHO0YOfWuU0XTl1KSQG/s7MRgEG5YruPtXZLPrQAA8Z6dgcAeZ/wDY0EnH6ncRT3bvBaCyjwMQKxYDjrk880U/xC876tMbu+iv5tq5uIjlW44H4dKKoD68h68dRUobjtmq1uST1qzj5civMNmtRxbGPSno+TgZqEkk88mnqeSelILEwOTSM2TTckn8PWlPK4xkipYWIXwR+NVZD2xVlxxgcVXc89se9SXEiCDdnk1YjT8qjQZbqM9asxgbQapDbJY+RkjAqdCc7QKhRfUmpGyBkdTUkkgbBxnj0qQH5fQe1V1Jxg8GnhsYx070mMh1Szt7+0kguYlljYYKsP5V4X4++HEuntJd6QpkgyS0Xda98J4PH51Ru03xsu0MD1zTTtsa05taHx1cwqsjIwYOPUdKoyLgHzOMdK92+IXgSO6dr7TEEcwyWUD7xrxq8tJ7eVo5029mBHSuiMlI1kuxjk4GefbFM34HzEY9D2qeaEKxAOPSqcq4Pc/TmtCL9xd/+yD9DSBsn5ajOCeDjjpTWAHGRRYLku/Ck56Ub+ScZquzYHQ0gf5cg4NFhXJHkJ6dKfcXHmiMbVUou3gdfrVUvn60hYY96LC5iYHkcj8acGAHIyfWq4YDHp6Upbv26UWDmLDSFhjcNqjgEUCQkY3cdxVcNgZ4OaDISAM0WDmLDtg/Keo5pQ4A7Cq24dKNx7HgUWDmLhfaAoAPFMZ2I/xqBT3BP1p5kBbngUWC5Iu485xUxBRAQwOR2qssgGTn6CozL2P86LJCuy0Sx4Y8YpWYJtCkmqgkKsOc49akafzH6CmJvuXPNi24UYPfNJ5mExng1AMR/Mwzn1pjzbvTHahgiYvnr1pyudo6GqgenNJtXFIbHzy7QabaYOSxqrM+8hRTw+1QoNUkRctby8oVeBmtpXYRAEnjrWTYRhQXcZJ/SpnuGYnBPPHNN6AnqWjI2efzq7C+1ckc1mwHOM/jVqUkKAOp/lTSC5bsptt0GY5Fad7OrKFTrWNEdqZNKZzuyc1S2sJlyXcI+/PUUPIEj9wKpXF1kKM896qXE52bQeelO5I8ybn4/wD11PC2CS3WsuF9hzT5bkgfKfyoTEzUkmURn3qhLID3qs05KjJzUTyjjPHtTvcRc83gEnOe1RTycgYx7VB5nTPPNMlfL9eAOKaIZIpy4qY8DioEOWGfSpGI4+tMTL2n2F5fsy2VrNcFPvCNC2364rQHh/V8f8gq8/78N/hWVYXN1bvi0uJoXkIU+W5Xd6ZxXoMlnY2kd6LzxFrbSWLRpdNETtUv3XnkA8UCOEvbaezlaC5ieCZQCUddrAHpxRV/xfALbXZ4UmuJ0CoVluH3NICoIYH0IPHtRQB9bW7fKMVbGfzrNtHJ6dO9Xom6e9eatTeSHsORzk96XGQQfwpRypycCnAdyOlAriqOF9c9aXB7DFKo5OO1I5IBwfSpYEL4xxVV+TU5IIOKik+7xjNSXEYhG4HOfercZAPtVFTg461bjYZH0pgyyCSfQ0rMBxnmmgkdAckUrEjnGfakJAD6c09Tg5FQqevYGnDFAybdzjtVefJ6dalyBUUrbgPzpMaMq8QMGGAeK4PxT4WtdS3OECTeor0K5GRnFYl4mGJzzQnbY6qcj578QeG7nTrhjIh2f3gODXM3NuVQ4UYGeRX0je2kN4jJOikMMZPavP8AxL4IkQtNYDcOuzHWto1X1LnST1ieQyx4OMHkdT2qs8bYLYBA610V/p8sM8kc0ZRx2IrInjcOwxx3FdCkc7i0ZzYPbH0pmM8gn8asSRjfjPPU57VGwAHNUZsiB4Pc0nTAPXNSMvy8UxvlzmnYTdhjn1/lTN3PNKzluOgphGPrSsTzDtwJI5oB5xUZPOBikCg5BbFOwuYm3kLyMYqRGwOmaqH5Tx1x1pBIQ2c4x0p2DmLiuC2H4FIWAJwcr2qoZDu3E0quck5pco+ZlkPj5v0oJAGTxmq+SVyW5z0pC5L/ADH6UcouYsbsgZNSoyKQao+YQ3J4oM2SccCiwcxenuAze3pUfmZNUTJ05NSqcAE/lQ0NSLoftUc8wVMd6rSShRmqvmFnyTxQoicy7Gc/M3enxlnkDA4Aqm0vYGrFsxwCadrCUrmqsuVC8g9zUgY4Hb0qjA/zZPNXBMML7d8ULXcq/YsByqk5z+HWrdqssi7+nHesxHMrhVPJrUjnEUYUj2qkkK4ryFRj0qFrgdsn1pJZF2deoqi0nzYzSa1GmXS2V9+uKjOWJ4qDzwvINOFwNpGetMhizsEU4qqH+Y5qKe4LvgfWojJxnoaAuWHkByfSoyxBqAOeSe9PDY9DSEydXpu4s/SomfbnIoi+ZxntWiIZoR+uck0Ox6YzTFOFwfzprEdvxpolly2/LHINd01zdtrKw6ppduravbolzCZ/L805ysjH+BuBXEWmV2sMEgggHpxXX6mmia1ezajJrBszcYea3mgZnVsAEKRwRxxSYzH8Wz3M+tTi8thZyRBYVt858tFXCjPfjvRTfFF/FqWrPNbK626RpDGZPvsqKAGb3OM0VIz6st259CavQtisy3PIB9avqxwRXmnTIuIxAwRkVIrEdD0FV1JwBT0zkEdBTM7FlH47Y9aSTG2mI3PBIpXAwfWpbuLqVXPOe3emMdv41JJnBz1qvIcepqTRIRCS3HSrMIxx6dzVRTxVyEZwSATTHIsL92pAvY0xOo9qcQe1BFxoGGP60wZB6A809zjjoajY4GcDNBSHM2OMUjHKjPemb+h6ZpHbHOc56VJViKZcjkVj36cE+prZkIIGTjFZ16u4H880GkHYwJBg+wqSFgSNwB+tOmUDr1qFWwTjtTR1XuVta8LafrEB8yJEk9R3ry/xH8O7qxZ5LT94i87T/jXstvJgYzjPappGVxh8HIxg1ak1sQ9dGfKeo6fKkjCWJkbPQisyW3YcqDivpzWPDtjqCNviQEjg4rz3WPh9PH5jWuNp5xjpW0avRkSo9UePOCo561DwCc811eteH7yz4lgYAHqBWDPblRx/Kt07nPKDW5muASABioz1weatyRBT0zULKMHHHaqTM2iFgOvSmNgLyTin7cHk801iMYpkXISQx75HSlyMe1DcdPxoUheT3piGYweScUFvl/lQ7fl6VGxJODRYLjtxxSiQAEd6jYjABozxkcCnYVxxc4poYk9fpTCecDp70dDzRYLkw4PJ6U5n461CNuM88VGST06U7DuOdi3elBIXg00cDpmjPv8AhRoIkiGWyauQ9AB0NUlyDVkMOOcVLQ0y7FjcfmAqV5FYYQjms4ynAA5NOU7fmLc4pFXNW0bywG9epNTtdDHBwB196yvtHygHvUDTFjyaewXNJ7ktkAmkyccHBqkkuOetOecFcClYLj2kySM8CkaUbeDVUvim7iSaBXJgSTnBNBbPBpAcDjrTDjOe1MRIG5qYP8vtVZepp7OMelMVyQvk8flU0A5yaqp81XEGE5qhE5PAPHSiMAtyKiJ6gf8A6qfbEl+54600Sbun3U1vazwRuqw3G3zBtBzg5HPUc+leiXEur200UNx4q0eKVlUhHt8EZHGfl4/GvNrU7AGXAK4IzXcT2Vj4gaXV5bTXIzKA08dvbebG7YwSr9gcUMZleL9H1BZru+u7+0vpYGSO58hSjRZGFJXA4PqKKZquvWtxDq7JbzR3d6I7ZI2+7DBHjGT1LnFFSM+lYyAcdT7Vei6A96z0BHPYVdt2wAec15kTqlqX0BI96fj0H1qOFsgc5qyvPHAqrGQiqeuAD2pGODg07setRO/BzjA71DBEMjnLDvmqzk54PWnyt3quTluOpqTZIehwxA6VdhOMVnrkGrUbsRwOneqTJaLytjkfSns3qcmqyuT07U/OCfWixNhW681GzfMPSnHqCeeaaO+McHvUstCA44GMUuCTwQPTikAx1xSngAGpGQy5HIxjoarXIBU1eIBBB49zVeRPlOf0osWmYdygHUVmscDjrW3exEbsdB0rIuF55GD607G8XcWJs9+gqYy5AI61SRse1SbsY9MVRTRMzZyR1FXrXa2NwByORWcpyBmrdt0HOMUCloizd6FY6hEVkiQE9OK4DxP8MLaffJbAISM5WvS4Gxjmp3IYfNjFWm47GPNfc+VvEHgm+05mIQug71yM9m8bsHUgj1r6z1/T0ukb5QePSvHfF3hcB3kiQD14raFW+45UU1eJ5FJEScdAOtV3jw/Nb19ZGKRhjDDqDWXLCw+tbqRyygZ5B6Y4zTWXI4/WrMiEdh0qLZ7GrTM2rELg5z3qPB/KppBgnkVFTRIwgelNIB6CnkHrTcUxIQjik9DTs4GKYc4p2C4HJPtSHA4HU07t9aY3JpBcM570oP60cdhTT1HfFAEo+vFODH1496h3/wB3pUgIxkigZIW49aQzNn2xUQ6kDpQDk0ATBsj0oBCmmFgOKTJwOaAJN/rSg5J9aiXg07PHpSsA5m9+/wCVPi45B4qIc9vrUyAAZApgPBwOuaaCT9KaaXPFIkevfNBOT/nmmrzUqrnjvTAfAuD0q1zjIqKPgcU7cSOTxTAGOSMVatV5xVdQMfyq/bLjHTPegDQgwu3eCVyMgdxXc67Za/qOqi70OaSTTiF+yPBOFjhQAYBGRtI75rhl47U2VmEbBSw45Ck0MZq+N54p/EU7wSRysEjWaWP7skoUB2Hrk96Ki8X28NrrKxW0SRRfZbd9iDAyYwSfxNFID6nIAwCDycCnxOBwOpNLIODkVEvy9OBjArzNjstdGjE5wCMgZ5q1FIWHI6H86zoztAK+nSrat0NUjNqxZLcYwcetQu3J7jpS5yCentUZP4A1LEiCY8jBGPWq4wGx71NKASRUWOcZqTXoToADUo4JP6VFEMjI5x1qwuce5polkkZ+XgdKkXkdOajTg855qdF5psnYaAc0oU7een0qZYwQc0FRjFSK5AV+XGaR1PGelTMvIwKRhzz1xmiw7kRXcMdqY8fp1qyqcc0MnqMdqLDuZNxH8pGOKwrpTuHHTtXT3KYDYyT2NYGoLhjkHpQa02Y0gx70ivnAzxSz5FVw2CRmg6kWVOcDtmtC2IzzzjisuOTuO1Xrd+DQTJGxFIAoPrUjSDA549KoxOOn6UrSYY9qpmKQTvwxJ6dKwtUskuY2+UZ9xWjM/YnrzVRpCW68Ujog7HlXirw0WLPGgBrzq/snglKuhGK+kbq0juF+YZPeuI8SeG0mVjswa3pzM6kVLVHiU8XJ4yBVZoeldTrOiy2kjZXK1hTIVPIxXQmckomRLGRmq+0gdP1rTlQde4qsy8dKpMxcSoW60wirDDBx61G6+vUVaMyFc5wRSE5z7U5sgnHWmFeDzTAbn0oxTsZJppGD7UAIcDiggYyOKXpz1NLjHH40AN6dqD0zk89BQfpS9uOSKBobkcZzkUobrmk9/WgDn0oAcuSAR+NKfUHik4wOADQSAOKQxwOCPXrRnIzTQPXpT1GexxQA5Rj61KGFRdOefxoJOPSgkkZu2OKQE5B7UwZJA5xUirn6UwHouWznk1aTp0qKMAfWpRwDQA7djOB060it831qPJ60sa85x+tMVy5ECf6GtK3XC89e1UoFLYI6VowgKpwcc0hmtpOsX2jtK2nzLGZcBsxh846davSeNtfBwLuPH/XBP8Kq6HY2k8N9e6m8ws7NFZkhPzyMxwqgnp9aNT0q1uNLl1TQZJngh/4+baYgy2/o3H3kPr2ouBk6nf3OqXj3d9IJLhwFZwoGQBgcD2oq14psYNN1g21oG8ryIZMM2TlkDH9TRSGfWU55Y8A1XUkEHHzdqsSj1FVyvOM9eh9PavKO1bE8ZwRj8quJggY6jrVFAO2AauwHKAnr3qkRImBwB3pCuec08Lk5p+OpOMdqHqRcrSDjpg1XkGOtXJR2qrMO5qSojYm5IOauRnkc9qzx8r4/WrVu24jrTGy9GNzD36VYUbQSw59Krx8DpxVmPtngVRkx6DjilZaei46dacF/Wk0TcrEEc0mD36VOUyKaUwBUloaoJBI59qRlGBgc9alXgZHWmY4PrQIqXALAgVh6jH1IroJRlDj86x79Ovp6U0jam9TlrxSCc+tZ7kDr1rUvhliOlZMmVb1Pakd0NSWNsdRV+B8AYx71mo3GM1cgPbigczSU8ZGOeetDvgH1qFG4AP6UjkHP+NWzBIinYkkE8VUlbmppvXAz3qjK/U5xUGyLCSheO9OlCyKQRwfWs8y++R1pftBxnPFVElowde0uORXOBivM9d0cxMxVceteuX0hKHp0rkNaQMD0z9K3UrEyipHlE9uykg9qpyRHntiur1C2G9sL+NYtzBgk446VopHLOFjFlQgk8cVXfPHGfetSWIdlqrJERWsWYSiUivemMtWGUjqM4qNk71dzOxEaQ8VIQKYQcHPSmJjBRkgUuD37UdxTAbj5valPHSlwPxpGGRk4pCExSMOAetHfrxTwBQNIaM4Bx9aXnOAKU4zSZ44osO4o47Uo7n0pP1oP4kUWE9Q3dKePm681GBnipQMdKLAOVcABR171KAMDIpidT6Uu7aKAJQ3XFKW4GPyqDP5U9T+dBJKMHqMVYtx04znpmoI+o4GKu24x9KYy5bpjnFXEI29OarwD+VT7sCkUaGkapLpssxW3juredPLnt5VLJIucjOOhB6GqthqN5pl+LqxVkflWUxlkZT1Rgeq+1W/DviC48P6gLiJj5D4WeIHG9P6EdjU114w1wTy/Z9Wvvsu4+W0qgNtzxnjGcUhFDxBqbavqjXsluls7IkflJnChVxxmiqt/fXOo3TXV9M887ABpG6kAYFFOwz7CmGR1NVXzjnpV6RSTkc4qnIDnpya8pnbFjouuR3/Kr0HTBx+FUIwQx/zir8J6Y/CqRMi2AeOlOY8jIHSmKSQM9TThx1A/OqsZkco9Rj3qtNwT/WrknTI6471UkG4A5x+GahopFU8Nk9Knt8nGTUDL8xxU0JAIPOaVhvY0oR8wycHvVteOTz9apxdAT+FW4zjoc9q0sZMsKe/apVHHPPpUMfp61OOegOKLGbGFfzppTJweMVZ257Hmo2TgjHJNTYEyuV9KVhwKmKDjsO4pjoTk9hStqVzFWVccD1rLvEJHtWy6FlIHSs+6jIDe/enY0gzlNQj+me4rAuFIziuo1KEZJ5APFc7dqQ1S11PQpSKkbfNg8CrkJHGOtUM/Nk9KsQvjvz3oRpI04jxnPJoYcYHXNV0c5GD+NSFs5HO2rMHuRT9+elZk5xnLfnV+Y9etZN4Rk5qGaQImkx0xjoRUZnHPOB0qnNIcnJ6VXabnO7JNOJo4li5n+U8k+9c9qcgYEGrs8+QRk+maxr2QkHpxWpNjEvFyfbrWTcx5zxWvdEY9azpVyaaMJox5o8fSqssQ9q0514zz71TkHPP4VrGRg4me8QycVXdMnNaTL61BIgzVpmMoGeyE5x1FMZO/bvVwx7c1G6ZBx1rRMyaKZX2oK8VMQMf0pjDP9adySM57nikIB61IwGMg8dKjPFMBvSk7H3p2OtNPTg0wDPY8Ud/ekAJNFIQuSaOn+FBPGKBz2P40wHrjOakAFQqDjvUufSkA7IAxSZ4x+dNB6ntT0ye1ACJySO3WplHPUYpEXnA59amUDODxQKw+JcjOOa0bdCBz09qrwR8elaMSjA9aZRIowBikY+lL0qNzjrSGdD4PjZ/7TksoIbnV4oQbSKVQwzu+dlU8FgOgq3FqnjeSbyxb3sr5/wBVJZgqfYgrjFYWgWNvdfbL2/uZ7aysUWR2gGZWZjhVX0JPetPVvtcujtqOi61qF3piHZPDPIRLbk9NwBwVP94UhFHxjFb2/iK4jtEijwiNLHEcpHKVBdV9g2aKh8T6dDpOrG1tmdo/IilzIcnLoGP6mimM+wZgAOAfwqsV4Bq3KT0xmoH4IArzGjpiRKAeB0NWoh0AqBRlsVYiHTAyKcdByLKAAjvT8YJ5/MUijkEHPuKkALGqMrkZ5UkckVXlyRwB+FXCvJ9qgm6n2/WpLTM6XG3qRSwkZ9u3NLKPmPpSRjaw7iixfQ0oSCBzkdquxjGcY4qhAcEdhV+PnIU1SMJEyE4AIzzVhAB1FQxnjOM45qdCM7jQQydSP8MUhHIxSqMCl25JzziixBCVIOAM0m3+9U5T0Xj2pCO47VNhplR0J3Y5qlcrzitR1yCcY7VTmUbTx7UGkWc1qMXB71zN/GPTvXaXqLg8dK5e/j6tyMZHSk0d1GRzc67GPcU1X6dOtS3ikMaoh9rnHWoOy10ascvAqdWzgkgVlRS4xk8/WrKSgnI4OOa0iYyiWJeVJrJvu+Pwq+zlh8pyKz7zuRk+wp2CBh3bbWYjt+tZ0sxHetC8GOorAvG2tnkGpSOi90LNOTnris26lzx+tPmmqjcSZzzWhm3YgnbuKqPzmnSPg1AX5B4FMwkyCUA8dR7VTlADdOKuucrxiqsvcYq0YsqYzTGABqRwQeKjPvWiIkRsMj0qCRcA1YJ49KiaqMmiq6+wzUOM9c1bfk8VA/WqRm4kJHB6Y9KaQfwqXHtnJqM5z0qyGrEZGO+KY3XINSv0qIcUAHWkPU+tFKOmcc0CGjsPU07oevFAB7ClGQfemA9cYwKUdB2poy2c8GnD+fWkAq8nHWpR1GKYM5yKkVc/zoAkVe3tViND3qJBkjuKtRjp/hQOxNbIcZ4zV5MAGoIx8vtTy3OKBj2aq8rk4pZJOOarsQSaANXRNV/sx7iOW2jvLO6j8ue3kJAcA5BBHIIPem6Nqs+k3xubTbtYFHhkG5JIz1Rh3FL4f0+K9knluvNNrAFDJFjzJnY7UjUnoWPfsAa1oorWa+vbGbQrNBZqWlNpdMZwq/eKEkiQqOSMdqBGb4i1RdY1VrxLcW4aOOMRBtwXauODRVXVrP8As/UJbbzRLGArxSqMCRGAKt7ZB6UUWA+034P1FVpCc4qzJ2+lV5PuivNOmI3PQip4ieB61WT7oqzF1FERsvRrng+tTgAZ96ig7H2qY9qsxYm2q9xGQCScirg7VBc9DSYovUyphg+3rUK/KwxyPrU833yO1QMMOMUjpWxdtzggn8q0I2+Xvis6Ht+FXojgimjGW5bQgHFTg8dsVTH3RVlabIZajbd9amAzUEJ5qwv9aEZjgAabtHPanp0pp/ioEROuQQc4qpOM56Cr0v3Qe9VLmpZcTJu0O1ueDXN6lF1J4NdTcgbawNRHytQddKRx2oJ19axJTtbrXR6l1Nc3e8OB7VEj0oaoVW+7g8jnirCzZPPJFUFqQdqaCSLpkB+tQTPkECmEnb1qNieeasyM2+HX0rnr0Yzmuhvulc9f/eNOxonoY0zkE1SlkJ+gq3c/erOn6NQZTZWmcjrVcyDuelPl71TY8imZN3LaNkYBprng96r7iOhqVSSuT1rVIzZBKBioHGTz0qxL0qBqCWQtn8Kif6/Spn6VGfvGrRkyE/rULd6nb71RP1FWiGQuce3aoz8w46GpsZJzUY+6PxpozZGVppUVKOv4Uh6iqERbcdeTS7fSn9zTR1oATbwcUYz3wKcOSPrRQAgAGeetPUfjTe4qVepoAVR2qVR2pq9DUsf3vwoAkjHbpVuIHIz0qspPSrSdaBk27Az7Uwtg/SkJOKhk6/gKAFd+uMe9MByOajY/P+NO7igR0PhO9ELzWrTRW8ryRXNtLMcRiaMkqrHsGBIz2rbg0s2l7LeW2k31lOyvia9mQWttuBBfeOXABOB3964QdD9aBygBJKg8AngfhQBqa9dwXWo/6GWNrBElvCzDl1RcbiPfk/jRWb/EKKAR/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24721=[""].join("\n");
var outline_f24_9_24721=null;
var title_f24_9_24722="Repair of cardiac injury";
var content_f24_9_24722=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F86034&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F86034&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 553px\">",
"   <div class=\"ttl\">",
"    Repair of cardiac injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 533px; height: 445px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During resuscitative thoracotomy, temporizing maneuvers to control bleeding from cardiac injuries may&nbsp;include direct digital pressure on the wound while the patient is transported to the operating room, stapling the cardiac wound closed using a skin stapler with care to avoid the epicardial vessels, or suture closure of the cardiac injury.",
"    <br>",
"     Venous and atrial wounds can be repaired in a simple, running fashion using 3-0 or 4-0 sutures as depicited (A).",
"     <br>",
"      Appropriately trained individuals may choose to suture repair isolated&nbsp;ventricular cardiac injuries, usually using double-armed polypropylene (eg, Prolene) suture, preferably on a cardiovascular (CV) needle. Digital compression over the cardiac injury should be maintained while placing pledgeted horizontal mattress sutures with care to avoid injury to the epicardial vessels. As the finger is carefully withdrawn, an assistant gently pulls up on the suture, crossing the ends. Additional sutures can be placed, as needed, prior to tying the sutures.",
"      <br>",
"       <br>",
"        <br>",
"         <div class=\"footnotes\">",
"         </div>",
"         <div class=\"reference\">",
"         </div>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24722=[""].join("\n");
var outline_f24_9_24722=null;
var title_f24_9_24723="Clamping broad ligament";
var content_f24_9_24723=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Clamping of the remaining portion of the broad ligament during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 332px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFMAc0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoqrqWoWum26z30ywxNLFAGIPLyOsaLx6syj8atUAFFFFABRRRQBALy1MUkguYTHGpZ28wYQDuT2FSQTR3EEc1vIksMih0kRgyspGQQR1BHevlX4ceFtcsbaAroGorO+ialbXol0uS1MJYO0XznH2h2OABg7QQO3HReJJ/GuneHPD9voVl4jtLmx0Cw8tbeCaSOSYKA6NGq4Vh0IkznAAUdSDsfQtzdW9qIjdTxQiWRYo/McLvc9FGepPYUS3VvDcQQSzxJPOSIo2cBpMDJ2jqcDk4rw7xTbeIdR8cQLqFt4gna28UWUtrHDbu1glipU+ZuA27wS24k5H0qrYW/iy88aaBe3lrrsuu2s+qmZrq3cWFuTBItuImxs2H5BnPJPNAj6Bor50s7r4hp4d1VxceJDqbWkG+GSxlLR3H2qIO0TldpBRpPlTK7RnjFeveKLTXdL+Hep2/hy8u9Q12OF2t7i6KNM7FsnoqrkAkKMAcAUAdPc3VvamIXM8UJmkEUfmOF3ueijPUnB4HpU1fP+n2via/m0MXo129trfxHYXKre2UyvbL5U4lJd1BZQdmT91SeDzV/wsvjq98Vy2+tX2tWUs5vILgfZZGtlUq/kyRSY8tdpCYwcnoR3oA9xorwuw1Dx7c+DdZv9WstbS7h+yabFbQbo5SUK+fdKFUswYn+AZIzjHUY9pY+Kb7/hH73Xf+Eoli03X7mJZY7SQTrbNAuyTYylyNxZdxzgEgmgD6MqH7Vb/bBaefF9qMfmiHeN+zON23rjPGa8TS4+IC+N79ml1RJlu7lbeA2skllNAVbycOB5agfKckhs5yDU3wptdXl+IdlqWqweImmPh1oby41W3dFW6M8bPHGSoG3qQBxgfWgD2aK6t5rieCKeJ54CBLGrgtHkZG4dRkcjNTV4T4ltvEVt8RvFk+gQa/FqF3e6abGSC3f7FMqxRrKZpNu0qF3Dk9ffNbfhq+8S3Pxd1Hw9c38z6To80t+824HzY50TyIG9NpMh9wo/EA9booooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOQ8T/2leeM9E0mx1q+0m1msL26mazjgZ5HjktVQEyxuAAJn6AdueKl/wCEX1b/AKHrxJ/340//AORadqI/4udoBxz/AGPqPOf+m1jXUUAcr/wi+r/9D14k/wC/Gn//ACLS/wDCMattI/4TnxHn18jT8/8ApLXU0UAcqfC+rknHjrxIPYQaf/8AItKPDGrZ/wCR58Rn/thp/wD8i11NFAHNR+HdVRcHxnrzn1eCx/pbCg+HdWwQvjLXMnuYLI4/8l66WigDnl0HVAD/AMVZq7E/3oLTj8oRSjRNU5z4p1Q/9sLX/wCNV0FFAGAdF1THHijU/wDvxa//ABqo20PWSPl8WaiDjva2x5/7910dFAWOc/sPWNq58V6jnufsttz/AOQ6qX9trOkvYXLeI7i6ja8hhkgntIQsiu4QjKKpUjJIOewrrqwPGLEWumAd9TtR0z/y1FILG/RRRTAKKKKACs/XtXtdD0/7bqDFLbzoYWcYwpllWNSSSMKC4JPYZNaFcj8TrJdT8PWunvP5CXOo2iMcZ3ATKxX8duOh60AddRRRQBx3xgtftfwx8RovEsdo1xC2CSssZEkbADkkMqkDuR3rX8QeJLDQPDL67qRlSwRY2Yom5h5jKq8D3YUnji3a78F6/bxnbJLp9winGcExsAfzrEsNOtPH/wAJtGt9QMsFtqNhZ3L/AGZgGQgRygAkEfeUDp0zQBBrPxU8P6OIft0WqRyPCbiSJ7No5IIg5TfIj4YAlSQMFiOcYqufirpsGpeKIr7T72HT9DWFzeohdZVkVSDjA253Dbydw54rW8U+ANM8Q61Hq0lze2WoLB9meW1MZ8yMEkBlkRxwScEAH3rGl8B6D4mbxN5Go6wlvqHl6ffLGyiOSS3CKHQshyy7dhIJXcHGMjgA0Ne+Jmj6FY297qNlrENrNuO+WzMRUK23JWQq3uAATjnFWp/H2ljVJbGxtNV1J4REZ5LG0aVIfMAZAx65IIPAOM84qDxt8OdK8Xakb69u9RtZ2smsJPsrxgPCWLYIdGwck8rg9jkcVNa+A7Kx1hdQ03U9XsSxgNzBBOoiujCAqmQFSeQoB2ldw60AY/h74rWOqeGtJ1KfSdTivdSaRbewgiMzy+WMuyNhQygYyeOeOTWtb/EbQbu60q3sPt15JqVqt5b/AGa0kl/dGQR7mwPkw3UnAGOtUbP4W6XZabp1pZatrVu2myyvYXCTx+bapKMPEpKYKH/aBPvwK1fD3gXSPD+qWF7pf2iM2WmnS4oi4KeUZBIWPGS5Ydc45PFAB4h8WQaH4gNreSItrFpdxqUqiJmk2REZIOcdM8YyaPCvjrSvEupy2FlDqFvcpbJeIt5bND50DnAkTPVc8dqk8SeDNO8QajNeXs12ksumXGlMImUARTfeYZU/MMcHp7Gn6R4QsNL1u11S3mumuLfSotIVXZSphjYsGICg78nk5x7UAV28eaIuqHTmecXo1H+zDCY/mEmzzN//AFz287qybL4u+FLr7UwuLqKCG2ku1mkgIWeJDhmTGSeSOCAcc9K2G8C6O3jxvFrCdtSa38gxFgYSdu3zNuM79ny5zjHbvWTpfwt0nSoZ4NP1LVoLR4nijhWSLEKv12t5e8+wdmHtQA6y+Ilpqd5oi2Uc1tBf3Lw5vID+8AiMmUZWKjgc5z+FSxfE3Q5NMuNTNvqiaVGheK9a0YRXP7xYwsR6lizAAEDPJ6Amq+h/CjQNHv7W9glvZLmC6a7LOYlWVzGY8MiIqgYJ+6ASeSTUkXww0pNIm0htT1qTSDHst7J7lfLtD5iyK0Z27tysowWLYGR0JFAFy0+IeiTyW8UwvLO4lvv7OeK5h2NDOU3qr84G5eQckGqGo/FXQLDQ7DWJYNSOm3qNJHOIAAFDFckMwJ6ZwMnHOKlvfhjo194d1LSr261KeXULpLyfUGlX7SZVxtYMF2jAXAAXGCfrUXiD4VaFrK2qm51GyS300aSFtXjAa3HRTvRsEeq4J75HFAFnUfiZoFjfzW2L64jgMCzXMFuWhiabHlozcckMDwOM8+lVo/iRY28s8F5Hc3l02p3lhbQafZvI7G3wWUrk5YA9RgfQVz3iL4W6le+IGGlXsdpok8tnLdBrlmaUwBQG8rysb8KBkSAdyua6/T/h9pVjrttq0NxfG4t9RvNTVWdChluV2yAjbnaB0GcjuTQBTvvipoFp4c07XTFqEmm3qSOsiQgeXsbawbcw+YEEYGTwcVP4M1y11Xxr4qgsbKyigjhsLlbuGLZLdCaJmBkPfAUAZ6A1lz/B3QZNOtLRL/V4Vt7W5s96SRFpIp5GkcHdGQOWOCoBxwSa6fwv4RsPDl/e3djNdSSXdva2ziZlIC28ZRCMKOSDz79MUAZSfE3QpbzV4YY7+WLS1uGubhIMxr5KkyDru/hIBIAJ6HmpLP4j6Pdx3pittTEttaR3ywvbFXngc4WSME8rngk4x9OayNf+FFheya1qVvd3U+s3dleW9s10yCOJp42T5mSMOyjdgbi+B0GaWy+E2nTeH3tNcv8AUby/nsra0kuPOU+QsJDhIfkA2BxnDKc96ALtj8VPD1/YRT2SX9xcy3bWUdjFBvneVV3sAAdpAU53bse9JqvxW8O6VcRw341CCQJHJch7YqbMO2F80E5B4PAzxz0ptp8K9JtAZbfU9XTUReNfR36yxLNFI0YjYLiPZtZRgqVIp198L9Lu70Xranq6XrwpBc3HmRO90FzgvvjYBucZXbgcDFAHfUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5Z8WNTj0nxj4YuJNcu9GDWV7EJLRLdpJd09ku3M6sgAzuP8R24GTwc7TfEaapOo0P4pX0t2ORZXen2dw/DAYaOGNJDnII2kZU5B4JHQ/EkWieIdGuNRZfIt7SaZFMwi3zpe2DwgueAvmKu4noDWB/bGk6pvsvE99od87wi5FpeWkZ+1XDjyonaLYzR8Q7tpy480K33BuVwN221rxvb6xc2kh8HazsjWVbeK4n066CscKxicSjnawGWGSOvBqxceKPGsKyM3gJQiAnf/AGujD/vlI2c/QKT7V5vpuh6zdX62mh2niNIYLaILBfWgXTv+Wh2+XdghBteCNvIUEbJdq8jPo2g6D4osNLKC5s7K6hwFgguHltJsDduXzFLw7jlGXLgD5h81MDN1rX/ibGsNxZ6D4dtbR/K3GW5lnaMN1LZEONvfIGPeqCXnjLV5Ldx4hfed0d3YaLa2xKPgjbvdpFjHDMWMxbgAKCcBNUtLq41zTYdRT7ZftsuYZL64SKOSQFgiR7WQvIqF3OwlELk4J2bfRPD/AIX0vRZTdQafpy6kytE13BZpDIYy2RGWHzFRgdSc4BPNIDkpfhxFLpl0dUvda1OfzDJDBeX73ca9QPkYoCCCMgkdOCOc8+vgR4QYB4I0G72sSbibQbMNIM54b7XkenK/WvaqydZ1OTTmtQ5tI0nukhDyzKp2YyxAYrluGGASQMNg4K0wPIofB2qWfmXlx4W0LTIkDCNdJtZYpoj0WQNbSbzndyBkgA4x3l0m+1jT5Ps82qanpd2jqJYU1EanEpx1kF2vmRqeSAJRkcgnBC96/jVrOWZ9W0q7trESiCOYRSl2csBgxlBng5yhcEA454rM1/U/DOrRtNc6k8V1JiJbaSUTIsgIMbeUwdFbJVg6gNjoTg4QEOk+KvFL6k1nK/hO+eRVkgjmnuNKuShOC3kOk29d3AZW2nsa2LrXPFdq2J9J8KxEttAl8QyqT0x1tOvI4965XQdHh1B9QhuNXsY9ImeTzTZ6iJUknV8s6o3yhw4LNlQoORtbhlsj4dlnD6N4wu71ljZHt9Sfz4WVsAlvs7QuzHby0jPnLEgsc0AWB4m8QRzyNq/iXwLpUQO5I41lvGK9SC5liwcdDtOfTjFZK+ORruu+HrHSvEWi65by38TXK2Vs0LwrhmV9xmYH5kClNpPzZyuKNK0WbwpeQS2umeCjeQ5SR7K5SykwWy5SJoWAdwEDbpPuoACDzVcSyx+KfD9lrWj3mlSJf27WMRtv9HZws6lEkiZ4gscIVUQmM8yPsJYbQD2miiimAUUUUAFcl8RLqK2i8PCeMSCbWrSJQQThixwfbGK62uE+J6rJqfgOJhuY+IomUD/Zt52z+lAHd0UUUAFct8Lo44Ph9oUECkRQ24hUY7KSv9K6muF+DMrr8N7L7XJzBPeRlmP3VS6lVQT7KAPwoA3fFd/cw29vp2lSiPVtRfyYH2hjCo5knKkEEIvIyMFyin7wrR0jTrbSNMtrCxQpb26BEBJZj6lieSxOSSeSSSeTWP4VV9Tml8R3JlxeoFsYXGPIteqnGT80hxIx4ODGpGY810lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5j8U7ZrnxZoRNtZ3EEWmahJML6eRbdFEloN0saD98oJztYhB94kbQazbCXWNTtbSGG/wBVSBH2yRaZapY2kafwhDElwxOByBKAMjO3gDa+Ia27eO/DAnSdpzYX625trNbmdZDJaYMYYMiH1dxtAzkjOatHU5rOUWMmrR6CEKkyazcRXE93/DuQCbEY+U9RyW4C4IKA4bT7LXNTSa80i08TParczwRA39wxjeGZ4mD+Zqqb/mQ/wDj9O18IT+IdKv8ATrXWpby4sL4yW6i8jUz29wqeYDvRmBiZFk+8zsrKBvbdha3hCK7j0G5v9P8AE2NFXUNQkfOnoZXf7XN5m1g7Agybtvy8jbxnis+XUGufFmjXEUWrytb6lHHLqOpIqLEkkUi+VAgCoSW2qxXLjdzkBaYHoeiQh7m+1ErbBrqTaDBIJA6ISqsW2g5I6rkheg53FtasfwZBHa+ENDggTy4orGBFT+6BGoxWxQAVzviXSL69TNhc20MSjJikjlwTh858qRCwO4fKcjjPWuiooA8ie0h0+8UWtre6dbSLw1slxAsTjhSC1unBY5KvMBgk89ao+VcXlnAILmxuZGnkS5YRNGI853bWhLxo+ckNNJJ95s9SDe8aW+n+HNYnbTSthJcESv5V7Hbq7k8L5f2u3PHLHOd26l1NPtE0JvIbi9tbqEtDKbdriIHOARKsc2wYGctcJz/d6hAQ+HNF0FtO1rxB4osY7rS7GLaFuRDeoEiyZHLxlhKcqCSVBBHOSuaraHpN9dXK3+o6HpVtFcyMw0trcRQbCDiEFQDM6opZj5UwZm/dsqitnxAZovhdHLa2a3l7eajZxNtdSXLXkajzHM0u4dv9Y3UD5RnGj4d1LUPEursl5qDtYbBPH/ZKutuVZRhXucbWYZ6RSHnk4HBAOZtLSPW5LlPDPhjw7Ha211LYzRv4cSQRyIFzlnuITjLH+DJHpUsmjto3iDw3jRTpO7UY4GOnr9ns5xtkYZhSdkBA4+ZM7uQ3arPhLwx4ZvbLxPe3q6peRw69fSSCV5gUkWQbgiRyNuAK8NgMRjgdKsa34ti1vWfCdmdJ1exkbV4nR7uAJG2IZWwGyc8A9O9AHqNFFFMAooooAK5Hxhbi58WeCA5GyLUJptu7BLC0mAx69TxXXVx2u6jbT+PfDdjFvkntppmmcL+7iZrd9sZb/noVO7aMkKMnAK7gDsaKKKACvKvC9hcvYy+DiiG3bUb261B45OEs3uZGjiHHJl5QjA+VZeh259G1zVING0m51C6WR4oFz5cS7pJWJwqIv8TsxCqvckDvXMfCv/kH6z9pFumrPqk8t/FFMJDHKcYU4AOFQIq5AJRVPfNLqB21HfFFIUUuHKjeAQGxyAcZH6D8qYC1k6r4h07StX0nTb+ZornVHeO1yhKuyjJUt0BweM9e1a1cj8T/AAvdeKfDsUWkzw22s2V1Fe2E82dkcqN3wCcEFh09KAL9t4w0KcXzHUreCOyu2sZZLhxEnnKAWRWbAYjI6Vo3Or6baeR9q1Czh89d0XmTqvmD1XJ5H0ry/UfhnrH/AAiPhzSbK60+d7Yzyap57NH9pllGWdZQjMAHJ4wu4YBIxXBeKPA2v6HpY0iHTV1u+u9Eh0/zIraeVbZlkb/VS7Nig9SHKY4PNAH0PBrlnJc3sUrfZxayrCZJmVUkZl3Dac8/jilk1/R4rKO8l1bT0tJGKpO1ygRiOoDZwTXm9/8ADPUr68umuH02W1uNdsNSeKUswaCGMJIjDZgk4OB0I6kVRvvhbraw3ltpsmjJp0+s3d79k3NEBBLHGqAOsZKFSjEouAQR83FAHqMPiKxm8Uf2DEXe8+wLqIdQDG0TOUGGzycj06VsV5p8OfAeq+GtZ0u71C4s5Y7Xw/HpLiF3YmVZ3kyMqPl2sBnrntXpdABRRWT4t12Dwz4b1DWbuKWWCziMrpFjcw9s8UAa1FcNovxL0e8TU/7VhuNFl09IJJkvChykwzGVMbMGJ9Bzk4xWpJ468NR6Xb6i2rQG2uJGhi2qzOzr95fLA3ZHcY470AdLRXGad8S/DF/rt5pcN8Fe2tlu2uJAFhaMqXJDE8YUZOQOverUHxA8Kz2E96mt2q21vJHFK8mY/LaT7mQwBAbBwehx1oA6miuUtvHWizSajMb6yXS7O2iujeC4BBVyQMrjgZGByck8VKfHvhZdMTUJNbtIrNpjb+ZKxj2yBdxRgwBU45wcUAdNRWVqHiLSNO0u11G+v4YLG6ZFgmc4Vy4yuPqKzX8e+GE0iLU21eD7JLK0CEKxcyL95fLA3ZHUjHA5NAHT0VzT+OvDImtYE1uxa4u40ltovN5mV87Svrkg/TFZel/EvRLrU9F0y4fyr7VLX7VEY3EsIG7aF38EknOPlxweRQB3NFcxa+PfC11Deywa1avHZx+dM2SAI87d4yPmXPG5cjNFn4+8LXllqF5ba5ZvbaeVFy+4gJu+71HO7tjOT0zQB09Fcu3j/wAMLpa6h/aqNatK8O5IpGZXQAsrKF3KQCCcgdR60umeMLPU/FsejWCrcQS6Umqx3scgKOjSlAoGPbOc+2KAOnooooAKKKKACiiigAooooA4rxZp6at450axne4SCXSL8uYJCjNtuLFtufQ4II6EEg8E1Jp/h7w/DbiC8iaJ5lEYtLqdEAQcKoijYRqP90c9+ah8XX9vZeNtIF3HdyxS6NqS+VaRSSSv+9sxhRGNwPJ54x1yOtZmm2egsqW0Hh7wPCXZsW/2qJ5CM5BYCIgtzkjJ57nrSAZ4f8E+GI7ZLyyjuJZYtQ1Fft9nI9p5AN1KZI3XeAyIQY+QwOzcAAa5jxfBaaHaWC2N42px6G9pqLTGR7yZY4pk81sliLdSilT5aYwfmKqSDueGtEtdD8NTxnRbySI6leM7eGr5hHGDdSEJtR4mPl58sqEONhGCKl11dMvYotO/4R2+1TSZkaS5u9fnuYYLUHKl2FwOSA3AXDdMYxkAHbeCiqeHLa0EplNgz2Bdhhm8lzGCQe5CA/jmt2uK+Fk0k3hqG4ubx7u5nPk3DBSVFxbgW0pDYGAzQ7gG5yTye3a0wCiiigDz3xpql9Z3ttbXFxC6hWZ/LRoNwZiFAP2lOQNozhgSDjbnA44ajpEhtGhlhN1G4cEXKzXkBU9YwwuWI+Vc/Mo5z1r0zxzbK1nDdyXV7bxQEq5t7iSIYbABbZLHkAgdz1+tcjoeoak9/a6bba8jx3DnkMzSqMZOGkaXOAD1AHHNICl8Tbi/g8H+CtOV5NTv7zUobiWFYWke4jiR5yNjbicMsQORjnPy8Y7zTtdvr+N49M0rcYEAL3t7GgZscDEZlYHjncAfrXD+NpY9b8b3VuxnmtNJtl0+W3h8tmnacxyzKY3jdGUIlt9/ag3tkjGa3kvfDNs1msV7ql6PNYSXC6lKYYMcs0khkEQUHA2Ke+FXGcMBPA0WoW/hvVX0SXTbzUJtbvZbhZXljhgczv5kasU3OVYbd21QeSPdPE02vSaj4WTWLLTIIP7Yiw9reSSszCKU4KtEoA/E034c6jpDanf2Gkz3eozi91Ge4mT5YbXfeynY67yNxYNtbG5lXPyg4purCzl1fw5d2v8Aa8ZuPEAEsV+1wArra3Dfu0l4Vef4MKcY6igD0aiiigAooqpqt9DpmnT3lxvMcS52oNzuegRR/EzEhQBySQB1oAzPF2unRrSJLVEk1C6by4EcMVXkAuwX5ioLKMDksyqMFgaw7jTF0XWfClvATcXTz3U088hCNczmBizvgcbj2AwowAAAAJfCFlcavqL+JNTkjbzGP2WOHJQKAVDBiAWUBnCkABt7yciRFjyNS8TDUPjT4f0S0kV7S1t7qaXaAQ0oGz73ovzLgY+bfnlMUgOsEniqS4ObXRLaAZx/pMs7Hng/6tAOOo5x71YuF8QLE5tpdKklA+USRyICfchjj8jWxVDXG1AaVcDRkibUGASEzHCISQN7eoUEtt74xxnNMDjrK51vxH4lt/tNppMul6LMRO1veyMr3nAwAYhu8pGYkZI3uvIaM4zvDek2viK+1udWhs9Wtrl3sNUtVAukiaSThifvxeYJR5bZQ46dMei6Rp8Olabb2Vs0jxwrt3yuXkkPUu7HlmYkkk8kkmvJfhXqwjtGlaT99pt/NbXqMFYm1uJS0MoxgqquNvPQLMcHg0uoHpHhzW5byafTdWhS11u0AM0SZ8uZD0miJ6ofzU5U9id6uN8YWl0NStLqKRBOJMafduNv2ScgDyZCo+a3m2hWB5DFcZJj8vovD+qR6zo9tfRoYjICskTHLQyKSskbf7SurKfdTTA0KKKKAOc+IHiCfwv4bk1iGBJ4reaL7QrEjbCzhXYY7gNn8DXDaL8WptU1qOw+wQW6s9zdtLIzELp6RCSOfgZy+cY9j1rtPFsz6pcR+GLJUeS9jL30jIsi2tpnBJVgVLSEFEDDBw7fN5ZU7Nto2l21wk9tptlDOluLRZI4FVlgHSIEDOwYHy9KAPCte+Keu6l4R8Sw7YrO4j0qHUrO+si8TbGnVOjEkZzwTtOO3Nem+BtQvLvxl46t7q5llgtL6GOCN2JESmBSQo7DJJrbh8H+GYIpoofDujRxTp5UqJYxASJu3bWG3kbgDg9+a1LaxtLa4uZ7a1ghmuWDzyRxhWlYDALEcscDGTQBYooooAKw/G+g/wDCUeE9T0X7T9l+2wmLzvL37ORztyM9PUVuUUAcBP8ADDSY/DsFjpBXT7+G5tr0XwQyl54PuM6s2WXr8u7AzxWXqXwna90g276xC1/Nfz6lcXUlkeZpQqkxBJFaIAKMAOc9816nRQB5mfhYW+2wz6/dXFnqGlR6ZeCeLfPIYwwWRZN3By2cFWzjrVa0+Erx2oiuNXtWkFzaT+dFp5RnEDlgr5lOSc4yMAeleq0UAcD4m+HMeval4gu5dSeE6pDaJGEhBNvJbuXV+ThwTjKkDjv3EFt8NpBqlrql7rAuNSXVxq1zItr5aSlYjGsapvOwAc5JY16LXmPxAvbyw+JOh3GnQtc3UOjalNDbDOJpFVCq4HXJwPxoA2Piromq65p+gR6Gim5tdatLt5H2lYURiTIVLLuA4O0HJ7VgXPwiE9vb3Da0W1pL+51CW5e1zDK84VXXyg4IGI0xh8jB5Oa5XRfidrzeHdZvb/VLacR2cMwNtBG09nK0qoysnAVPm6vyME/NjnKl13XPHNvoum6nqtvJAPEhsneCMMlwnkCRC20qGA+boADkHtyDPWPCfw9Xw/qE10l9C4k0xdO8qG08pExI77lG48fPjb7dTVPSvhnJpv8Awjnk6yGGmafJplwGteLmF2DNt+fMbcdfmr0dFCIqKMKowB6CloEeTn4QPNpE9jdeIGlVNKbSLFhZhfIhLhyXAf8AeN8oGflHtnmtHxH8LodcutXmm1R4mvYLNI9kIzDJbklXOW+YHPK8fXvXo9FAHlE/wmuZbKCEa7bREXMk88UWnsLe43xqnzxmYlnXbkMWIGTxW34G+Hv/AAi2qafef2n9q+yaMmkbPs+zdtmaTzM7jj72NvtnPau8ooAKKKKACiiigAooooAKKKKAOG8ZDHjjQpBHqU7Lpl+Bb6e+ySYmWzwN2VCjvkuo4wSQcVYjS2vr+80W+t7+xkntC8H2m6W4WWPgSERsXTcjMmQQRh1IzkgZvxBtZ7/xjodlbacdQafS9QVozqD2UYXzbPO90BbaeAQFbOeRjNVrjwP4jms4Rbaj4Z00wyLcR2VtohMKuFKlGYygupRmjLbVyrEgKcYQDNJ07TtD0a7S2u3iu3vr9o5rQXb2ahr+UiNliKqHXcEI4IKkDIBpl7p+oyWLavPq2nz2sA2yxxw38jKcgjb++YjnYGUR5KlgSATWf4R8DX0ukS3thqOkKt41200SaZcWU2+SZ2khkaO6K/I5ZBlX2hcDPerpuv28MCxXd9Jc2gVGS9tbi81Wx3Z24kuldEQ8KfnVVXJO49QAWfBetzaHq+s6PZSJqM95ANatdkCQx3GxljuI4o1c7GZVjdQcZeRmKgcH160uIru1hubZxJBMiyRuOjKRkH8q8YvRJp+hWus6NAky6fdfbbJ7cQJHcBA4mVpDLNLNI8ZnjBHdgTjBYek+D5Y0bVNPt3lktra58y3kdtweKZRKNh/uBndF9AgHamB0dFFFAFHXZHh0W/kjDmRIJGUI+xiQpxhsHB98GvMdE1z+ztG1zxTqtnfsdJVoLeK9uVeWSZgpWNCIlzvLxqDuYZPrmvRfF8Rm8M6kimQfuST5cXmsQOSNmxy2QMYCknPHOK8v8VRwWmgeDdHuI74RTTHWLqCzV2lmjt1XEaR7AzOJJbd9mwfLE5+UrSA5C3+0omnHxBJcWVwxkee7itNM1GNZ5naSdznMyLuY4ULwm0YyCa9K0S08O2EjeVr7T6qlqc3MdhbC4kJX7ybYcu6jGEXOPlBXkA4OpXmmmCHTtMvtF1SK4nEVvFc+I/KuH+fblIVC+cTkkI0oBwuCNxqLQ4JZ7iy8PL4itxJcAtb2up+EL2wjlWMbigUSwxyADkqwY465FCAtxSaHa6cG0PUJ9WJ1C8Fyk+sX1lNBK1zI7L9nhjZshncElV6A5IIxpG4n1DX/AAlJBeXE2mjXJQi3BWQjFndlQrELIpCjLLKrH5l2tgZOrofgXV9OsZrb/hNNUgSS4nuPL0+ztYY1aaRpXwJI5WA3u2Pm4GB2yc+88Jx6H408GXq6neXryalJEftUcO7iwusYaONDjA6HIHYDnLA9NooooAK5dXj8R+IZE8/FhpRysSS4aacll8wgchE2uq5OGcOcfu1Y2/F2oXltYiz0ZBLrF4rrbqGQGMAfNKQxHyrlR3+ZkB61zfifX9E+FHhFHkRbnUZIysFuh2zX8qJySTkhVAyznIRcewKA1vHOu31lHBpHhyD7R4h1H93B08u0To1zLnjYgyQvVyAoHUjyHwVFZaV8bdHtbCe5aF7W5RhdT5nndeRNMGVSZGMsjEnLZkYcbTXoXhvTL7RfDt/4n1byX8YawsZnaXbGsRYhYreIYOAoKgISdz9WyxavOCYbfxV4SuJo5pbi71+GOO6IkbFvEs8ahi33S88ty+3uFzzgUAfR1FFFMAPAr518OWB0/wAy/hgh8+0ubq3uUZSIri3Z8eXMxONrAfew+MxNjnn6IkZVjZnICgEknsK8U8JzxzWNuYMO8dxPEuxz5qyLOykRhuNxaRSc4VWmTkiHNID0zRda0zW9A+0Qzm+t5JfJljnCB4mdhiKReACodRg8kbT82QTXhhHhvxGqxiU6TqxVWZ3Z/Ju1UKpYnJxKigEkgb416tKSfOZSLHULbUIgvkxLFbsrRfuJA8kcsBbcD+7DgCNySEWaQ5WSOQN6xcRWfijw5JExkW3uoyuRgSwOD15ztljcfVWX1FAGvWX4i1mDQ9ONzMrSzSOsNtbIRvuZm4SJM8ZJ7ngDLEgAkM8MajNf6Vm/CpqFq7W14FUqvmpwWUHnYww6/wCyy1l+Hf8AipNSj8TSEnTljKaRGw6xt965PvIAAnpHzwZGUMDS8L6TJpllJJeusuq3sn2m+mUkq0pAG1MgHYoARR12qM5JJOzRRQAUUUUAFFFFABRRRQAUUUUAFFFAoAKKKR2VFZnYKqjJJOABQBgeL7+8jgt9L0YldX1ImKGUBT9ljGPMuGU9QgIwOcu0anAbI6AcCuZ8IA6rNc+JZlIGoKsdkrKQUs1JMZIPIMhZpDkAgMikZSumoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOY1A/8XM0EYH/ACCNR7c/66yrp65q/I/4WToQx839k6gc5/6bWXauloA5m4J0DxKLknbpOrusUw28Q3nCo5PYSALGcnG9Y8DLsTzXijQdN8I+HUNlFrNyslykCA63cQpaiQkGTIkBVAWJOwFueBgceg6pYwanp1xZXaloJ0MbgHBAPcEcgjqCOQRmuSmtbnxR4W1Xw7q8+zXLJ0DTwHyPMdWWW3uE4barFVzwQGWRRnZmkBz11oniS0igutZ8TanrMQjVnSFDFFIrfKVP2aFiyjO77ikhuWwONXwBqVwukeFkhWRrFLeTR7pJn2PHcW52K4R8Od3lykj72ChI4JHIWd5JrtzcpeaTceJdVErpgqjLp020E7EfKW+AQCHm8zfuChlwxnsrRJG8ReEPEWk3djHPAus2MawpIHePCzLBt+ViGWN9v3szHPY0Ae10Vj+EtWGtaFbXe53cqFd2hMQc4B3JyQynIIZWZSDwTWpLNHDC0s0ixxKMs7naFHuT0pgYvjpIH8K3wulieLCkiTGMh1K9UfnOMYQnOMc4NeeazaWWp/ES6gTUEsZtKtLHSoDMWWMSuXndEfOfM2fZ2AyC23AORvj0fFHirTtSvPP3Nd6PpQS+SO3h+0HUJMgQiLC4G6RgkbFv3jBwqnYWXO/sbXdB0C8n1rQl1O4u45pL2bS3F1N5krF5Qq7IZBGzeUNoaX5IUQrxupAbXw+KX2reJ9Me1in0pGU3AntcAXcjSNPFuKgSruIkII+VpSASpXb1GmeDtA0vULe+stNjjubaNordizMLdG6rGpJEa+ygCqvwy0dNE8E6ZAE2yyxi4lLWv2ZyzgEBo+qsF2rg8jbiuppgFc34qUHXfBpPVdWkI/8AAG7/AMa6Suf8TAnWvCZ6Y1Nz1/6crmgDoKQkKCWIAHJJpa5rxtJLdWkWiWjsk+pK6O6symOEAB2ypDDJZE3LyvmBu1AFLwvqa6jPq/im7eK30Yp5dpPcDyyLaPJaUlsbY2O5skAkAEnAWvOfC+lH4o+Pn8T6naxtodvAoWG5iJLK58yGHaTtI8nyJmPIzOV5529L8YVt4PCNj4U0iwiupnEX2fTtgaErGQIlkXOdgkCMF6MImXpmu0022Twn4VhtnuLi+a3XaJZsCSeV34B2jALOwHAxyKQGR8QWk1C807RNOkn/ALSudwOwApbwsNskz5UjIUuqg8HcRkMVI4O5urew8R+HrMCGA/2jAnkvccRRqRHHEIyDuYHyxvU4Ji3BiGIr0KGxuPD1hf6zdJFd69eDdcTAkQQALkDLHKwoBkn7zYzjJCjx/wAWW95fQSvbMEazmt7nybjerRsJkCN5aERhyBI2ckKobaAFyAD6QoozxmimBj+Mpjb+ENcmUOxjsZ2Aj+8SI24Hv6V5D8ObPUH04afLbmaKR/tYEq7cRXDMxC4BBHmPdKWUZEV1DJ2Ar17xagm8P3UDS+UtwUty+cYDuqHn/gVeSeA9SaDTdGv7KN/Mt4wJrVXCkqVG9QowHJUxlegGYVGBHIaQHVy6NNbT3EeqoJUm3wyZKKLsyAghAymFhMB88LhQJcsPvhjz/hzXo/C3iiy0+6vZIdOuoysd3LFI0MyxJzHcZ+aC5ijUHe3WNSsmSiSV64TBq+lxvbzh7S5RJFkQKyyRnBxhgQVZeDx0Jxg814X8S4r/AMLqbvST5esadIt/apLGximSJfnwAeY/LLIGLB4y4iLFZYjQB3XiCG2vfHZ0uFiNO1NUg1oohKtKiGSK3Y/dBliLbyQT5aRqceZGa9Grzjwpo4PgO+07RPKlhgn+1aZNMyyeZJuW4idgoVdpYowAxhWC8bcnu9G1G31fSbPUbIsba7hSaPepVtrAEAg8g88g9DQgLlFFFMDI1zxPoOgSRR67rel6ZJKC0a3l3HCXA6kBiM1nw/EHwZM22Hxd4ekbGcJqUJOP++qs2cIXx3q8+0bn02yQt3O2W6OPw3frW66K4w6hh6EZoAwx4x8Mt93xHox+l9F/8VTh4t8OEgDxBpGT0H22P/4qtGTTrKX/AFtnbP3+aJT/AEqrN4d0WZQs2j6dIoGAGtUIAzn0oARPEeiP9zWdNbtxdIf609de0dvu6tp5+lyh/rVZ/Cfh1zl9A0hjjGTZxnj0+7TT4O8MkYPhzRj/ANuMX/xNAF9dY0xvu6jZn6Tr/jUq39myllurcr6iQY/nXJ+ItJ+Hnh62W71/TPC+nxNlEe5tYE3nHKrkZY47DJrz6+8QfDcgT2Pwq1DV7MqJFvLbwmghZCM7t0qphevJwODQB7kk8LsVSWNj6BgTT1YMMqQR6ivFrC++GEk0kesfDqHQVQKTPqfhyJYAGOAxmjV41XPG5mA4PNd7D8PfAk8McsPhHwxJFIodHTTICrA8ggheRQB1tc14rVtZubfw5Gu6C5Hnai2MqtqDzEfeUgpg9UEpByozQ1TwP4A0vTrm+vfCHhtLa3jaWRhpULHAGeAEyT6AcmqXhz4ZeFBpgn1bwd4eW/unNxLF9ghZYC2MRKduMIoVcgAMQWxljQB6DRXGv8LfAb9fCGhDHPy2Ua/yFMX4V+BFUKvhXSQoOdogGM+uKAO1orlPhfawWXg6K1tLdLa2hvL2OKFPuxoLuUKo9gMV1dABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHL6gT/wALO0AZ4Oj6icf9trGuorE17wzYa5fWd3ey6hHLaRyRxmzv5rXhyhbcYmUtzGvBOPaqg8F6cu0C98QYUYAOu3p/nLz+NAHTVzniqKXT57fxDYwyTTWSmO6hjPM9qSC+AAdzJjeoxk4ZRjzDTl8J2YJP2/XCT66tc/8AxdRN4PticjVvEC+w1Wf+rUAb9mLc26yWfkmCUmVWixtfd8xYEcHOc575qnr+jQa1aRRSyz288Eontrq3YLLbygEB0JBGcMykEFWVmVgVJB4vT/DEGma42hz6r4hitZUM+myDU5ArKMb4PvfeQ/MM4yj4GdjY6BfB0IYk614hYEYwdTlwPfrSA4GK0+IXg+4njtCdQsppZJFW2s0u7dSzFspE08MsH+4HnQZ+Ur92rian8UNXwkemR6fAxx5nlw2zjg4IkeW4xg4yDAfY+nYSeDIWYFdc8Rpjsupyc/maYPBSjzP+Ki8TfN0zqLfL9OP55pgZ3gTwFJo8v9o+IdSuNW1Uv5qLNKZIrVyu0shYAvIV+UysAdo2osaHZXe9q40+BmJyPFnisc9r5f8A4imt4CdmZj4u8W5bsL9QB9PkoA7SiuNHgWQHjxd4r655vUP/ALJTk8ESoCB4t8VHpybxD/7ToA7Cuf8AEuf7c8JhV3f8TKTP+yPsdzz+eB+NZp8DSE5/4S7xWO3F6n/xurOleDksdUtb6413XdRa1LNFFe3KvGGKlN2AoydrMPxNAHU1waeJtM06w1LxjqF35umS3P2NZYz5i28MbtGNoUbmLS5JADMd6jkKMdH4snuItIMFikjXd5IlpGY2KtH5jBWkBH9xN8nbOzGRWD4vsrXSfB+l6c0r+RBdWzb2b5n8lxMSf+/RJx0GewoAx/Dsi32p6pr/AIrW2s/sf+kSpK6kW2HYRxu2SP3axq2VOPMkkIroPC66nrl6+sa3bXFlbRylrCwuUVZIjs2tI+CecZCjgjc5Ody7eWuLVdH8B29hcaXuudK099d1CGefdG1ygZ0EpBJYPMHkG3IHk9B8oqG+m1XVvDFnqHjLxJDYWV9AG/s7SkZWuPMQFY4nPzySeiBWDZK4OchAaXxG8R266i2mtcI/2cJL5MTgYk3Agu7YRXBwVTduAV3UF1jFeda/balo3h/+3dTLWljpmoWd2ljnyzO/2u3AldCoCrtXaoOCojwBwzN1cWnS6deyTaBptp4eh5n/ALQ1CB7u9uXZNjeTbD97hWZFxlB82FTGCZF8EaNfabq+t6xHea0LWWY2cF+8UyBkTysmAERlgQwUS/MoIVgpHAB3WrePvCulzyW9zrlnJeROUe0tWNzcIRnOYowzjBBB468dTWTa/F3wZdl/sd/f3IRS7GDSbyQKo+8xKxEYHc9u9cV4Y0+000Pb+GrWztLcxq9zNZad5odwSERxGgl35cnA3qojJJU8V10cF6dLvl1o3EyiMwovmSBChIDufMjQKQoJyNxxuwCcAgDbz4weBJtLv5LfX7KZ4YHkEUoaIO6qSI8uAN5I4X7x7CvOfhZcibRdOto5bVL7U9PhntfKRY4r0KjRyw8qVyCCNrLhG3bVKkiTq7q0gnsp7Rn1K2tLmIQMLiKeWEcEKNs1oEI57sB0z0rm7XQdO0myjjSS4ttMW7X7fEk0O+CZv3cWoQiKWQKQziOXOAQd+wFTuAPWGlTwnC+p7Z4vDsqG4uonBZ7B8bmk2jJKsc7wMkMd3O5yIYvD8/iG3uNX1QNa6pPzpwlj3Np0X8Klc4JfrKoxuB8skhFNcXrHiXxH4bvbFfHtjNqXhiyl819Y0uEyBpEfCtcRjlVTHmnAHzBQpcp8/o3h59P1Hw0snhG5tE0i6ieSzubb51V3dix2EYwGP3eMHK4GKAOO+D2o2MVzqekWElyq2MqWUthIkjtZOsZKLuwfkEaiHexAJt1PJk57TwtKEu9e08yyyG0v3YeYOQsyrNwe6hpHA/3cdq8+0TVpdG8bny0hze29vY3AZt5R4LpYSN+AzY+07VLcsNpbDLJn0QNJB43ZWljMN5pwKR/xq0Mh3H3BFwn0x70AblFFFMDDtSP+E31QZ5/s604/7a3NblYFmpHj3V3K8NplkAd3pLdZ47dRz3/Ct+gAooooAK4Hx342nsNQj0LwytrPrbuizTXDqILINyAwLL5krLysQIOCGYqpBbY+IXiKXw34daewiW41a6lSz0+BkZxJcPwuQvzFVAZ2xztRsc15X4c8M6fql55cELXEF4Xe+uZLdJxPhvMkkljcOjSu3HC7lyOETy1oAn8PaMU1e8vLgTXmvXduxjupnkivnbO51Mm1zDHxIuESEJjYFfcrVLK8Dai8iTW0N5BOI5w7m6dCuSwWS4aLHJO4CN+M8EkYtC5t9ClhuNJmvJX80/uorbdb3KofJQRMZCu/aoLFW3ADJCEeXXKGaSxeHSLGODWYJZGTUES1M0TyH5wDvO7Ks0ZcJC7AOp+V9gZAdFeWLSefbXUUHPmtBNFKxKqu1A0iTFJB8rMglV1jGUwPu1F4Ev28Aa3Z6aJrx/Cer3JSJJkDJps8rZgWNlwwjk5BDKBvKspKszGCyuFvE+xWYFuWYJJAA7rKixsER4mJkzuif5oTJKCmH8ooVjg1x4L7S7yxELG71BHgSHcsv76VgA8TKp3BW2s+N5BgZwJnXzFAPWL9Rr/imKxDFtO0d0uboA8SXWA0MR4OQgIlI4IYwEZGRXUVynwreGfwDo93Hcx3k95D9pu7pDkTXLnMzf8AfwsABgAAAAAADq6YBRRRQBzHw3Up4VVSCpW9vQQW3c/ape/eunrlvhmrJ4SjWTbuF5e52nI/4+peldTQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVxeo/EXR9J8WahousypYraxQSC5kYlXMpIwQB8oGB8xOOR0oA5z4v3ccPivwzD4ku7yz8GyLN9rlt5ZIkecAeWsrx/MF9ORk/TjnpdctNE8R6jqWgXmo3GnW3hDzbaV1a4k/4/ZAG2yEFgPVv4RnkV6vN418Nw395Yza1ZR3dmHa4iaQBoggBYsOwAI5pkHjfw5caTcalBqcb2lvIsUpEb70ZsbQUxu5yMcc9qAPItL+IniS+ge2GoadcXKa7p9lb33kJMFS5Rtx+XapI6ZGOpGe9afhfxt4qbXdGg1PUrW7trq61TT3RbMREtaozrLkMeSRjAAGPfmvRLn4g+GIdIg1EatA8Nw7xQqoYvJIgyy7ANwI75HGRnrVOXxxBL8KH8YSae5gezNwbTzeSCcbd2P1xQM8rt/iLrmseF715L6y1aOXw9cXd9AlrtSxlXhFZged4z8pOeMjArU1bxt4os4Neu9Pv7OCw0H+ygLM2gbz1uI4tyl92VALk8DPvXe6L4i8PeGdNvdOJttL0nRlt4owbhpXHmoHVSpBbPPAyxPWtKXx74Zj00X51RGtTK8G9IpHIdACylQpIxkZyOKAPO5viDrS+N1sZNStoHbxKuk/2QbYbxaYJFxvPPz4GO3PFdB8V/FWp6BqVhb22oRaRYS2lxOb6W3EwknQDZAM8Atkn1PQc07VdQ+HOn6xZa/qepQG7nQX9q8t3NLHhvl82OPcUXvyFBHJ45ro4PHnhe4sb+8g1uzktrF1juJFbIVm+6B/e3fw7c57ZoEef+ERqniH4uWepa83ky2+gWt4LFoyBbySBg4GW+U7snJGcEKema9mrlpfiD4Ui06C+l1u1S2neSONm3Al0++u3GQwyOCM8is+bx74Q1rU7Dw9JJFqMGs2pliLRLJbzIW2bGB7k5GCMcHOKAO5ornW8H6SlqtvYi906JDmNLC9mt0TknhEYLjk8Yx7cVjeKNRk8K7rmTxTczSeUzR6bPawztJjuqoI2A4OWZ9ozyQKQGzq9r/aviS0s5o2NpbWss7usm0pI5EaYHun2gZ7Z9SCOG+IniJdR8UaZp2ml3hsmF49wEk8p3ikR9iMiu0hDIgZEXkM4LDawq7pGjeKPEzavca/PFpUVyFtQtpFJG11FGXADEybkQl3bEexiWGJCvLUby48N+FYmTR9HufEFzazh7ma2ty9pYyxbVLylFKq8anIUK8oCgYwBQBTu08U+M7O7iuvszWF5AkUj2qPa24QF9zNKsm+eNhkYV1KgnKZYEM8M6H4e0u3sriwTUdZ1UxJE93pcxtLNpC2zi5Xy0f5uCNzscDKk4raaKXXbY3+v3o1vS0+dzZKY7IREjbNEgJzJE8eWWRpGX5mXb8qVcvbeCxmurRLueIsCBa6gimwu1df3rELxslJVTgfJIRhcSlZQDiNe8NtY6JdQ+HtM0fSkuhLsltdfu7hL2NsrKpjMISWQx+YQu4sGUEZwa2dd1ixu9Pgj0O0t4tIt7ZYbaWR5PssaAExsYpNsK4CghmDlcqSOMGp4ktor+0aLS7rV7F7mRbgJan7W/mAFkkdEbM0RMcZWUCUnbtYhVZKuS3RnuYtRVIrZngSOO+tykMMagYWFZwq4XzB9wPOeDmLoADJxFc3cRbVkhlV/LhWyu8iCOQBW3FnUwrhCR8kZ3FxhgRkSWuo2F0C9pcqZUdHL29rCQZNw2jzYnUbScD5iMjGSKigWCHRIoNItL2PbNIBJZwzom75RJho1t0CE/Mzb4gWViQxXNalrcyXcT28kf9o3M1uYza/aoiFl2g5KvdTLwVz9x8deecgihcXshubh11FpCJJI1nuNe+ys/wA2Cyp5eFXIwNuVO0HJ5NZ91FNdLNZX2q6xcx3FpNaT2/29biF1kRlXbIiAI4JyGfHOMnuNDU4fEd1cvNbQExE7jJNq+oxnPThIo40A9h1qE2d7bxR/2xcReVIceTdXl2Y5ADnGbmcox6cMhFA+htaBqN5aXcOiarqk9zM8bXFjeSovmXduDhkZcY8+PIV9oO4FWA+Z1SP4I21lY6T4gs7IRLJFq8j3CpGI/wB48UT5KjgZBBwvA6DGMDCmtor/AEb+yrezhtZoLuK60lJ0iaFJgp+XEXloUdS8fylv9ZkkdByfwp1NdFvr/wAYLHf2+n3+rXOl6rb3y7Jogkg8iR1JyZI1c+ZzwolY52AEQjrPiVEkHiHR/E+lajAWuZDDbTIUEDFoynzv90srBJFPUqkqE427e88RXUVvfeF9WktpwGuxas5QhoUuIyoDjsDKIVPoSPeqHxGtI9W8L6zp0t3EHiMc223UCSBGPySNluMOGfdwuEIIIDZhsL28uvhFBq0kT/2oLVdTngkZhi4RhNJGNxJVfMVlAzhRgDAAoA72igUUwMK03f8ACdap02nTbTHrnzbn/P51u1g2oH/Cd6mwPJ020BH/AG1uf8TW9QAUUUUAeSeLZItd+Id/FMkl5BotqlnHZbBgzTo8s7juzeSsKhQHO15AUKs1VJJLeO2nuhZoJZoSl1ctGkjyQgEBZG8tpCmVzubzwWYrmThlzmh0vUfiV4supYnR21WOza9hIMse2C0AI6EBJFRs84Iyc8Cp7t7iNlvY5h5iEzuZYckuNyeaQrAq5B2rKj5ZAwEkjEAIC2rmeZ2juI5jf4ib5d32hhtDE8S+YAG4UrcBeBvh+6PPNfYXMun2Gsx6dd2c9+fOxeyQ2sv7yCVXkYI5CGSSdXVxwb6Nhk7AvXySWkkzwyW89tczMYpY7aVJYrva28qx2t5sZLzZEkBkBLFnXqcqP4UWWv3H2K41WSGDSAxd1tCVmhZRFK0YLDZOXhmLghlHmxkqQFFAGrpP2mbRLK4vdR857zSIbqUC4jdJS1taBlkE25JGUo0o8wjInJ3KckwGQ6tq9zOdvkWP7qI79gmkPyyzqXLEfMnkozl0yrqkjgiN62oQfZ0tba3S3h1KSVI7S1ty0gsswW53IOjtBCqKowzmRVcJ++QJqwW0dn/oemgRxwzmJLdpWaMSFWUkEEurAMwdwfOJLF9iZFAz0D4TSh/C9zEPM/c6neoxkVlYsbh3bcGZiDuc5BJrtK4j4ONFL4JS5t4xFFPe3jIiurqFW4kRdpQBdu1FxtAAGAK7emIKKKKAOV+GLM/g63Z2LMbm7yT3P2mWuqrlvhlI0vg63kkGHe5u2I9CbmWupoQBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXnPi74b3PiDW9ZuY9dWzsNYt4LW8txZCSQxxEnCSF8KTk87TivRqKAODl+HFrPoni/S7i9c2/iC48/Mce1rfCIFGSTuwUB7Z6VQu/hpfXtprElz4kf8AtjVJ7WWe4itfKheOAYWJolfJUgnd84zx0AxXpdFAHk+l/CS40k29xp3iCKG/iurybf8A2eDF5dyFDRiPzPlI2jDA/ga6H/hAv+LT/wDCFf2l/wAun2X7Z5Hvnds3fpurt6KAPJ/F/wAPL1ZdQ1jSZ5rzUpNQ0+/toYoY/wB09tD5WT5kiq4IJONykds4qho/wy13UtBU61qa6feTareajcWjRCeGUT4AEiK4XcuMjDMBu717PRQB5XF8JhDpSWZ1onHh6TQN/wBk/vyh/Nxv7Yxt/HNTap8J4tR/tRpNXdJbr+z2gZbf/UyWiMoYjd84bceOMepr06mu6xozyMFRQSzMcAD1NAHnugfDY6Xq2iag+o2xk068urx0t7IwrMZoBF3kYgjbnJLZ6cVmWfgy18AQ6Fq934nt7W30eG5guHuLUBbiKWZpyqjflWHIGN2cdK0fEXxJjUSxeF47e8CP5D6pdSFLKGUhsIpHzXEny/6uIEncvIzkc0dKvV1W31vXL29l1aVnWxlnt1e9fGcCysuY7cbWGZJd7AH94E5IVwNnxH4y1bU3+x6Os2jQTK4hmmtmlvrkdA0NqBuCA8l3CjGPmTrUfgq/8P6cLy9k0u5a7MqtZ3jyC/uNSZkZj5TKDvkQO6uY9yKo5kIDbcW5SJmuLX7LHI91N/pFgkz3IlmB+5dS58y9kUdbdCIo1VlkYJsauv0XwKbx2vfEzPKZlTfavtLuincsc7r8pjXjEEe2IEvu80neRAZOpXWtfEa3uLPRdRfSbRGQtPZyxSpH/HtlbDCckGPMUWI8bw0z5C1zXhC71SJ1ub3R4tOjghgkur/QrMK2x4yUzDECwKgYKkXKMw48tfmHpmhvDpd/411K8kEUUF1mZ2UgLGltE4P0Ctjj0rj/AAVBp+i/DTUNTsV+wXd7bQW+9ZXDqDGDFwSQrgTFunGQGOF4ANiwtrC7K3GnX0Al1GQO2q6Khkt7nDbVd1BZFlBRgH+ZQY/nOGEbM1NreyefSL+OWHSI1kuLYiNJPKgK4/dluPLBO0g5CLJ5bqI2jY3fHkZ8J6Nq3i/QJEgaCNry/sukGoKAMk45jm2jAlX23hwqhYhrEPiDwzHPbvIs1vPHHa+ePLvIb1UIeCcFdsMpztDZ2P5oGGRgsgByGt6SL2ezstVi0/U9PlJISN5hNIwKkypiNniuFxKoUvufdtldtgJZrUMpaEeJLq7vLoO9kkQTy5Z43DAW7gOBlmOMhpUbGQgG3Eeh2G3xdNrVm81tpFjEIxfQbo7Kbaryu4AR2iMHnSjymYxO3ygoUKC1YhIZYrfw9Y7biaExNdSSyRu0YBRXdlT7R5bNtP7tIVBEhLYxuANXVEinjsrObTkt3tIobQ2jCC4ltwi5XZFHFccEE87Ivlx/s40CNebU7VFF6dNMsUU8rrKpK5UE72uoSD94krCe2FbABZ4smn0y3aCWWVLSIQ26yLLJBCAEXOGeeBNvHQSSscnJwCBVhsRZ6naRaNbwrbR7XZbSHdFw+4gvFZMCSMZHmjOPqaPJgZGq2PiTUtZmW+1SK5iik2rFd6LYOgC8hGD3Ik+YFTyFJDA/LmrX9n6hFdXb6TqaaXZK3mraXNtYpCY+NybopDggBmyVA24HUE1teKLBNVv7lJIdSlFwjSWyNJcoqEDax2bJVU53YJRQcjCt96uWm0eG2kxIFmym2RP7REYXHBD4hibPHf8AQ5pdSron8RTtYalY2V7p8o1C6bLfZFIDRnAeSAhtsTBcEkZz3xgGr9zYLNf+M1ePdbNb2ev2rH5WQyxPFMGCghgRa7ymCCzZ4OCKosLPWNKm0yWG3vLZlLHT1u5bxiVB2PEQymBlJ6rgMDgsuci/pmoXd/4u122u7C6hlm8L2/2ctvZboJJcbiqth8/vYwythgcjkFXZkhot/FqOl35vmWa7fSwBcNIPmW3nk2MZCGRmHmqc4IJ3bgOVG58Hrfd8L7CyuEjAja6tSqNuXas8iDByeCoBAzwCK5H4fPD5Xi2CWW7RdNsQFdg7OkM6GQHbKxBwqLwCOVcFQRz2Hwldl07X7SSPy57TWLhJv3wlLSOEldiQFGS0pJ4HPQYxQBv+BxcDwXoAvM/ahp9uJstuO/y13ZPfnPNbdZHhCRJvCeiyxHdHJZQupBByCgI5Fa9MDCtv+R61L/sG2v8A6NuK3awbYj/hPNRGRk6ba/8Ao24reoAKKKKAPFdcumtfiR4j0+RGtpDLbX9pM4DROJYliI6jBLQSAgnYwyMxlmkpmoy6b9vkttPuI9OmcRywwRlYNxLIjbIZnVG4DoJIpQVDKFUjDNo/FvQIm8ZaNq5W6c39nPpMggOSpQG4jYL0YgJOuDkEP/CMsNHXbi41TSLWzuoYLiFFWOe8TZdWl0pQNsWM7ySwxnMZwu4hgCCUBzV9azxSPBdaXHfxTRXDNbomySVQ2BGIWj37SG+ZliOcKwYY5u/DuziuNI1TxMuo6ZYwW9tcWsU0Q2RL9wyTTI+QqkQQlcszeWS7O3mDbxHiiFLLTpLZNCnazjtPPvbW31BxZMyeZJHBJEXYZIgfc8TN8qhSAHFem+JNKHhrwJBDc6sx1W61CC6ur2UBmublSrtJzhVWNYt4BAREgAOEBoA4XRIJXa71OSKSC2uJnsYV1CPyJ4rfLDyWVwu8GR5JCP8ASBk7Gi3Lga99e/Y7C5u9R8kLbwNdNGY2cxQICxTyuJSqlCCCbaPa/KcEVd0u0LWaahYWKRKwJ329vcSfaIuFAfyEjLEhekm8rkbgCCK5zW7O9u5rXQrfSb+yh8R3iWtwbgvGFjYl5xHH5ez/AFEcoLZV8nOaNw32PWvhNbfZfhn4YUq6yy6fDcTByS3myKJJCc85LsxrrKAMDiimAUUUUAcb8IHEvw+06RSSGluWBP8A18SV2VcT8GCzfDTRmckswlYkjqTM5NdtQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVkeIPEOn6DBvvpsysCY7ePBkk+g9PVjhR3IrmvsWv+MEb+1C+jaQwK/ZY8+ZLzg7sgEjjowCkMQyOMGgDQ1fxraQ3X2DRIW1jU2YosUDYjVgQCGkwemfm2hiv8QA5rI/4Qm/8VnzfiHdJd2TESJokGUtozlGXzCDmQqV7kjJPO07a7LRNF0/RLfydNtY4FIVWZR8zBRtUE+gAAA6AAAYAArI1/wAWW9ktxHZS25MDeVPdSkmC3c8BPl5llJIxCnzHgEruUlAYGtabp3gsWp0aC1tbh4ZI11XVJ3uBp8I2qEiVmLNlnRViQqGPUk4DZGnW11rF9cW+jW95+/8AlvdSvJCLmQ84W4kXaYlGS4tYSrcgN9nBZW0LHwlfeJtZ0/XdYnvLKCCKQRCVQl9N5oQM24DNmu1SoSIh9rEuwYsB6PYWdtp9nDaWFvDbWsKhIoYUCIijoABwBTAyPC/hmz0C2j8v9/eiFIHumRUOxRwiKoCxxjtGgCjrjJJO9RRQBw/iWKXPjGMFl/4lTzwurkgmWJkYFMHJX7OpBwfvkc81w8VzprfD/VJr2zilhMmneasF8DMiSXC43k/KAm9iGztKkpkBK9Ul8+HxtbFAn2a60+QSHA3B4pE2c5zgiaT8vpXmmjzWGmeBfFmlzyyTW2jLJbsN0c4WC3kIyVABDLH5ZZDxjYR8zOSgOp+N95bQ/CzV3mxLb3AhhKqxxIskyKeRzjaSTjPGTXm3jHUYfCfiay8QR2znw5qkQ0/Vp3l2zTRJiJZsKSGeAxCRZACWW4wuMA16B4puYpZfh/purWS21xNeM81rCu5YAltLFuTA+6s00AVscblPGOOQ8f6ZPrNjomh2/wBms4ZUuxrIgjigMksIghBMmxxBGQVfIGdojHBIIAIrTw1d6FruuzTm2u7a7v47iDfe+WXmmAy6HkoSzyMoQCQl2VXOCauQW1xqU1rZ3V4kMc0yxCKNVjjE/mFmIVuDIELKVcvKNuZEYHI6fQdFhj8Fy6fHcNZrYyi0F/dxPEs1pCS6LyVZ4kR2QFmIbYSxdSQ2BZwanaxWt/oUdvPEqRwrc2chmTCnIjZwI28tWJIQeVAFLfKmQSAdFr0m/W72eUXmy3KhJmka0Zuc+WrHyAygggfvJBljkDPOIVe8tItbIi1Z1UCLyrRp1TkjKyLDdszDn7khXkggVeuDafb7290+5slv7izSOaWGZTcO4yXiDKC7NyAqC4HQAAAEtDq9jJ/YiRa5ZSSzpGrFbuH7QVycHHmS3QXcFx91iexzQAmraZFDdGBtMsYZ1tluHkkldolznjyYfLYqCCFZkHzM+Mc7sH+wrWMtqElno9tAk+VmeC3sGDnplHhLr6A78nHNadssWpaBa6hfWU19aadILe3trnYgibgMsa28KsVUKPkKgEAZwM4yrm5s7nTZtXu/slxYRQkvcarZRmNAoLBR12hsbcOWOeBQnYEJqd5pjqVfxBosDkEEf27ETx1O+SMlee4q9p6fZdAF9ZaleXt3YXL3SSKxCXFvM3l3HzpgNGC4lJQ43RKwAYEHA8PaD428Q6fBNpljJpVlNE58u7ji08RkhBGqlo5p32YkyX2q2V2AKATq3/gbxxZaJqa6XZ6ULq5t7iNxaXlsrTl0dUJU2EY3Ddgnem7nPbAFzb+Dliy2Hi3ULi3guLeSVbOCG3iP+kQww535bljI0rnnPXgkEGrfwhZbLRPFcEU8E8NjerDFcRDas0UdlbrE+OmfLVASOCVJHFJ8PLqC7+HGvyF7yINfXgmjZ3aexJbmNujBogQDjPCZBOQTX+G86XWj+P7qK2Fqk127G2CgeQy2yIY8DjjZjigDvPAahPA3h1VAVV062AA7DylrdrH8GxyReENCjnRo5UsIFdGGCrCNcgjtWxTAwrdR/wAJ1ft3/s22A+nmz1u1g2wP/Ceagedo022+hPmz1vUAFFFFAHCfGKJW8O6XcHaHttZsJEY4ypadYyRnHO2RuhBxnlfvDEvJrSx8OSX02gzXM0c3lzXNswEtwHfKLjaGkZnMS7JFbdvBLSAmQ7/xG23uqeEtHZ5kFxqX22RoV3OqW0bzAqMH/lqIR0OQxHUiuBsTZ6lFdQTTL/Y2lbWiSXaI3u3ISZgMMAiJJtJUqu6ZmLDckgQGa1vew6VDCkEj6rqF8kV1dPEr20ly7wqIZWJ3CNGEY2hQrx2xQbWfFdV4mS7g1bS/DyRXUsOk2cEFvd3cbXMl4zxuWlIjdWYhLWRCMgs8275QgLcR4+ayS00uO91CKCM3Nmn225dXaFWLsgLMC6xBLedxhmQt5eGkDO47bxPcr4k1u9Mrxx6fC7WpjYBiRbyfM5XOSxkYKqqCFiy7H97GAAQ39ksRElxpWpjefmuJ5J4I2Zj2VrzIz/WmfCHRbOfxtqWqWFkbSw023FskLeY2y6m2vKCXkfLLElvyu0fvWGCc1zfiGbTdGU3lvE8d9gR2g0uBftV3ISFjg80W5CbnZed24bgQD1r2j4feHX8MeFbOwuphc6k264v7rqbi6kO6V84GQWJAyMhQo7ULuFjo6KKCAQQehpgFFFFAHIfCNBH8ONCVenkk/mzGuvrmfhkuz4f6AP8ApzjP5jNdNQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTZFLxsqu0bMCA64yvuMgj8xTqKAMHR/Cum6ZdvebZbzUHIZru8bzZSQuM5xx1bpgDcQMKAo1768t7C2e4vJVihXGWb1PAA9STwAOSeBU9cTNcXOu69Ovh25le2G1JtUkKyW9qVyClqmMSTctl23Kh4JbaYqAIvEOr3mpXX9mW0F1vmj3x2FvIYZ5UJAWS4lx/osPD/APTRgDtG5TGdXw94Wjspba91V4bzUrdSlv5cQit7JSMFLeIcIMZBY5cgkFtuFGromj2ejWzxWasXlcyzzSsXlnkIALyOeWOABz0AAGAABo0AFFFFABRRRQBga7LJb+I/DTxuoWe4mtXBXO5TA8nB7cwivKfGjXSal8U9Ot4LoQ31nFFHFFEGSeaaOGJQHHKOWkYbT97duXJDV6z4ma1gn0a9vpIoYLK6kuGmlcKkSi2nDOWJwAFLZJ4ryPxBdXmtT6nc6pbPpmkajexS21pbymK/1dLcM0THgG1iYqrNKzKyrER8m7dSASx8UQeKPFl9fW+qQahZ6HbRadK8GXScLiS9kXADoWGxomUnebN8ZFdb42ntLTxOLiP7ahnsTNKY1DROiXFqTKnH3gmdxB4WMFlYBKxW8O362cHiWJ4bGaJ1hCRILeO1t0GxDbtwViUdFdZlYHcIlLstY+r694n0jw+7SsIYdHg+0RrBZLbPbhEMZSOWNZ4cYONs8EQw+4Fdh2AGisr3On6nqV1FcjSrcrp1rE7yzMCFDXMnmSRl5U+Xy1ZwpH71coGBq1oV2+pW+raVZajYTlLVZHsowbkI6sAWKxyb2Vg2QjMH+VMvtOBx2k2t3NBougXxv9XE1tczQ6LaTpb/AGlXyXkumjPlQQB5GTaN7BiwEkhHlDqNE+C2o2+m21vceJxp22JVI0i2ZJITtAKxzSyOV5H3lRCwzwM4ABp3yjTWuZJ7G7hijs0tpXmuUtDC7cjfMgXI+YZzcsckYBY5qS0u9Rh0y+iga1WFFLSG0sXS3l+Qgl8qVbAUZYXIzxlk6Ga38B+J9HeKXT/FEWuJa7mt7XxBaCR0djy6XKfPG2CwyFYAHG2sWzluNa1K7sL/AE6az1G22yy2l3Eb26jG0FTG0iyI8bOjASK8a8fdVqALeoXMOtaPBJp8jiytJrhG2vbSrExRWATyHZFUAMMSlRgnc4GNz/hz4esvEdzFrd5a282m6dcltPdCfLvLlMq13s3uuEOUi+Y/8tJMsXQrj+Jtcv4vDWuaut6iQWMU9zDFPdROHmijbyWGJ7gsVfy22jygSQzEYKt7J4f0uDQ9C07SbMH7NY28dtHnrtRQoz74FAMv0UVFcXEVtGrzusaF1jBPdmYKo/EkD8aYHnPjOGDRPE1/dzMsVjq1ml1KzXHlj7VayRqoQE48yWKTbx1ECgg98/4dbIfhD4l1WdPskl5LqN1dSmUuWlTdHLKSemWiY4HAGBVz49QXkmjaBNp11b2k0OpFpJbiN5IzCLadnRwis2xtoBIB2j5v4ar+HpbO++Ecug25S11C4gEVzayYO03cnzMpHEkTNK4WVMq2Dg5BAQHqyAhFBOSBzS0UUwMK2/5HrUv+wba8f9tbit2sC1/5H3Uuv/IMtf8A0bcVv0AFUdcubq00i8m022W71FIZGtbZpBGJ5QpKpuPAyRjPbrV6uL0afT/G+uWPiKwuZ5dL0aa6t7UbSsN1OVVDcxsGxIiqZolOMEs5HY0AcXqF9quneJdRZ9afUNf07S7fR7WWaFI4zd3btPPMI0XlY4oYnC/3IWBOcua7XlpoVrNLdXUkGmR27STZVnkuIwTJudkZQWY738zKhmZ2BHzmeDxfqPkeNYvE1xDHDo2qWot9PuWcqHlhkYg7RlWeZSrxuPnMcICDzCuIrHRdW8bXN3rlhBb3NlpF6v8AZVvNKIoLs7S1w4dAwLiQx7GdX2tBhju3lUBg2xudNjg8WW+kSNrlsL1hp92pLWM06SCFI0TarTytJbiRZNzncUjAMTKlfwq2j6U+lWEeoW2riOy2LK7RkOSkahyzghQywQIBtxGkcYJJZybmo3uqQ3ol8VWU1/qVjcNb22kWt00kcWE8x5Wmm3FiiyDcz/wyqAUj3l8z+xXvbC41vzb3wx4Tjy8uqwQ7iSVkZ/s+Nr/Z3+T94ACXfChlcsoB6F8L9B/4SLX28Q3OH0DTJWj0mFbp54prhco9yCVVSqjKJgbQ3mFRjax9nqh4fMDaDprWlhJp1ubaMxWUkQia2XaMRlBwpUcbRwMYq/TAKKKKACiiigDmfhlk/DnwwxOS+m2759cxqf6101c38M/+SceFOMf8Sm049P3KV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTIYo4IUihjSOKNQqIgwqgcAADoKfRQAUUUUAFFFFABRRRQBwXjrbqniPTtN3wCWzAubRJUDg30iyrbuyngrGsc8hGc7ghXkAHkNC8qz197PxTGLLVG/eajd3HXUAARv3cZBIBUJxGQFVflXy+4NjDfeKNUS5sIry2nuTaXO8LhU+yxOhYN94Z3jjkb84xkifxLoEt1CiPb/ANqWEYBSFpSl3bsAAHhmJyW46OQSSTvwNpQFLXdct7m4sYtJk3QREBWhcxgsWCoAcqApbaAfmVt2Aj4O3ndQsINOuLltOljitrSWYs0YUwAAYC43MkOz5l+YwrkOMEOxGda6VqtgjN4dvF1m0gCmW2aFbPVLRSiAlkwu6QxAKCPJOMYBzk5ll4j+zXVnFdWE9vqKwyQxWZHlTqQButYjhZIxs2OqxgKw2kFiPnAO5+CulS2Gna5Le3kV9dHUHtUnEgkcW8ICxRsVAHBLvgDkyFjlmYn0evN/hBrFrf3fiWC1u4rsvcQ6iJIVIXZLEIwGySQ++3lLAkkZGecgdU+qXGm+IzaaoynT9QZRYXCrtEcgUBoH92ILq3fLLwVXewN6uG+MHh2HWfCN1fx7INY0iKS9sLvaS0TKu5k45KOq7WHI6HGVXHc1FdW8V3azW1zGskEyGORGGQykYII9CKAPIdD+Hl54ls9Rk8Sa9fw28oksRbWFtbQxGIpskQSMjSSIGLAM3l8puVFG016J4A1SbWvBGh6hePvvZrOM3RIAInCgSggAAEOGBAHUVnfDRdmhzwSXCTTLcSCeONsxwzqTHMqA/MFMqSOM/wDPTA4ArB8Pr4k0m5i0vS00531OOW4mmuHPl2k8LpDNIkagGQSkrIEyuHMhL/MMAHfm/Da0NPh2l44RcT5B+VWJVAO3JV+/8HTnIwdcc6t440fRozJ9n09P7XvduQpOWjt429QX8yTvzbjPWo9R1LTPA1hHZ2qTanruoSF4bRGVrzUpyAGkY8AAADc5wkaqANqqq1PoFl/wjGjaprPiW5gfU7pmvdSuYUJRQq4SKMY3MkaAIvGWILY3OaQGD8VL4NrGg2UZk861MuojZCZCX2GCNAAc72MzlcBuYznaPmXg7bQbTUG064a5hsb4P9s024jDXAhv5HURSSSICgSR0kV8bY5WYKhcxqw7XTPB2oeJNSv9b8TrNYG+8sx2LSLL5ca7lWOSM7o/9W7gjLAtLIcDiuyu9Bhi8O31lp3mJcSoZFneRnladVGyRnbLMwKJyc8KB0AFAFnwxq8ev+HtP1SKNohdQrI0TEFomx8yE+qtlT7itSuM+GE8UmmX6WsaxWT3X261i/iSO6jS5Ib/ALayzAY4wAO1dnTA5w3VtaeN79rq4gg3adbY8yQLnEs+ep9xTr7xp4es/EFvoUmqQya1PIIhY2waeZCRnLpGCY1wQSz4UDknFc54uXwq3jSY+MdJtLxFsLc2st3phulU+ZcFwrbGAOApI4PT2rUj+IHhGGSVE1FInJ3yL9mkUknjJ+Xr70WYDlt9f8Q6peQ61Z2un+F9k1q1jIyzz6grAqWcr8sSY6KCzHPzbelTeJlFyLLwrpgW3W7j/wBIMS4FvZJgOFAxtL5ES4II3M4z5ZFV2+Jfg9YGmbXLdYlUszMjgAAEknj2P5Vh+FvHfhtEutW1jWLSHVdQKvJFlmNvEufKgztB+UEkj++8mOCKLAd3rOh6ZrWhz6PqljBc6XPGIntnX5NoxjAHTBAIIwQQCMECuOvPBXiu3KQ+G/iFf2Ngq4WC+0+C+dOScLK21yOg+cseOtV2+Mvhea7u7Wxnk8yK3aWK6vo3s7SWQEBYvNdc5Oc5CkYBPOKrQeP9M1XSLu21nxvoGjXksuYn0i8SR4oePl3zphm65bYOCMAHmgCnr/hTwxo9xa6n8SNSuvFeuyoUtrSS3X/SymTtisoVAlIDjJcPjgkgAY7yXStQ1bW1udTuVTQ0hIi0tV/1zPGVc3J6MAGZRGMr/EckLtxtG8Z+ANLsrW2h8Y6RO0CMiz3urrPOQxy26SRyxyQDjOOABgAAai/EPwU33fF/hw/TU4P/AIqkAuhXE2iXyaBq1w0quW/su6lcs08YBbyWY8mWNR1JLOg35YiTb09cXrvibwPrelzWd54q0MR5DrLHqUIeGRGDLIp3fKysAQexAp3h3xzpE8Mtrqmt6QL612q86XcQiukP3Z4/mOFYggqeVZWXLABmLoDsqKxf+Es8Of8AQf0j/wADI/8AGnDxPoBPGuaWecf8fcf+NMLGxQeAcDPtWR/wk+g5I/tvS8g4P+lx8H86bJ4n0HDKNb0vfggD7XHnP50XCweC4lg8HaDFG29EsIFVsYyBGoBxWzWJ4HaN/BegNA6yQtp9uUdTkMvlrgg/StugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA466nk03xTrMs0jfYxHZXahIfMZWZpIZSB6bVjJYdAT+PY1yni+0g/tXTbi52pbXcc2kXE3meW0azhShB6EmSNEXPeQY9Dr+GL+TUvD9jdXA23TRhbhOPkmX5ZFOO4cMPwoAm1XSbHVVQX1skjx58qUErJET1KOuGQ8DlSDWXd6DcmyeGO7i1FftCzRxavAs6RKP4EK7Wz3DMXI56jgdFRQB5hqHhnUdGuY9V8KeGbODV7FnaJLe+zFewyczW8hcJsLFUKEBgrqmcLuB044dH+ImjNqekzzWs7/AOi3lvcRHKuh+a3urckYdCQcgq44KvtPzd5XM654TS61J9X0O9l0XXWCiS7gQOl0qghUuIjxKozwflcDhXXJyAZunHxnoEi201jaa9pKACKWK8KXsY5yrCUbZewVmkDYHzl2y5nf4iaLbKg1W31rTJ26xXWlXHyn03ojRt1HKsR71GnivVdECw+MtEuU2r/yEtHgkvbaQgd40BmiJ5OGVlHTzCaY/wAVvBUbKJ9cSBmyAJ7eWM5Azg7kGD7HrQBj+FvEOmaj8Tb+TRXu5I7uGJ5opbaW1Kl0dTMUlVTIo+yRoGAwDIfU1h/FmXUNCmgn0XU7/RLeG8uY7iSJEkLpcxCfcu9WCqZonGTgg5AwGFXPGnj7wxfLp+q6O8+p3enzjIgsp/mj3KzL5uzavzxxNycHZjnOKv8AxktrW50i4eS8khhubRJ2lSRgFjt5leQoVwdzQyz5xnKr0IU0gOm8H6X4f0PQ5NZsbVbAX0K3l7dXk7SzEbd376eRixCgn7zYHPSq+nmfxjq0GpSo8fhe0IksoZFKm/nBBW5Yf88kx+7B+837zHyxseY+F+jrrVldWuuXF7NbaPdtbLpFzGEh3/LL5sg+9MdznaWwo2jCbl3161TAKR2VEZ3IVVGSScAClrJ8WPIvhvUEt08y4miMEKbguZJPkQEnoNzDmgDnvAEE66xqk0ykD7Dp8DEsrHzFiZmyVJGcSL0JHoTXb1zPgJVl0/UNSRZEXUb+adFYYXykxBEUHZWihjcf71a0GtaZcaxc6TBf20mp2yB5rVZAZI1OMEr1A+YfmKANCimTzR28Ek1xIkUMal3kdgqqoGSST0AHem21xDd20VxazRzQTIJIpY2DI6kZDAjggjnIoA5/U2bW/EcGlRb/ALBp7Jd3zhfleQcwwZI65xK2DkBY88SV0tY+i2Efh7RZDd3BuJ8vdXt35eDNIeXfaMnHZVydqqqjOBWlZ3MV5aQXNuxaGZFkRipUlSMg4PI4PQ0ATUUUUAFFFFABWL4i0dr1IbvThBFrFmWa1mkX5Tuxvicjny3AAbryFbBKLh9t4m0S6t9Pnt9Vs5YdQdorR1lBE7KSCqHuQQfyq/p99aajaJdafdQXVs5IWaCQOjEEg4I4OCCD7g0AZmg3NnrViZ5dPS3vI2MF1ayope3lAG5G9eCCD0ZWVhwwNXn0rT33b7C0bdycwqc8Y9PTiq8ujgeIYdWtJjbysnk3cYTK3MYB2Z9GVjkN6FgQcgrq0AZTeG9DYENo2mkHqDapz+lNPhnQTjOiaWcDb/x6R9PTp7CteigBEVURURQqKMBQMACloqjqurWOkraHUbhYBdXEdpDkE75XOFXgdz+FAF6iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigChr2mR6xo15p8zGNbiMosigFom/hdc5G5WwwPYgGuU8GapNFePHfBYjeTtBcQLHtFtqCLmVRwD5cqjzUZgMg5z+8UV3VcV4v8PxwX0+vWdj9oWeNI9XtYY2Mt1FH80UsW35hPC3KFfmIyB8wjKoDtaKxtJ1yyuZrOzgumu/OtFube9yhjvE6MyMmFLD5SQAB84xx02aYBRRRQAUUUUAZviTTTrGgahpyTNbyXMDxpMvWJyPlce6nB/CuQ0kHxX8N9KW4iFywxa3STw7CyMGglbaRx+7kZh7dcAmvQa4HQraO51Dxz4ZubkXBklNxskT5UjuUJwB3AIOffnjOAgOV+Buo6jHrF1p2rSo260EcEYQKYjbMEmXAAwPOllAyOQuR3Ne0V4ToHn6f8VrO5mtY4vtjLcJGtzuMUN1GXf5cjg3UsuGAAO09692poArgPiBqUl3dQaVpwL3S3CQQsFLBbx0JjJA4Ihj33DBsY2RbTuIrr9X1W005NtzeQWsrxSyq83KIka5eR+RiNeMsSByoyCwzyPw60trqc+ILoyvEUeHTjcwGGd0dg09zIpA2tNIqkLgBY0jACksoQHaafZwaVpdtZWEJW2tIVhhiU5wiKAqgk+gA5NeKeGPBfjTS/Gek+Lbmys2u72+n/ALUtoph5scE2OGcttZYtiEKuT7Gu48YfEM+HtV1Oyi0W4vhptimo3MiTIgWEsVOAeSw2k47+oqk/xZsn8Tppllpd5dWv2mG1lu0PKPIAQ3l4yUXcuTkEc4BxTA4vSvhp4gTSNASe2uVv7jS9RtNZaXUS4Lsv+jBvnII3f3Mgd6hu/AHieXw94atF0m+js7TT2tbqwivomkS6woNypaUJg4OPmyvYDpXaR/EifVdK0PUbfTL/AE6wvtYt7COdmhkE+6Z43XGSyrlOSQDzx61FpHxO1NrPUn1TQR9oGvPolhHBMqiWXcQEcknBUKSz9D2FAytYeC9cmuvEl3qi6hJc/wBkWsOms2oEb7kWrxyllRwpbcR8zDGSSPWsfWvBXjC5sNNT7LPc3q6JY2trcDUBH/Zd3HjzZG+b5s/3l3E4x05rrV+KD3Emn2eneHru61i6nvbR7MXEaeVNa7fMUuTgj5gQR+VZ9z8aLL+ztKuLDRru6nvLA6i8HmBTHGHaMgHB3tuRsDjOOozigDd8E+GL208VeI9W1sXLTSXzGxc3bGMwmNASIg5UZYHqMiu8rzbVvira6f4gsbD+zZJrW6ktojOkw8yEzhSvmR4+TG4cMwPoCK2vhZrd94g8Km+1SRZbn7Zcw7lQKNqTMqjA9gKBHX0UUUAeFeFPAfiSC38F6BqWlrDY+Hry6nn1D7UhjuUdnKiNVO8E7/4gMYqpafD7xNZ+AbHSbbTJopbTU5Jb6Bb1GGoQlpCjJl9oChl+R9uSMnmvc9cuJLTRdQuIDtlht5JEJGcEKSK8s0j4myWOmWt/r81xOE8MQavPHFEgV5HlKZGMEMTgY+6BzQMZ4L8DawniLRjrseqjSLLTJEQTaiAyzi73xq4ik+YBM8HcuAAScAVm6N4K8X27yCWC8gu1sr6HUL+LUl3arJIf3LR5J8tl6gsFx09665/iXJbQ63HqWiCy1HSvsge3lvk2ubjcVAcDkgL0AJPYGqtr8WheWOnmy8PXk2o3dzd2n2Tz0j2SW6b3yz44x6gHg8Z4oA46x8E+MIPC11YSaHDLDLfW7bGljW6aJUcO5XzjCWDEYy3PJIyFxc0rwb4pg0Tw3Fr2k3esWNiLxJtKGoojhnkzDIW3hHAXjG75c8DtXTaX8YLO5tri6v8ARr2xtU0c6zC5kjkaaIOI2ACn5TvIAyeRycdKjtfi6JbbMnh29F095a2cMSSqVmM+7btkYKMgrgg4xkc45oAoWXgzXY9F8X3R06VtWmJTS7W51SSSLymhjVl+WQAnIYbmwSQMkA1i6H4F8VQMkUmnXMdjH4i0zUYoZrmA+XFGD57hUcqMHHA5PGM9a6O7+KOrynSU03w5i6fWpdHvrWadCUkRA+1HDAZIOdxyBtI7g161QAUUUUCCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAO9FFFABRRRQB5/4t01NCuHv4keLQbib7RdyQ43aXdZyL5M8BDk+cOVOd7DDTFuo0HVZLt5rHUY1g1e1C+fGoIR1OQssec5RsHHOQQQeRWtIiSxtHIqujAqysMgg9QRXni2dx4d1Ky0W1DbIFeXQZ3bAdAMyadIx7bRlD/cQEgmAsyA9Foqrpd/bapp8F7ZSCSCZcqe4PQqR2YEEEHkEEHpVqmAUUUUAHeuW1C5XSfGRu7mHfDd2tvbRPGpZ0bzyjFh/dzNByOnJPA46mub1+GaPxZ4XvoJAq+ZcWMyHHzRyQmTIz3D28fT1PbNIDzfXdIWfx7pVrpccttci/ltbm4wWWMRyLfRBcnHIuCeSOjAdMH2ys06RAdW+3FmDb1lCKcAyCN49zeuVcDB/ur6Vka1v8SanPoNvI0WmW+3+1ZkPzSbgGW1U9iykM56hGUDmTcgBh6LocnibVJtS1OX7ToxmEqsfu6kyEmLCngW0WcoP+WjZlPGC/otNjRI41jjVURQFVVGAAOgAp1MDiNa+HOl674xuda1pmu7aa0itvsWXRMxuzbnKuA4OfusCOK1LrwToFzrR1Z7FkvmZGdobiWJZCmNpdEYK+MD7wPSujooA5C70Pwno2n+H9FuYFgto9RWbTYTLKf9KDNKCDkk8lzhjjt7VPN4B8NTf2l5mnHGoXAu5wLiUDzwc+amG/dvnncm0nvVbx5o1/qus+D57CDzYrDVRc3Lb1Xy4/Ldd3JGeSOBk15t4b8FeNNMvb6e6gubnU2tbyKS5e8T7Nfs4byy+H83rtxwu31oA9MudD8JeErOx1a5gisING80wTtLIdhnIDk8kyMx2j5txz0qCx8CeEL7RdJ+w6fIlpbQFLOSK4nglWJzuKlwwcgkk7WP4V5JB8NvFNzpGr2l1pFzHBPNp9xDbPeQqokRyJyoSQgAIx6nJ4PLDj6MtoI7a3ighBWKJAiAknAAwOTyfxoA5a4+HPha41BL2TTG+0K8Mny3MyqXiAEbFA4UsAAMkZPfNbuhaNYaFYfYtKg8i28x5dm9m+Z2LMcsSeSSa0KKACiiigCO6gjuraW3nXdDKhjdckZUjBGR7Vyt78P9CfS57WysooZG0saRG8xeZEtwSyqULjdhjnOQ3+1XXUUAea+GfhLpen2uqR63O2qvfy28pKmWHyTBu8soxkaQMNx+bfntwOK6LTvAPhvTpbaS005kktp57mJmuJXIknTZKxyxzuXjnOOowa6iigDmrPwL4bs0iSDS02R6e2lqkkjyL9mZtxjIYkEE85PPvUNp8PfDVqsCxWMzLb3ENzCJb2eQRyREmPbuc4AJPyjj1FdXRQBzF74D8OXkE8U+nttnv21N2S4lR/tLLtMisrBlyABgED2rp6KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKyvE+jrrmjTWgl+z3IIltboLua2nU5jlAyM7WAO0nDDKnIJFatFAHE+Cdae4vXS7txYT3ZcT2TSKTbX0eBNGOeVdSkqYHzLuc43V21cZ4g0+SHxbp80E728eoyKBIqbxFdwqWU7egEkAmiduuFjAIODXZ0AFFFFABQQDjI6UUUAY3im/uLSwS300qNUvpPs1oWQuqOQSZGHdUUM5BIzt2g5YVa0LSoNF0qGxtmkdY8s8spBeaRiWeRyAAWZiWJwOSax/D/8AxOdfvtdfa1vAX03T+h+RXHnydMjfKgXHI2wIw+8a6egAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAxvGGltrHh27toEje8ULcWnmMVVbmJhJCxI7CREJ9h3HFS+Gblr7Q7a9+0i5S8BuoXC7f3UhLxr1Odqsq574zxmtSuf8CJFD4cS2thtt7S5urSJefkSK4kjVeewCgD2pAdBRRRTAKxvGF7PZeH7k2UiRX05S0tXfos0rCNGI5yAzAn2BrZrnNcNzceL/AA3ZxKBax/ab+dyuc+WgiVM9iTcbv+2dAG1pdjBpmmWlhZqy21rCkEQZixCKoUAk8ngDk1ZoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACsrw5psml2d1FK6O0t7c3I2ZwFkmZwOe+GGffNatFABRRRQAVly207eJ7W6CH7NHZzRs+4Y3s8ZAx16I3NalFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    It is important to make certain that all branches of the uterine vasculature have been ligated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24723=[""].join("\n");
var outline_f24_9_24723=null;
var title_f24_9_24724="Pulmonary plethora PA";
var content_f24_9_24724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Graves' disease with high output failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows pulmonary plethora with equalization of blood flow, due to recruitment of upper lobe vessels in the process of hyperperfusion with balanced flow. The periphery of the lung in the outer 2 cm is well perfused with clearly visible vessels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24724=[""].join("\n");
var outline_f24_9_24724=null;
var title_f24_9_24725="Guttate psoriasis 1";
var content_f24_9_24725=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Guttate psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDyLDQjy3XZ0b6gip1G4KByRz9KiZSxHUjucVZtk+f1+leHWep7VJWRo6aQqk4IAwCMY/EVrQBpSox16c9KqadA0zhDsUAE7mOK6LwzaRXOpwrdbUiY4Z+nT3rKKc3Y22HWcX2aQMrkSEdQcYq7M4uIo48qpXghe+addoBK6KECZJUE54z602KHCGTG0Dg4HSiTavBbGsVoWYbaIyoGdGO/BYjjHrXR67Zx2dlaLIkKXMoLMynIK9j+Vc9bKQpdhjsPcU8vmRct8o4XPYelVGajBxsXGOtyMgBgRjg4JNWFkkSMCIspPy5B5x6UwqoYFiTxj6jFKjlxtVuO3HQVgnbYpIUuolZ5leduqYbHPoTVi3hWfUIEwBsycZ4z9T7VChCRhcnPY5/OtWCaI2UyWceFDBd5IJPHQ/WuijHnd2Uk2tC/c6z9pkVb47xGCobaBIRjsR+BrnrmYmKSeQHIQsR6Y7Cppgyuio2VZc7iuOB6fyoVQFWQ7SRyIyeSBVVZOpKxTio6ILJbeext7u4YQsxZJkjO/wCYDIBPqRjjtUchDsqoo3D8PwpEhW2AWFv3W4yEDpuJ560rJslWTnlsFT0Hes2k0ZrQdAgcqN2PU56e1TMWUkZGzJGfaoJCAxJTA6jB7dakSLIf5s7gMg1jLfQtFgIAoKn5j29qUbnYgZBA71CjAbTyT6VPAnUyHBHrUat2GTRpxjqD0p0QO8ADGRyazoVni12WQ7mt9pAU/dPoRWnE+6XG0HHWk42QFqBOMHJ469KkC5wWwp7YpYsshIyOxFOwGXAH1OKkPUytdsReWuOQVIIweBWRY2csEDiUDDNkL7e1dPO/7rlfbgY6Vj6jFIyAxyYwcnmrtfVD5rx5TJmTawVQcZyR6Cqk5RwyPhgRyCe1aU0JL5wAT39agvEhFo+0YkCqMjruz1/+tTjT5iCtbQ/dC4BOT7AAdarzSzWrWUjqWiuRwy8bW9PpirkyJaBd7Zd8fKf4vWqt3CZriJ2ldxEBhS3yrgcYFVUgoLXchPUsSzXCW4MCBnPA3VpaUbe908zThDhj97np2H1NVBEk8Hlvyzd6mggSIBFXaE4yBWcXyu5aaStYqrHMyxQyNGUjYuNq7c57H1rThXOCT8pH0qIwl8gE5YHBx0pkTyRFo8tsHA3daV7u49ywrKz9M7etTwMqqzcD2I6VWUknd0FTLt2bh36j3oWoh5bdz19TTCSFYA9O3r7U5Pu4xjPWnBVbhgNwHrSKWjFmtpLOzguJTkTNjGM45qq4bezkct1z3q3ezTTrEruvkj5gB/8AXquxO059jTm43tEvmYhIc4xwq8D2/wAafGqqMMC2PSlQgNsDfMO/4UuW2nkDP8R61IhjHf8AdJA9KhlDRRySCJ3jjI8wryFB6E1Jv9VOcd6ilj8xWKM0e4bXAbG4ehoBDM7o+MlTySDRt+YDcQ/oe1OEYjjUhhs96kaMqNwYknuwppEEDjaDzjB7jioyCznbkY6elTriRsPnAPfvTpk2DKEAN1zTC4sbLJCElG5lOEJ7f41uzJvsmMqMPLiCjHZe7cetc/bhldEjG6VjhQehrqYZxaWpNvEsxkQeazEHy26FSO/UnFdeHlo0RNuWhzmnSgPhJAFPYd/p+FM1S3CyRywhWVuGw24j61uyadE9uslvEYRG/wAuB1Gf0qI2qu8yyofJnQtEMcow9/wINaKk2rDumjnY2CkKMnbz171oWrS38yQgeYwVivsOpqO7sI1SR4piJNpypGMMDyv5c1Ut1DqhyVYdCprDldN2ZCLgyxK7MEHac+tSKAuM9B2qGCaFXMIkDSHBOe1FwHlQodxBwTg9Rnpms5blkrMuGYrgg9TS4GxeMgjJz3piwBCwG5Qxyisc4Hpmpgm0EY78ZprfUBojAK5AIxnFU78iYQhUCrGSd3fpgj6Vbdiehznv0qrOPl3HJHTmrU7KxLehzvnLO8yxlldDyCOv0qsxXy/mPBGOau3cKRSM8YIZ/vMTWbOSWB6D1xWaM5rsZ92yl2jU4YDp0IFFV7mAi6N0HwWGDxRVEOyKt7bLFpkTqykHgeoqpYqSRxgk06NnntIFYMVVSBVuxgwcKR65J6+1dGIleWhhTTS1NmwsyU80qoycKx56VtWw8n7y9TkE+vrWxHHYHwxAIVAuekrYPzNjr7VlxJvIAP5ipqx9laxvTXMrsmdTNcKU5OepHT2q7ceTIA8MUkWR80bHKr7CrOh2LXzyKCF2DLE/TrVe4BV265Tg4749Kl80Y3NklcqyBlUENkkcA+n0qx9maJ1D53nrz+gqlPMN7HqentVu2V5rX7SzfIFPvuI7H0qKaU2OTsOuHiL7Qcf7x6UxkGEkGN6AjaD2pjlfm2tkDoO/I4pkch5faBnipm1zMtErbplAIz8vyr0zVplktxCjAJFu8wDHU99350/TI98gYzJCAN3mSDIFaeqyR3ksMUDi4uFBXco2jaMYOPzropRfJzIqMrOxnGRnZXO0pGNgXHRfaopSqupG4c578ipZYngJhlXEq84Poaj++Sz9f6CobYtiQoHkGzAQnGG7UrIpk2uDx0NPjiMkIOC55HHU02ZhK21d28HHNBNrkKIHmyrYx6jPHfim6hK9pFEoQF5G6Z7VYiKxyBQuD37mnTuJkVZQGKEYJ6j6VLsiluSuEAXEYx1HPOKSNwC6luSO/T2qBxvbIJGAAc96WGPaVY9D3P8AOsZT10HYvBQyhcAZ561NDFzheqg8+tMgT7rAj169auwqC+QQAenNRcCSLBGGOOOKeik45yCevpS+WDjJB709VBO0H+lO47XK064ywJ9fY+1Y96x2FSCM9wa3JkJ6/WsS+XKnH6/rTuIz3kB4xk5yM8VSuXaZWAPzc9eKtTRj5eM5HSsxl27m6HkYo5rEXI72+R2+zxwztyvzuQFVsdPfpUkZ3FFJA7j1qJ/mKM3XORn8s1KqB1aQzBNvAUjqO5BonJ1GCjd6F23zndlTxx14q6rfMo28dyBVG1fcnyHKfkcVdVgo3LkDoBUXHYcDliVY4HYU58kcAbunPamgb8kdSaZGp3HPU+ppXsBLFD500ce9hGxwTjoKde+XbXKQQOrjO3cBwRSx7SHDcgjp7VEqDzC6jIA4qk1bzLTSRZiAJGRyBxTsblBK/P6io4zgEtjB5yBTmLBgVX3pECEFg27g9Mmo87iF464+pqx/AUJ5xzxTEAAxgYJzxSLQ1k5G/GexWlELbOCT/OlJwmWZd3YinqrkemR/k0wIdvADKRnue9RsqouTjA7EVMqM0u0nAUHPtT5FzjILEDp607iK0SMU/wBnOBngUrPuZATnPTA61OhxuDJgZyPaoyGyAOp5IHSi5IwoFJUsMnnP9KX5WJycccgjikYnPAxkcGnEnocnA5FAFSbK4IHzDowOMVLbS4DtJ8xdgW78+tNlztO7aPT3qJCQfmOAKcW4MFobr35hRokjZ4mjxHvkOcf/AFqPDn7y2gtri6kmlhiYEysMNzn8cVjCQtGyNxjvnpUkDLt4JDKMjFdUcRrqK2mg+a6d57yBVVQTguuPmYcZqgwMcRXbwuT15+lWpwpDBQCxblu5JqOaVIBlyCQMcVlOrzSC19Dd1H7BPpKNBIBNhdse0ZB6Ef1rPhB25OSOBj3qlaXiOzIq7W28ZGDitCGRSu0KAAO1OU1PoFraAyYz0BPY05VG38OmKcuRjcOcfpVG8uZllcIuQhHB9KnYVm9i5JGAONwH+earSKpQg9B29asBy8a5+bPAGOap3Dsmewxj8KpiaMq/RQcfw9KxJ1D7ipwq1s3T8DZg7upFZM+yLeACWb5jnvUGcjC1a5+xwRnaW3tjAopbzzXDL8oMbAo2MiitEtAuupQhDTWtvDGdqryzH+VatlBmZQpB57cVmWMZDEnLAcfX3robHCgEkA+taSnzSVzGGxtY8tTHj5wACM/5zU8MZIJDDZ/dPrULqN4z8xbnGcfhV+2jIQFjnmspybep0QRatJJbfc1tIYzkHHXI9x3qG4VF3KGPrknOaniXayjPLH71Q30bDIPBA7UOb5bGyWhh3Tkb23bfqODUVprVzawSQW8ojDA5IAOc/Wk1DI3K3I7471zMt0qTYIOfXNTTm4u6Iml1O3topTYiZzthPA4+8QPWmAnDHkFeOKq6fq7T2VtDcMVtbcNyg5J7D86VJssoXC4PPpWlaK0a3Ji2zXhkKxrld2OhPIqfSZZY7grbLJ5kxG4xAZVByQB781mwv827BB64HPep54wtyZE3IF67fl+tVRm42bNYaPU3PEBtTqh+yowiCAYZsnPqfes55FJUBV4I4ApykzCQ4wT1x3/Go12mUKcjHODzSqScpX7i2VjZ0yEyaddSpuWXIKup2heTkflUFiytNcSuQUUjDE4Lf7QHvVW2eC7gutkgVrYfNHk7iv8AWlDLGehPf0rbmSS0Gn0Hn5T8o5IBP0qsWMgODxnJHc0kr7g4U4B5PvU9lbPNJtQFm27toPbiuR3nKyBaDUxjO7Jxxx2qaIg/d4z+eKZMpiZh0wSpGOlSRRHsF4PJrEot2ynYM9Mnrwfyq1byMh2Zxzx71AoIYHnPTdVm3OG3ZU5OKBpF2MbgQzcHkZ70/GCCcY9aiBOQMjg1KMlcenSgCKR/kIycVlXP3iDyScYxWs8fygnGcc8Vm3YIUllwF6etPYlmJeRnaNwGVH6VmyIMNwDz36CtO7yg2kn2JrMmHysOUGO/Sk9yLFQhlIxgqfX+VSRgSMilQCpPOajc4COOnTiprVD1OMHke9TsUrovQRlBkFBH3GMVeMfyL2bqOetQW4wmOvPSrEYP8Y4A79qSZQhAUZJBbHrSxruUsh5zxmlC/Nnacd6fEAFOccnNC3E0Mbaud2Rx+dOjOIwNoHH4inCPpzxu4A7051Az7nBJq0J6CRMoTheM9+9OTh84x6kn9KaxBHT5R79aZgnaeVBPHNA0yygPzAgE9c9KRiqthQfr6UiE7hjgfXj6054h5bZyeetFrDTItuQSBhuvPOakDAAByDn27UpUlT8xA6kU11kzvGR8ueuanW4bgqDzGXgBRuJ9afgOjdOnXPNRP5wTcgGAPTrVqJcpl9o4z1ppahJEbICO3YcUBdmGKjcRxntTnJ2/MNo9RSjDDgZOMdKogqBsu24AntmmNsyPbvVyVQAT2A9KzSWdiQFfI7GgLNiNknJGCBwetRKMNkkHuSfSpz80YXBJBA3U3GSQB8uT0PNFwInUH1L+o7iov4ioyD2PapSygjKkH1pu7cd3Rs0gWghaWZmWHYHRS5VuMjHPNRcXMCFFOTyAx6VJJbIz5fjA55xkVZgjVE+Uc44AFM003QlrppLG4+Vdi4x6496twKTINg2DHUc4ojyqdDg8HHerCKqgEZx161aa6EvUcqZJL5z7d6eltFI4Z1XcfUU4kMCQpwKmjztOCeRzk1SJ2IZUUBlBGfX+lZt1GHGT90deK0pc4Jxn3NUbgFgAQV9x3qhGDdxgSfLgCsa/4GOOnSr19P5N68bRhcgHg8D3P1qhdsFZgcEnpn0qTOUWmZ0kYYgMWAJx0opJJGjZXjIDoQVOM4PrRW1OStqZFC0Td5ZweccV01ranyA52rk4IPSq/hu1gnkYy7AoXnf/APW/nWxZOAsiId6scg4yT9KcqdlzMmnqMs0YyAkZ+h61vQWrSRR5zk9DnpWfbKqygkEDJ5Fdfp2jyXVpHJa7do53OxGTjPSpp03U2OlWjuYDwsGKPwO/+NMuEdodpcMvPPerV5vM5J+XaSNuOhquwYEZ5BrCSs7G9rHN6lb5RiOQATmuC8QK0EqzLnbnnivVJ1ikMnmZ3c/SuH8RWW62lAGeOMj1pxVtSakW0VfDlyLgxpvGGIA6966VNscjgEleQTnpXnehStAzRsSHRsg5wa6+0l3L948fwnvWkrLQwSsbtoPMYjgMe4NauoyRokUcEU6Tx8TeYOd3p/TNYcY8yzkjLEM0ZUHb93/69XJrh5mzOwLyDkDr06/XimnFRsWnrc7GNraTRBIkMSxNHkMH3PG3cE9OorGkVTKHUqRIvUVVjZvsb25lJiJztHA/GnROd4DuSeMj0rapKM2rBfsTpEY/M8uLYz48xwSSwHQH0qN2LNtVvlHGadJcuykCRsED6/SoSxEQBC5Yn6j1rmqVL6FIehHnOwGQDjk9KswXMts/mW0nlOfl6Z49qoqdv/1hUsfDEqcgDIB9KxjNrYsut6liX7H1qaE/MxbJYkYBqmrZIbaRgd6sWzbiwxx+tGr1YF5NxQ8Bec8HPerUI7HOc5BAqlExwQcjtWhAymPvwe/epZS2J4Rv+6CAefxqaMMq5PzZpkXyADOaUMMcE8c81RLCVlBwTx6ms+6fJI5JA475q42OTjI6kYyKzbzhCGI9AarYlmXeEMwJYnPGDwMVkXR5XAzj8q0rtt2Vzz34/lWZcEknOQSeamWoFdSCFAfPODkcCrkK4UDjCmqkhBuGEIwABjjAJq9Cq/KWXIbj8azluMvW65U4B47elWVBJ6Njoc96qwMAjjlT3zWrb2lzcRCWKJmjHfvx7URTk7IpWKuzOSVORjkU58AEqMccEilZ95YPng8AdqecZALHkdKdrEsiRtoPH4+9Mbe+AoJHXBp7hXIIB2j9ahhVlLkZ2knAPXFUKxOBsG05yeATTtsjqoJGxe3Bwe9Q7gSCpIIPp+lWIWCgbmBHegCSOMovHI9TSsGwMjBx1FOZWKdSuTjnpRgglm+YkYqQXmNQfJtzhR6Ugn2EK6kgfjTkwS2Bgjnik8lVbJZi2PuildlqwqDIY8HjpnoKfKNkZDqVU4z/AEFLGpcHbnrzmrN5OblYmdVBQbAQMA49auNrXZN7FSJQ3Q/h1xTjGo5GQ/pWhYWaXFlPIJolkjGQjHG71IrOIUAAHDc5puLSTfUnd6Ecm5nGT044/rVORR5rEgYz+FXZcqedpUjt2qtMDjIXGTxz+tD0GV5ABuGM5qAu4GV7/gBVmQbSR0PrVcxjYRkk+tIEMBDEnkkdMdKRV3tkrgY4GeaMkBsBQvf2+lNDE5yM4HT1oCxLIRwNuD0z6VLDkE5+Yduc1EMsAcA5PBPFCE7RtyF9qVxpF4MM4Q/L796mjk3Eg9BxtqpEhRsHqec/XtVqNcbcqBjpiqQyePKnIPX1p6sAMAtyeKbwh39famhiD7dvatUSwmLAYJI75rNu5G3Feq9j7+lXJSEfrnJHbrWbdv8ANtBwAc0yWY+rWcVxIJCzbkAz74rLv/mUggD6dq2LuQAkEe4xWDey4OM/L71OxlJtlB8MCWOF9+1FQ37M8KoNuSdxJ7Yoq1YnlT6nQ6TYvDaQ3gYPC5ClgOmP61t2SK9yEZTtcHDD5QP8a5/R5UtUlgZT5byCQrkkbsY6V2F/OryoYpGMYQBdowBxyB6iu+Si4X7GdFu9mUIwA+BkDqxNdLpuq3lnHEkZ/cBvukcY9j1rAgKyN0568Cr0alUUEcZzzXFCcoO8TrUVLcuXW2Wc5UBiNx9KrPGeT0QdhU4B53DJYcUh7r2x1rGbcpXZulcy5U3ybVOwEYyRisTU7SSTeu3cegNdK8Y2lSf/ANdUbh5IlKKuQwOR60426kS0PJbu1eHWCIlyWByB7Vr2MuM8kY6Gp9bElrem+PLK2SAMfKeorNhnBnLR8Rk5A7ba0aurmE9zqLNgzAAtgDII5xVlG3OGYgHOM1zqzyC9tZLZ8Ro2ZB2wen1roYpUMpbHzHnA6Ck46D2RcScRJ82WY8AjpRFI+/1zx9RVffw3fP41I0iBflJIb+Eiod+g0iwHAbsG69aYHPmqcqScZxUEUwYskmN4A247ipDGJVxnhsGs5bll1woJzu3GlimBYKTwOuapFiAFJJK9efSrKLk7gSB71A7lxJEz1IA6DGaspLsLbgQx6ZHFZ5TjgDNWLdcFT+AHXmqv0GmakTkrweDxV+1XauM5HbNZttuEjY4xx7VdSRy3AGD1wOlFhpl5zt5qQKMDnJHJqozEBWGS+eAewpySEcsPwpjZLMdq9ef0rLvWUAkjgdj1960Hl3ZBwKxr9trZz/8ArpmbM2YqWzyMfyqk+PNA+Xc3T0qzKxYnaCCO5NVRgqyMoY4+X1qbXAYsR83IU8dDV+2GVIycHgZ71DFEdoYk7RgnjoauxR4xgnB5AHaoY0bPh7To7iGa4nBMcRCr/dJ75qzc63LbpNb2AC78IDt6e4qrBdyWds6QsAJRhh1FU7dZneRlRpMYLso9a3VTkio09ylG97i28QRBxk8de9PZThh0HoB0qRHDN+75B6Cn8fxHPYVgt7MGisIt/wB04J7t3puxlfC5bHUdM1PuaMZHLDpntTDmRCTyRyMcVZNiE4EmD09qdGm5iTg54pxADA4XPt2qeEZXJwTngYpWC9hyk7cFVGCKsyLmEkc+uKgRhycYz1zUiuNrEEAdRjvSQbkUcbI+Wj3bverGFTDZx7+1Nibc4APHTntT5FV2AX5lHBLDimMj5x94KDnORUoIMQCjkjoe3vUKRgbtoABOWz1H0qVZctk8Y44HWl6g0NWN1XjaeP61FJCzEg7lXpx1+tTxH+Lnj1NR3CMd5APTse1NElYAqWGOOnNNQByAWx6cVKybNqtkjuTUDStby7hk7eT9KdrjWpHcoPOxISCfmx0zxVeTKglRyOoXvVvWJYp543tU+Vhkn+7VZixftjv2/KnJJOyHaxXbHUk47cc1GOAwb061IzfMTyRjGDUUh+Ukc8/nUdQJEkyB6HjPvSptLbQQV7j0qsMh8ZAHfHrVnphlweOmOtNq4rlhDgYIPuc1NCzYADEjPSoOw2gH/Cpo22gjjmqSBtFlG7njtn3pTIu07Pujr71XDcHHBoLAdeT9cVaJuJJIG+n8qzL1ixYjqB6VadidwUjkVn3L4Jwcdq0RLZl6hK1vatJgMegrHmkEqB0G0kdM1r3u2SMrIMq3bNYs6jkKCFBqGtTOTVihduADtPA68UVFeMT0GSBzRVIzudBAyvcNKOcnnHFdFbYEIBfoOhHQVnaXawXOnfaFmCKoxKD/AAnHb/GrVpbPbQNGu9lbLq8h6/8A1q7JxcU33FT97U0rKJnbegyOdvrWwYw8a5AGRxz1rM026lhIeFgJlHykjoa3NOiZrVvNHyyP1xnB68HtUxpqULLc6oPuRJGSFKdF7U5oyRk4BPWrP2WeEsXjdojxuHQj1+lRsCFYOMjtj0rlnBx3RqpGdvYbsYIycZqpNEzDaD17itLG1t2MD17VJFbecN6puA4HHeiMW3ZA/M4TXrHdFIHUlu/Fefwk2k00Tgkduegr1rX43+0lHjVE788sfSvNPFNsY386MYMZ5UelbOHKzGaCykJVo1YfNxmtiykcRp5jHaoCk+1c/ZTCK082Q5iXsDyCa2EnVoldG3K/INRJWRmpaGrA5dxtYbvT1qUSZYAKDtPGOMZrMgkd0G2MlunIzV61KpIBNu2jjIrFlrQtvsWJpSMKBT7W4E0HmIpUA4I61Cihnkwf3cgAKnocVPBCI02RJsVj196l2Rd1YUgqBn8KuwSjC84B461WmOQoByR3z2ptuoLDbnGagEaOQ2054PU1csGinh3Kw3KcYPf3qkUPHSnafa/Z5PkdmB9ulGtyk1Y11Lh8JzzVtCARwenXNVV5+62e3pmp2k24wOh/KqYblxNrAMT14zTOqFlyp9+9VwxIc4PPTmklm3AEnj0pO4bE0rDGTggdMGsa8fc2Cw3E96sTzbzjJx3wKpvkuScg+wB4oJ2Ks3LjA59qikjG4LGCS2Me9XY1VmdmG7YMZA/U0W6O8zBTzjt/Dir5L6lWNO10xbaIveASjH3em0/3vcVRgZXuHKnaoztHrV68klTT2V2ZzId25snn196bo1rHJbySzNxEPlUY/M1pUinaMUaJWJnC5ySBmiKWe3tpUgIDSH5sjORjFV0LvcbIyrHBxjnj1P8AKrSMpkJjwfbPNc12mFrC28SxQgAc+nWnScbhwBgYx3NDtuAxx2ORiojnIK7iM96F3ExrKG7dKR87fm4DccVI3D43A9uOhFQu6kF3DeWpxkg4qt9iUm9iMybn4BHYk1IjkgKSDjgnPWo5NrMTuB/l+FPjTaANxw3TFBJcA2jBzkjAPpUs0MK6aszSHzyeVAwPSq27cjIe+MmmzR8hSuS2T7ChaFIniCiMYPzY7nr05pM4U85Geg9afI9r/YyFEP20thh2YeufaoQPMhwSA4/ShpRG7PUfDIpGG43H5QevvSu22QcfT0FRLERzuGV5zjpT1JYDIGcY5HFIB4YKvzBSD1Oac8gYdApx0HPFLYyW8F0Wv0YxEHCrzzVFMkkjld3y9sVXLpe4iwcyAYIyOAT0qrdB2Y552j86tOH2E7MEDOcVXWTKh2IbI6UC1WpABsjwcDPY1UkfAG3nP6c1ZuMuirnAJ3HiqjEZIzls1IbjRnawwajB2twvXkZ6VJu+U4AHPfvTCxbIPOeB7UxXIuvzAkYqWNto9M989aiIYAMWwTkYFJnoAeD2pJgaCfIBnuMjntShwoCLkkDJqtCQCwOD2GaGcg4HUDkiqTuIvCTKZGM55FRF89uaiRhsw3TOTSnByGzx+Rq0JuxHIcoSzkHrjHGKzbklc7jnPetCXcoOADgdTWZdnJYjIq0ZtmbPJlSOCp4H1rPuPv8AHQDJq5dcA7cYC9BWdcviH9TQZy1KF4wwcdxx2oqtcy7/ALwzjiiqWxJ0+jMzW7xM5RGAyM9R9K6pp/Ns4Y5JAyplQR157EVxdjMIoRMwYoBkkDoK6S0nHlgxnIbDKQf88V0+0XJyscE1qadshD7W49c9q2bK7MHypyrEZFZNnMhYtIcBhkkjNalzGvlKYSpGOo71lG8VzI3SudFc61C6HYAgICDJ56YOBWdJsZepBPrVS1YMoGCDjnNWSmBuLcHgAiitVdTc1ilFWRWcEEh8Y7fSi2vJbYOsTAE9cjNWJUQRpIxI5A6ZqldKEkKZ4Bxg1mlKOpTV9x1wY7qGfcFdmG4L6mvOddtVljkGzDqdrLXb5aFlKlVwfSsbxRbC5tN1u37wsWbPFdKnzx13M2lszyQu9rNJBJkoexPBrVtrsLbpGuVVeFGelJ4itCqiVVy3X6isu0uA6DJwQf8AIrKS0uY+R6T4Ut4rhcyMqrsJJ/iOPSq1zKglZI9xAyBz15rAs55Y4MpI4yMHBxkelWoAw+Z398d/WpqzjKCjHcUU76mrLcbYydpIGAF6dxWrLIyxeVLFtmRtrYOc+mKzLdkMBGdwfgipxuBG0nAGBk81ztpR8zVMsKckgkY7eg9qmgwBwvQ55qtECeABz6mtKCI+WAc9PyrOKHclj4Vc88VdgHyjsfSq6LtxhvlNW0IjQDgnGc5q0hFgNt+vt0oQ/OGJ4PqKZkliMH1zTwy4XuWwBk8ZoZUdSQnCj06nFMlwDtOOB2FJIoG5ScnNRyj+IHmpZTViGRlRSTyx4AFRqGk2iNPmz25xSSqu5AQSuckDqR3qZ7yKLdFHuPmFTHsXnPp61pThzblKPUTzzAsSpHmMElm7hj39/pTLW6lhtGhjiVppSfnPXB/lxUl5BLabUnMbcjhW3FSeeabGAcSAk9vX9a1nJwaQnJSNLxDcRy6bbLNIhmVAqiFPlx0yT1zRqU0CwQ29ovzBMFh1x7/Wsxgz7pGXeqDJHUCrSopVpAoyRU1K/NsilHlQ1IR5JAHPXg9KiikWIORI/nY+VCM7j6ew960V2qcdMAE+1NZFeQsVHHr2rnTSBPoJud2VdrO7HoKnWIxBvPRkIHHHXmksC8d6sywGbYD8m7GaL++N3PFFGjxxR5wp5JNWlFxvfUfK2V5E3uduf8amvLuRNOSzMCEJkBz3z600sucDgDuKji8ma5CXspigAO89yfrTg2nZdSbWKkYMUCBjwD1zUiOMgk4IPPHSmS7HuJVt9zW4P7tmHX6URcZ5O4frUtWdhMtoGBBU57jNLk7t0gJyOMHqagU8j5xgYIHXFTRuv3j9cZxmpAmdUaMc8jsKgkcR/J8pB60oxgso5OAcGl6tk5Zj0yKTQ9hQWcfLjAHHNSL8qYxnjggYqMkKOeAB6d6RJCH4yRyKYrEmctsPK9SR1/CkQgMGxkZ4FJGMdVGen1p3yhyuOehA7fSnYVwYSFWCOULgq4HpVcR7AVOSBxnpUjMFOM4X3odS5ZuSoGTjnAqlsCuypNndnBx0qrMxB6j+VaaiKa1OJHMoO3bt4A+tZEh3SshIIQ43A8GnKDjqU421GTjEe8dM4IqASnpzwMVJMg29cnP5VDyrByOvGKggFlXzepdAORjp7U773TIHamFtuAo+XrmnAZfcx96TVwZKXZY8DAIOc023SZi7SspdiTgdqa7ZBCcrnmk3EErkjIwaErCv0J2faF5H5U8SBsEbfrVRlbyS+3KdDgUwOUAGdozwauN0JomnlUg7jms64ICE85J4qR5Cxzj8xVW5cKmGLDNaXMpFG4JAIXHtWfcLhCGXJ9jVyZwQWwfaqFyWKklgB34pozMudQRx24OetFE3U+/f1op2uI6GythGqxZ3RMgPXPvg+9asZOVK4wo2g+tVrdWjhCl9+3AVhjv2NWLYxqSuAiZAJc4AHqa6q0XdJDhL3dTbtixiU4X7uOfWtO2chB5jdf4fSqFugfT7e8gZZIpiwQqepBwQPpVyMtwDg889sVlKLjozeOpo2x6fMCScKf8AGrU8VwkEBljZd5IKkHA9Dn0rPjKltoOBzliPatpXkh0VIJJY2jYc7sglT6VrShGUXc3V1axnM/mYXf8AKe3bioZurOdznpz2pyIojKAcL8ox0NNZ8DYCMgelYTutBzVnYpXQA5wxH1rIuipQ4zjnkGtW4IWIhhk9jmsudcoePmHcUK5nJHG63CrIw+bngE1xAT7PdSR8/er029tfMjkeThQOorz7xMgtb2IggndtatIptGUo63L9nKSoXrgd61ogXVQWPHfPNYOnyEHdkZ961oJGHYZ7VyyVhM17c7nwCT+NaaS4K4Az0/Csi1HPZX69atQiZLkMOeOMnpUWZSZsW77BzjPTNXkk3BdoJOcGs+JcgZwAT6VadWaIeSQrdiarVbDW5owo8jsi87QScnAUetWY0Ty/lO4EcYqlJbSXUDknIZQHBOCy+hPvU2mgRYhf5QAcH+lW42NLFhXK7lbGT3qRzHFBkjMp754FRXMRjOZBjPYnrVXaEk+Y5THIzU6LRlxtaxcTClZpEZoj1wemO4qK5uBNKXRGROwzkj/GlnuTMERdyxr0Hp7UwjYC2D04IGM0TtbljsDbRCJzCk26Le7jCnGajjSZbiOaNgkinIapd2SWwSew9aQuzAYXODyM4/Ks+bYLjriaW4YM7g4YMQo6tjHSp9gUdySOhGKq3E8rXImRFiw2VRen0qe1L3bs8uQzk8joPpVSfM73uLlVtC5pdi2oTyKp8uFBmY5xwKdqASzuTDExIGOo6GiF3tXMsLlZemfSoJBIQXlbe56knnmiSiqdluCfccspbPXcanjXaQM7e9QW8M81wI7ePLdWJ4VR7mrt6r20q20igSqMnHcEVMacuXm6DbS0GtLIrDY+N7Yznp/9alui9qBHE+WmUhj6fSkt4t+RIo56g0ySAIcliT9On+NNWSGmMXAI+bjsTTX2Mp+UcDODzUwjCrtAB684qKUeYyhT04OBQl1Je5AgVF2oOCPrTWC4GQSw9ulSMwU7c5HsMGoSQQTtbj1qGIlU7YxggEenepPL3EZ+VTz71T8xieCOeasRFpBtO5m+nShajSJlwGXOCDwcU4OSuclh7VA0nlgY4PqetOhlBBHB/Si4WFkbqNx3ds+tEZcuSDj3xwaa6kkM2eM9R0pyOpYe3PFMRKpbJ/8AHfalLEBixGfapIypQ7lH19qikKnlRgD2q0yWIfuDABzzn2qM3E65MEnl8YbjqPSlE+wMOM+/NQkhiW4yRnmh6PQaditNksCCV4wMcD/9dR+SsaDnHfOatfeXcGAzzzRFCbiN8S7SvAyO/aizk7F3bRmk7h1z6n0pCcgjuvQ1EJJBIybdoyVYDvTjFKykxKz4ycDn8KlJ7WIGK6ttBx9acQOAPrwaqowbapG04yeOR+FaS2Re086PGcHA+lJJyeiFYggA3srnIHGcdqjdwQ+DkA8Ec1aaDyrSO5KFk+8ApxkZwRVbVFHmNPZoRA/O3HCHuK09nK1w0JIb7zbUW7xpwfvnrj0q6LGO3uBFfAhWUsGAzis/RoluJthJ6E/KOR+dOmlnlZrWWVC0IO193zEEdM966KWsbzQNlCSRPtkqIcxg8EntVfUyqyKU5B7HrSrbGSNioO3v+dUZ0KSZkYsTxyemKyk9WmZu1iCXIySc8dugp1zbhbFpGY78ZPpQYy65XJ4qrqU73EXkqmCM5INaUl3MWjFuPunaccUUycAR7Tww9aKa0IvY3NMumQMxYlXAHNbthMsk0ZQBsMCQy7s/h3rl9OHmMF49s966LSwYw3AJByATWnO+ZNjSO0eX7TZI+2OBgW2pHwCM/ex70kkgLF1A7ZC9qxrdyQCpzx8taMEhYBscgcgVVWfM9DopqyNCJf3eG9cg0vmRxXS+ZFO4fnO/5c+ntT7aX5GU4IzV61Y3UyRrGuw7gx4+XA70qbaehtGTWpGbKKC63pKrJKu8ohyFOKrToFYkkA84Lda0mVbRURkw0h+UKPyrPnAK/Q0Vo66heW7KNyieWONzD0qhcRkqc/KKvu25sEZ45x1qncEklO+PSsSWY5uPLlJxkZBIxXBfEC1T7MblWJmMhfjoF6/zr0K+jwh2jnHNcT4siMlpJGWyAO3uK2pzcdGZyZhadMHhQjoyg5xWvHJu2nJH1rF8KWsl1pMkikf6OdpHrzWzZLuYx4P1rGrDllYm6tc2bWBzCJmI2npjmtBZPsyQS3BcQytsViO9ZlrKwha3RwQDkgnn8KtFpZIEich4kYMARxnHWo0D1NdyRM6A5IIzg5H1rd0i1R2UbgZSM4PvXP6UI5WK9H25J9q1Fikt9zO5SIjKMn3s49a1owu7stWRrtsS3LxEsBwSegNZyTN5pkBBHuOKk1DVo7i1S0sYjHbRH7zfePHI+lVbJfM4VScHGQKivJc1olxk5WZcSSWaYFssxGR7Cll2BxH5g+YjmpbMRJukmkAYE4jzgiqe3dOJozyORvrJxtrLdmqtfU1tMjs7aczag7ERjMYBxg/16VS1a+ju71hZpsj6ZIxk1GVmufmdg6jikKCFCTyAOTVVaq5eSKE73AKUiDNyRxU8uyC0Vi37wnpnpUMNxAsiiXLB03BlGR9KV03sWA91GKxVkgStuJawSXsq7AVhBzI+M4Fbl5dWttbwR2fL7PmG0foaoW92LW1lCxMzsgREBwOfXvx1qCe5h8jyrUMzA4G4c9OSfxrpglCD7jdmx6P5hB42jk+9TEsFyCcnu1Gl6fLPB9oLoqAkYxyfr6Ux58ylYx8vYE9K53FrWRLRNZTvYTrOYfOjI+bD4YfTPFRLK9zdvM2EDZCr6DPr6+9Ssp2DLDmopYgcjnpnA7fSqlN8qiGly0JCAdp4HT3pJpyUDAZ4xj61Asyj5CQT39qsxKJFw3Kj25NSh3sRl9knlEhmA5pocLnaSGzx7UkqJFlQNpY8n0/GotwZ9ysMr0py00Bu7IpHGQxHPek3+YGC/KMcmmXJJyQfmHp3NSTixi0uMif/AE45LYznp0PoM8Uow57+Qtiv8zEhMFh7dvrW7ot1bRWrQ3GFyTlhyc/54rAhnlTa8REZ27emeo6U+Jm2HcC7k5+lOnJQd+o2SzOJLiYQ4WMk7R6D2pVUKRnp3I7mqNxOIkwFAfBz22+9XtQRLE2a+YZTNEJS3GMn0xU2cryF5E4ckgk9BzxTlPvzVaFsnHTOOSelWBggHuPzoQiwGJiIx/jUMjjZg8E9OaQS+gPoKryuFfLDIGclaGMkYjOCDx0xUTSkcHAJz74prygMNhHTJqOdyTyAB060XJQ7zmiYMgRvZqps8sczOr7SxzkCpUOTggDHPFI7LIvoc0+ZgpWKyfKJMn5idxP1rU02ZmgnhZliBAKzNxgjkYYdP61mTcOc5xgZqKSZzbvGh+V+o9fwq6M+SV5C3K5Yy3ErcDLn5h6966PQyTZTAP8AM7CNRjgEnnJrnIwqxohA+UdqkjlkiDeVIVzzxwCfpTp1FGfMS9VYlX7REZYW2t5THfs5AH+Fbmk3Nv8AYt0hVoFj3s55KkHoB3zWBYXT2tw0vzSFwVZc4JFVF+0SSOZHKksSoUYAB7HHBrZVor3hPXQZHcPFeu9qdoyQpP8AdPb6UJ+8kLSMWck7iadtHmIFX5SMZFMvIhbXOxpA2RngEc1hzSd3HYbWmpqWK+X+528yj939feqGvW5tUjldVLBsMO2fT60g1MyWyxOu5k+VG6bR6GquqPNdmIMD5aLjls7j6/U11x5HT0MpN9CpBfLblsDBbjg9u9VLKVWv2cqpDHue1QXW9JNrYBboO1XJLKxtNeis5ZppEiwLllAUlu4T25HWs6bbsmZSehmalp8y6jMk0LRnIbaR2PIPPtRWt4xtEsJ/IjmLRhFYF+rKwyM/gaK6nRsZJruZGmEggYBUCui0thdRN5R+5ww7iuetf3TBXBUr+db+jIII7jyGIabk57HHUVi1rZnRTszagAxjjcMcAVdgjIctyo6N2rL0GOf7NsugSynqe9btt1JDHHcDnms1qb2sXoJFPylgX28jvVtHEUbKxO0jHHB/Cs6ONGuBMM7144P3gPWtVEW4HKrhuxNWnbUtWI7O5kcSJIUaEjZu25P/ANaiYLHH5aHJ9anj8uKIRqgRehA7VVee3a42bh5390HNU5uW45XlsUZVVWOCCeo96qF2Z2JXb6d81qTRBm4O4g/lVOdCJAoUbQajyIM+8hbyyQDgcdOtcV4ij3owwecgj0r0HVpZ1khjijBjI5YDk8c5rjNfjRU2qenH1NXOPLqiLWOO8EXQtbrULR2CjzAWz3Wtuyu0guJpNuNjlVI/iWuUtUCa/PEvDum/2IHWum+zyS2kckK8L8rbecfWqqX0M7K7uXJGiknEsY2A1bjfJUDdjrz/ADrKjRlwoX5gcHmuk0jTpJXVfLeR8ZVFYAniudQc2Lm7kumlhK/lhS2Nx5xkDrj/AArX+0tcRxwqS5kJLZHTHasuNhYXedse18KWb+HPv2rRnuBdqz2kTBEDAuDwCfet4x9yxrF30LtpaxS2sh8wCYHaEZvmNR294dNdxHxJ90MOeM8motNhdIDcIUZtpyOpHvVd1LMSfY/Wsaj9nZpGskk9CyZBeygk+g6YwK05oUtIo5t6SkDOwdfYGsi3TaweP5SARz2qQgsck5YcZHFZKUbcz3BSRfN29xOE2IkW7cV6bgfcVJqbW7lkiGzsyqelVSuVzx5g7elRLGWchRkE85pSqXjZl81xlnaLGSwZipz1PQVdUFly3AB/Cpbe0ZxuYZA6Gm3oKKOdozwfWs2mlewnd6silkEeANx/2vWtHQtK+02sl7KFWLOAzHA/P61kYJye3Zs1paTcXMBjiVle3t2MgQ/w+30rShyuXvE69C5rV3JZ6UtkqAOGDb8/dHoPUc96o2mnyqokKls/eAGdtU9Uvrm9nlkm2mVyQNo+6uegrvfD0otdBZIwskjg7i/LA9gD2H1rpjBV5tPZCcuSN0jlpfkG4MN3bjiqSlnIUklR/OrmtxSWsv2mXYFuTlNvA47Y/rWpp2hTJDHNeyBGmG4Qjr9PrWHsJOXKinJLUwniIJjUEs2MfU1rwWIjhG1C0gO52YnB9qh1aEWtyYgwx96NxzkVVn1GcKyKAMrt4Jyf89acIxg2pFxasVLu4JupEB3jJAOMZ/wqNt3l9Bj1xWbqM91AFktrdrmZpAGDHBwTyavBy/UfgO1YSd9SRHZVYF8ADtTLwBkBRQT3xjn8aljkWF5PPztfB+QAnIqrDjc7OWOSSAewzQ42iNhEg2ruyWPp6VPcA7F4OKkMDocyo6+hIxk9eKrszTyELlgO/SocXHcRFJH5g6BlxggjOfrUtvaxoBtQKTyBnGKZGjEf7IOeTV2MjauV7YwR0pRFceykIVPAzk+tTxqQhYHLds85qKaRVk2leT27inoxZc5yRx9KrZ2HYVYwMde+PY1VeP5gSTwe3erLkoH5wTVIXCSThOrZzntQFuxYEZCZ3dR0qrJ8zH17EVMxMkohMixKeC7jhRUT2slpGjySrNFKSEdQSOmQM+uOapRbV0idCMHcrDd83b3piEB8SHg8ZAzilChWLkDHUYpZV+XcOozzSJKZ3ICFbK56kdaYQSMnio5hMWMpdVUHZ5Zb5mYnqB6VMFx95uPU02gloRDBwSef5U2XCxEkAg9zWk9iXtlmjZACC2GPPFYLs0wAjfG8dTzxRODhuCaZYQ5O4Ec/pTpnKgrEedvXHQ1HGpjfAII/lUV02Cu4BeeG7VCegtnc09H043VixY72b5RzgA/1rBfel1JHL8zKxBJOa6XSLgafqFqbiXEEh3BuPlOP0rM197O51RpLJk2q5R3jQqG/A/zrt9kpU01uTOfvWZFFafJFOz7UY4JxnjOM1LfGC3nERmU+W21ucb/pVbWs29mYEdfKYjkda5y43sWeRiT1HqKqMoUdLENnS+L7eFNJSVNvIDoV69eQahVb/dDcahpukvd7Rh7i5EbsMcb1zya5Ge+uJFRZ5mdFbKgnpWlrX9iajfPdHWGSSUguDbMRuxzj2rSdSM5c0Dlaa0ZL4la4a+lu9SMEk7LudYmDJjHAGOMAUVka3MkemiKylFxbL/y12FC3rkH0PFFdLm0lYzNGCJplUec0z4yWbkt71r2JIwCCp4zWRoDrEzythgF2/MfzrobeIvP5YzuKhzjng1jUp8y5kdNLVGlbNtOAfmXjIrTtNzcsMPnAOetZtqhDgc8jArStxjlQTj0Fc/KzdX2NNIdgGAeeSKkjnRJgrbjJ2Ud6ak7BF5zmmyAxXIvLYHlduB/DWsY3NqdvtGpIspiV2TCuDhz3/Os2KzUTJOzv5cQJEfHc+ver3mubbCTPJLj94G+6oPb/APVUDMQ43DaO/wBaqpFLYOZxehDqNwUuBtQCJgCuO/qarTqS/J98+9Wbsb2VjHuZfu56gVX8uRyNo5HbpUuzFN82xHFMI5SWI3AHBx1ri72OSQyb1JAOAzdT+FdTfBklaMff7+1YupzBLcvIpZmJBAqt1ZkK9rHmepNFpvjC0ebmIkxORxjcK6rRkDiVBIYwo454JB4rjfHKiSYTLgfOGzXR6NE82n+eD9w4x3FXdJJmMtGdVPYQtBFJA/z4DFsdfUEVNcyysYrONtjBTli2AFPb/wCvWZbXYiyiszSELtHdX9avLK9oTJcp8zoVDFgRjv8AU+1VZdCXoOvNPeGELMySO2cEHINTWOoJZ2LwwKQrD5425+bswNVbi/eSKJRghR1C43ZP6U55g8MarEoccEjvn1rjlLkk1EtMt6JMsLkSszFuNi9/xrait3nAkSErE7EIT3xWG8UasDG2ZFODnoPT61pWequGRLoM0Kn5lX0749zQrTXLNm6kmiwYWWUKPvHqD6VEUl84QxglmPGOavQXsbDeiBAckM/LD/IqG1cyakJIJ1t3VsrIwOCfQ1nOlFNalP3dS9Barb2xE7ZkDbSqgk8diPWrmh6Yt2WmkK4jG/yx3X0NUp9WfMhuIY5N7s5dcg4I5A/HFMtbzTRaSvLNOl83JTb1Ppx2roUKSZTbt2OymNhZ2BlDW+1QzeUfmLnpkHPTHavOpZmeVy/KseB6ChJAzktExUA7Rk4U9jUkSswL468CsMVVVS0Ykwjy3u7ky27TJCkLB55GwIwOw7mtLUtPlsYsXUZi3DqG4YdcZ71o+Fn020tJZLoq92VbcHAwD2x61Q8Taqt+FigmMluoDbiuMHHYdhVeyhCnzvcTm3Ky2F8Oaet9cyzK8aeUwBD5Bx61dS6a1lV4HWUohBJ4Hf5j7Y4qfw5p0TaYrvAk6SAMX3lW6/yrD1d1kvpYbSQG3Q4GM4P+IFaaUKaa3GpKTcWVdUuZdU1B5ZZAecDAwqj2FaUeqzxosEsa+UOrn5iwHTA7VnwRBWAbGCenepGlzOI4wST0HeuaNaabkuob6JDLiW4vboNIAGOFSNegHpV6XRry3hNxcrGqA7XG7BU+nPX8KIbKVSkhUZJwdzY2/U07WdS/0NbBXMx3Fdh5Ve+4H1q1CLTlUHK6tYyZAGYqB2xkmmYAKjpgc04KQigHOPXmlcZYdeB+Fcr1GVy5MmeuOKdaEJco8iF0U52nuaRgRID0A6CrFjDNcAtFE7ruCkgcAmnBNy0E2Wtb1X7YpjBkO8hyScqCOAFHYVlwHBHzcjPNSXaGOd4pVMciMQVP1qPA6jnPqKqrJylqSOQnby3U849cda0dMEcl0glDtGGAbBxWFK1yAzQIWDjjABq14ftNV+2LtVs3C7Qvr/hU0/i2NFFct2zoNduLa4XMa/v1wNmzpt4yW6VmW7lOM54qaWKSAOkvCrnODnvj+dQBlZt8QIJPJxzWlaXNK9iCa4QSqy5IDDqe1U/swSRXMaoUQJwxJc/3jU88ogVpHb5VH5VDOJfLs7lXjaCc7Rz8270IqUrrQOZogmyG5IAxyKVCfJXccqDkDqOakuIHQguCATxxxmoo8KDkdulTqhPUZqs6Q2ryxsu+NhmIqctn0PTiobdztJkBGfX0qzIqupLgcHjPb6VXlGQNp+tNu4XVis4Bk3FQT/Dx/Wned8u3ae3PtUzqAoJYE/lVaUEnJJOOPwpXsZ7jbi7l8t4Ubar/AHsrng8fyqnGFC4Q4C9O2Kmli80kLjAH40sFjNdOsNtGzz9kA5Pem+aem40kiv538KjGeveh7yJbOeBoS7vjy2J+6aikUhX6g56D9apsCCFOQfSkrxdx3Vi05knRYtzFEORjnFNigLnuWJ+8TUujS28N3uu22x85we/bNXp7uzhv4ZgyfMC7RhfunsK6aUXUV7mUiGayjms9pLm5Un5em0euKxLWa0XzoroAyJkZ7Gr3ifVG+0L9gBT5SHc9SOx/U1y827O/kjHPeuifJBq2rM276mto0z20l29r5YVh0dFfHpjNZc3izU4pjE4s9ynBBtU/wqfSpoYXdrg54B2evtWDrlupuGngD/vDkg81cVeF0YuxW1nUrnUbhp7hlySOEUKvAx0H0oqW4trBUWSGS5YLjcJlUBjjnGPQ0VrGEmjJs6TQLfzpJWjJ8yEZdOu5T2rftbmQSKRgsMKWJ/hFcrpqZu4Jkd0K8EqcZ4711tjEoUnCl1fsc/Q4qPeWi6HVT8javbl2S3ms0zPBIsh3cbhn7v4ir7TsX8wkMZPm2AYHrisWKRlbBJb1yM5rZtW3puJzz9cVk5tu6OhSaaLiM7ovmYUbeFH8P41YhQp91s89+9QKxjhaQkNgZwOc/hTrKVpo/mG0DjFTfW7NbN6lx3HGBtOfWmPKfvSH5u2aeUYgB23YH6VHIMx4HXPcUXuSNDtI2OB9KTUxJDGpjJTIzvyMGmKro+cfL6mpb60WcROzmFlGS+7PGem38q0pq44u2plF1PmzmNyr7Vde4Pr9awZGDF1Kl0XcgYj7ua6eWGQwukRKhxmR2bBAHU1zuo3KWtjJ5KgSTSFiWOSF4wMeprZxS3Jb00PM/FkLfZJyATsHf2rT8L3Rv44xbyKsU6L5h7Bu4/Ojxinl6UY8nzLjJ+oFY/wpmHlXduzYKuHUZ5Bzg0RheDOWTakk+p30thPbXKMqpuHGSfvD1q07S3LbZYSixnlA2AO9WkVJwFaUNtk6nIIx/EKh1tyl2jROWVTgkfxAYo+BXFdMuXclvdrGmAeBgrj+XartjYx2SLNMNyc7Cozk+jegPtWBLcK8rPa5Vt4cYHQdOa27qaA2iiCd3TO7D8NuPH5VEuW3MWlYp3FxFcXREUYwOqr6/wCFTxwsSN58tPUc5qppNwtvKq7V81mwdxxke1dE4YxeU6qgyByOnHauRUub32bxSIJLSJbTzR8smdpDdSKq2y25uNsx2rjjmmXFuYJihBx7npU1g8dujma3WV+i7jgDnrUfFU7GnNrqWJWDPsRcIOjdKY0AyWIyO3tW/p1ppoZTcSPcXEilvKiXAVsZAB71Qltpb7U0tLVNpcZBPPy+tOph5fFuJSTuUY/mABOV6bsdavSo+AzBQMYwBjitZdM/siNBMMzvyjMAQ3YYB/lUiabcXzRvNKkUKELuA4kfvj/GnHCytZ7gpxtuc8YPlBORg8VGsWHYyZwfzqfVpilyYoyPkJB+tQTt5jhYQWAI3Y4J55/SuWV07MqzsSW1vd3c6WunebvfIKo3y4963ZPDUtgu4yxyBFySlXtDuIZtSc6ZaJBaQx+W2Ttdye/Par+sXaWFlM0k0cjuCkUEacr6g+telDDxcLyd/wAjCVR8ySRxkqYmZUc/Keg75p9iHg1FZSDu7fLnb71a0g20Vg804VpV4Zm4xnp9fpVSK7kMzyKdoYY5HP1+tcTjyNO5uTarfefK8cO7ylP8fVj3/CqDxgKWQ4PU1buEZIN8kbJuHGRjNSRacUtTNK207c+Xt4xSlz1JNsdrFDlUGTgH1phZipGSc9c9MVK8gkULwQM9amtoI1sjLdB3ldvkRW2gKO5pQpuTshX0Mpx8+DkHNaul30lpaNajYkEjAyFjkkZ7eh/Gsu7bbcsgX7vYnPHbPvVe43NkAnPXI+lOE/ZSutyXqtSW9vEu7qWSFMJkkZPOPeooSQGJJ56ZqKIIsOw545NSRuM/u8BR1PrWc3zycmCRcspIxcxLMV8sk5yOP/1V3N1qpXTmlt44gkaYEZOGGOmPb0rgVdYyG43EZAqYysy4c8MckE5rehWVJNEySe5avJmvJCZUCFgMhev0qNIliYGIAITg+/tSKOSflxnmnFk3EbjkenFYzblK7KT6CSncVAUYPc9DTfNcgRuzv5fKhjkL9KN28DA75xUdzIE5I4PU/wBKUXJPQdro07GC2uY5RfSyPg/u4g2Np/ve9QXtosbO0EgljUYJI6DPanjTJBBbyNkSSt/q26qP4WyO1GsPdLC7eajRZClgMEnuOOtdqheNpISsyrdQPGudpIxg8etUsbedvAFWJryV7fyt5KEdjzVYyhclzyBjd61hKMehLfYhmIOOeRjNS6bcacLpo9TEqq+EjdcbVbI+97f1qtPuLlunpxUDoGB3KMnrUQfK72JdrWG3hWGSZYX3KGxkcZB7c0+fUJhfm4slNuqxiNBkZAA5JI61Nb6fJeRssKElFLHHoPWswuVLKxywOCM1fNJaxJZA8zFyzsOSTk+venQxCZsFdrMeKqzsC2R0pbO6khkRxlWQgg5rNSvLUEWNV0+SFCyo5AGDleD7VhovmZD5z0+Y5Irq9d12OWBfs5VWZy7rt6nuc965dpXefI2kk5JHSumrTjHWLJ5m+hqtaQtpUZZk3hiWYnnGOBWDNp9w0W5BnPQDvWwWkvoDbJEAdpJJP6ioI9ST7MrAR+ZFwoY9D0yK6FTU0jKbscy5+TdvO8MBgdfeu1llmsLm/uY7e2WWYR2mmBVU7geS/fn3NcpGgTUPNl+WCV9okxwGPetbWl0iJNYgjtmd9MngiM7yHfNnO4AdFHFdFCm0ctWS2OZ+IsiTeKGhtdgVkQS+WRtMu0eYRjjG7NFZPjiKHTPETi1Mq2vkJKquclA6htv1GcUVtySewRlCKXMzr9DMe1pHLCSBt23OAV6HPrXV6WsYmnlhOzgA7gdzc9B2rixDLZXsbSqVBwTjk4rqLO8KyJJCFAkwSpPArCLSdmbU79zUM4OoLbOo8x1Djb79vrWrbLKrFCvPPTvVNkRSkyFSyjrxnFXknlhw8AAk4O4nBA74rncffaZ2bk0MNyl5M8MpQvH8jA8o3GCB6VrqjxIrTMHlf5mIXGT3qqJzLGZXUmQH5I35z9T6dakg1GVRJvjyqLgZ6qD6epq+RG1kxwuIzcFZZGjUKH+UZJ59+MUlgWLzEzLcqTlW24HuMf4U2WANtI+9gZz3FWrPMYI3KqnjHpUJK9mJvQbfTsYZIiiYMZbeM5BHSqcN2ZI8S9Ox7n3rT1BYDDGtuyeaSAzopzWJciQliUZcHGSMZA71q/dWgpbBe6i8dmEAVnLYLMecduK5TWJvPcbuSo6jt9K1bvhyy/TpWXcRZPPf1rOdVyVjKy3OY8Rj7X874CRRNyWwAcV5v4Rvms9dGwgAnIz6ivQPFLbIryE9WXaa8w8OqkniS0jlbajS7SRXVQV4M5MVLklD1Peor6SSCPUEwS5IZVHA9eKuWQF2SmGLPk52/Mvp9RWfbq8WjRlCxiDbdhPRqu2JlayedEby0YfPGcMmeCGHoay30ZqtdixolpPCtyViWSM/K6EjcPesa5me4uH25QA8D0qxqd1KrxvEzByMOQOD6A1QQqzhudxPPNcmIkrKKKgadt5oeOZFI2EMO/Nbqav9pVzdFA5HAIy2RyMmqemyvLYmKOFi4xuJ6CpYtMnJPyDnpgZ/+uamPPTVo6o1WhNcXRu7xptgVWwQuM1PDG0/GDt+lEVl9nuAtwrLkZ+YYH0/GugstQ0+Kx8uaNxESDHGDudm9T7e1FPDylK8nYuT5dTJcXapGvnuoiPykjBBHTBqGy1C4TVYp5i7k/IXjIUovrn+lampzHUbuFpIXtrKIhGAADYzgfjWvrVrpWn2S28RUyL8zEg5IPTnvWvJNa30QNrS63ILTXY921m3Iw8rJbexBblnJ6celSat4hhSw8qwJjYnEY2AFQOM59Mdq5Rtj5JTr0yP88U+2hWRpmeSNPKUHax+ZvQD1qHjJNcsRexiRhmM5eSUktyzsMk+5rX0Owub6TzIIiYSDtZuC/uPWs62hjurlIXJWJmG/AycZ9K9Mt55LGykMzQNFHGdscS7cIOuSfwFRhsOqrcpjq1XD4Tk1M0NwkdkgWZiE2HA3Z9zWjPpAeK4u728le8j5bKAKB3UCnaTqtosN5JJZFo3wEDoOAT0X0wM1zuq3dxcFohM/wBm3DAc8j0z7gV1S5acLXuR705divcYuGkcIAP4QPSpLBTHcxTSqfJHGQPun1ra1G002w0xGgjaSV0BDF84+vtXPNNuGDwDyRXDUTpSTkbxfMrl/VdSjuTtQFhuyZGPJ9vYVlzSSzKAsz+WOgLcAU1RuY/KNtOUocc7fQCpdSUncew5AoXqwXsMc/jTZHO7KyMBnGOuDTZpcjA6+3pUQXLAkY45zSi2tiCGVQqEnBOSSc1bmsporMT70yRnykGSB6k9BVe4CK2H5A549Kjm1KVbY2quBA3OO5pw5G3zku/QrOFAdlboccHpUauc45MY5PFVriaQiQxiP9yBJISPXgD60kc2dgRXIz0rKceUpGpG2AGI7455qdJEdgBzxz2xWfHIxOwnJ6YJqxbwsMkMSv3euahXKsi+kqvEemVPPPaiY5Vhxuxg+9UEkdJ3PBUcg1PcSbYgVOA3Q4qri2HxP+6+8APQGlmiE4MRQurds1CMuueM4xS2xYyDoD6VUWJo6FoDPbwN54Z0C/Kkh+QD+E44qhdatHNaRWxQq7SBWXHyKvOSCOc5/OrNtDE4ZZZthP8ACxwKq6nCIbFZDDiRWC5C4XNeld8t0KyQy5tiluJOGQcZA6inx6ZA1lb3DyMIpg23YAeR9T09aznuJTbiLzD5atxu5x2/KqbFshj91Rwc9awTgndoiWmxueHIRc35tZUjkjdCuxjz+B7fWodb0tdPYxmRSeG2BTwD79zWbDcvbSCSGQo7dGXjFR3k9xdlmuZ97EZYgYJ5zW0XT5GmjGfM3oXdNv5dOkdlYeW42twDwOmKyNRkN5ctKkax7h8xGBubPWo5JfmDcbc4IA/Wp7kLFbxyQzqXQBtnfGf51jzuUeUHHqZF8kgMQkiYKBhSVIB9frVRsADn24PetfWNWnvYYUdcFOGOc7qxpTgkLwcDpWNSEU/ddxxlfcaxVlIIOe9RW0ZNwqxjIJyPWh4pCASpx1J60s0skgSIbRs6FRyfxqoRvuJ3Rq63qSQCCBSIZlTb+76kc5z781zNzb/ZI/tcrboC2SD0xmrPkZmL3BZlA5b+L2qLxTDHFYFPMAjIGxejEn1H9a9GPvq/RHPKVitqM0V9HMUlj8nbk7eAFHcCtO1s9UhjihuJ/D09xIqyBriXLsBxHnoGODxmvPp5zGMITwOnrWzIulapfzam2pXFm0uHmgNs0jLgc7GHBHp0raMr6mEosyviNZ6muo3E97LDO28LcNDIGKN2DDt7dqKbqOrWmranqJto5Ve9aG2hgZekSbcOx7sdv6miunm5FYyjQeIbkmegaw+TGWDq6gLhhyP/AK1S6YBcWjyhwPJkEZ3dSfXHpWbNcvdbj85AHA68dq0LOEx4VSEVzulAHL+n5V5lWS52zto7I3rJnmLJIqEY256ZArbgJbbv6AdCOlY1sf3g2HcehFbVpGZlwGBZffBGawV3sdqNBZdwLR8qOo9TVhW3YL/hzyKqqTFKVChZE65HJqvaKWuFJG0Fsk7sg/gelDbLjFdTYVPMI2nluPar1hYvOywLGDIf7xGMd/r9KpRRmPZh/pxjNQaoZ5zErSZXdhWTKkHtz61pT7saV9Ezau5E0+8lhAdykW1JVOCozyMetUV8mYvPLOSZiMozZJ7fLTDPdXcCM7CWSPh5NoHHuRVS0lb7ZFNFJtMZOAwzgc9OwrrZHLZamdr0AhvHhXAAXJK9j6Z71mqrNbkxIC69P8a6PVlF5pYP2T92rkeZv5Zu+0dh3JrnIZlgiIlA2bwCxPIx3HvWMqfvpondHnXjFc3V1IGLjpkjFeS7zFdB1OGV9wP416x41lZnupApAfLkH+deSzHMrH3rrw+7PMzB6RZ9G+H86zo9u0ci71jRVUcbzjOTW1bSS29hDPsjSIJ5JJXjdno3r9e1ee/CTU2k06CJ92yJirbepx0/IGvSdNtl+2PG9yk69UjkGUC4yT6f1qHG0tDWErxTKGpW7Xl1IljHlQAWGQQOOxqvZ24tA5uI0JyAM8nHYAfXqauXD29pPJKihYSfkEYIB9MD0rNvJnupIkVfn6AKOtc1RQT5mbRZ0emmzyXBYTrnbhvun+tU5Nbe0nZY/MaRW++oww/E96oRWGqW8qLtZGlwcFeoqSa0kglVjHknpnvWVStJL3UbrU1r7U5tRhiklkJlKBSCeSR3qLQ7SafU1a3fDr1lJ+4PWs+O1kDZkUljkgen0rq/C2nT/aDMsY8yLDiN+CynuCeDUQlKpU1LbsrIva9bi2hj2MORsYRpgHvk+uea5iQzO4DuzhRwHOa67WtTnuEfTzbx+cGBHT5SBnIx9a5rULWWzQNORvYdAehp4yLv7uw6fNazIBkDJYnIxikmbcVztJ7EdRUcBaSRQCc9MDrWxYaG95cLGskcTHoWbgn0rijGU9Iou9tWJpKMWV40d7ktkbQcqPWts2V089nFq07yWs2W3KwAx1IPvmgzy6ZEkElqjiFh84bBIHBGePXisi81KS8YJGHMKkkMWyfb8a9GPLRjqZyvJnW6jqGn2elG3Xy5GckqABux65FcxfXUUigw7TzjIXg8e9Z7FmbMu5sDjcc4qWzimuLlLeCMShcnYTgVhUxHtfdSKpx5VYXyizD720dB2FJa2rX19HBFwxIGT79Ke7F5PJztJbZtJ+6fTNPhkbSr1mkKi7t3V2Rhkeq4rGMby9/ZFvyLuuaW2jhVlzyDnjjPsa5xyPNRVyASBuPQVY17XrvVZY1lBEa/3cYB9v8A69VMkLy+PTHWis4OVobCi3b3ty5eJHauE81Jd65BUcGqXnNt4zgZxUDIFZSrYyO/NREMZCuSB2qJu7uhCNMTubB+uaryYyHbOBzirbMqxnBGRxis2cO3Q/L161kw2JpRDKS+z5u+O9Ot0GVwu3nP0qpGg43H/wDXV0EbQiAsR79KG7oByB2lYqpIB/T61ct5DtO8D0wDUMIAi6df5etWo1BVeMe4pJFEQ+Rm3pheoz2qxsDoCAgAPfOar3AaQ/OxPoc9amQDjb2OeT1oQnsIkJZjt7evarFnbyXM6RxRCSVztXtzVm3uY7ZxJJAkp6gPyB/jUdxchb77VaL5Kk7sc7fyrphTirNslt2E1K2uLK6+z6jEscjLuCBw2R7+n41Fd3bXMYWQEqO2emPSorm6mu5nlum3SsMF+5qiWkZXAYkD86qVWztHYnV7k7yKZOGO0DP0qJ8FBjBK81FGByTnH0okU/KV4PQms1K5LSNfTrT7VCMFdxyORWbPCTOYyyArwcdMikjnmQYDFTjnBxiq5dY33yFmY9STmuhzjyeZDWuhJd2Eqkx4J45ZP8ayLuKW2IZmwCcK1dxcSR3NnYR6RbCS7YBZNpO6M9ztzgj3rO8U67DPp01sxhnlPyAKm0xMMdOOnWtXh4tXvYh1LWscqgecfdOeufWq93bSxRmSSJxGerleM1oaPN5LowDOehA657GrPiTVGWO5s7aJ4d4AZXHL46n2FZU6KlFybHUlaxlWt6otRAAd/IHvnuayQzaVcxTY8yMtyD/Kod20AZ5HX/61SXtxHdW8ZYyPMpz14FXCStbsJy0Nay8RafLqV3NPFHBvUCMOMqMdf51w2rXqXGrzTMT5bPwPb+lLeI0cqqwZQ3Tiq0YW3vgbslVK5GRXVGo5rlscrgk7lfWFgu9Sgit+V4DEcD3/AEr0DxBq2qWf9t6dpbqrQ20c1ksca/PDuAIA75H8q84tzLPePPbfK6sWU46e9X/Fdzo+ky/ZUs7ye7V+bg3RQuMA5AA4BJ4ropauxjUdotsTR7drjx7JLc5MqxJJIp58tyi5X8Dx+FFTeAmg3315b27IjkLsZ95GByc8Z5zRRVjzSKox5aa0NlE+x3brLkJGfnKng1uwlXIIDBSAVHesa6m3XcbKqqSvzKOQDWzpkvnSsWwIlXcZQcKvsa4asdbI6aPwo1rLcG3AcA8k8ZFdDpbRRyyDbC4kTb856NnqD61hXontrBpbVVeTI2hRuJB9BWlpczz2t59rOby1mSMfKBvU9SfTFFKNnY6fM14o5jJM0zM7nCsWXsOlO2BiQmMg4OP4T6VNY3t7FGrSRxTpNlC/Dg4PPTuKvtbq8YlVtqnoSucmqlR6o3t1MOedpLpoVdhGAFYdC2fQVOGITy/M+XtzWm+nPwxiZeB8wU9aozW+3MbKQ69u9ZcskPfYmtp3SD7IdwgcYyg+9z39TUVyEgeVozt3AGJG+8PX2z/jUUeFOZN2Mcio9TuDMY8ugZM4VATj6nua3hUutSHcmNxvsHlgTfLGhRieg3HisK+tmFm26QLuADOR/T096siRwcZ2g43AdD/jSaiqtGzlZHWJfMOM9MdMd6tT59jPZnlniWNp0uBv3bQfmHcCvJJhiVh717TratY6YkvKvOHOGHY+1eMXJzcSH/aNdeHjZHmZg7pHoXwxmJ028jWXY0cocL65GPyr13Q9SkMVzHOqxhVVo1Rd2W6V4d8KZxB4mbcfkeBwR1zXslqhazLRBVkXDqY88CsqycZ3RWFfNTXkWniWSeF76UyRKCFA4AqNrRo5TcQAvDCw3MvXHfArR06yCWSRXUuQwLqzvlcf0qlp9zHp19KZLZ50IPyDkdO3pmsJRTtc6TRfVInnZY1lZWQAZB4BGCBnkdjVyHNsbYrCnyAKRKc5PXdmsrUNR+3RBjGd4PybhjC9h71YsbsIoSRYFzgxh8sgOfQnn6UXV7FI0X1Br+6QtHtlYcjbwBnrxRNqctnO0dk5kYrt2/eAH9PpSaw0McCmFVVmHylD0HcdfxrO0jVJrGGaEQAs8isH8sNwOxzWUpcr5TdPTQHe6gnEu7Dqc4PQ025lnu5Q8n3QNoUHgD0rRtYLnWbwyuFjiPzNg4Cj0HvV+5063smjZyWjJzwecfSuaVOpUVr6GkWr2M3Trcx7XCkEcnNbekXIluhMZRCwbhh0HWorqa0jjRc+X/fVTk7e1ZkjIZR5IwmcntkU4fuWosrSxqao17qU6ExSPAWIV0T7+OuPWoZrU26phcHoVz0P0re0jURMttDaf8e6LuWLO5g3rkcjr1rP1yCa2fz7mVHkkbI2HofStK9JW573M4SvozDBEkh3EqM9e1Sq72siy20jq4Ocg8mo40lmY+UpYv8AdAGck12Fh4egstMaXVEdrlxlQrY2jH0rmoUZ1JXjoXOcYbnK20TyK0rlxITuDIcEE981RlhPmSPLI8jufnkY5Y10+qX+mW9jHbWatPMfmDtgbc9jjrisEvI9o1z5eIGO3ef1wKdSm0+W92OMr6maw28AdO3rTJXKsFICnpwKtOyIpKjr0IqjLJgnjLn24rC1gIt7MW/McjOKI5Fxnn602UMyg7cDvgcmmxIA++QjB4A70hMDli3IGfbJNQgjBQ8DHerEm1Twxx6k/wA6y7iXJwjbsZyKT0AJpsnptA4471ctt2VKc5GcE9KyYyXccfL97rWlCzbhkEqR2FTcZqQAFeARxzznAqZJQoUn0qpaAK2FOB7n9KsSbAecAkc5700mFyeJFO5nO329KfGGMnOML6d6rW7neBg5P97uKseYI5cAkKeoFNdyWJK5TAycdwRTpWMiAKQfTIpufmIOCvT1/Oo9+zO0A7T3quZiIhI+SoUBs54phBSTcW5PoKliU3EoHCt6k4rbXwxe/ZhOVCoVLZbgY7fnVxpyn8KE3bcwHKlQTxx255qNs4Uhh+XWptmxip6enaq8ymIhgDhj8voaFFp7Ca0JI1DOFIx681NqOkTW+kvfXYMEbSBYo3U7nGM59qoPJglg3z+tWGW4vbTM07sofeAzE5OMd+g+lbU1BtpmWr2M6HUJrSQNDIY2IxuXrj0qo5ikZzK7KWy24DJJ9KnFuZd6/e2nis+dCkpDbhz0rNTnHToNpbjor240uSKeJAWxkjGRVfUNROoXb3Mq7C3IXOcVdggnlguBC4WKRAr/AP1qwL2BoZTGCOOvNa3koabGcrNjpApwQCQehqpO0sK/KGAI5OMVftrhYJEyvmIuGJxUOt3cU6HY++R24VRwgqqdO6uTcNXhQ6Ms02BIqgxseCT7euelcjqV299KrSIFZRtwtdBbW0clo0lxK7hc7EJJC1Rv4rVL6BI1UEpk4OQa7lFyV0c7unqZmmeZ5xhRc7vQ4PvWx40bxEdTWPTbaIafGgECCGJii/3TuBORVVU0xUu7jVZrmEk4j+yKCTjrnJrl5B4elmLNc6r8x6mJD/WumhHqc2IlZcvc9E8K214hB1JBHelQzgKqjGOOF46UUukR2tqIk0x55LdUXaZgA7HHOQKKylPU64RvFamdZvvCHcd3pWzplnH9pd2chJFIKZx161iWjfvAQBj0HIro7IDoDx7Vx1G1K5rQvy6G0rE3fnGScBIl+y+T93eDzv8AbFdBYQKZ3uljAuJR+8b+9xWDpjgZB3Elq34t0agk8detZxmzqs7Fy3DQELAwRVbcV+vJr0Hw5fWeo+UtwiLMRtKKcBmHf2rzy2kJbDAjccAsM1r285tY9sCgTE4cEbtw9a6sPUfUUqfNGy0OsktI72OaT7YYYopGURZHDZ4b6Y9awr61zE8sk+9o8bmA+Vj7MKltNTQJieMrECT84JBb6+lMa+mnu4rHT44pIVJd0IypJHI+veuiai9SoKcdLmHqV38yJHAGifJZuSyn0qvK0flebM5VsYwR1qSXaskwx8yscAHIqBgZHUudyZ546fSuKTs7GkmiNoPkDEZOOg9abFqBtWklVWYrlQM8NxjpV/U7eUaV59vtCFtrbuS+ewFcpNK8KMC24OTz0wR29jWsFyamUkuW6OZ8Z3cVwqwxxMZIIWViBgtIST+QFeHNksc9c817H4qkaG1mnKsQx2CTPGT2rxx/vH613UXdXPIxytym54Jne38T2TIQCzFDn0Ir6CDtKAsIRZljwxRcBhjnIr5w8Pbv7csPLGW85cD8a+h5pJJYDMXVpFCocDAx2qK7tqPA7MnlvJoreC3wyRRt8pxkqD14q3MtxFZvPCRJGyhWO37x9qoKy3FzEbwFUxtbAztPrxWtNeRaZblY/LuGyNrgHoPUHpXInzHoKxlwNLNaeXcBkVegPDEVc0iWJHZ/LJ2ONjEY/A5/nTJbefULO2ndY1c55DZz7H0NWYdHnitPM88SL/cR84PpWeqloilK2hI7m7uvLUNJIE+7GMjqeePbvU1rC9vOVcxRMCMNJ90eoPqadp0f2XT/ADI2j5lIwj/O3GDn/Paq2pa5E8YgghYIhw8kp3EmnPliuaRSui5azSTXO22O4iVljKjjHrjr9Kl1F5BDCrSNIoG1STjFYcOoiF1MZZTnOQcEGpHuzcguxJz6nr3rmnWi42TNEurNKfTo4445A+52XcR0x7U1bcoOW4xnjpVW0kk82PzwzR9R3rVluEkdtqbIx0WsWlujR7WEspjYStNCHV+cMhx2qa1uxd63Fda4ztAF+XauckdAaLJLR0llvpzHGuNo7N7Ct+yh0sWEbFkjbad7PJ8yt2K8dDXRSjUe70IaT1aHvqFml+0toyxAw8sq7cc+nasrWPElxNG8NnLIRLkSbyGwMY49PWsy8w5LYxzzj+LHeqo+VWbkkdATSniZJOMdAVNPUrKcuQQ1DM+wxo7CEnlaVCrBs4DHoc1G7bQe477etccW1rc1Gsp8oFSSR19B7VEilmBUDJ65PFODMxYADZ696aWRUIblh+tLVvUlhJjcFwwUDORUBCFgHBUkZzUj5KEjv2qq0jA4bv19vah6AMuJAysFXOOBx/OsknfKEycHnjnH41oyOdxwQOdp4z+NVLmKSKcPt4Ax06j1I9qIw59g6kUSlHbp1+X2rRjY44IJPpWfGHa4yHUqeRiraMpPPYdcVLVtBl21LtwDjHPXGasuAFXOS2e/aq1u4wmfmWrrbGAJBK4x60RWhIRhhuOeeMc0q/Nktjjvmo7gM6jyySAM9cZpIi/lnJyuM49aAZMbj5ecKQPpmiF8ff5JPWoCUI3YJ4zg+tCOpU9QwPAqhF2J9k2/aMHoa3oNeuWtpLZrcTGT75LHOB6dh0rlZHdk+UHK9R6VNY372BdwdwwQynpg/WujDVZQduhE43Nme+jXUDLeIU+UFFC8MAOMVjaxI1xdSNCR5bEORj7poubwXUzuCqL2UjOD61Rcu45JxngjmtZ1d7C+HQrypnJDcdh9aibfGDtc47AVZYIwVWYCT2qC4/dqWGT7Vy7O5K0L2kQO0g2MFYdOM5qr4kR/MEwQIANrFRxn/GqkGqTWc6sqggfwnpTdS1EXsksnkpFuKnAOegxXVTcHBp7kSbRnxXEsKhRIcqc9OM1mySO05kbqTk064nKybsAj06VWlm34wD15HpWSk7cvQhimQs5Vwefwqk9x5Mx6ZzkZ6UswYDzS+F6An0qlqNzCYoiqHzF5LevrW8I3M35El0l0IGuFJ2M3zBegrOvYDBNHvbLONx9aualqMl1ZxrGrLGPvehNVrBfPuGa8YHC/xdvSumMbKyMpXI7yH7fp1ybea1gO8J/pEojwvtmsS08OTSXUSC/0vJYD/j8T/Gk8QTwvbwRRN8xkdm9AOg/rXQ2kekWl/dwjRo5vsDxqzSSvmRSdrMecDkgjtzXoU17hxVtavKdla2AsZBC0sUxUA7oXDryPWirN9GlvrBihijgt3hRokjBxsZQRnrz6+9Fckoq56KWl0clYs2cKc+tdJYN8vBGe4xVLQ9LkeN5HZY0UdHHU1q2SiNWErfvQcbTzxXLVi73KoO60NuwjUJHuIGTgHP6Vu28mwbcBs44NYdhyVDY5Pp0rSiW9luo7fT4RI55cnHyjNYpN7HWtd2aisdwG0D0zxU8JkTgHIHIPanzWiQN+8YnBA3EbcnFMVWJAiDYI5HbFNqUXruapXL63znaMAJwAP7vvSzaoYx5M1wqoSfkAAZs9arrbExrtT58feBJz+FYt9pEkl40rOfLbB69cVoq01sEYrZm7qF5DchsRIhYbUVPvKo9azoI3D7VBIPTvTIyw+XcQew9KLp3a2khileMsBudeooc+Z3Ia1NGCSOO9t47mN58fvI0DYG49Ca5TxDavZzSJJJGZGkyyxjgMw6fpXR/ZyNL5RpriNABKWwSBzke9c5e3PnSoZmDqCCrEc4966m1ykPc4n4jyvBoqw5A2sGMeMc4614u3JNeqfFJZkMpk3KrgMoJzxXlVdVHY8nMNHFGt4UDHxLpmxdzfaEwM+9fQkqm4tbi1CAMGDDI5x65rwDwXs/4SvSzKSEE6kkV71DdPDcGc/OkjhGJHT0I/CoxGugYHZixRuMBmO5cEVpNJ9otwipufucdalLQTwGZVRMEhlA5B9T7VX094o70/aJ/JtwpV2z8x+lcCi4vlPQbsJp9xfWy/Y47ff5rFxng7sVbbUpLZ4l8oxlFKkY+Yk9j2plxcygRypbNLEwEiOWH0zj3rIutQm1C82zQsGAwSvTI71Up8itcuMeppeR5kE0yXLEhvNeMDC46cVntE8qYGAp56dag82ZPKScFoQeUGASOpBNascltLjyCVjPRW7HsK5KrVR6Gq03I4NOcxI207M43Hofoa0Le0RWwp3cc4NDuBbtBDLvMhGVU9Pp6Vr6TdW1rCsVxCDsUgEryW9D6ipjQje1yndFMJhcYzjrxViOHcvIwcZ/Cp/Ntli8xn27zwCMY9AD61FLEzMu3PzH7oH60pQcWupTjpc6G21aGWONBDbpsA4KjBA9j3NVZ9Tg5kFqiyNuzjpjsMD9axblXAHmJs7461X88gDkZYZ9MVs8S0rWJULEskwZAWXBPGBVO4fEoByR6dDSu7ZU4z+PSm+Sx3ylmbJ644P41xNuTuaIimAPyngcdOpqMoAFYtk4zzU7RNgnG3v1qCcqzbF5A6nGMUKPcLkXmjeSf4eRimj5pNzZwBwacoUYGfm9DSXH7pEDghn5Ap2FchkbGdpb3wKSNMxsGAbvhTk5qaVl2liNp7iqMbO7EDAB6ZOMe9GwhDjeWxn0z2qa4vR9m8sRDzt2A4b+E9RVeQfJ8pyMYz1/Gqpx54Z3AJHGR2/wAauE3DYTVxlvGtuApwSpHPtVxPnYY6HoKz/vygKMI3459qvWwEbYYcnp6VlLVlFlFAJYAqAcKOuTWjEQiYXg9cA9aoKWZR8p2jnOeKn24CmNCxAznNTZXGLPOWbJQDH4UyOZQ5J6nrUeSCWkyQOgIqNmLEEkDI5AFMGXQySDK4Hbmkn2pgg9Oc5qGB0MZUA+/FJvUq2fmyehHSgku2moRxSIWjDbSG2nocetN1m4ivJmlVJFyPm3nJZj/hWc7BJGJ5U8dP6VLvVUGcbu1WqjUeUm2tyoc+YXUgEDr60/GyLfncSM4HFIsaucpkDHNTxW55Zh8ijJNTFNvQHYqfaTgcAnrx2pyy7lJYnPQcU64R43jLQvEswJQsuCyjvSGNdgJIxjGOmKtRcdzN2KNyispIwSOg9aqOmDleOePSr92i5UgZHr0rOlyuCRkDtRbUW6M69QeWeSCc4PpVCFGDBSwPvjrWxK0cqFeRn1rHnzG52n8SK1ijN6hqNlPDbeewbyc4z61g3UiuRsJC9xXTXGo6gtvCp2GEg7UcAqc8ViQQRkhpzhevFdiSVrGDutyBb9xbRQFAEU7uO9UtQneVmkLYz2HpV6/tbjBmeIRxnHHt2NZd7GwhJB5rdN7C3Zz965kuD3xwK6ewvZtI8WWK39+sjJGkFw3leYIx/cYH7+OP8isC+tnMkslujPFCiGV15CE8c/jXUJYSXd5Dd6j4b1J7olS/kPtSUjHJBBxn2Nd62PLqN+1b8ztbue6j8QSm/lS5mIUrIgwroQNpA7DGOKKj8+8bXppb6zFrNsVVgI/1SbQFUfQUVyNXZ7EGuVXLx1E6i91ZH9wrP5gBI6jrz74qNebobCdxGOe/4Vi3sm28DqMBlHyr24rT0tGnKGEkSqeGxnFc1eTm7dicPHlR0VqjphULDPcE81qwtMk0FxaSvBcRchhzkHsR6VZ0J4ILKZJ4Q8ww6yOeGJ4IA9qV4Ssm5Qdp6fSsZU3CzudcdRbg3M3klHQurF2B5Vie9btufIgijcZlYDJB6VlW6hHAcKB9a17OQJdRhwzQHgkYz+GaukuZ6m6eljaNu0EEUcADiYEtIpB28cr6kmq13aW8UEYk3RvwpOc7j159KtSSwRvbtdRjZLwk0LbRgA/rWbqNyrSQBmRYFfLRF/3gX1A75rulCKJUmyje23kTANxv+YA9QKYIkdCQPnPIyKZqkwfUBJHuZQm0h+2aW3nCPEyOCVbkN0YVxyilMPUp6xJN5UVsQqMoJCqcdf51lG2jVWkl+7GCTWpqTW87mSJi0m4goAdqgdwTWYLeWS5ki6mXHymqn8RDsea/EU/brOR40wsaZJ715LXufia1iTSb9nLeWyOgHQ5ANeGV30b21PGzBe8joPArrF4mtZWx+7y/Izziva9Nu0kef7SqmOXHI4xx1FeNeAbfztYkdv8AVxxMWP8AKvXtLu4lnjEwXyyqj5VrLEPWxpgY+62DzPcXSRqpRV4IGefrVqS3n3spDHPOfb1rZsre3eBwyKZ35DZwFPoauW6NOkLuqCOJljbJx5mOSB74ri9lJu7Z3u7GaeH/ALPSEZEqJtOMEEE9xUTWz2Ers8BZX6kD+VdIyx3CNdRM0MMuXw5AIOMEHt0FV5cXMLW4kByAVwclAe3/ANatJwe6GrHJ6gyzudgK7uoA6UWEMcMqyXcReIEbgTwf/r1qXFsEvPs8QDODg025jaMEHDAda89pxlzSNk+ZHQPpcKQpdWaqsMn3Qp3beOhNZwby7yOQqZAjZZR0NUdMvLgFoY8kOMFVPAHrWlbxuZY+FCE4dm6Aep9a3bjKScR203OgElvcCCVo7a53JhudvldOMfTkmqmp30VpLIlsruh4DEc4J6fQU/XLyyYRmzt0hmK5kEbbkPbP4+lYJuBnaxO31PerrVVH3VuTTukS3t4bkjYHCooADHIHriqot5WxjOwdB61aW6jUhSPu+neojfAhWRS6LngHBzXHyqb1ZeorxgoVxjIxnHNaOn6pGLX7JqFvGxRCI5B0z9O319qzrnUbcgRxbjkAn5cEGqQbMhJYhc9zWin7PYGrlm8uo2d2QExg98c1mO4kbHIAPT1p877kOw8E0yJVJyxyfUVjJubuNaIBFtUsW79uMU8xsyGQ5JBwDmoW+YhIgSc5p4WQALnLf0poAlCFWJOT0wTUcUCeXu2OzdQPbvT1iCygcOr/AIkf4U6cO4KLkEghQG5xTSQjKnk8qQIqHA5OO/4VXuM/fAG3ONvvWhIpd9rAAIuBxnNZ126llVTye4IrOSKGxuOQnDnoMcCr0MbuoIK9dpOKzYs5IZdzdAc46VrWrKAmeuB9KkCxFEUB4wDgc1JEwKkdM9809FQjphhxgdqY7IqsHdlYLlAB95uwpw1BkcUTsxDD5RyOcj60x4owRsYkg/MfShTIFAOCccjH86R4nMYYNn/Zz2qm0hXHQ7wBjnPB5wKrvKEJKjoefrUhbap+bceh9qgYAOPmHJyQfSsxkrFJF5OTjOOlM2EJzwAcjPpU1vGGcI3TPVqbcLg8n2A+lUlpcQqMoBVTkkelaemNIsq7EY8jpWNJsEfXDdAafBqIUCNmZcHIIOfwNaUZJSVyJRuXPEjs1wGlLtOfkjYnjHsPpWSXIIVxnJ9amd1ncMmWWPJUM2R7/hTHiyN7HgHH0revJSd0YrQhuHDJjkHrVO6QNAzB+R61cCrn5x35NE0MWThQQfTmuZajvYxooWlTcMY9Kz7+AB41ZuvQAVtXdu0QzGxA6gYrHu9xMe8YZT8ua1jpuZ76stroBuLN2ld1/dlsg/Knfn6+1c0FBjVtwJVsBB1PvXRG81BrT7MJtkIyenJ4rHMfkzI/GFPXHOa7FKKSSOez1uVbuWWQsJiUJXBU8cVlzRFoWCjcT6V1REepahm5wQeMgYz71lzQrZai6xnMYYECtb31FFtHnt2jRXDoT1POO9dLNBoNlqsVrPPq5ZGUSsjphD3A45xWZ4qi8vVJGXbtYnG30roLOJri4tZ9WstJN++xl+03RieQfwl0Bxk++M16MXeNzzKq5ajR6U+iafaLObS4unltxHI4uGBEkb4wykY9RwaKbNeXF0s9hewJBdy7ftL4wQFxtRR0CiiuWcNdD1aai4rmMC6sZGV5/wCENjOe9afhW9isZnZ0J3EBueo9Kyru+muCsB7cdPvVNHbTWbozHBYdK55yUZc0R01zLlZ6Ml3ZC2imsZXkgd2QrNztPsac5KkGPDZ6Zrk9KllACfLsLbto6E+tdzpemx3thC6CYXBXhXO0Ae575ocfb6xO2m1FWkRRrFLCI5E+YnI9jWgrbZEjVHkkBDeWh+bjvWl4S021F4pun3Tb9oSRhh8909a34fDv9n6ibg2s08JP7tlO1h/iKuGHe6KdWC0OenvbyYoJdPgRGAZ1C43kHr9aZLd+U87lFjujzFJ5YxEPYY5NaOpa15d3avIgSGN5InQclA3Qn345rNuJ4J4d4aZgWPlqwzjnrk81pLTW4JWRRKyXUskrspLABiBje3rj1qlNA9u5zxtPPbH1rTFxHFtwNrDopPGfWs6+b7W5nV2LuclDk8fWuaa51e5cdVqUED25LMRJuO4YpUWS81KS4XEceF2Ip+6B1OfXNMuScEDPH6VLYzCAnOORjGOtZwl7yTJkr6nD/ESN5NGvZYzuKbiQOleE17541bZ4bu1Aw7sT8vQjmvBD1NerSd0eLmMbNM6z4fHZdXkgDFxGAh7A5716vogFxfrPegM2M7cYB4rzHwAmIZmxwX5/CvY9AKSRrE0IYYIJHBB65zXJXnepY3wkLU0yeCRbWZmChix4HYVspFBdaQYyZI5FYkoeh9/rWD5EyS5Kna+dp9q2rbUc6ZHaEM86YG4DBx3571nTlupHW73Raut7abBbQ7Xto8Z+9uJJ6lTUsdqkUmy2d4mH3tnb/wCvVe9lkkMSICCoA3buuPaoIbi6sZpJEbcX+9kZzSlUipFWLcdtBa6h5rh5GjAcIPvP6n3xWlrdvaxW8RjKNPIN0m3oDWZBMzzBmbIb7zY+79KtabaG7nVJ3aKMnG8gHJ7D60m1JWirlNW1uVtJf+z7ppBw0nGQOCOuDWpcs88JmSJY0ORlUIGeuPam6hpUlpOu9eEOVPof9qlm1a6uIWgCI0snybwuCR6en41n8K5XoXG26M6SBggORk8H1FVbm2MahnYcdz6VsXFtc2ijz0IDLuA4P+etZrTqWLSrgDgCuOpHWz3Lv2Kc1vK0KzFD5b5Cn+9/hVPDRrzk+2OlT3EzcJFIxQHIB6GoZ5Ayrv3cnmofKvhKaGuqqNxyST24piyojN6A1J5meFxnGeear3KFVB7t2qX3EPkm83iFcnOTzUscLLuLNyeSazkba27cQR+tWnkdxg+tNO+4hqMVlO0Ek/n+NWJFJAZThs+lVlcwvgnGepI6VPHLIw+UqoHAI5zTiA9FK5bKhs46UyVt0u4D5+m70+nvTXdYhk5Lk5HFKnK7mHU5zmqWmwinOpIBAOD07mqcip8oIUADluua0ZSCcbcdyR2FUUUeb6EnIJpS1GSRWUkj/u1L49s1NbRCObMgJzwPr6V0dlKI4VFk0auV3ZkIAH41kXoEUiHhWbklPm5radBRhzIzUm2RmMAkqX3njBqJraUruIJA7e9RxO7kZOApzkd/f2q9CzcYlAU9VPb3rmUb7GmpXETuu4jkcY9PpT2TYhwBuxz3NJ9oYM6qwOTwSOppjyyFt20/XHNJbgCp8gbI29uOaRwgG11JJOc5quzuR8vGDwSOtMM27IORn3pNgSFwHYBuMY9KUypwHycd/QVCMlsSZ2r0p02AhIA/E9qLiFuJLeS1kKBvOBATB4P1qj5OcgkgHnkcmkR0WQHbyKnWYNngfnVc3NuQ21sQoWiY7Q2BgY9aVnZmJarRQNtP3c9OadHBtO6Qgp71ViW7l3RtOgvpEhaTBb3AJ496tw29hDqKxbiyFthViNyjuffFQWclmhwV+bsRTb6K3N8GhZVAiG9lbID9wK7KMVGF7GEm72KGt3L73R41CBsRhVxuGeufpWBeguwYLk+46Vr3eS7YYvjknFUpY8uT2x0rOpNTeg0jPlZmTGOB1NVSg3KxAIByeetdFb28ItJHkU72GFwM4PvWNLA7khVIXNO1rNkS7EWtCNp1ktQ/3fmH+FYsykrlgSD1JrVuFkiUg9DxVSX54sqvHdTzW3PchK2hyOt2zSIzjBxyM89O1F3Bpusan9tbV4rVJ2DSxzI++M8ZAwCCPTkV0Fvot9q3nxWNvJcFRlgv8INc3L4O12G8EMml3Iyw6L1Fehhp3jZnFi4aqSPWmnh1G4ElmkggijSFHkGGkVVADH69aKsOWg1U282d62tvHg9j5S5oqJWudlNe6jmpkBvZY8ENnOR0qfz7i4jSF5GIVvl4+7SRS+UZlnU7wQQwHvW3BFa6hG6xQXDSycxvHjapA53VDhzRfKRGdpq4lmwGzcm3vjPFdLpeq3NoyiN0lQHcEcZXd61hOqqkYIy3r61qWGDgAZK+2Sa4lKdOVonocqktTcl1NZJbdZIo9sW7ymjXaUJ9Pp2rsIvFdnbkvLJKxaMK0aklVYDr1rjILR7gs6rgL1OKc8GFO7GeuDW0MTUhuinTUrFm8upr+4ae5lXc68qg2g+nFVcSqxO5tg7Hmont92Npxnn6GnrNJGoTC8dC3esZVHN3Z0KKGSS7pODk+nYU/wA50YhSM84HpUcaYQ55PXOentTByxK9RUXE7dB0NvNPHjduc9R61UvUI4H3hwSOxrcsVR4ZYWViWU7GU4IOPWsy6tDHtWJCEPQE5P41ooe6miJS1scf4uaOLT1kIVxghlI6nFeCN98/Wvc/Hcnl6cyZAKMW/SvEIhvuU77nH869LDP3Tx8xWsT03wjYm0sYY3I37d7Ae/OK9B0iQwsCFJDArx6muR0AFw2RwR09K66ykMcYIGGHSvNqTvUbO6lFRgkb0cj28dxFMAY3ClOc4NN07akxYSMrkcYXOfb2qgkzSSqVz75q6Q6t8vJPXHSmql5XKsbtiizRSkRjCjrjnP1qq8LAMCdwz6VXtrh0Q5Yhc1caZNg256cgetE5KWxTRWRG3eWgYE/hmr0cTxyJ565VXDYx0PY/WqUkbXAO1mRgQQe4PrV37Zd3CbbyXzCDkYGAv4VMJ8uo1G+5NeXyyBEiL/KCCXO7ce5qFSrxxl1JQHI5xkUiW6iANk8etOhcj5NvPQVnztyuy0raFi5vRcxohjYFG3By/QHqvuKxbqB2LBFyo561oTIQdxPfGM1VnlI4A4qakuZ3Y4q2xRjtyVO5Tuz6cimXaMIyODxngVfTfJgEgdeRUF2yxr8wLcYJzisuW6uVdmWjKq9AuTmoXlLtt3ADPAqyqo2WY4T3NQXUDO26PAQD5QKi3YAmAXqBnGQcUyVjsVsldvX1qKMsrjzcnHGVPX2p7Kzjbn733t3enuBNGA6qAdzDknPOKmaIov7r04HSqiKInUs+CAfxq2rl49wzg88+tVFX3IZHEhAyQNzHHP8AhXU6DoNrfJJ5twIWjAPQYJPbrXPWmxgXkYfu+Mjv9KsDUGhkZ4lAyMcDGTXVSUVrIiV+hXv4zDLPCPl2tjqOlY9yFyCMA4OC3OTV66EzuGkwSRjIODVK4+4JGB3DsO9YVEr6GkWV4IW3HJOAcFM9RVtIpAowvy9jmoo2nbou1W55FWxc4ZVLhnxkgdqzs2rXH5kEeVZsDnG0HsatwPuYLGB8o5bP6fSluGtmtrZ0kzI24vHt/wBXjjB+uajtsEcjaOoFVKLgxJ3JTanLN0zzjFLlwWO0AAYGP61PHJGEbzeg6c4pblraSVmtVeODaMB+oPehRTVwM24LyfJJnd1z0qu0arEhI456jitIqqtuK5GPvA9agnRWiMjHCg9c9KzUGFzKLsA7Ek88CnSM7Hn5fYVfS0f5co6bl3x7l+8vqKst4Z1ryWu3smS2ChizkDIPSqjRnLZE86W5j26DDFl3Y7kUxYmeQqiknPSki8wjjcCMgj0qzCzQsTty3bnk1DjZ2YrkvlMY/wB5wR0HpTfKY8opPOMZ61ImSxaUnd14PUVfs0i3qcgAnNO19CHoZE9tIePmLZxwOgp7I33AcgYzkYyK6QJGWHllTmq19HlCAAGPPFaKm+5Ll3MMKS+0/dUd6VrFmXcq85zgdamnh2/ezmmxyMgJ3HaOxqoq3xEy8iH96kRiC7QO/cms51aJ3UEMO+R1rUmeScbgQABjJNZ918jusZJYdT2zWtyHG5j6grsmNoXvms/DbApPXOCK1rjLoV3c+9UZoz5GMLlehqrdSGrGZeB4CoWRl3DOVJXNcn4gM25ZhPKWBwTvJ+hr0fRrVZIb65Nsl7PaxB4bduQSWwWIHUAdqz5dTv8AUGa0bTbCXeMCL7EOT6DHNddB8skzKoueLgM8GX5mtIZ5mZz91iTk5oqLQbeGw8S32mbPKChJDCTnynKgsmfYnFFaVPdkaUneKud7YR215BLeSmMqzFWQEZUgcViQ3raVexTxqTE4LRYbbtJ4rPs7oQXADAFG6qT17CrmsRRpYWoSQs/IKt/D+Nac3NT5onKo2k4s0La4kviDyzk5JNb2lh7e4guD5o8t9wVTgNjsa5bRrkQOpwScjjPWu9u72GS3hVXVgACeOR7VwcujnfU9SEm0kXY9VMjkBEXcxcoo9aczOyb88n+H0rKh3YZ0A3DoTVtS5AEh2y7RwvQ1Lm56s3WhNb5UASEGRicZHGKkliSVgi7yzdAOcmq07E4LjBI+mKs2t40ULqB+8YfePanCCb1ZpzWK/kObo28KtuzjHv6Ux7SWDZuU4kGVf+8Ku6RqP9lzCSVYZX5YAcsM+rdvpVJZ5yV859wjJMcfZRnPNaSpwtczcrPQv2Rhig3zSiOQHKgjIJ64qnfO73zzBsmUBiueFOO1RQIXmkeR+CSxOMAfSorxhBMyschOvzZyKcZcq20DzPPvigwSO8RnVpVX5in3enavJdAhE2qQgjKqdxr1T4in7VZ3UscYXarZ+lee+D4N9xJIen3a6YS5acpHm4qPPXgj03QYiIwV7etb8YO4BgQuOPrWb4fjCoAc4610tvGHcncvNeVuzubtoQwR4lyCV4ztNalvgIAwyc8DGajVERirrmpUY5wDznkiqSSBMnYcl1UhTxjNWUZViywyD6c1LpphllWBguWG/LNt/AepqafYHH2Uh0B4JHNaONlcEEDL5aN684IxgVLKnnD9yoIHvzUUoZlG70696ajmPCxtjAyazlLoUia1iByHA3A9DUrwrGuR17YpY8p5cjMCMZzTJp1zlMk1CsNakas8hwFGfU9qZJZAAuSM4zVe8lkiQSRqSu7nHp61JZ3Im8xCSADgHHWpaKs7XKssBVQY5M5PI6VUltpWVsZJ6c1q3ke0KF5Ge4pYlby+oHOBmlyibOYkt3j7cjsf5VJiZolRePrxiukmiXJzHkdDWVdxHdiLI74qXCwXuY9xBhgQn1PXmn7IwAXHzZ6dxVkhpTtYZPeo2tn8vcg4X160rDGKgeQgDacdKUq6NkjIHSmxlzIyucsOS2O1WGk3KxRhjpjv+VNaAAYOAFwBjpnqfagBRu8zH1NNU/vgVO0jjpxTbiLcpZSc+x5q0xFefY0pIy2M45qo80kbEJtIxzjtV+00m9v5DHYRNI4+brgKPeo77Tbu2uHtryMQycZxzn8abjK17E3VzNedtqlBtJznHU+lTKySKF6MRnJ7UhsTHJhSOnWrBtfLj3gjPHHX8axT1LZ0vh/TLKW1MmpI0u3H7tTjIx94f/XqTVdPsbO4EUcu5Cm/B6r6A+tc/HJOkgdJHBHA5xipGMkhLXLs78bST09q7PbQ5LW1M1FphNCnQHcG43UxY9uVKNx7dqmgULGV5Ab+EnNNMqoDtJJzXJotUWJPebImQKAzjGe9Z1zN5sP2by/k4J29z61bfEhOc88ZxTGSJPm43dOtPnbQrE+j3cdgUkfMix4wH+bHsM1va54kttQsnkjYOsi7WjPAU+uPXiuPlw0hxkDPT1qHyBJMVHGOSBxmtqWLlTXKZSpc2pJDJhAEJYHrxjHtSNGxBOQA3bvU8VqREdp56kZqUQnheCoFYyk5O49iOKNnIJwoHBGKvxR4HzKWJ5GBxirVjFHIFGzkda0fIIjKhQOOOKcaelxNmLIqggYx3qwrxOOpyB3qK4haM7Txn1pxfEQRFUehqldCexVumDjJyBnGAKqvHuX5ByfX0q0UPcZx296AcHaVAx3NPWRL0Mi6jkjwTkA+xqrKgzx96tq+lBCqMH3qjLbBk3K3PXnpVqJF+5hzRHLZODVOWNtrBDWq8WZDEepqteQta/ePJ/UVSJeuhnadp+qXN076QsvnQjdlJAjL79RWgy+NlOfOuNw7iaMH885qtZ/a49Rjl01He6U5RUUnd6jHcdqh1HwzrMlxJMulTRIxLeVGc7fYDJNdFN9jJ76nJOLrRvGavfpsndwZAWDfe75GfrRVfWbYqGBDLLEc4IwQR2NFdcbVFdlxlyaHS6nA1pPhl4zz61rXFnDLpFpPbeZkZDlmyM1BqMM+pfarsAGNDk9utX1lSXQIYomznlgW5Vgew+lZUvgcWY1bOaaIbJCAGbB966nRY1m/dHO7G7OeMd6yvNtpbOPEQSXvtGAP/r1qaLZzXDZjUe3ODmudQtOy1OyFTlWp0FrayMu+NCIwPvY4rQNs8aI4iVgTnnIyK1PDWsRabp62F/biKBciQgZLt2rL1C7X+17h7JmW3Y4VGP8AKuiVGMVdMcat3ZhLCJUVsx5cEhc8gd6z2ISXyy3B4+lN89mmHBGPbNBXeC21jjv2rmkl0RupFyTTJXTzLcbwSRuHTI5xWS00hYlu3HSpTfyQlVUEYPGDirMaM9sBKiKZW2kt/D3OKuUVJWiC3K1rciPIYfKwIxu4IrPuUjjG2Ik55Oe1XwilZdzgIp4J4xWde4VSwbntz1rFtpWZfQ4bxxciPRL0jG5vkyfeua8CWZkj3Dua1vHMbyaVcN0RGBPuaPB0JhtImA528muibtQt3OVxvWv2R3OlptRUZcqDzita0uv9KlgMB8vblZc9D6VRsDug3Rjk9c961LSOExbtwznv2rkTZpewsDs0g5OD0zWnb2jZDHBzyc1XMSR8pkntVpJJTGFJJp2ETXBjIUIoBByGx0qVFI2qANvUbT1qvHbS+WW6jPQ9akhkMZKumeM/Sm5N7jRYk3DqQ2707VYhWMthxkds1SdtwGe4xxUlv/rArD86m5aRotHGSP4VHbPFJNbqU/dOEPr1pv2cgbQ4GOc561AQfMKg5B/LFS3boNaE/wBmMcYyd3HNRolvkAn5uvIqyI5nQAHI9CO1VbmBo3AxkZ6Ur+Q07lnMAx8w57UjBQpZdu08YPNV4o2fgAhzxVgweTliARnGDQmTykQcl8uuF9z0NQ3McRDbhtI/WriYdCMj6VXmMJdgX5HG49AfSm79B2OfulYuRsK8jDDvT47ZZSAxZSvLE9K2lSMYOOn61FOigbtvI6c4qVHuDZk3FgEaRoT+7zkHaQcfjUAtZd6+XE7Z7qu7P09fwrclVWtv3ZJfrz6A9K1tW1GK4sY5tPVLeRRt2gndG3cgduO4rohRhK7IcnexxYQlzzlA2D6ZqzmMLkKxIGCM1L5aRhjudmlO9ye5qKeM+TlQwzxmsXaL0KuaWk69DpMzGOL5m6Ntzngjn2rA1HUjfXEbSeYzwhgHIxwe2Ke9u4GPbPPUVQuIGjUMxzx/D3pyryceXoJQV7khQMrFThgeD61NCruCzkYz3qnbSNgKwwD35rSXiMZbn6Vz6N3L2FQqmW656ZpAhaTls9/rS/Z9wOxs8dT61LENrhW6jvRa7AqvBNjkHHpRBHuyHyDnitTABzkkjoaqTvtkDdeOafIkJMr3CLbxr5mDuPGO9QzxAyDZgZPQCnMGaQHZuGeAe1TlZZMMqjj+E/zoSiwbSHW+g3d9FIYntsopJTf8+PpjiqtvagQls7jnkgVr2eqahaRSQwuixyNlsxhm6Y4NQxJI3yA4B7Vs4waVtzFOV32MwIAflB/CniMkk4OOxArcFmqkRt8rHnkcmpVtlxkY+WkqfcZT0+2mRQwOAe3Wp57iVAVIGM/jUnKN8xYYNMnkjZcIhy3fvT0S0C3Uz7iR3bLgYFVZHUO2AeePfPtWlFEsnXBXtVW8VVf93wfWp6XEVzJg8D5sdDVedyzjdk+/TmlaVtwyOvWieVnTAVQvoetC1JZnXiAjIGO59zVWV3VOT8o/hq85JJGOCevpVRkXqwzntVIkoTMNwZRgkdc9ar3h+07TIuTGOua0zaqyk52vjIqhIu0MD0z1q7Ml9yXRJlSDULVrpbOW5jCRzsSAMNkqSOgI71Rbw/dQuWfU7CMDnzftfT3HetPRrW2MF/d3Nv8Aavs0askLE4JJxlvYVUvrC11izml022FtqEILS2qElZE/vJnnI7it4bWMXozmPG08F7rM0lu/mpsSMykYMrKoBfHuRmirXjS0httYeOGNY4/Ihbao7mNST+dFapsuMrLQs21xLHpctsv+qkOXPvUuhWJuZX+U+UCMnNS27wjQpUc5uPO46cLXR+BbM+ZLMjRqYyrgOuc888fSqpxvJGE3obceh2U0EgtXzsbbn+9gZp6aVd29issRdIGIPmRgFhz2z3rfuILjL3WmFTJJ1i2fdzz8vtVHSbWPUJfsrq0Fw54bJ+b1yOwrd01e6QKbKMt/hEhjWaZ2ZmaWVNpfjjP/ANatnTJPDd3p4/tK6S3nJwwkJXb9D3qPV9CmsQ/2sskiA8hcqfxrmbaK3kvY4rhl+zlssxzms3JxeqNG5PW5r2t3ZWZZQVu4z9xg3Kj3qWPVraGKRFiRyc7WzyKzNWhsftoWycmEjG8riptX0UafDFPFcLMzKCQOMA1lOTWiRvSfNo2XpLCP7OkhDLv+bjkdKfHepFptzbNGHd1xHuAwp9c9ayrW6lVAuASe5/lV5rcyjcBlum1R1PoKyjLW8DrS6GVJlovIfLDPJBqhqBxC2B0PArVniKM4O4MpwVI6GsTUn+9jtWTvezKvc868dXP+ixWg6vKN3NbegQ/ufl6BR2rlvFal9QtGY53SfnXZaEDFCehIXtW1b4Io54/FI6TSt0acjnHWtSygR1eSOQMxOWX0xWRbNtO9sfMO1aejhoZHYDJfjnuKwjYpW1uaq7Yxz1I5qZXJGVwcciqzRu0nOSOcgirls6IAUUMw4Jz0pkipO53AnjPrUkatMm4EEdvamTtkB2ABqOA8kjgAdallosrFl8c5zjAqy1uYwCOfoaqkkcngk5z3qdnkKjcTjsfSpHcUM44U8dsdafD9/I6mmZC8sNwJ5NLG6rIRKBt7AdqnYq9y/veMY35IHWonZm5f73TdTIg0reYRiLO3g55HNaLIpUhCoOQeadri22KYYgE4Ib19acqSyLnLDHarwVXyMDbioJJQhIzhT2BpciBSKqxEP8qknpn/AOvUFxZzyoYxKVt2be0fqe5+vStBfnI25PfAp13kDI4OO1NK2wnKxksSrbUH3Rg8c1ZDxuuTjOPyqF1O4vj5h0z1qKSOROSuQf196Bk/l7ifQ8/hVdwgJU4OP1qcTRpAVBJfHWs9zk5C9D170XsJCXCh+UyOajBK43glQenvU68tyCozirPkRsnGGHvQo31Y2zMkzIxAQBcVSmVy52gHseOK6CS3gyfm2HHTtWZcoY+QRj+dJwFcpQW8YfkYOcjFT+QijO7PH50jsysODlum0f0qzHEzRgjJ4/iGKnlC5CyAAbM+gzUtqM/M/wAzDg5qU2+VIB/DFPiBjwPmyO2aXKMURjbnGRnpUHkxs5IB9QKsNO2wBVycde9RYmV9y59BTsSVprYg79hXH61HFKQ4JU9cVaeRvKLSH2JNZTBt7YBwDwabXLsTqzSmdQvAGD2psTBIiEzvPIPpVSHLkBzg+4rXgtkUDGPaqV3qh3S3K8WACQ0hk/vMc1qWxiVBv69ce9VXgUOFjBA9M1aQm2i6BgO/WizvdibuMvHhddy7gxPAxVSGNpULAEEcZq9I6yR5banHGRVJLloiWxnnnHpQ0nuO+hFcRmJAGG1vUHtWU0m5jtJI9BWjdTGVsnkemO1UGQBht6Z6ilbsJ7alOVWJLnB4/OoGBwAG+hq9Oo75HpVWUEZJ+6B0qbEN3KDE4GTjnNTQ7D/rCuBUc4zjaMEd/Sq4LDOTkjn61oiJC3CCKViH3A9s1TuY3ChgmUPanuuSMtjHQetRSMwBBchRVxa6ifkR2l9daZOJrSTY54JGCCvoQeDWY8k0V0LmCR45lbKspwQa39FtlmkknZElcOkUUcv3DI5wC3sACaWLUbi61C4tTe/aY1VzHHLCPKm28lSv8OQDgitEvMyb1OQ127uNTuXub1g9ywCswGM4GBwPpRU/iG1jtrzNrkQSIssanqFYZwfp0oqrsEyxaxG4uNqkASSfKemMmvSNEmttKmi+zgXDSKI5ogucdiPrXnFgSEYg45FbyE43ZO7g579RXXQdrsxqK7sexaXfwrpYVyrSLlA0Yw688A+/tWReW1xaSPfoQoB4x0J9D6GqVtxqUpHBaNSSO5wOa1bj/kA3x75Brok+ooxVjlNU8S314qW90GJT5GYMTuxUlubG08i5vkLndzbIcMR9e1Y19zf3BPJGCM9jirEIBtgSBn1rl5uZ3kbpWRPqUcD3MjWaSiAtlVY8gdue9ME0jfLLyMAYPNa2hKr3Q3qG+TuM1FqKqLxgFAGew9qxmru5tTsilDuzjIz1rXs7yW3E0kLBXddpB7D1FZh+431p8hIiXBPesoe69DrY+6K53YILckdc/jWBrIxCTwCc9sVtOSTyaxNdJ2dT0ppc0tRN2PLfEMbyarZYBZEbkgcCuv0ziMbhtBH0rpPBMMU/hTxt50SSbY4CN6g45PrXMWX32Hb0/Ct8RC0Iy8jkp1PfkjqbdF8hTzz6dq0LRyhyQemAax7QnYvPateTp+ArksaN6mlZXUL3CxSSbS4yM9DVu0gWGZiGZgwI2k8D1xWfZKMx8DjParbkg/nVdLlXLTQ+a21f1qQQ+WASC23qMdajtz+7T6ipwT5SVC1KuSG4iYglehxkdqnhntvLJ7+hrGP3zVhR8hqLj5S8s8aMQU4POMZwKJFWQgxxHGetU4fun8K3Lb/VflS33G1y7Gescke5wpAJ6ClSeQkMQT6Zqw3+vf6UQ/dk+tF9SlqSJK7A7VPzDH0pVtZGyWOTnvUsXUfSpo+34VVtCXoU9rxS/K4Ck4OO9VbpisknzSn5R5e0DBPoc1fm7fSocAhsgHihKwouzuxWjaS3TcP3mPmwOM1WktnwGbnAB+laRA3xjHG2o36f8Cob1FzGFNG3nEEEA81Yhhjfb2J6+4q3IAbgZHep8ARLgCi2oX0M1rQBSVZePeo49iSqHJGT+Bq9MB+84HQVTvuAuPQU7DT0I7wMh4GQeg9aqSwyMRI2PYVp3BOwcmqR6j8KJEuRXS6liBIj+fHyuByDTbYXr3RmuZ2Y7cFG6Crz/e/CheVBPJ9am7LT0HIHbLZJzz1pybiwJC8Z6VWc8x/Wr03E0ePSnuTcXaqktgAn86bIxGAvIPI45qKbqfoKjkJGMEj/APXSvYTK93tbKgHDdahZGWMAJj3q4/8Aqkph6x/WhaiuZ8gk3AEZJ9BWlaxbgo5UHk5NSgD7R09alXp+NOMdxNjXCxxAq3zColleRwAO3Wq1wT5lXtO/1a0JXYJkMsbPjJ49fSqrx4kIVwM+tas/V/oay5PvH6ihxsNFZlyMnj6Cmq3lkgKM+uKvx/eqnc/8fZ+lQDdyKURFRuPzYweKqTeXhscj0HerM3VKz5v9VTuQV3RWfDqCCe1RSwxh8A5HbB6e1SSchs9lGPamXX3BTjKwmiOaGNgZBhE4znpVK4hMgyjjC9OOtLqZ/wCJZL/nvVPTifsg5PSqTTM3oibTbpLWWWG4LrDKAd6ctGwOVYD2/kauzXNtmWR7rTgZARJLawv5zg9QAflUnuax7n/Wn3FVJOI2xWkXYhq5X1q6N5dySrF5akKscfUIqjAH5CioJ+g+tFWOx//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous, scaly papules are present in this patient with guttate psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24725=[""].join("\n");
var outline_f24_9_24725=null;
var title_f24_9_24726="Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency";
var content_f24_9_24726=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24726/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24726/contributors\">",
"     Deborah P Merke, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24726/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24726/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24726/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24726/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/9/24726/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defective conversion of 17-hydroxyprogesterone to 11-deoxycortisol accounts for more than 95 percent of cases of congenital adrenal hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This conversion is mediated by 21-hydroxylase due to mutations in the CYP21A2 gene. Based upon neonatal screening studies that detect classic congenital adrenal hyperplasia, 21-hydroxylase deficiency is one of the more common inherited disorders.",
"   </p>",
"   <p>",
"    The laboratory findings and diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in neonates and adults are reviewed here. The genetics, clinical presentation, and treatment of classic 21-hydroxylase deficiency in children and adults and an overview of nonclassic congenital adrenal hyperplasia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=see_link\">",
"     \"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31754?source=see_link\">",
"     \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7433?source=see_link\">",
"     \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1367?source=see_link\">",
"     \"Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A very high serum concentration of 17-hydroxyprogesterone, the normal substrate for 21-hydroxylase, is diagnostic of classic 21-hydroxylase deficiency (",
"    <a class=\"graphic graphic_figure graphicRef81907 \" href=\"UTD.htm?1/15/1278\">",
"     figure 1",
"    </a>",
"    ). Most affected neonates have concentrations greater than 3500",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (105",
"    <span class=\"nowrap\">",
"     nmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    Classic",
"    congenital adrenal hyperplasia due to 21-hydroxylase deficiency results in one of two clinical syndromes: a salt-losing form or a non-salt-losing (simple virilizing) form.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Girls with either form present as neonates with ambiguous genitalia. In rare instances, the ambiguous genitalia may not be identified. These affected females may present with a salt-losing adrenal crisis at one to two weeks of age.",
"     </li>",
"     <li>",
"      Boys present as neonates with a salt-losing adrenal crisis (hyponatremia, hyperkalemia, and failure to thrive) or as toddlers with signs of puberty (non-salt-losing form). With the advent of neonatal screening programs, affected males are typically diagnosed before they develop clinical symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Routine neonatal screening is now available in many countries, including the US [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The role of prenatal testing is described below. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Prenatal diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In countries where routine neonatal screening is not available, the diagnosis is sometimes made after infancy. (See",
"    <a class=\"local\" href=\"#H285022119\">",
"     'Interpretation of results'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H242985469\">",
"    <span class=\"h2\">",
"     Neonatal screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many countries, including the US, neonatal screening for 21-hydroxylase deficiency is an approved part of the neonatal screening program. The screening test for 17a-hydroxyprogesterone (17OHP) is measured using a filter paper blood sample obtained by a heel puncture preferably between two and four days after birth. The assay used in most programs is a fluoroimmunoassay (DELFIA) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/4\">",
"     4",
"    </a>",
"    ]. Most affected neonates have concentrations greater than 3500",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (105",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H285022119\">",
"     'Interpretation of results'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H285022119\">",
"    <span class=\"h3\">",
"     Interpretation of results",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic biochemical abnormality for diagnosis at any age in patients with 21-hydroxylase deficiency is an elevated serum concentration of 17-hydroxyprogesterone, the normal substrate for 21-hydroxylase (",
"    <a class=\"graphic graphic_figure graphicRef81907 \" href=\"UTD.htm?1/15/1278\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A very high serum concentration of 17-hydroxyprogesterone in a randomly timed blood sample is diagnostic of classic 21-hydroxylase. Most affected neonates have concentrations greater than 3500",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (105",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The biochemical findings are less severe in patients with the nonclassic form of the disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1367?source=see_link\">",
"       \"Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Additional lab testing that should be performed once a diagnosis is made is described below. (See",
"      <a class=\"local\" href=\"#H285022333\">",
"       'Additional lab testing'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      False positive results from neonatal screening are common with premature and sick infants [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/6,7\">",
"       6,7",
"      </a>",
"      ] and many screening programs have established reference ranges that are based upon weight and gestational age [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. Although most labs in the US use birth weight-adjusted cutoffs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/2\">",
"       2",
"      </a>",
"      ], gestational age criteria have been shown to improve the positive predictive value of screening [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some studies now suggest there is a substantial risk of false negative results for the neonatal screening for CAH, particularly in girls [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. This was best illustrated in a population-based study of all newborns screened in Minnesota from 1999 to 2010. Of the 838,241 newborns screened, 52 were diagnosed with classic CAH, but 15 cases (nine girls, six boys) were missed, for a false negative rate of 22.4 percent (95% CI 14-34). Among the nine females missed by screening, five had further evaluation and were diagnosed because they had ambiguous genitalia, but three others had ambiguous genitalia and were not diagnosed until three months to six years.",
"      <em>",
"      </em>",
"      Thus, newborns with findings suggestive of CAH (eg, ambiguous genitalia) should undergo further endocrine evaluation even if the neonatal screening test is negative. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=see_link&amp;anchor=H25315825#H25315825\">",
"       \"Evaluation of the infant with ambiguous genitalia\", section on 'Diagnostic approach'",
"      </a>",
"      .)",
"      <em>",
"      </em>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H242985503\">",
"    <span class=\"h3\">",
"     Effect of antenatal glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of antenatal glucocorticoids, particularly multiple courses (administered to induce pulmonary maturation in pregnancies with expected preterm delivery), may decrease 17-hydroxyprogesterone levels in filter-paper blood, increasing the risk of false-negative results [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Repeat screening for CAH at one to two weeks of age should therefore be performed in infants who have received multiple courses of antenatal glucocorticoids; salt loss should be carefully monitored in the interim between screening samples.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H242985530\">",
"    <span class=\"h3\">",
"     Mass spectrometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;The positive predictive value of the filter-paper screening is increased by using tandem mass spectrometry as a second-tier test [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. The use of tandem mass spectrometry rather than antibody-based assays also improves throughput and reduces the time to obtain a result [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/18\">",
"     18",
"    </a>",
"    ]. However, the test is expensive and is not widely available as part of neonatal screening programs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H285022333\">",
"    <span class=\"h1\">",
"     ADDITIONAL LAB TESTING",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If a baby tests positive for CAH during neonatal screening, follow-up 17-hydroxyprogesterone, preferably measured by tandem mass spectrometry, and electrolytes should be performed. If the 17-hydroxyprogesterone level remains high, immediate referral to a pediatric endocrinologist is warranted.",
"     </li>",
"     <li>",
"      Although a cosyntropin stimulation test is the gold standard for the diagnosis of CAH, it is not necessary to make the diagnosis of classic CAH; infants with classic CAH have baseline adrenocortical hormones that are markedly elevated due to a highly stimulated adrenal cortex. A very high serum concentration of 17-hydroxyprogesterone is diagnostic of classic 21-hydroxylase deficiency (",
"      <a class=\"graphic graphic_figure graphicRef81907 \" href=\"UTD.htm?1/15/1278\">",
"       figure 1",
"      </a>",
"      ). Most affected neonates have concentrations greater than 3500",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (105",
"      <span class=\"nowrap\">",
"       nmol/L);",
"      </span>",
"      all have concentrations greater than 1200",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (36",
"      <span class=\"nowrap\">",
"       nmol/L).",
"      </span>",
"      17-hydroxyprogesterone may be elevated in 11&beta;&ndash;hydroxylase deficiency, but this level is &lt;1200",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (36",
"      <span class=\"nowrap\">",
"       nmol/L).",
"      </span>",
"     </li>",
"     <li>",
"      To define the metabolic defect in infants, serum concentrations of 11-deoxycortisol, 17-hydroxypregnenolone, cortisol, androstenedione, and dehydroepiandrosterone (DHEA) should also be measured, listed in order of priority.",
"     </li>",
"     <li>",
"      A distinction between the salt-wasting and non-salt-losing (simple-virilizing) forms of 21-hydroxylase deficiency is not necessary; clinical management is the same and there is a continuum of disease severity. However, patients with the most complete enzyme deficiency typically have the highest 17-hydroxyprogesterone levels [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      To assess borderline cases, the standard high-dose (250 mcg cosyntropin) test, not the low-dose (1 mcg) test, should be used. This is preferred over genetic testing (see below) and can be done in an outpatient setting by a pediatric endocrinologist. If the diagnosis of CAH is highly probable (ie, random 17-hydroxyprogesterone &gt;10,000",
"      <span class=\"nowrap\">",
"       ng/dL,",
"      </span>",
"      and electrolyte abnormalities or ambiguous genitalia in female infant) treatment should be instituted immediately and a cosyntropin test is not necessary.",
"     </li>",
"     <li>",
"      Patients with classic 21-hydroxylase deficiency have mineralocorticoid deficiency and are at risk for volume depletion, hyponatremia, and hyperkalemia. Patients are also at risk for hypoglycemia during an adrenal crisis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other abnormalities that may be present in either form (but mostly in the classic form) include high serum concentrations of androstenedione, 3-alpha-androstanediol glucuronide, testosterone, 21-deoxycortisol, and progesterone, and increased urinary excretion of metabolites of cortisol precursors, particularly pregnanetriol, pregnanetriol glucuronide, and 17-ketosteroids. (Pregnanetriol and its glucuronide are the major metabolites of 17-hydroxyprogesterone, and 17-ketosteroids are metabolites of androgens.) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21445?source=see_link\">",
"       \"Measurement of adrenal androgens\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H64509828\">",
"    <span class=\"h2\">",
"     Role of genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic testing, which detects approximately 90 to 95 percent of mutant alleles [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/20\">",
"     20",
"    </a>",
"    ], can also be used to evaluate borderline cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/21\">",
"     21",
"    </a>",
"    ]. Genetic testing should only be done if the adrenocortical testing is equivocal or for purposes of genetic counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H242985810\">",
"    <span class=\"h1\">",
"     ADRENAL ULTRASOUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal ultrasonography is another potential adjunctive test for CAH in neonates with ambiguous genitalia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    life-threatening salt loss, when the diagnosis is equivocal based upon other testing. In a retrospective analysis of 52 children with ambiguous genitalia or salt-wasting crises, abnormal adrenal ultrasonography (ie, adrenal limb width &gt;4 mm, lobulated surface, or abnormal echogenicity) had 92 percent sensitivity and 100 percent specificity in differentiating 25 neonates and children with untreated congenital adrenal hyperplasia from eight children with the disorder who had been treated and 19 children with other conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=see_link\">",
"     \"Evaluation of the infant with ambiguous genitalia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal diagnosis should be considered when a fetus is known to be at risk because of an affected sibling, or when both partners are known to be heterozygous for one of the severe mutations, thus predicting a one in eight chance of female genital ambiguity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link&amp;anchor=H10#H10\">",
"     \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\", section on 'Risk of classic CAH in offspring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Measurements of amniotic fluid 17-hydroxyprogesterone, HLA typing of fetal cells, and molecular analysis of fetal CYP21A2 genes in amniocytes or chorionic villus samples have all been used as screening methods, although the",
"    <strong>",
"     molecular analysis of CYP21A2 genes",
"    </strong>",
"    is now the method of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. This test is available commercially.",
"   </p>",
"   <p>",
"    Prenatal diagnosis also is undertaken if prenatal therapy is being used; that is discussed separately. If prenatal therapy is not planned, then prenatal diagnosis is not indicated, but it may be a parental choice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31754?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children\", section on 'Prenatal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 90 to 95 percent of CYP21A2 mutant alleles are detected using PCR methodology that targets the 12 most common mutations. Although screening for the most common mutations may miss mutations in up to 10 percent of CAH patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24726/abstract/20\">",
"     20",
"    </a>",
"    ], if at least one mutation is detected, the patient can be evaluated further. CYP21A2 mutation analysis is not helpful in diagnosing other enzyme deficiencies as a possible cause of CAH and is expensive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 95 percent of cases of congenital adrenal hyperplasia are due to 21-hydroxylase deficiency. It is one of the most common known autosomal recessive disorders. The clinical manifestations of classic 21-hydroxylase deficiency are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=see_link\">",
"     \"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The characteristic biochemical abnormality in patients with classic 21-hydroxylase deficiency is an elevated serum concentration of 17-hydroxyprogesterone, the normal substrate for 21-hydroxylase. Most affected neonates have concentrations",
"      <strong>",
"       greater than 3500",
"       <span class=\"nowrap\">",
"        ng/dL",
"       </span>",
"      </strong>",
"      (105",
"      <span class=\"nowrap\">",
"       nmol/L).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H242985469\">",
"       'Neonatal screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In many countries, neonatal screening for 21-hydroxylase deficiency is performed routinely in all newborns. Conventional screening is done by measuring 17-hydroxyprogesterone in the dried blood. (See",
"      <a class=\"local\" href=\"#H242985469\">",
"       'Neonatal screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      False positive results from neonatal screening are common with premature infants, and many screening programs have established reference ranges that are based upon weight and gestational age. False negatives may occur as a result of antenatal glucocorticoid use. (See",
"      <a class=\"local\" href=\"#H285022119\">",
"       'Interpretation of results'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H242985503\">",
"       'Effect of antenatal glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of classic 21-hydroxylase deficiency is reviewed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7433?source=see_link\">",
"       \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31754?source=see_link\">",
"       \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/1\">",
"      Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/2\">",
"      Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:4133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/3\">",
"      Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics 2006; 118:e934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/4\">",
"      Gonzalez RR, M&auml;entausta O, Solyom J, Vihko R. Direct solid-phase time-resolved fluoroimmunoassay of 17 alpha-hydroxyprogesterone in serum and dried blood spots on filter paper. Clin Chem 1990; 36:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/5\">",
"      Witchel SF, Nayak S, Suda-Hartman M, Lee PA. Newborn screening for 21-hydroxylase deficiency: results of CYP21 molecular genetic analysis. J Pediatr 1997; 131:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/6\">",
"      Cavarzere P, Samara-Boustani D, Flechtner I, et al. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol 2009; 161:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/7\">",
"      Coulm B, Coste J, Tardy V, et al. Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003. Arch Pediatr Adolesc Med 2012; 166:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/8\">",
"      Olgem&ouml;ller B, Roscher AA, Liebl B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab 2003; 88:5790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/9\">",
"      van der Kamp HJ, Oudshoorn CG, Elvers BH, et al. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J Clin Endocrinol Metab 2005; 90:3904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/10\">",
"      Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. J Clin Endocrinol Metab 2002; 87:4106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/11\">",
"      Sarafoglou K, Banks K, Kyllo J, et al. Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota. JAMA 2012; 307:2371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/12\">",
"      Varness TS, Allen DB, Hoffman GL. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. J Pediatr 2005; 147:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/13\">",
"      Gatelais F, Berthelot J, Beringue F, et al. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res 2004; 56:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/14\">",
"      K&ouml;sel S, Burggraf S, Fingerhut R, et al. Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency. Clin Chem 2005; 51:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/15\">",
"      Minutti CZ, Lacey JM, Magera MJ, et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004; 89:3687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/16\">",
"      Soldin SJ, Soldin OP. Steroid hormone analysis by tandem mass spectrometry. Clin Chem 2009; 55:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/17\">",
"      Schwarz E, Liu A, Randall H, et al. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience. Pediatr Res 2009; 66:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/18\">",
"      Lacey JM, Minutti CZ, Magera MJ, et al. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem 2004; 50:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/19\">",
"      New MI, Lorenzen F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/20\">",
"      Finkielstain GP, Chen W, Mehta SP, et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2011; 96:E161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/21\">",
"      Nordenstr&ouml;m A, Thil&eacute;n A, Hagenfeldt L, et al. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/22\">",
"      Al-Alwan I, Navarro O, Daneman D, Daneman A. Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia. J Pediatr 1999; 135:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/23\">",
"      Gueux B, Fiet J, Couillin P, et al. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid. J Clin Endocrinol Metab 1988; 66:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/24\">",
"      Mornet E, Boue J, Raux-Demay M, et al. First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet 1986; 73:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24726/abstract/25\">",
"      Lee HH, Chao HT, Ng HT, Choo KB. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 1996; 33:371.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 145 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9F1D191359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24726=[""].join("\n");
var outline_f24_9_24726=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H242985469\">",
"      Neonatal screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H285022119\">",
"      - Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H242985503\">",
"      - Effect of antenatal glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H242985530\">",
"      - Mass spectrometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H285022333\">",
"      ADDITIONAL LAB TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H64509828\">",
"      Role of genetic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H242985810\">",
"      ADRENAL ULTRASOUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/145\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/145|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/15/1278\" title=\"figure 1\">",
"      21 hydroxylase deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1367?source=related_link\">",
"      Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=related_link\">",
"      Evaluation of the infant with ambiguous genitalia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=related_link\">",
"      Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21445?source=related_link\">",
"      Measurement of adrenal androgens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/16/7433?source=related_link\">",
"      Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31754?source=related_link\">",
"      Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_9_24727="Histology case 3";
var content_f24_9_24727=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Histology case 3",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panels A and B are the findings on electron microscopy and indirect immunofluorescence with sera containing anti-GBM antibodies. Panels C and D show electron microscopy and immunofluoresence with anti-IgA antibodies from a second patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24727=[""].join("\n");
var outline_f24_9_24727=null;
var title_f24_9_24728="Evaluation of otorrhea (ear discharge) in children";
var content_f24_9_24728=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of otorrhea (ear discharge) in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24728/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24728/contributors\">",
"     Christopher G Strother, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24728/contributors\">",
"     Karin Sadow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24728/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24728/contributors\">",
"     Stephen J Teach, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24728/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24728/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/9/24728/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otorrhea means drainage of liquid from the ear. Otorrhea results from external ear canal pathology or middle ear disease with tympanic membrane perforation. The physical examination and the history will differentiate among most causes of otorrhea in children.",
"   </p>",
"   <p>",
"    The evaluation of otorrhea in children is reviewed here. The approach to ear pain is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/47/13050?source=see_link\">",
"     \"Evaluation of earache in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The table provides a list of etiologies for otorrhea in children (",
"    <a class=\"graphic graphic_table graphicRef68061 \" href=\"UTD.htm?20/12/20684\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otorrhea in the setting of a traumatized or immunocompromised patient may indicate a serious life-threatening condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Traumatic cerebrospinal fluid otorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral spinal fluid (CSF) otorrhea is a serious sign in the setting of head trauma. If any ear discharge is noted after serious head trauma, particularly clear or bloody discharge, the patient should undergo evaluation for CSF otorrhea caused by a basilar temporal skull fracture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation and management of middle ear trauma\", section on 'Evaluation of ear or nose drainage'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link&amp;anchor=H23#H23\">",
"     \"Skull fractures in children\", section on 'Basilar skull fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemorrhagic otorrhea may also arise from middle ear trauma caused by a direct blow to the ear, auditory barotrauma, or intrusion of a foreign body into the external ear canal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=see_link\">",
"     \"Evaluation and management of middle ear trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35397?source=see_link\">",
"     \"Ear barotrauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Infectious complications of acute otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the mastoid air cells are connected to the distal end of the middle ear through a small canal or antrum, most episodes of acute otitis media (AOM) are associated with some inflammation of the mastoid. In rare cases, resolution of the mastoid infection does not occur, and acute mastoiditis develops with pus filling the air cells. The child with mastoiditis will have painful swelling behind the ear that typically pushes the pinna forward. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5385?source=see_link\">",
"     \"Acute mastoiditis in children: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other intratemporal complications that occur by contiguous spread of infection include petrositis (Gradenigo syndrome with sixth nerve palsy) and labyrinthitis.",
"   </p>",
"   <p>",
"    Intracranial complications of AOM are particularly a concern in children who appear ill. These complications include meningitis, epidural abscess, brain abscess, lateral sinus thrombosis, cavernous sinus thrombosis, subdural empyema, and carotid artery thrombosis. Patients with these illnesses usually develop fever and, over time, a toxic appearance; a few may manifest cranial nerve deficits, especially cranial nerve VII (facial nerve) and less commonly, cranial nerve VI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H32#H32\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Intracranial complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Necrotizing otitis externa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Also called malignant external otitis, this is a complication of bacterial otitis externa. Infection of the skin gives way to deeper seeding of cartilage, tissue, and bone. As the infection advances, osteomyelitis of the base of the skull, temporomandibular joint osteomyelitis, brain abscess, and generalized bacterial sepsis can develop. Although most commonly seen in the elderly and adults with diabetes mellitus, immunocompromised children (eg, cancer patients on chemotherapy or HIV-infected patients) are at risk.",
"   </p>",
"   <p>",
"    Patients with malignant external otitis classically present with otorrhea and exquisite otalgia which are not responsive to topical measures used to treat simple external otitis. The pain is generally more severe than that found in simple external otitis, although the two may be difficult to distinguish in their early stages. The pain in malignant external otitis tends to extend into the temporomandibular joint, resulting in pain with chewing.",
"   </p>",
"   <p>",
"    On physical examination, purulent otorrhea is seen in more than half of cases, and ipsilateral lower motor neuron facial nerve palsy can be present as well. Granulation tissue may be visible in the inferior portion of the external auditory canal at the bone-cartilage junction (at the site of Santorini's fissures).This finding may be absent in atypical patients (eg, HIV-infected patients and children). Early empiric antibiotic therapy and otolaryngology consultation are essential to good outcomes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20216?source=see_link\">",
"     \"Malignant (necrotizing) external otitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Neoplasm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer is a rare cause of otorrhea but should be considered in patients with abnormal tissue growth in the ear canal or a lack of response to prolonged external otitis treatment. These patients warrant prompt referral to an ear, nose, and throat (ENT) specialist with pediatric expertise.",
"   </p>",
"   <p>",
"    Ear canal cancer occurs far less frequently than auricular cancer, although the presentation and behavior are more sinister. In the early stages it is often indistinguishable from external otitis. In addition, rhabdomyosarcoma and neuroblastoma may manifest as auditory canal tumors in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H26#H26\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Carcinoma of the ear canal'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\", section on 'Metastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Common conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otorrhea in children is often caused by one of several more benign diseases. Clinical findings with cleansing of debris will differentiate among most of these etiologies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Bacterial otitis externa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bacterial external otitis, often called \"swimmer's ear,\" is an infectious inflammation of the external auditory canal. History often includes either water exposure or instrumentation with damage to the outer ear canal (such as cleaning with cotton swabs or finger scratching). Common symptoms include pain, pruritus, and hearing loss. Minor trauma to the canal's protective skin barrier and protective cerumen layer allows for bacterial overgrowth. Otitis externa is most commonly caused by Pseudomonas aeruginosa, although Staphylococcus aureus, Staphylococcus epidermidis, polymicrobial and anaerobic infections can occur. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26816?source=see_link\">",
"     \"Patient information: External otitis (including swimmer's ear) (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H191116177#H191116177\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On physical examination, moderate to severe pain with minor tragus manipulation or pulling on the auricle is classic. An erythematous, edematous ear canal with cellular debris is seen. Since the middle ear is not necessarily involved in external otitis, there may not be any middle ear effusion or purulent otitis media. When visible, the tympanic membrane (TM) itself is typically erythematous or covered with debris. Often the membrane is difficult to see due to edematous narrowing of the canal. Otorrhea is purulent, white to yellow, and may dry to a crust.",
"   </p>",
"   <p>",
"    Patients with severe forms of otitis externa may also have fever, regional lymphadenopathy, or erythema of the pinna. If the pinna is infected, very aggressive treatment may be necessary such as admission for intravenous antibiotics, topical soaks, and surgical debridement. It is important to make the distinction between a generalized cellulitis of the skin of the pinna and a more serious cartilage infection such as perichondritis or chondritis. This distinction may be made by inspecting the lobule, which has no cartilage. If the lobule is spared, but the rest of the pinna is erythematous, this suggests involvement of the pinna cartilage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=see_link&amp;anchor=H16#H16\">",
"     \"Other Pseudomonas aeruginosa infections\", section on 'Perichondritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H277656#H277656\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Malignant external otitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Foreign body",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ear foreign bodies (FBs) may cause otorrhea if they are long standing or consist of highly irritating substances. The history may or may not indicate their presence.",
"   </p>",
"   <p>",
"    Typical foreign bodies include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Toys or small objects placed in the ear by toddlers, or placed into younger sibling's ears",
"     </li>",
"     <li>",
"      Insects, although they are often so irritating that removal occurs before otorrhea develops",
"     </li>",
"     <li>",
"      Food material, especially nuts with irritating oils that can cause a significant reaction",
"     </li>",
"     <li>",
"      Button batteries (often used in small electronic devices such as hearing aids)",
"     </li>",
"     <li>",
"      Expelled tympanostomy tube with granulation tissue and bloody otorrhea (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Tympanostomy tube drainage'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Button batteries require emergent removal because pressure necrosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severe burns from residual electric current or leakage of caustic contents may rapidly lead to extensive damage to adjacent structures.",
"   </p>",
"   <p>",
"    Otoscopy is diagnostic. However, cerumen buildup or otorrhea may obscure the object, and cleaning may be necessary before the FB can be seen. Most ear FBs that do not cause otorrhea can be removed using simple techniques in the emergency department or primary care setting without referral to an ENT specialist. However, complications do result from multiple manipulations, and an ENT consult should be called when in doubt or when necessary visualization and removal equipment are not available.",
"   </p>",
"   <p>",
"    In patients with FBs that cause otorrhea, visualization and removal can be extremely difficult and must be done with care. Unless the clinician ensures visualization of the object and has the proper tools and setting (including the ability to restrain and possibly sedate the child), referral to an ENT specialist with audiometry is warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28504?source=see_link\">",
"     \"Diagnosis and management of foreign bodies of the outer ear\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Acute otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, the tympanic membrane will rupture in the course of acute otitis media. This is usually associated with ear pain and fever of relatively short duration, followed by pain relief associated with the onset of otorrhea. The drainage often has a clear or white appearance. By the time the patient is seen, the perforation may have healed, but the drainage may continue for some time, especially if otitis externa has developed. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Bacterial otitis externa'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Often the perforation itself may not be visible on otoscopy because the otorrhea obscures visualization of the tympanic membrane (TM) or the perforation has rapidly resealed. When seen, the TM typically has abnormal appearance and lack of mobility on pneumatic otoscopy. If the perforation is of recent origin, it generally heals spontaneously once the infection resolves. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H29#H29\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'TM perforation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Chronic suppurative otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic suppurative otitis media (CSOM), or chronic otomastoiditis, is a perforation of the eardrum with chronic drainage from the middle ear cleft. This condition is more frequently seen in children who lack access to health care and, thus, do not have timely diagnosis and treatment of acute otitis media. It should not be confused with longstanding otitis media with effusion (OME, or \"serous\" otitis media), or persistent acute otitis media, both of which involve an intact tympanic membrane and no drainage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H5#H5\">",
"     \"Otitis media with effusion (serous otitis media) in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CSOM is often painless. On examination, a debris-filled canal is noted. The discharge is often white to yellow, and mixed with soft cerumen. Pseudomonas aeruginosa and Staphylococcus aureus are common pathogens. Treatment typically consists of topical antibiotic ear drops, with topical quinolones being the best studied treatment choice. Parenteral antibiotic administration guided by culture of the ear discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tympanomastoidectomy may be necessary in refractory cases, though the evidence for superiority of systemic antibiotics over topical quinolone antibiotics is mixed and not convincing [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/1\">",
"     1",
"    </a>",
"    ]. These refractory cases should be pursued in consultation with an ENT specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Cerumen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Annoying to many parents, but generally harmless, some children have thin cerumen that can present as ear drainage. In general, cerumen is only a problem if it is impacted or if it precludes examination of the eardrum. In such cases, removal may be necessary, but precautions should be taken when instrumenting the ear canal. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'External auditory canal cleaning'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Tympanostomy tube drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ten to 30 percent of children with tympanostomy tubes will have at least one episode of acute otorrhea while their tympanostomy tubes are in place, either immediately postoperatively or during an episode of acute otitis media. The drainage is usually foul smelling, mucoid, and may be mixed with blood. It is generally treated with antibiotic drops. Suction cleaning of the ear canal may be needed for drops to be effective. Rarely, systemic antibiotics or even mastoid surgery is needed if the drainage is persistent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H13#H13\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less commonly, otorrhea may arise from the following conditions:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Contact dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical medications or cosmetics may cause local irritation and inflammation with ear drainage. A typical history reveals the offending agent being used, often for a pre-existing condition such as otitis externa or cerumen impaction. Pruritus, pain, and inflammation on examination accompany the otorrhea. Treatment consists of topical corticosteroids and avoidance of the allergen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H24#H24\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Contact dermatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Bullous myringitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Often associated with respiratory symptoms or acute otitis media, bullous myringitis describes serous liquid-filled blisters, or \"bullae,\" on the tympanic membrane. When the bullae rupture, thin bloody otorrhea may occur and pain is often relieved. The external ear canal is not typically involved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H25#H25\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Bullous myringitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Granulation tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granulation tissue can develop in a number of conditions and can be associated with otorrhea. As mentioned previously, this tissue can accumulate around a foreign body (such as a tympanostomy tube). It can also be seen in granulomatous disease (such as Langerhans cell histiocytosis), or in chronic inflammatory conditions (such as chronic otitis media). The rich vascular supply can also lead to leakage of lymphatic fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps in the external ear canal may occur in response to an inflammatory reaction or infection such as chronic otitis media, cholesteatoma, or retained foreign body (eg, expelled tympanostomy tube) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/3\">",
"     3",
"    </a>",
"    ]. Rarely, they may arise from a tumor (eg, Langerhans Cell Histiocytosis, teratoma, neoplasm). Polyps create bloody or serous otorrhea, generally when manipulated, similar to granulomas. Ear polyps may resolve rapidly with topical antibiotic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anti-inflammatory therapy. However, if drainage persists for more than two to three weeks, the child should be referred to an ENT specialist with pediatric expertise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Otomycosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otomycosis is a fungal infection of the external auditory canal and a common reason for external otitis treatment failure. Patients with fungal external otitis most commonly report itching, a feeling that something is in the ear canal, discomfort, and discharge. Otorrhea is generally thick and purulent. Deep seated itching is the most troublesome symptom; pain is less intense than with bacterial otitis externa. Fungal organisms have a very characteristic appearance in the ear canal, especially under magnified vision (",
"    <a class=\"graphic graphic_picture graphicRef56232 \" href=\"UTD.htm?10/16/10510\">",
"     picture 1",
"    </a>",
"    ). The clinical manifestations and treatment of otomycosis are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H21#H21\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Otomycosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     First branchial cleft cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first branchial pouch arises in the pharynx and extends laterally and cephalad to contact the first branchial cleft, forming the eustachian tube. Rarely, congenitally anomalous first branchial cleft cysts may drain into the external ear canal. A mass in the periauricular region may suggest this diagnosis in the face of chronic drainage with a normal tympanic membrane.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Cholesteatoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cholesteatoma (sometimes called a keratoma) is an abnormal growth of squamous epithelium. These can occur in the middle ear and mastoid (middle ear cholesteatoma) (",
"    <a class=\"graphic graphic_picture graphicRef72870 \" href=\"UTD.htm?34/39/35440\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef59937 \" href=\"UTD.htm?20/54/21344\">",
"     picture 3",
"    </a>",
"    ), or more rarely, in the ear canal itself (external ear canal cholesteatoma). It may progressively enlarge to surround and destroy the ossicles, resulting in conductive hearing loss. Hearing loss also may occur if the cholesteatoma obstructs the eustachian tube orifice, leading to middle ear effusion. Surgical therapy is required for most cholesteatomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"     \"Cholesteatoma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5013267\">",
"    <span class=\"h3\">",
"     Keratosis obturans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Keratosis obturans is an accumulation of desquamated keratin in the external auditory meatus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Unlike cholesteatoma, keratosis obturans is associated with an expanded ear canal as keratin is shed from the complete circumference of the canal, and does not cause osteonecrosis. When compared to cholesteatoma, keratosis obturans is generally more acute and painful, produces less otorrhea, and generally occurs in younger patients. It can often be managed with removal of the keratin plug, antibiotic ear drops, and periodic follow-up to remove any reaccumulated debris. Operative care is typically not needed. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Spontaneous cerebral spinal fluid otorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to basilar skull fractures from head trauma, cerebrospinal fluid (CSF) otorrhea may also occur spontaneously through tegmen tympani defects in the floor of the temporal bone. These defects should be suspected in cases of persistent otorrhea after the more common causes have already been excluded or in any child with more than one episode of meningitis. High resolution computed tomography (CT) with thin cuts through the temporal bone provides a noninvasive means of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following historical features should be sought in patients with otorrhea:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Features of drainage &ndash; Onset, duration, color, and consistency help distinguish among the etiologies of otorrhea. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Physical findings'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Fever &ndash; Fever suggests the presence of acute middle ear infection or necrotizing external otitis.",
"     </li>",
"     <li>",
"      Pain &ndash; A painful ear makes benign chronic tympanic membrane perforation less likely. Pain with manipulation of the outer ear signals external canal inflammation (eg, otitis externa, foreign body).",
"     </li>",
"     <li>",
"      Pruritus &ndash; Itching is a prominent feature of otitis externa (including otomycosis), allergic dermatitis, and ear foreign body.",
"     </li>",
"     <li>",
"      Swimming history &ndash; Excessive water exposure is a common factor in the development of otitis externa. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Bacterial otitis externa'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Trauma &ndash; Otorrhea following significant head injury requires evaluation for cerebrospinal fluid leakage. Minor external trauma such as cleaning with cotton swabs or fingers may lead to bacterial otitis externa. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Traumatic cerebrospinal fluid otorrhea'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Bacterial otitis externa'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Perforation &ndash; A perforation of the TM may be traumatic, infectious, or surgical in origin (tubes). Any history of prior perforation of the tympanic membrane is important.",
"     </li>",
"     <li>",
"      Medication usage &ndash; Topical medications, especially those containing",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/42/29348?source=see_link\">",
"       neomycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/19/11574?source=see_link\">",
"       benzocaine",
"      </a>",
"      , or propylene glycol can trigger a contact dermatitis of the external auditory canal. Other potential allergens include new cosmetics, ointments, and certain outdoor plants (eg, poison ivy). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Contact dermatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Previous treatments &ndash; A draining ear that persists despite antibiotic treatment may indicate chronic suppurative otitis, otomycosis, or noninfectious causes of otorrhea.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the ear requires inspection of the auricle and surrounding area, otoscopy of the external canal, tympanic membrane, and middle ear, and, in patients without obvious tympanic membrane perforation, assessment of tympanic membrane function by pneumatic otoscopy (",
"    <a class=\"graphic graphic_movie graphicRef70700 \" href=\"UTD.htm?24/11/24766\">",
"     movie 1",
"    </a>",
"    ). In children with otorrhea, the external auditory canal is often filled with debris and requires cleaning to allow proper visualization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     External auditory canal cleaning",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, no cleaning is necessary to make a diagnosis of otitis externa or otitis media with perforation. Not infrequently, however, removal of a small amount of debris enhances the view of the examiner, and this can be achieved using a cotton pledget wrapped tightly around a curette or a wick to soak up excess fluid. Less often, cleaning through a standard otoscope head may be required to eliminate profuse, thick exudate totally obscuring the view of the examiner, using a suction catheter or careful curettage. Care must be used when curetting so that iatrogenic canal or tympanic membrane trauma does not occur. Thorough cleaning is best done under direct visualization with use of either an otoscope with an operating head or an otologic microscope.",
"   </p>",
"   <p>",
"    Some practitioners will use irrigation to remove cerumen, but this should only be done if a patient is known to have an intact tympanic membrane. Otherwise, irrigation of a draining ear is potentially dangerous and should not be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Physical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient examination should focus on the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Head trauma &ndash; Any obvious head trauma or signs of basilar skull fracture (eg, raccoon eyes (",
"      <a class=\"graphic graphic_picture graphicRef69662 \" href=\"UTD.htm?15/54/16237\">",
"       picture 4",
"      </a>",
"      ), Battle sign (",
"      <a class=\"graphic graphic_picture graphicRef69660 \" href=\"UTD.htm?39/39/40561\">",
"       picture 5",
"      </a>",
"      )) should raise suspicion for cerebrospinal fluid otorrhea. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Traumatic cerebrospinal fluid otorrhea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tragal motion tenderness &ndash; Pain with manipulation of the tragus or gentle traction on the auricle of the outer ear is a classic sign of bacterial otitis externa. However, some pain with manipulation may be present with any condition that generates inflammation of the external canal. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Bacterial otitis externa'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Foreign body &ndash; A foreign body (FB) found in the canal may be the source of a child's otorrhea and requires time to cause drainage. A child rarely may place something in the ear in an attempt to relieve symptoms from a pre-existing ear condition. Thus, after removal of the foreign body, careful otoscopic evaluation is important to exclude other coincidental disease or complications, such as tympanic membrane perforation. Care must be taken not to cause further injury during FB removal; any FB that is difficult to remove should be referred to an ENT specialist. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Foreign body'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Organic mass or polyp &ndash; Polypoid masses or granulomas most often arise in response to chronic otitis media, foreign bodies in the external ear canal, or cholesteatoma. Rarely, they may arise from a neoplastic process. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Polyps'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Neoplasm'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Quality of discharge &ndash; Thin white debris-filled discharge is typical of bacterial otitis externa. Tympanic perforation generally leads to a mucous discharge as does contact dermatitis. CSF otorrhea is a clear or thin bloody discharge that may be mistaken for more benign serous fluid. Purulent discharge can be from severe irritation, foreign body, middle ear infection, or severe external canal infections. Blood-tinged discharge is more likely caused by trauma, foreign body, granuloma, or carcinoma.",
"     </li>",
"     <li>",
"      Inflammation &ndash; Inflammation of the tympanic membrane is indicative of middle ear pathology. Inflammation of the external canal can occur with many conditions, but it is less likely with isolated middle ear infections with or without TM perforations. An edematous, erythematous external canal with debris and a generally clear tympanic membrane is typical of bacterial otitis externa.",
"     </li>",
"     <li>",
"      Tympanic membrane &ndash; The tympanic membrane should be carefully inspected for signs of middle ear infection, such as injection, dullness, and bulging. Perforation, bullae, and evidence of trauma are additional important findings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H8#H8\">",
"       \"Acute otitis media in children: Diagnosis\", section on 'Otoscopy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=see_link&amp;anchor=H10#H10\">",
"       \"Evaluation and management of middle ear trauma\", section on 'Findings of middle ear injury'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;History and physical examination are sufficient to diagnose and manage most causes of otorrhea in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Culture of ear drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Culture of the external ear canal in otorrhea is rarely helpful, as Pseudomonas species are commonly identified with or without local infection. It is also quite difficult to obtain samples from the middle ear that are not contaminated by external canal flora. In addition, culture rarely changes management decisions in children with otorrhea.",
"   </p>",
"   <p>",
"    Indications for culture of ear drainage include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Suspected necrotizing otitis externa",
"     </li>",
"     <li>",
"      Otitis media with chronic drainage, where previous treatment has failed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When ear drainage culture is needed, an otolaryngology consultation is often necessary to obtain a proper specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24728/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Testing for cerebrospinal fluid otorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;To test for cerebrospinal fluid (CSF) leakage, the clinician may perform a quick bedside test by placing a drop of ear drainage on filter paper (coffee filter or paper towel). A rapidly advancing \"halo\" or ring of clear fluid around red blood defines a positive test. However, the halo test does NOT differentiate among CSF, saline, saliva, and other clear fluids and has not been formally studied in a clinical setting.",
"   </p>",
"   <p>",
"    Alternatively, the clinician may test the ear or nose drainage for beta2 transferrin, a desialylated form of the protein, transferrin, which is almost exclusively found in CSF. This test is not available at many institutions.",
"   </p>",
"   <p>",
"    Urine dipsticks have also been used to determine the presence of CSF by checking for the presence of glucose. However, this approach is NOT reliable because both blood and CSF contain glucose.",
"   </p>",
"   <p>",
"    When in doubt about the presence of a CSF leak, it is best to obtain urgent neurosurgical consultation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation and management of middle ear trauma\", section on 'Evaluation of ear or nose drainage'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should obtain specialized computed tomography of the head with thin cuts through the temporal bone, middle ear, and otic capsule when it is necessary to evaluate patients for the following diagnoses:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Basilar skull fracture with cerebrospinal fluid leakage",
"     </li>",
"     <li>",
"      Spontaneous cerebrospinal fluid leakage",
"     </li>",
"     <li>",
"      Necrotizing otitis externa",
"     </li>",
"     <li>",
"      Cholesteatoma",
"     </li>",
"     <li>",
"      External auditory canal mass or chronic polyps",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Tissue biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic external auditory masses may require tissue biopsy by an ENT specialist with pediatric expertise to establish a diagnosis. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Neoplasm'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H19\">",
"     'Polyps'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation should be focused on life-threatening causes of otorrhea (",
"    <a class=\"graphic graphic_algorithm graphicRef78623 \" href=\"UTD.htm?19/45/20191\">",
"     algorithm 1",
"    </a>",
"    ). In a stable, non-toxic patient, a systematic approach should start with a thorough history. Careful examination of the outer ear, external canal, and tympanic membrane should then reveal the diagnosis (",
"    <a class=\"graphic graphic_algorithm graphicRef81237 \" href=\"UTD.htm?7/62/8175\">",
"     algorithm 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef59068 \" href=\"UTD.htm?26/26/27054\">",
"     algorithm 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with otorrhea and severe head trauma require evaluation and management of presumed basilar skull fracture with cerebrospinal fluid otorrhea (",
"    <a class=\"graphic graphic_algorithm graphicRef78623 \" href=\"UTD.htm?19/45/20191\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Traumatic cerebrospinal fluid otorrhea'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Children with fever and ill appearance warrant rapid assessment for infectious complications of acute otitis media, and necrotizing otitis externa. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Life-threatening conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Chronic bloody otorrhea in children with an auditory external canal mass may herald the presence of a primary or metastatic neoplasm. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Neoplasm'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Non-toxic children",
"    </span>",
"    &nbsp;&mdash;&nbsp;History and physical examination should be sufficient to establish a diagnosis for otorrhea in most children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Non-inflamed external canal",
"    </span>",
"    &nbsp;&mdash;&nbsp;An external canal that appears pink, non-edematous, and non-inflamed indicates likely tympanic membrane or middle ear pathology (",
"    <a class=\"graphic graphic_algorithm graphicRef59068 \" href=\"UTD.htm?26/26/27054\">",
"     algorithm 3",
"    </a>",
"    ). On examination of the tympanic membrane, bullous myringitis appears as multiple intact or ruptured blisters on the membrane itself, with possible middle ear inflammation behind. Granular myringitis can also be diagnosed on examination with visualization of the typical vascular, friable mass. A perforated tympanic membrane makes middle ear pathology the most likely source of the otorrhea.",
"   </p>",
"   <p>",
"    Debris in acute otitis media with perforation may make visualization of the tympanic membrane difficult, so other signs of otitis media such as fever and pain preceding the drainage may lead to the diagnosis of acute otitis media with perforation. A non-inflamed tympanic membrane with serous drainage through a perforation is likely chronic serous otitis media (CSOM), especially in an otherwise asymptomatic child. Although extremely rare, spontaneous CSF otorrhea has been described and should be considered when other more common causes of otorrhea have been excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Inflamed external canal",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inflamed, edematous canal is typically associated with diseases external to the tympanic membrane (",
"    <a class=\"graphic graphic_algorithm graphicRef81237 \" href=\"UTD.htm?7/62/8175\">",
"     algorithm 2",
"    </a>",
"    ). After carefully clearing debris as needed, the examiner should check for a foreign body. A nonorganic foreign body can cause otorrhea when associated with concurrent irritation and inflammation. An organic appearing foreign body or growth in the ear suggests an inflammatory granuloma, polyp, otomycosis, carcinoma, or cholesteatoma. These masses each have their own characteristic appearance as described above.",
"   </p>",
"   <p>",
"    An inflamed, edematous, debris-filled canal with no foreign body is typical of contact dermatitis and otitis externa. History of moisture exposure or minor trauma differentiates infectious otitis externa from contact dermatitis, which is associated with exposure of the ear to some topical medications, cosmetics, or plants. Otitis externa also tends to be more painful with outer ear manipulation, though contact dermatitis can become painful when severe as well. Pruritus is typical with both diagnoses. The clinician should carefully check for pinna and cartilaginous involvement of severe otitis externa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/57/10130?source=see_link\">",
"       \"Patient information: Removing objects stuck in the ear (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The table provides a differential diagnosis for otorrhea in children (",
"    <a class=\"graphic graphic_table graphicRef68061 \" href=\"UTD.htm?20/12/20684\">",
"     table 1",
"    </a>",
"    ). The approach to the evaluation of otorrhea in children is summarized in the algorithms (",
"    <a class=\"graphic graphic_algorithm graphicRef78623 \" href=\"UTD.htm?19/45/20191\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef81237 \" href=\"UTD.htm?7/62/8175\">",
"     algorithm 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef59068 \" href=\"UTD.htm?26/26/27054\">",
"     algorithm 3",
"    </a>",
"    ). Most children with otorrhea have bacterial otitis externa or acute otitis media with perforation of the tympanic membrane. Patients who are ill appearing or have otorrhea after head trauma require aggressive efforts to diagnose and treat potential life-threatening causes of otorrhea (basilar skull fracture, necrotizing otitis externa, infectious complications of acute otitis media). Children with persistent or recurrent otorrhea that does not respond easily to appropriate treatment should be referred to an otolaryngologist.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/1\">",
"      Macfadyen CA, Acuin JM, Gamble C. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane Database Syst Rev 2006; :CD005608.",
"     </a>",
"    </li>",
"    <li>",
"     Sanna M, Russo A, DeDonto G. Color Atlas of Otoscopy, Thieme, New York 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/3\">",
"      Gliklich RE, Cunningham MJ, Eavey RD. The cause of aural polyps in children. Arch Otolaryngol Head Neck Surg 1993; 119:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/4\">",
"      Harris KC, Conley SF, Kerschner JE. Foreign body granuloma of the external auditory canal. Pediatrics 2004; 113:e371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/5\">",
"      Persaud RA, Hajioff D, Thevasagayam MS, et al. Keratosis obturans and external ear canal cholesteatoma: how and why we should distinguish between these conditions. Clin Otolaryngol Allied Sci 2004; 29:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/6\">",
"      Shire JR, Donegan JO. Cholesteatoma of the external auditory canal and keratosis obturans. Am J Otol 1986; 7:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/7\">",
"      Rao AK, Merenda DM, Wetmore SJ. Diagnosis and management of spontaneous cerebrospinal fluid otorrhea. Otol Neurotol 2005; 26:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24728/abstract/8\">",
"      Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg 2000; 122:934.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6444 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-71969A6E96-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24728=[""].join("\n");
var outline_f24_9_24728=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H38\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Traumatic cerebrospinal fluid otorrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Infectious complications of acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Necrotizing otitis externa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Neoplasm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Common conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Bacterial otitis externa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Foreign body",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Chronic suppurative otitis media",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Cerumen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Tympanostomy tube drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Bullous myringitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Granulation tissue",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Otomycosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - First branchial cleft cyst",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Cholesteatoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5013267\">",
"      - Keratosis obturans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Spontaneous cerebral spinal fluid otorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      External auditory canal cleaning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Physical findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Culture of ear drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Testing for cerebrospinal fluid otorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Tissue biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Non-toxic children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Non-inflamed external canal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Inflamed external canal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6444\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6444|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?19/45/20191\" title=\"algorithm 1\">",
"      Approach otorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?7/62/8175\" title=\"algorithm 2\">",
"      Otorrhea inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?26/26/27054\" title=\"algorithm 3\">",
"      Otorrhea no inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6444|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/16/10510\" title=\"picture 1\">",
"      Fungal otitis externa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/39/35440\" title=\"picture 2\">",
"      Congenital cholesteatoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/54/21344\" title=\"picture 3\">",
"      Early congenital cholesteatoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/54/16237\" title=\"picture 4\">",
"      Raccoon eyes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/39/40561\" title=\"picture 5\">",
"      Battles sign",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6444|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?24/11/24766\" title=\"movie 1\">",
"      otoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6444|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/12/20684\" title=\"table 1\">",
"      Otorrhea causes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5385?source=related_link\">",
"      Acute mastoiditis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=related_link\">",
"      Acute otitis media in children: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=related_link\">",
"      Cholesteatoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28504?source=related_link\">",
"      Diagnosis and management of foreign bodies of the outer ear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35397?source=related_link\">",
"      Ear barotrauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=related_link\">",
"      Evaluation and management of middle ear trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/47/13050?source=related_link\">",
"      Evaluation of earache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=related_link\">",
"      External otitis: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20216?source=related_link\">",
"      Malignant (necrotizing) external otitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=related_link\">",
"      Other Pseudomonas aeruginosa infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26816?source=related_link\">",
"      Patient information: External otitis (including swimmer's ear) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/57/10130?source=related_link\">",
"      Patient information: Removing objects stuck in the ear (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=related_link\">",
"      Prevention and management of tympanostomy tube otorrhea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_9_24729="Lung abscess";
var content_f24_9_24729=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lung abscess",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24729/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24729/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24729/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24729/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24729/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24729/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/9/24729/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung abscess is defined as necrosis of the pulmonary parenchyma caused by microbial infection. Some authorities use the term \"necrotizing pneumonia\" or \"lung gangrene\" to distinguish pulmonary necrosis with multiple small abscesses from a larger cavitary lesion, but this actually represents a continuum of the same process.",
"   </p>",
"   <p>",
"    The classification, clinical features, diagnosis, and treatment of lung abscess will be reviewed here. Aspiration pneumonia, which may precede the development of a lung abscess, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"     \"Aspiration pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"lung abscess\" is often applied to reflect the clinical features that are useful in management decisions, such as duration of prior symptoms, presence of associated conditions, or microbial etiology.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lung abscesses can be classified as acute or chronic based upon the duration of symptoms prior to presentation for medical care; symptoms present for one month or more are considered chronic.",
"     </li>",
"     <li>",
"      Lung abscess may be primary or secondary based upon the presence or absence of common associated conditions. Abscesses in patients prone to aspiration or patients who have been healthy previously are usually considered primary; the term \"secondary lung abscess\" typically indicates an associated bronchogenic neoplasm or systemic disease that compromises immune defenses, such as HIV infection or organ transplantation.",
"     </li>",
"     <li>",
"      Lung abscess can also be defined by the responsible microbial pathogen (eg, Pseudomonas lung abscess, anaerobic bacterial lung abscess, or Aspergillus lung abscess).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When no pathogen was recovered from expectorated sputum five decades ago, the lesion was referred to as a \"nonspecific lung abscess.\" It is now thought that these infections were caused by anaerobic bacteria. Putrid lung abscess refers to the offensive odor that is often found in patients with lung abscesses and is thought to be diagnostic of anaerobic bacterial infection. A review of more than 1000 reported cases of lung abscess during the antibiotic era indicates that approximately 80 percent were considered primary; 60 percent were putrid; 40 percent were \"nonspecific\"; and 40 percent were chronic [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most lung abscesses arise as a complication of aspiration pneumonia and are caused by species of anaerobes that are normally present in the gingival crevices [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/2\">",
"     2",
"    </a>",
"    ]. The typical patient has a predisposition to aspiration due to compromised consciousness (eg, alcoholism, drug abuse, general anesthesia) or dysphagia. These patients also frequently have periodontal disease, especially gingivitis, with concentrations of bacteria in the gingival crevice as high as",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      11",
"     </sup>",
"     /mL.",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    first step in the development of a lung abscess is for the inoculum from the gingival crevice to reach the lower airways, which usually occurs while the patient is in the recumbent position. Infection is initiated either because the bacteria are not cleared due to suppressed consciousness or because the inoculum size is large due to dysphagia. Pneumonitis arises first but based upon the usual mixture of organisms progresses to tissue necrosis after 7 to 14 days. This necrosis results in lung abscess",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an empyema; the latter can be due to a bronchopleural fistula or direct extension of infection into the pleural space.",
"   </p>",
"   <p>",
"    One unique mechanism for the development of lung abscesses occurs in Lemierre's syndrome or jugular vein suppurative thrombophlebitis. This infection begins in the pharynx (sometimes with an overt tonsillar or peritonsillar abscess) but spreads to involve spaces in the neck and the carotid sheath, which contains the internal jugular vein. Bacteremia due to Fusobacterium necrophorum and septic emboli to the lung, which subsequently cavitate, are all characteristic complications of this process once the vessels are involved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/0/2055?source=see_link\">",
"     \"Suppurative (septic) thrombophlebitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tricuspid valve endocarditis, usually due to Staphylococcus aureus, also typically causes septic emboli that are widely distributed in both lungs. This is a common feature of endocarditis complicating injection drug use and an infrequent complication of septic venous thrombosis in other settings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40215?source=see_link\">",
"     \"Infective endocarditis in injection drug users\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/0/2055?source=see_link\">",
"     \"Suppurative (septic) thrombophlebitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung abscess is caused most frequently by bacteria, usually anaerobes. The bacteria in lung abscess reflect the predominantly anaerobic flora of the gingival crevice. The most common organisms are Peptostreptococcus, Prevotella, Bacteroides (usually not B. fragilis), and Fusobacterium spp (",
"    <a class=\"graphic graphic_table graphicRef62555 \" href=\"UTD.htm?1/29/1500\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/3-8\">",
"     3-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many other bacteria can also cause lung abscesses, but do so with substantially less frequency. Probably the most common non-anaerobes are Streptococcus milleri and other microaerophilic streptococci. These streptococci can cause monomicrobial lung abscess, but most often are isolated in mixed infections with anaerobes.",
"   </p>",
"   <p>",
"    Other bacteria that can cause monomicrobial lung abscess include S. aureus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/9\">",
"     9",
"    </a>",
"    ], K. pneumoniae [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/10,11\">",
"     10,11",
"    </a>",
"    ], other gram-negative bacilli [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/12\">",
"     12",
"    </a>",
"    ], Streptococcus pyogenes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/13\">",
"     13",
"    </a>",
"    ], Burkholderia pseudomallei [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], Haemophilus influenzae type B, Legionella [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/16,17\">",
"     16,17",
"    </a>",
"    ], Nocardia, and Actinomyces. There have been occasional case reports of lung abscess caused by Streptococcus pneumoniae, but the bacterial etiology is in dispute due to the possibility of superinfection by anaerobic bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The bacteriology of lung abscess may be different in Taiwan, as illustrated in a retrospective evaluation of 90 adults hospitalized with lung abscess from 1995 to 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/11\">",
"     11",
"    </a>",
"    ]. Unlike earlier studies in which anaerobic organisms predominated, gram-negative bacilli accounted for 36 percent of isolates. Other organisms included anaerobes (34 percent), gram-positive cocci (26 percent), and gram-positive bacilli (4 percent). Of the 118 pathogens identified, Klebsiella pneumoniae (25 percent) was the most common isolated pathogen, followed by Streptococcus milleri group (16 percent).",
"   </p>",
"   <p>",
"    An accompanying editorial noted that the study might have been biased since 25 percent of the patients had received antibiotics prior to culture, making recovery of anaerobes less likely [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/19\">",
"     19",
"    </a>",
"    ]. In addition, the study may be limited due to selection bias in terms of which patients got transthoracic aspiration, since only 90 of 336 cases of lung abscess (27 percent) had evaluable microbiologic studies. However, the K-1 strain of K. pneumoniae appears to be a more common pathogen in Taiwan than in other areas. Patients in Taiwan with K. pneumoniae infection had a high rate of bacteremia in association with pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/20\">",
"     20",
"    </a>",
"    ]. Higher rates of abscess formation of other sites (eg, liver abscess) appear to occur in patients in Taiwan with K. pneumoniae infection compared to other regions. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29526?source=see_link&amp;anchor=H4#H4\">",
"     \"Pyogenic liver abscess\", section on 'Microbiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=see_link\">",
"     \"Invasive liver abscess syndrome caused by Klebsiella pneumoniae\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38426?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Selected non-bacterial pathogens can produce lung abscess including parasites (eg, Paragonimus westermani and Entamoeba histolytica), many fungi (eg, Aspergillus spp, Cryptococcus neoformans, Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis), and Mycobacteria spp. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=see_link\">",
"     \"Clinical manifestations and diagnosis of nocardiosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/16/33031?source=see_link&amp;anchor=H15#H15\">",
"     \"Extraintestinal Entamoeba histolytica amebiasis\", section on 'Pleuropulmonary infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6599037\">",
"    <span class=\"h2\">",
"     Immunocompromised hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the immunocompromised host, the most common causes of lung abscess are Pseudomonas aeruginosa and other aerobic gram-negative bacilli, Nocardia spp, and fungi (Aspergillus and Cryptococcus spp). A number of opportunistic organisms can also cause lung abscess in immunocompromised hosts, such as Rhodococcus equi, Mycobacteria spp, and Aspergillus spp (",
"    <a class=\"graphic graphic_table graphicRef57589 \" href=\"UTD.htm?21/59/22460\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18791?source=see_link\">",
"     \"Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23991?source=see_link\">",
"     \"Microbiology, epidemiology, and pathogenesis of nocardiosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=see_link\">",
"     \"Clinical manifestations and diagnosis of nocardiosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link\">",
"     \"Epidemiology and clinical manifestations of invasive aspergillosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31207?source=see_link\">",
"     \"Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/26/12712?source=see_link\">",
"     \"Tuberculosis in solid organ transplant candidates and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with lung abscesses, and nearly all with lung abscesses due to anaerobic bacteria, present with indolent symptoms that evolve over a period of weeks or months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/1,6,7,21\">",
"     1,6,7,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Anaerobic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic features suggest pulmonary infection, including fever, cough, and sputum production. Evidence of chronic systemic disease is usually present, with night sweats, weight loss, and anemia. Patients may seek medical attention for these systemic symptoms, hemoptysis, or pleurisy. Nearly all patients have fever, but virtually none have shaking chills or true rigors. Most patients are aware of putrid or sour-tasting sputum. Lung abscesses due to S. milleri behave like anaerobic infections but do not have putrid sputum unless the organism occurs in a mixed infection including anaerobes.",
"   </p>",
"   <p>",
"    Typical findings on physical examination are gingival crevice disease, the stigma of associated conditions that compromise consciousness or cause dysphagia, fever, and abnormal lung sounds reflecting a pleural effusion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parenchymal disease. Chest radiographs usually show infiltrates with a cavity, frequently in a segment of the lung that is dependent in the recumbent position, eg, the superior segment of a lower lobe or a posterior segment of the upper lobes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/22\">",
"     22",
"    </a>",
"    ]. The approach should include evaluation of the expectorated secretions for evidence of putrid odor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other bacterial pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the majority of lung abscesses are caused by anaerobic bacteria, aerobic bacteria such as microaerophilic streptococci (eg, S. milleri), Staphylococcus aureus, and Klebsiella pneumoniae may also cause lung abscesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Staphylococcus aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most characteristic form of pneumonia caused by Staphylococcus aureus is fulminant disease in young adults or adolescents with underlying influenza infection [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/23\">",
"     23",
"    </a>",
"    ]. The putative strains may be methicillin-resistant and have the Panton-Valentine leukocidin (PVL) gene. These patients often have a fulminant course with shock, neutropenia, lung necrosis, and high mortality despite appropriate antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. This syndrome was initially reported in 2002 in 16 young adults (median age 15 years), most of whom had preceding influenza and six of whom (37 percent) died [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/23\">",
"     23",
"    </a>",
"    ]. Initially, it was thought that PVL was an important virulence factor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/26\">",
"     26",
"    </a>",
"    ], but subsequent research refuted this theory [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/27\">",
"     27",
"    </a>",
"    ]. The community-acquired strain of MRSA, known as the USA 300 strain, has caused a global epidemic [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40758?source=see_link&amp;anchor=H4#H4\">",
"     \"Virulence determinants of community acquired methicillin-resistant Staphylococcus aureus\", section on 'Panton-Valentine leukocidin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=see_link&amp;anchor=H18#H18\">",
"     \"Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults\", section on 'S. aureus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for methicillin-resistant Staphylococcus aureus are summarized in the following Table (",
"    <a class=\"graphic graphic_table graphicRef53504 \" href=\"UTD.htm?5/9/5275\">",
"     table 3",
"    </a>",
"    ) and are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Klebsiella pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, Klebsiella pneumoniae has been associated with lung abscess, particularly in Taiwan. The course may be relatively rapid with necrosis of tissue, high rates of bacteremia, and a slow response to antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38426?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Nocardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nocardia can cause lung abscess, particularly in immunocompromised hosts receiving prolonged courses of glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23991?source=see_link\">",
"     \"Microbiology, epidemiology, and pathogenesis of nocardiosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=see_link\">",
"     \"Clinical manifestations and diagnosis of nocardiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathogens that sometimes cause lung abscess include mycobacteria and fungi. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=see_link\">",
"     \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=see_link\">",
"     \"Clinical manifestations and evaluation of pulmonary tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link\">",
"     \"Epidemiology and clinical manifestations of invasive aspergillosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lung abscess is typically diagnosed when a chest radiograph reveals a pulmonary infiltrate with a cavity, indicating tissue necrosis; an air-fluid level is frequently present. However as noted above, multiple pathogens are associated with this radiographic finding as well as numerous other conditions (",
"    <a class=\"graphic graphic_table graphicRef67943 \" href=\"UTD.htm?28/36/29259\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important component of the evaluation of a lung abscess is to define the probable etiologic agent in order to select appropriate antibiotic therapy and to detect associated conditions, such as malignancy. A chest x-ray will generally demonstrate the pulmonary lesion to the extent necessary for diagnosis and management. However, better anatomic definition can be achieved with computed tomographic (CT) scans (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79327 \" href=\"UTD.htm?18/17/18708\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54525 \" href=\"UTD.htm?39/32/40453\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/21,30\">",
"     21,30",
"    </a>",
"    ]. CT scanning can be particularly helpful if there is a question of cavitation that cannot be clearly delineated on the chest radiograph or if an associated mass lesion is suspected. A CT will also distinguish between a parenchymal lesion and a pleural collection, which are managed very differently (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82576 \" href=\"UTD.htm?15/49/16149\">",
"     image 3",
"    </a>",
"    ). Distinguishing between lung abscess and empyema with an associated air-fluid level can be challenging in some cases. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=see_link&amp;anchor=H12#H12\">",
"     \"Imaging of pleural effusions in adults\", section on 'Empyema'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Classic presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When patients show a typical presentation with indolent symptoms (cough, fever, night sweats for more than two weeks) combined with typical underlying conditions that lead to aspiration or a cavity in a dependent pulmonary segment, it is appropriate to suspect that anaerobic bacteria are involved. If there is putrid sputum or empyema fluid, the diagnosis of anaerobic bacterial infection is confirmed. It is difficult to isolate anaerobic bacteria in these circumstances since most respiratory tract specimens (sputum or bronchoscopy aspirates) are contaminated by upper airway flora and are consequently inappropriate for anaerobic culture.",
"   </p>",
"   <p>",
"    The only methods available for obtaining uncontaminated specimens are transtracheal aspirates (TTA), transthoracic needle aspirates (TTNA), pleural fluid, or blood cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]; TTA and TTNA are rarely performed currently. It is realistic to obtain pleural fluid and blood cultures, but blood cultures are rarely positive for anaerobic bacteria. None of these specimens is likely to yield anaerobes after effective antibiotics are started. Thus, in the present era, the only anaerobic lung infections that are likely to have bacteriologic confirmation are those associated with an empyema. The same limitations apply to microaerophilic streptococci.",
"   </p>",
"   <p>",
"    A controversial alternative to TTA is bronchoscopic aspiration using a quantitative brush catheter or quantitation of organisms obtained from bronchoalveolar lavage (BAL) fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/34\">",
"     34",
"    </a>",
"    ]. Although bronchoscopy with quantitative cultures seems to have documented benefit in determining pathogenic organisms in most pneumonia cases caused by aerobes, the experience with anaerobic lung infections is limited by the sparse number of cases that have been reported and by the number of laboratories that are capable of isolating anaerobes, which are oxygen-sensitive. It should also be emphasized that none of these specimens is likely to yield anaerobes after antibiotics have been administered.",
"   </p>",
"   <p>",
"    Routine cultures of expectorated sputum for aerobes can be performed, but care must be exercised in interpretation since most yield deceptive contaminants [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/31\">",
"     31",
"    </a>",
"    ]. As an example, Klebsiella spp, S. aureus, or P. aeruginosa may be cultured from expectorated sputum in a patient with a putrid lung abscess, but treatment still needs to be directed at anaerobes. Interpretation of sputum cultures in these cases must take into account the clinical features of the patient, concentrations of the different organisms found in the culture, and the antibiotics the patient has received.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Less typical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with a less classic presentation, the differential diagnosis is broader and includes both infectious and noninfectious etiologies for the cavitary lesion. It is particularly important to exclude epidemiologically important organisms such as M. tuberculosis; placing the patient under respiratory precautions is standard in such cases until AFB smears are negative on three morning sputa. A more invasive procedure, such as bronchoscopy, to obtain material for culture and cells to exclude a malignancy may be warranted under these circumstances. A bronchoscopy specimen for AFB can substitute for one sputum specimen in excluding the diagnosis of tuberculosis.",
"   </p>",
"   <p>",
"    Some patients with lung abscess have previously unrecognized underlying conditions such as an aspirated foreign body, a pulmonary neoplasm, or bronchostenosis. At one time it was recommended that all patients with lung abscess undergo bronchoscopy to detect underlying lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/35\">",
"     35",
"    </a>",
"    ]. This recommendation is now reserved for patients who have atypical presentations and for those who fail standard therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=see_link\">",
"     \"Airway foreign bodies in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A classic review of 2114 cases of pyogenic lung abscess in the pre-antibiotic era described the natural history of this condition [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/36\">",
"     36",
"    </a>",
"    ]. Approximately one-third of patients died, another one-third recovered, and the remainder developed debilitating illness with recurrent abscesses, chronic empyema, bronchiectasis, or other sequelae. Drainage via rigid bronchoscopy did not alter the mortality rate in this study, suggesting that lung abscess, in contrast to most other types of abscesses, does not require assisted drainage as long as the process spontaneously drains via the bronchus as indicated by the air-fluid level.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;An early study of 1560 cases of lung abscess after the introduction of sulfonamides showed that these drugs had no important effect on the outcome of the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/37\">",
"     37",
"    </a>",
"    ]. Resectional surgery and penicillin were commonly used for the treatment of lung abscess in the early 1950s, and the relative merits of surgery versus antibiotics were often debated. Antibiotics then became favored, using penicillin as the initial agent with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    for those who did not respond [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/1,7,38-42\">",
"     1,7,38-42",
"    </a>",
"    ]. Patients who had persistent cavities at four to six weeks were defined as having \"delayed closure,\" and these patients were candidates for surgical resection. An important study from Philadelphia General Hospital in the 1960s showed that even patients with delayed closure eventually responded when antibiotics were simply continued [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/39\">",
"     39",
"    </a>",
"    ]. Since that time, surgery has been limited to only approximately 5 to 10 percent of cases in most series [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Antimicrobial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard treatment for an anaerobic lung infection is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (600 mg IV every eight hours, followed by 150 to 300 mg orally four times daily) based upon two published trials that demonstrated superiority of this agent compared with parenteral penicillin in the number of patients who responded and the speed of defervescence following the inception of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. One of the reasons that an alternative to penicillin was tested was because more anaerobes began producing beta-lactamase and, thus, were resistant to penicillin. Examples of beta-lactamase producing anaerobes include Bacteroides ruminicola, black-pigmenting strains of Prevotella (formally B. melaninogenicus group), B. gracilis, B. ureolyticus, Fusobacteria, and others [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/8,45,46\">",
"     8,45,46",
"    </a>",
"    ]. Other data suggest that up to 40 percent of Fusobacteria and 60 percent of Bacteroides spp other than B. fragilis produce penicillinase [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite in vitro resistance of some of the anaerobic species, it should be emphasized that lung abscesses are usually polymicrobial infections. It has never been clear that all components of such mixed infections need to be specifically treated. A number of antibiotic regimens may be effective in lung abscess (",
"    <a class=\"graphic graphic_table graphicRef64257 \" href=\"UTD.htm?16/63/17403\">",
"     table 5",
"    </a>",
"    ). Available in vitro data also support the use of a combination of a beta-lactam and beta-lactamase inhibitor, and a modest experience with these agents is favorable [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=see_link\">",
"     \"Combination beta-lactamase inhibitors, carbapenems, and monobactams\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The experience with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    for putrid lung abscess has been extremely disappointing with an approximate 50 percent failure rate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/46-51\">",
"     46-51",
"    </a>",
"    ]. This is best explained by the concurrent presence of aerobic and microaerophilic streptococci that presumably contribute to the pathogenesis of these infections in a substantial number of cases. Although metronidazole is probably the most active drug available against anaerobic bacteria since it is uniformly active against oxygen-sensitive strains and has a time-kill profile that is unique compared with other drugs, it has no activity against aerobic and microaerophilic streptococci. If metronidazole is used, it should be combined with penicillin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31817?source=see_link\">",
"     \"Metronidazole: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are few clinical trials regarding the treatment of anaerobic lung abscesses, due to the infrequency of their occurrence and the difficulty in establishing a microbial diagnosis. Nevertheless, other drugs that are reasonable to use are any combination of a beta-lactam beta-lactamase inhibitor (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    3 g IV every six hours), or a carbapenem. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=see_link\">",
"     \"Combination beta-lactamase inhibitors, carbapenems, and monobactams\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lung abscess caused by organisms other than anaerobes is best treated with antibiotics that are active against the infecting pathogen and penetrate the lung parenchyma. Most drugs used for anaerobes are also active against aerobic and microaerophilic streptococci, except",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    . The appropriate antibiotic for aerobic gram-negative bacilli should be selected based upon the results of in vitro susceptibility testing.",
"   </p>",
"   <p>",
"    For lung abscesses caused by methicillin-resistant Staphylococcus aureus (MRSA), we prefer",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    (600 mg IV every 12 hours) with a switch to oral linezolid at the same dose when the patient is afebrile and stable [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/52\">",
"     52",
"    </a>",
"    ]. The main alternative to linezolid is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every 12 hours, adjusted to a trough concentration of 15 to 20",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    and for renal function). Other options are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     ceftaroline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/42/27301?source=see_link\">",
"     telavancin",
"    </a>",
"    . Ceftaroline is active in vitro against virtually all strains of MRSA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/53\">",
"     53",
"    </a>",
"    ], but it has not been approved by the US Food and Drug Administration for MRSA pneumonia (because the experience is too limited). Telavancin is not available in the United States.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     Daptomycin",
"    </a>",
"    should",
"    <strong>",
"     not",
"    </strong>",
"    be used for pulmonary infections due to inadequate lung penetration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40986?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of community-acquired pneumonia in adults who require hospitalization\", section on 'CA-MRSA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of therapy is controversial. Some treat for three weeks as a standard and others treat based upon the response. Our practice is to continue antibiotic treatment until the chest x-ray shows a small, stable residual lesion or is clear. This generally requires several months of treatment, most of which can be accomplished with oral agents on an outpatient basis. The rationale for extended treatment is the anecdotal experience with five patients who relapsed after therapy was discontinued despite receipt of antibiotics for more than eight weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Surgical intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is rarely required for patients with uncomplicated lung abscess. The usual indications are failure to respond to medical management (which is often merely a subjective impression), suspected neoplasm, or hemorrhage. However, several predictors of a slow response or no response are: abscesses associated with an obstructed bronchus, an extremely large abscess (&gt;6 cm in diameter), and abscesses involving relatively resistant organisms, such as P. aeruginosa. The usual procedure in such cases is a lobectomy or pneumonectomy.",
"   </p>",
"   <p>",
"    Alternative approaches for patients who are considered to be poor operative risks include percutaneous and endoscopic drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/55-63\">",
"     55-63",
"    </a>",
"    ]. Percutaneous procedures require special care to prevent contamination of the pleural space. Bronchoscopy may be done as a diagnostic procedure, especially to detect an underlying lesion, but this procedure is of relatively little use to facilitate drainage and can result in spillage of abscess contents into the airways [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/64\">",
"     64",
"    </a>",
"    ]. Endoscopic drainage, which requires an experienced operator, is performed by placing a pigtail catheter into the abscess cavity under bronchoscopic visualization, leaving the catheter in place until the cavity has drained [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Response to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with putrid lung abscesses usually show clinical improvement with decreased fever within three to four days after beginning antibiotic treatment. Defervescence is expected in 7 to 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/1,3,4,65-67\">",
"     1,3,4,65-67",
"    </a>",
"    ]. Persistent fevers beyond this time indicate delayed response, and such patients should undergo further diagnostic tests to better define the underlying anatomy and microbiology of the infection.",
"   </p>",
"   <p>",
"    Cultures of expectorated sputum are not likely to be useful at this juncture except for detecting nonbacterial pathogens such as mycobacteria and fungi. Serial radiographs have limited use because there is often initial roentgenographic progression even in patients with a good clinical response [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/22\">",
"     22",
"    </a>",
"    ]. Major considerations in patients with a delayed response include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An associated condition that precludes response, such as obstruction with a foreign body or neoplasm",
"     </li>",
"     <li>",
"      Erroneous microbial diagnosis with infection due to bacteria, mycobacteria, or fungi that have not have been suspected and are not being treated",
"     </li>",
"     <li>",
"      Large cavity size (usually &gt;6 cm in diameter) that may require unusually prolonged therapy or empyema, which necessitates drainage. Empyema can have an air-fluid level that is mistaken for a parenchymal abscess; the two can be distinguished by CT scan.",
"     </li>",
"     <li>",
"      An alternative, non-bacterial cause of cavitary lung disease, such as cavitating neoplasm, vasculitis, or pulmonary sequestration",
"     </li>",
"     <li>",
"      Other causes of persistent fever, such as drug fever or Clostridium difficile-associated colitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/25/2456?source=see_link\">",
"       \"Drug fever\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/39/29305?source=see_link\">",
"       \"Clostridium difficile in adults: Clinical manifestations and diagnosis\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Associated disease in the host is the most important factor in determining the outcome of a lung abscess. Patients with primary lung abscess (including alcoholics and injection drug users) with typical putrid lung abscesses generally do well, with cure rates using antibiotic treatment of 90 to 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Patients with underlying diseases such as immunocompromised patients and those with bronchial obstructions have mortality rates reported to be as high as 75 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/67\">",
"     67",
"    </a>",
"    ]. In one retrospective series of 75 patients with lung abscess from Israel, the overall mortality was 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24729/abstract/68\">",
"     68",
"    </a>",
"    ]. The mortality rate was higher among those with more than one underlying condition compared with one or no underlying disease. Patients with P. aeruginosa, S. aureus, and Klebsiella spp also had a higher death rate. The mean length of hospitalization in this study was 25.7 days (range, 5 to 94 days).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/34/13858?source=see_link\">",
"       \"Patient information: Aspiration pneumonia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232496574\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lung abscess is defined as necrosis of the pulmonary parenchyma caused by microbial infection. Some authorities use the term \"necrotizing pneumonia\" or \"lung gangrene\" to distinguish pulmonary necrosis with multiple small abscesses from a larger cavitary lesion, but this actually represents a continuum of the same process. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most lung abscesses arise as a complication of aspiration pneumonia and are caused by species of anaerobes that are normally present in the gingival crevices. The most common organisms are Peptostreptococcus, Prevotella, Bacteroides (usually not B. fragilis), and Fusobacterium spp (",
"      <a class=\"graphic graphic_table graphicRef62555 \" href=\"UTD.htm?1/29/1500\">",
"       table 1",
"      </a>",
"      ). Many other bacteria can also cause lung abscesses, but do so with substantially less frequency. Probably the most common non-anaerobes are Streptococcus milleri and other microaerophilic streptococci. Other pathogens that cause lung abscess include Staphylococcus aureus (especially methicillin-resistant Staphylococcus aureus) and various gram-negative bacilli (especially the K1 strain of Klebsiella pneumoniae). The most common agents in the immunocompromised host are Pseudomonas Aeruginosa and other aerobic gram-negative bacilli, Nocardia, and fungi (Aspergillus and Cryptococcus spp). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with lung abscesses, and nearly all with lung abscesses due to anaerobic bacteria, present with indolent symptoms that evolve over a period of weeks or months. The characteristic features of anaerobic lung abscesses suggest pulmonary infection, including fever, cough, and sputum production. Evidence of chronic systemic disease is usually present, with night sweats, weight loss, and anemia. Patients may seek medical attention for these systemic symptoms, hemoptysis, or pleurisy. Nearly all patients have fever, but virtually none have shaking chills or true rigors. Most patients are aware of putrid or sour-tasting sputum. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A lung abscess is typically diagnosed when a chest radiograph reveals a pulmonary infiltrate with a cavity, indicating tissue necrosis; an air-fluid level is frequently present. However, multiple pathogens are associated with this radiographic finding as well as numerous other conditions (",
"      <a class=\"graphic graphic_table graphicRef67943 \" href=\"UTD.htm?28/36/29259\">",
"       table 4",
"      </a>",
"      ). Better anatomic definition can be achieved with computed tomographic (CT) scans than with chest radiographs (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79327 \" href=\"UTD.htm?18/17/18708\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54525 \" href=\"UTD.htm?39/32/40453\">",
"       image 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When patients show a typical presentation with indolent symptoms (cough, fever, night sweats for more than two weeks) combined with typical underlying conditions that lead to aspiration or a cavity in a dependent pulmonary segment, it is appropriate to suspect that anaerobic bacteria are involved. If there is putrid sputum or empyema fluid, the diagnosis of anaerobic bacterial infection is confirmed. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Classic presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is difficult to isolate anaerobic bacteria since most respiratory tract specimens (sputum or bronchoscopy aspirates) are contaminated by upper airway flora and are consequently inappropriate for anaerobic culture. The only methods available for obtaining uncontaminated specimens are transtracheal aspirates (TTA), transthoracic needle aspirates (TTNA), pleural fluid, and blood cultures; TTA and TTNA are rarely performed currently. It is realistic to obtain pleural fluid and blood cultures, but blood cultures are rarely positive for anaerobic bacteria. In the present era, the only anaerobic lung infections that are likely to have bacteriologic confirmation are those associated with an empyema. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Classic presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Standard treatment for an anaerobic lung infection is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (600 mg IV every eight hours, followed by 150 to 300 mg orally four times daily). Other drugs that are reasonable to use are any combination of a beta-lactam beta-lactamase inhibitor (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"       ampicillin-sulbactam",
"      </a>",
"      3 g IV every six hours), penicillin plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      , or a carbapenem. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Antimicrobial therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For lung abscesses caused by methicillin-resistant Staphylococcus aureus (MRSA), we prefer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       linezolid",
"      </a>",
"      (600 mg IV every 12 hours) with a switch to oral linezolid at the same dose when the patient is afebrile and stable. The main alternative to linezolid is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every 12 hours, adjusted to a trough concentration of 15 to 20",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      and for renal function). Other options are",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"       ceftaroline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/42/27301?source=see_link\">",
"       telavancin",
"      </a>",
"      .",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"       Daptomycin",
"      </a>",
"      should",
"      <strong>",
"       not",
"      </strong>",
"      be used for pulmonary infections due to inadequate lung penetration (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Antimicrobial therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest continuing antibiotic treatment until the chest x-ray shows a small, stable residual lesion or is clear. This generally requires several months of treatment, most of which can be accomplished with oral agents on an outpatient basis. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Bartlett JG. Lung abscess and necrotizing pneumonia. In: Infectious Diseases, Gorbach SL, Bartlett JG, Blacklow NR (Eds), W.B. Saunders, Philadelphia 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/2\">",
"      Chung G, Goetz MB. Anaerobic Infections of the Lung. Curr Infect Dis Rep 2000; 2:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/3\">",
"      Bartlett JG, Gorbach SL, Tally FP, Finegold SM. Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis 1974; 109:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/4\">",
"      Bartlett JG. Treatment of anaerobic pleuropulmonary infections. Ann Intern Med 1975; 83:376.",
"     </a>",
"    </li>",
"    <li>",
"     Beerens H, Tahon-Castel M. Infections humaines a bacteries anaerobies non toxigenes. Presses Academiques Europeennes, Brussels 1965. p. 91.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/6\">",
"      Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/7\">",
"      Clinical conferences at the Johns Hopkins Hospital: lung abscess. Johns Hopkins Med J 1982; 150:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/8\">",
"      Perlman LV, Lerner E, D'Esopo N. Clinical classification and analysis of 97 cases of lung abscess. Am Rev Respir Dis 1969; 99:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/9\">",
"      FISHER AM, TREVER RW, CURTIN JA, et al. Staphylococcal pneumonia; a review of 21 cases in adults. N Engl J Med 1958; 258:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/10\">",
"      Bullowa JG, Chess J, Friedman NJ. Pneumonia due to Bacillus friedlanderi. Arch Intern Med 1937; 60:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/11\">",
"      Wang JL, Chen KY, Fang CT, et al. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis 2005; 40:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/12\">",
"      Williams DM, Krick JA, Remington JS. Pulmonary infection in the compromised host: part I. Am Rev Respir Dis 1976; 114:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/13\">",
"      Keefer CS, Ingelfinger FJ, Spink WW. Significance of hemolytic streptococci bacteremia: Study of 246 patients. Arch Intern Med 1937; 60:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/14\">",
"      Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis 1971; 124:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/15\">",
"      Peetermans WE, Van Wijngaerden E, Van Eldere J, Verhaegen J. Melioidosis brain and lung abscess after travel to Sri Lanka. Clin Infect Dis 1999; 28:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/16\">",
"      Sen&eacute;cal JL, St-Antoine P, B&eacute;liveau C. Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus. Am J Med Sci 1987; 293:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/17\">",
"      La Scola B, Michel G, Raoult D. Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses. J Clin Microbiol 1999; 37:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/18\">",
"      Leatherman JW, Iber C, Davies SF. Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria. Am Rev Respir Dis 1984; 129:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/19\">",
"      Bartlett JG. The role of anaerobic bacteria in lung abscess. Clin Infect Dis 2005; 40:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/20\">",
"      Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/21\">",
"      Stark DD, Federle MP, Goodman PC, et al. Differentiating lung abscess and empyema: radiography and computed tomography. AJR Am J Roentgenol 1983; 141:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/22\">",
"      Landay MJ, Christensen EE, Bynum LJ, Goodman C. Anaerobic pleural and pulmonary infections. AJR Am J Roentgenol 1980; 134:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/23\">",
"      Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/24\">",
"      Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/25\">",
"      Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/26\">",
"      Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/27\">",
"      Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, et al. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008; 198:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/28\">",
"      DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/29\">",
"      Yu WL, Ko WC, Cheng KC, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis 2006; 42:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/30\">",
"      Williford ME, Godwin JD. Computed tomography of lung abscess and empyema. Radiol Clin North Am 1983; 21:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/31\">",
"      Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977; 115:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/32\">",
"      Bartlett JG. The technique of transtracheal aspiration. J Crit Illn 1986; 1:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/33\">",
"      Bandt PD, Blank N, Castellino RA. Needle diagnosis of pneumonitis. Value in high-risk patients. JAMA 1972; 220:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/34\">",
"      Wimberley NW, Bass JB Jr, Boyd BW, et al. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 1982; 81:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/35\">",
"      Sosenko A, Glassroth J. Fiberoptic bronchoscopy in the evaluation of lung abscesses. Chest 1985; 87:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/36\">",
"      Allen CI, Blackman JF. Treatment of lung abscess with report of 100 consecutive cases. J Thorac Surg 1936; 6:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/37\">",
"      SMITH DT. Medical treatment of acute and chronic pulmonary abscesses. J Thorac Surg 1948; 17:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/38\">",
"      Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/39\">",
"      Weiss W. Delayed cavity closure in acute nonspecific primary lung abscess. Am J Med Sci 1968; 255:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/40\">",
"      Weiss W. Oral antibiotic therapy of acute primary lung abscess: comparison of penicillin G and tetracycline. Curr Ther Res Clin Exp 1970; 12:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/41\">",
"      Weiss W. Cavity behavior in acute, primary, nonspecific lung abscess. Am Rev Respir Dis 1973; 108:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/42\">",
"      Weiss W, Cherniack NS. Acute nonspecific lung abscess: a controlled study comparing orally and parenterally administered penicillin G. Chest 1974; 66:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/43\">",
"      Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983; 98:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/44\">",
"      Gudiol F, Manresa F, Pallares R, et al. Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/45\">",
"      Finegold SM, George WL, Mulligan ME. Anaerobic infections. Part II. Dis Mon 1985; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/46\">",
"      Finegold SM, Rolfe RD. Susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 1983; 1:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/47\">",
"      Appelbaum PC, Spangler SK, Jacobs MR. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother 1990; 34:1546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/48\">",
"      Goldstein EJ, Citron DM, Warren Y, et al. In vitro activity of gemifloxacin (SB 265805) against anaerobes. Antimicrob Agents Chemother 1999; 43:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/49\">",
"      Perlino CA. Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy. Arch Intern Med 1981; 141:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/50\">",
"      Sanders CV, Hanna BJ, Lewis AC. Metronidazole in the treatment of anaerobic infections. Am Rev Respir Dis 1979; 120:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/51\">",
"      Eykyn SJ. The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital. Surgery 1983; 93:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/52\">",
"      Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012; 54:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/53\">",
"      Richter SS, Heilmann KP, Dohrn CL, et al. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrob Agents Chemother 2011; 55:4154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/54\">",
"      Bartlett JG. Anaerobic bacterial pleuropulmonary infections. Semin Respir Med 1992; 13:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/55\">",
"      R&auml;s&auml;nen J, Bools JC, Downs JB. Endobronchial drainage of undiagnosed lung abscess during chest physical therapy. A case report. Phys Ther 1988; 68:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/56\">",
"      Neuhof, H, Touroff, AS. Acute putrid abscess of the lung. J Thorac Surg 1942; 12:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/57\">",
"      Vainrub B, Musher DM, Guinn GA, et al. Percutaneous drainage of lung abscess. Am Rev Respir Dis 1978; 117:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/58\">",
"      Weissberg D. Percutaneous drainage of lung abscess. J Thorac Cardiovasc Surg 1984; 87:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/59\">",
"      Mengoli L. Giant lung abscess treated by tube thoracostomy. J Thorac Cardiovasc Surg 1985; 90:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/60\">",
"      Herth F, Ernst A, Becker HD. Endoscopic drainage of lung abscesses: technique and outcome. Chest 2005; 127:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/61\">",
"      Schmitt GS, Ohar JM, Kanter KR, Naunheim KS. Indwelling transbronchial catheter drainage of pulmonary abscess. Ann Thorac Surg 1988; 45:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/62\">",
"      Rowe LD, Keane WM, Jafek BW, Atkins JP Jr. Transbronchial drainage of pulmonary abscesses with the flexible fiberoptic bronchoscope. Laryngoscope 1979; 89:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/63\">",
"      Connors JP, Roper CL, Ferguson TB. Transbronchial catheterization of pulmonary abscesses. Ann Thorac Surg 1975; 19:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/64\">",
"      Hammer DL, Aranda CP, Galati V, Adams FV. Massive intrabronchial aspiration of contents of pulmonary abscess after fiberoptic bronchoscopy. Chest 1978; 74:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/65\">",
"      SCHWEPPE HI, KNOWLES JH, KANE L. Lung abscess. An analysis of the Massachusets General Hospital cases from 1943 through 1956. N Engl J Med 1961; 265:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/66\">",
"      Shafron RD, Tate CF Jr. Lung abscess: A five-year evaluation. Dis Chest 1968; 53:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/67\">",
"      Pohlson EC, McNamara JJ, Char C, Kurata L. Lung abscess: a changing pattern of the disease. Am J Surg 1985; 150:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24729/abstract/68\">",
"      Hirshberg B, Sklair-Levi M, Nir-Paz R, et al. Factors predicting mortality of patients with lung abscess. Chest 1999; 115:746.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7030 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-07BE0D3610-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24729=[""].join("\n");
var outline_f24_9_24729=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1232496574\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6599037\">",
"      Immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Anaerobic infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other bacterial pathogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Klebsiella pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Nocardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other pathogens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Classic presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Less typical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Antimicrobial therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Surgical intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Response to therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1232496574\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7030\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7030|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/17/18708\" title=\"diagnostic image 1\">",
"      Necrotizing right lower lobe pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/32/40453\" title=\"diagnostic image 2\">",
"      Lung abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/49/16149\" title=\"diagnostic image 3\">",
"      Empyema due to Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7030|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/29/1500\" title=\"table 1\">",
"      Lung abscess bacteriology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/59/22460\" title=\"table 2\">",
"      Lung abscess in CMI defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/9/5275\" title=\"table 3\">",
"      Risk factors for MRSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/36/29259\" title=\"table 4\">",
"      Ddx cavitary lung lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/63/17403\" title=\"table 5\">",
"      Antibiotics for lung abscess",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=related_link\">",
"      Airway foreign bodies in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38426?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18791?source=related_link\">",
"      Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=related_link\">",
"      Clinical manifestations and diagnosis of nocardiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=related_link\">",
"      Clinical manifestations and evaluation of pulmonary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/39/29305?source=related_link\">",
"      Clostridium difficile in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=related_link\">",
"      Combination beta-lactamase inhibitors, carbapenems, and monobactams",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/25/2456?source=related_link\">",
"      Drug fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=related_link\">",
"      Epidemiology and clinical manifestations of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/16/33031?source=related_link\">",
"      Extraintestinal Entamoeba histolytica amebiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=related_link\">",
"      Imaging of pleural effusions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40215?source=related_link\">",
"      Infective endocarditis in injection drug users",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=related_link\">",
"      Invasive liver abscess syndrome caused by Klebsiella pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31817?source=related_link\">",
"      Metronidazole: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23991?source=related_link\">",
"      Microbiology, epidemiology, and pathogenesis of nocardiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31207?source=related_link\">",
"      Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=related_link\">",
"      Overview of nontuberculous mycobacterial infections in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/34/13858?source=related_link\">",
"      Patient information: Aspiration pneumonia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29526?source=related_link\">",
"      Pyogenic liver abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/0/2055?source=related_link\">",
"      Suppurative (septic) thrombophlebitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40986?source=related_link\">",
"      Treatment of community-acquired pneumonia in adults who require hospitalization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/26/12712?source=related_link\">",
"      Tuberculosis in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40758?source=related_link\">",
"      Virulence determinants of community acquired methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_9_24730="Treatment of hematogenous osteomyelitis in children";
var content_f24_9_24730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of hematogenous osteomyelitis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24730/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24730/contributors\">",
"     Paul Krogstad, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24730/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24730/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24730/contributors\">",
"     William Phillips, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/9/24730/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/9/24730/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/9/24730/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis refers to an infection of bone that is usually bacterial in origin. Microorganisms can be introduced into bone in three ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hematogenous delivery (bacteremia)",
"     </li>",
"     <li>",
"      Direct inoculation (usually traumatic, but also surgical)",
"     </li>",
"     <li>",
"      Local invasion from a contiguous infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children, acute osteomyelitis is primarily hematogenous in origin. Treatment usually is initiated with empiric intravenous antimicrobial therapy, which is followed by a specific antimicrobial regimen if the causative organism is identified.",
"   </p>",
"   <p>",
"    The treatment of hematogenous osteomyelitis in children is discussed in this topic review. The epidemiology, pathogenesis, and microbiology, as well as the clinical features, evaluation, and diagnosis of hematogenous osteomyelitis in children, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW OF TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the preantibiotic era, the mortality rate for acute osteomyelitis was substantial. As an example, it was approximately 20 percent in those with",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    osteomyelitis. With current antimicrobial regimens and surgical approaches, successful treatment (survival and complete resolution of radiographically apparent damage to bone) is now achieved in nearly all affected children.",
"   </p>",
"   <p>",
"    The decision to initiate antimicrobial therapy for acute hematogenous osteomyelitis is often made before the diagnosis is confirmed, by either imaging or culture. In this setting, epidemiologic factors such as the child's age, underlying medical condition, and organisms prevalent in the community will suggest likely pathogens and the appropriate antimicrobial agent(s). (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Choice of agents'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Surgical therapy, which may include drainage of an abscess or removal of devitalized bone, must be initiated promptly when it is indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H25\">",
"     'Indications for surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Isolation of a pathogen from bone, periosteal fluid collection, joint fluid, or blood confirms the diagnosis of osteomyelitis and greatly facilitates planning proper treatment. Antimicrobial therapy can be chosen with greater specificity when an etiologic organism and its antimicrobial susceptibilities are identified. Aspiration of soft tissue foci, periosteal abscesses, or the bone marrow space should therefore be considered when surgical therapy is not initially required.",
"   </p>",
"   <p>",
"    Immobilization of the affected extremity may relieve pain. It also may prevent pathologic fractures when bone involvement, as detected by plain radiography or other imaging modalities, is extensive. Evaluating the need for immobilization is particularly important for patients with vertebral osteomyelitis or osteomyelitis of the proximal femur.",
"   </p>",
"   <p>",
"    To help minimize some of the hazards associated with long-term parenteral antimicrobial therapy, a sequence of intravenous antibiotics followed by oral therapy (known as sequential antibiotic therapy) is commonly used in children with a generally uncomplicated course [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Although many patients have clinical resolution of symptoms within two weeks of the beginning of treatment, four or more weeks of combined intravenous and oral antimicrobial therapy should be administered, as complications have been linked repeatedly to short duration of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Sequential antibiotic therapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H22\">",
"     'Duration and efficacy of therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EMPIRIC ANTIMICROBIAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolation of a pathogen from bone, periosteal collection, joint fluid, or blood confirms the diagnosis in children with suspected osteomyelitis and is essential for planning proper treatment. However, no organism is identified by cultures of blood and pathologic specimens in as many as one-half of children with clinical and radiologic findings consistent with osteomyelitis. Thus, treatment usually begins with the prompt initiation of empiric intravenous antibiotic therapy, which is followed by a specific antimicrobial regimen once the etiologic organism is identified.",
"   </p>",
"   <p>",
"    The efficacy of this practice has been supported by observational reports in which overall cure rates have been excellent (greater than 95 percent), including complication rates between 4 and 7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. As mentioned, the mortality rate for acute osteomyelitis in the preantibiotic era was substantial (approximately 20 percent).",
"   </p>",
"   <p>",
"    There are no studies that directly compare the empiric approach to a strategy of waiting until the diagnosis of osteomyelitis is firmly established (particularly by the identification of a causative organism) to immediate administration of antimicrobial therapy. Despite this, the empiric approach is widely used in children because of the excellent cure rate (compared with historic controls) and, as mentioned, the inability to identify the causative organism in as many as 50 percent of cases. In addition, the risk of delaying treatment for these bacteremic patients may be significant, particularly for those with community-associated",
"    <em>",
"     S. aureus",
"    </em>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H16#H16\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Staphylococcus aureus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of the following combination of general clinical and laboratory features suggests the diagnosis of osteomyelitis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Constitutional symptoms of infection (irritability, or decreased appetite or activity) that are consistent with osteomyelitis, with or without fever.",
"     </li>",
"     <li>",
"      Signs of localized inflammation of bone, including redness, swelling, point tenderness,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      loss of function.",
"     </li>",
"     <li>",
"      An elevation in erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) levels, although this is not universally present. By comparison, an elevated white blood cell (WBC) count is not necessary to begin empiric treatment.",
"     </li>",
"     <li>",
"      A plain radiograph is performed initially in all patients with clinical features suggestive of osteomyelitis. Characteristic abnormalities (such as lytic sclerosis, periosteal new bone formation, periosteal elevation,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      deep soft tissue swelling) are occasionally observed on the initial imaging study. Occasionally, the plain radiograph suggests another diagnosis (such as a tumor or fracture).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Before initiating therapy, cultures should be obtained from blood and suspected foci of infection. A minimum of one blood culture (but preferably two) should be obtained in all patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend that empiric therapy for presumed osteomyelitis be initiated in the following patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with clinical features suggestive of osteomyelitis plus characteristic abnormalities on an initial imaging study.",
"     </li>",
"     <li>",
"      Most children with suspected osteomyelitis based on clinical findings whose initial plain films are normal. A few children who are school-age or older and afebrile, with equivocal physical findings and a normal initial radiograph, may be followed closely without antibiotics. Further imaging, usually with MRI or scintigraphy, should be performed within a few days of the initial radiograph. This issue is discussed in detail elsewhere (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H18#H18\">",
"       \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Diagnostic approach'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The differential diagnosis must be carefully considered to permit prompt identification of disorders with clinical features similar to osteomyelitis. As an example, leukemia (and not osteomyelitis) may be the underlying cause of fever, focal leg pain, leukocytosis, and thrombocytopenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H27#H27\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Choice of agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bacterial hematogenous osteomyelitis should be treated initially with parenteral antimicrobial agents, whether or not the organism causing the infection has been identified. Epidemiologic factors such as the child's age, underlying medical condition, and organisms that are prevalent in the community will suggest likely pathogens and the appropriate antimicrobial agent.",
"   </p>",
"   <p>",
"    The ideal choice for empiric therapy would be a single intravenous agent that has an effective oral counterpart. This is because the response to intravenous therapy is an important consideration when choosing an oral agent for sequential therapy, particularly for the patient with negative cultures. However, the choice of a single agent may not always be clinically feasible. As an example, a two-year-old child living in a community with a high prevalence of community-associated methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    (CA-MRSA) may need antibiotic coverage for",
"    <em>",
"     Kingella kingae",
"    </em>",
"    , as well as for CA-MRSA in selected circumstances. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Sequential antibiotic therapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H7\">",
"     'Older infants and children'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There is limited evidence reporting the relative efficacy of different agents for the treatment of osteomyelitis. This was demonstrated in a systematic review of 93 clinical trials involving children and adults, in which the available evidence was insufficient to identify a superior antibiotic regimen for the treatment of hematogenous osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/6\">",
"     6",
"    </a>",
"    ]. In a subsequent, open-label, quasi-randomized trial comparing",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    with first generation cephalosporins, outcomes were similar among 169 Finnish children with culture-proven acute osteoarticular infections [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/7\">",
"     7",
"    </a>",
"    ]. All cases resulted from infection with methicillin susceptible",
"    <em>",
"     S. aureus",
"    </em>",
"    (84 percent),",
"    <em>",
"     S. pyogenes",
"    </em>",
"    (9 percent), or",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    (5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current cure rates for osteomyelitis in children are generally above 95 percent when an antibiotic for empiric treatment is chosen based upon epidemiologic factors such as the child's age, underlying medical condition, and organisms that are prevalent in the community. This was shown in a 2002 systematic review of 12 prospective studies in which the pooled cure rate was 97 percent for acute hematogenous osteomyelitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/5\">",
"     5",
"    </a>",
"    ]. Most infections were caused by culture-verified",
"    <em>",
"     S. aureus",
"    </em>",
"    , but a positive culture was not necessary for study inclusion.",
"   </p>",
"   <p>",
"    The following section provides a guide to empiric therapy based principally upon the patient's age and the antimicrobial sensitivities of the likely infecting organism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Neonates and young infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;For neonates and young infants from birth to three months of age, initial intravenous antimicrobial therapy should be directed against the most common bacterial isolates responsible for hematogenous osteomyelitis in this age group. These include",
"    <em>",
"     S. aureus",
"    </em>",
"    , gram-negative bacilli, and group B streptococcus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For neonates and young infants, we use an empiric regimen consisting of a third-generation cephalosporin, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    , plus an antistaphylococcal agent (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    or",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"      nafcillin",
"     </a>",
"     /",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"      oxacillin",
"     </a>",
"     ).",
"    </span>",
"    Because of the risk of hospital-acquired infection with methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    (MRSA) or coagulase-negative staphylococci, neonates who have been in an intensive care unit for more than one week should receive vancomycin, rather than",
"    <span class=\"nowrap\">",
"     nafcillin/oxacillin.",
"    </span>",
"    A history or the suspicion of maternal infection or colonization with community-acquired",
"    <em>",
"     S. aureus",
"    </em>",
"    should also prompt the initial use of vancomycin in a newborn.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Older infants and children",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1088553161\">",
"    <span class=\"h4\">",
"     S. aureus and group A streptococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial intravenous antimicrobial therapy in older infants (&ge;3 months) and children should be primarily directed against",
"    <em>",
"     S. aureus",
"    </em>",
"    and group A streptococcus. We therefore generally use one of the following agents:",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"      nafcillin",
"     </a>",
"     /",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"      oxacillin",
"     </a>",
"     ,",
"    </span>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"     cefazolin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The specific choice of antistaphylococcal agent depends on the local prevalence of CA-MRSA and the susceptibility of these isolates to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We prefer an antistaphylococcal penicillin",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"        nafcillin",
"       </a>",
"       /",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"        oxacillin",
"       </a>",
"       )",
"      </span>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"       cefazolin",
"      </a>",
"      if less than 10 percent of the community",
"      <em>",
"       S. aureus",
"      </em>",
"      isolates are methicillin resistant.",
"     </li>",
"     <li>",
"      Most experts suggest using either",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      when 10 percent or more of community",
"      <em>",
"       S. aureus",
"      </em>",
"      isolates are methicillin resistant [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/9\">",
"       9",
"      </a>",
"      ]. However, inducible resistance to clindamycin that is not apparent using most standard techniques may occur in some isolates. Therefore, the susceptibility of all CA-MRSA isolates to clindamycin must be determined using the \"D test\". (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=see_link&amp;anchor=H10#H10\">",
"       \"Overview of antibacterial susceptibility testing\", section on 'D test'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The following factors should be considered in choosing between vancomycin or clindamycin:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infections caused by CA-MRSA with inducible resistance to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      should be treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      to avoid the risk of subsequent treatment failure [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      is generally recommended for empiric treatment when &ge;15 percent of the MRSA isolates in the community also are resistant to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the association between CA-MRSA and life-threatening infection,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    should be used for empiric therapy for patients who appear seriously ill [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/12\">",
"     12",
"    </a>",
"    ]. For patients who are severely ill, some experts would add",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"     nafcillin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"     oxacillin",
"    </a>",
"    to vancomycin to provide better coverage for methicillin-susceptible",
"    <em>",
"     S. aureus",
"    </em>",
"    .",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     Clindamycin",
"    </a>",
"    is preferred for children with only localized signs of infection, when resistance to clindamycin is not a concern. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37159?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of Staphylococcus aureus bacteremia in children\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alternatives to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    when MRSA is a concern include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22345?source=see_link\">",
"     linezolid",
"    </a>",
"    (600 mg",
"    <strong>",
"     per dose",
"    </strong>",
"    IV every 12 hours for children &ge;12 years of age; 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose IV every 8 hours for children &lt;12 years of age [maximum dose 600 mg]) or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/39/39542?source=see_link\">",
"     daptomycin",
"    </a>",
"    if pneumonia is not present (6 to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV once per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/9,13\">",
"     9,13",
"    </a>",
"    ]. Daptomycin is not approved for the treatment of osteomyelitis in children; the appropriate dose is not established. We do not generally use",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    for CA-MRSA osteomyelitis in children because the data demonstrating its effectiveness are limited and the reported high rate of mild adverse events [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'MRSA infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1088553168\">",
"    <span class=\"h4\">",
"     K. kingae",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to",
"    <em>",
"     S. aureus",
"    </em>",
"    and group A streptococcus,",
"    <em>",
"     K. kingae",
"    </em>",
"    should be considered as a possible pathogen for patients younger than three years (especially those attending day care), and those with indolent osteomyelitis or a history of oral ulcers preceding the onset of musculoskeletal findings [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/15-21\">",
"     15-21",
"    </a>",
"    ].",
"    <em>",
"     K. kingae",
"    </em>",
"    usually is susceptible to cephalosporins (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"     cefazolin",
"    </a>",
"    ), but consistently resistant to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    , and often resistant to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    and antistaphylococcal penicillins (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"     oxacillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"     nafcillin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We generally do not provide initial empiric coverage for",
"    <em>",
"     K. kingae",
"    </em>",
"    in young children because the vast majority of cases of osteomyelitis in the United States result from",
"    <em>",
"     S. aureus",
"    </em>",
"    and other gram-positive pathogens, and because initial multi-drug therapy may complicate a transition to oral therapy when an organism is not identified in culture. In addition,",
"    <em>",
"     K. kingae",
"    </em>",
"    generally produces relatively mild musculoskeletal infections; chronic osteomyelitis and other complications requiring surgical interventions have not been described [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For children between 3 and 36 months of age who require",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    for empiric coverage of CA-MRSA, empiric coverage for",
"    <em>",
"     K. kingae",
"    </em>",
"    with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"     cefazolin",
"    </a>",
"    may be added if the child does not improve as expected. Alternatively, cefazolin may be substituted for vancomycin or clindamycin if CA-MRSA is not identified in cultures of blood, bone, or soft tissue aspirates. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Treatment of culture-negative osteomyelitis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H17#H17\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Bacteria other than staphylococci'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1088553175\">",
"    <span class=\"h4\">",
"     Haemophilus influenzae type b",
"    </span>",
"    &nbsp;&mdash;&nbsp;In areas where the",
"    <em>",
"     Haemophilus influenzae",
"    </em>",
"    type b immunization rate is high, coverage for this organism is not necessary for children who have been incompletely immunized. Initial empiric therapy with more than one antibiotic complicates the optimal choice of a single agent to complete therapy for children with negative cultures who are improving on the empiric regimen. However,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    should be added when",
"    <em>",
"     H. influenzae",
"    </em>",
"    type b is a concern in populations that are not highly immunized for this organism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Specific predisposing factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other antimicrobial agents, in addition to an agent to treat",
"    <em>",
"     S. aureus",
"    </em>",
"    , should be administered when clinical factors suggest specific pathogens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"    </a>",
"    .) These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with sickle cell disease should receive empiric therapy with a third-generation cephalosporin because Salmonella species are the most common cause of osteomyelitis in this setting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39946?source=see_link\">",
"       \"Overview of the management of sickle cell disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with chronic granulomatous disease, osteomyelitis is frequently is caused by unusual organisms (eg,",
"      <em>",
"       Aspergillus",
"      </em>",
"      and other fungi,",
"      <em>",
"       Serratia",
"      </em>",
"      species, and other filamentous or gram negative bacteria), as well as staphylococci [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. Surgical sampling or debridement of bone lesions is essential for accurate microbiological diagnosis, and addition of a third-generation cephalosporin is prudent as initial therapy. Debridement combined with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/60/12234?source=see_link\">",
"       voriconazole",
"      </a>",
"      has proven successful in some patients with invasive bone aspergillus [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11465?source=see_link&amp;anchor=H9#H9\">",
"       \"Chronic granulomatous disease: Treatment and prognosis\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with recent gastrointestinal surgery or complex urinary tract anatomy are at risk for infection with enteric gram-negative organisms. We suggest initial therapy with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and either an aminoglycoside or a third-generation cephalosporin, such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Organisms that cause infection among injecting drug users (IDU) vary markedly between different communities.",
"      <em>",
"       Pseudomonas aeruginosa",
"      </em>",
"      frequently has been reported among IDUs with osteomyelitis. We suggest a regimen of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/4/14405?source=see_link\">",
"       ceftazidime",
"      </a>",
"      plus either",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"        nafcillin",
"       </a>",
"       /",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"        oxacillin",
"       </a>",
"      </span>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      , which would cover both",
"      <em>",
"       S. aureus",
"      </em>",
"      and gram-negative bacilli. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43142?source=see_link\">",
"       \"Pseudomonas aeruginosa skin, soft tissue, and bone infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39528?source=see_link\">",
"       \"Treatment of Pseudomonas aeruginosa infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ISSUES WITH SPECIFIC ANTIMICROBIAL AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antimicrobial therapy can be chosen with greater specificity when an organism and its antimicrobial sensitivities are identified from bone, periosteal collection, joint fluid,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    blood. Often, the initial empiric regimen can be continued, or coverage narrowed, based on this new information.",
"   </p>",
"   <p>",
"    In some situations, however, the sensitivity patterns are unusual, and the following points should be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      alone should be used with caution for the initial treatment of staphylococcal osteomyelitis; numerous treatment failures have been described.",
"     </li>",
"     <li>",
"      Oxazolidinone (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22345?source=see_link\">",
"       linezolid",
"      </a>",
"      ) and streptogramin drugs (eg,",
"      <span class=\"nowrap\">",
"       quinupristin/dalfopristin),",
"      </span>",
"      have been used with success in the treatment of osteomyelitis in adults with methicillin-susceptible and methicillin-resistant",
"      <em>",
"       S. aureus",
"      </em>",
"      (MRSA) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. Experience in children is limited. Oxazolidinone and streptogramin drugs also have been used to treat enterococcal infections resistant to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      High doses of the fluoroquinolone class of antibiotics can cause articular cartilage damage in young animals, generating some concern about the long-term use of these agents in infants and children [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/26-28\">",
"       26-28",
"      </a>",
"      ]. However, tendinopathy and Achilles tendon rupture have been frequently and clearly described, most often in adults. In view of the potential adverse musculoskeletal effects of fluoroquinolones, quinolones are not recommended for children with typical osteomyelitis, including MRSA, regardless of in vitro susceptibility. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=see_link\">",
"       \"Fluoroquinolones\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MONITORING RESPONSE TO THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring the response to initial therapy provides important information about the patient's clinical course and guides treatment decisions. Most children with osteomyelitis follow a predictable and uncomplicated course, leading to full recovery. A satisfactory initial treatment response suggests that the diagnosis and choice of antimicrobial therapy are correct. Continued improvement affirms this and identifies an end point beyond which outpatient therapy may be considered.",
"   </p>",
"   <p>",
"    Patients who are not responding to treatment as expected require reevaluation and adjustment of therapy. Throughout the entire course of therapy, the need for possible surgical intervention, the possibility of misdiagnosis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inadequate antimicrobial response should be reconsidered under the following circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prolonged symptoms. A reduction in fever and pain, as well as increased comfort with movement, are expected within seven days and may be seen in toddlers in as little as three to five days.",
"     </li>",
"     <li>",
"      Persistent elevation or prolonged decline in erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP). The ESR should have substantially decreased (by 20 percent or more) by the end of the first week of therapy, with a 50 percent decline in CRP. Both typically continue to decline during the second week of treatment. CRP returns to normal in 10 days or fewer in most patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Progression of radiographic abnormalities in affected bones.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Monitoring tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring the history and physical examination, ESR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CRP levels, and plain radiographs generally identifies patients who are not improving as expected.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History and physical examination &ndash; Constitutional symptoms, such as activity level and appetite, should be noted. A careful physical examination also should be performed frequently throughout the course of treatment, with particular attention to the pattern of fever, signs of local inflammation, and the development of new sites of infection.",
"     </li>",
"     <li>",
"      ESR",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CRP levels &ndash; The ESR and CRP levels are generally reliable laboratory markers of inflammation and response to therapy. The ESR usually increases during the first several days after diagnosis and then declines in the weeks that follow [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/30\">",
"       30",
"      </a>",
"      ]. CRP also increases early in the infection but returns to normal sooner than ESR. In addition, the rate at which CRP returns to normal may be a sensitive indicator of a complicated clinical course. These observations were demonstrated in the following reports:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In a prospective series of 50 children treated for acute",
"      <em>",
"       S. aureus",
"      </em>",
"      hematogenous osteomyelitis, CRP returned to normal in an average of nine days, compared with 29 days for ESR [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report of 63 consecutive children with hematogenous osteomyelitis, those with a higher CRP from the fourth day of treatment on were more likely to have a complicated clinical course, as defined by requirement for repeated drainage, duration of symptoms, and extent of radiographic findings [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/32\">",
"       32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Either ESR or CRP may be used to monitor initial response to therapy, depending on which test is more readily available. Although we prefer monitoring both levels, CRP begins to decline sooner.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      White blood cell (WBC) count &ndash; Elevations in peripheral WBC count in children with hematogenous osteomyelitis are variable and nonspecific. The peripheral leukocyte count, if initially elevated, usually normalizes within 7 to 10 days after starting effective antimicrobial",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      surgical therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=see_link\">",
"       \"Clinical features of hematogenous osteomyelitis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Plain radiographs &ndash; A plain radiograph of the affected area(s) should be obtained as part of the initial evaluation for all patients with suspected osteomyelitis. Subsequent studies may help to delineate the severity of disease or the development of complications. Areas of devitalized bone (sequestra) become evident within two to four weeks, although complete resolution of radiographic abnormalities may take months. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H6#H6\">",
"       \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Uncomplicated clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improvement usually occurs rapidly with appropriate antimicrobial therapy, within three to four days. After 7 to 10 days of antimicrobial therapy, many patients have improved sufficiently to be treated as outpatients. In these patients, we suggest the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ESR",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CRP &ndash; In patients with the expected clinical improvement, a decline in ESR",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CRP is an indication that the child is improving and is a candidate for outpatient therapy. We suggest repeating these tests at that time, usually after 5 to 10 days of antimicrobial therapy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Outpatient therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      WBC count &ndash; As with ESR and CRP levels, normalization of the WBC count is an indication that outpatient therapy can be considered. We suggest repeating a complete blood count at that point, usually after 7 to 10 days of antimicrobial therapy. In addition, many antibiotics, particularly beta-lactams, cause bone marrow depression. Therefore, the absolute neutrophil count should be monitored weekly or so when these antibiotics are administered.",
"     </li>",
"     <li>",
"      Plain radiographs &ndash; We do not routinely obtain another radiograph before considering outpatient therapy in children with an uncomplicated clinical course whose initial plain films demonstrated findings characteristic of osteomyelitis. However, further imaging with MRI, scintigraphy, or plain films should be performed in the following situations:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Initial imaging studies were normal",
"     </li>",
"     <li>",
"      Initial studies demonstrated soft tissue changes and periosteal reaction without structural changes in bone",
"      <br/>",
"      <br/>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H18#H18\">",
"       \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Diagnostic approach'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Complicated clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;As previously mentioned, initial improvement usually occurs rapidly (often within three to four days) with appropriate antimicrobial therapy. Failure of the previously mentioned indicators to improve after seven days of treatment suggests a lack of response",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    worsening of the child's condition. This may indicate the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Development of a complication, such as thrombophlebitis",
"     </li>",
"     <li>",
"      The need for surgical intervention, such as drainage of abscesses or removal of sequestra",
"     </li>",
"     <li>",
"      Ineffective antimicrobial therapy, as would occur with unusual pathogens, such as a fungus or",
"      <em>",
"       Mycobacterium tuberculosis",
"      </em>",
"     </li>",
"     <li>",
"      A diagnosis other than osteomyelitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prompt reevaluation with ESR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CRP, WBC count, and plain radiographs is indicated. Further imaging, such as magnetic resonance imaging, may be necessary to identify a lesion requiring surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     OUTPATIENT THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continued treatment as an outpatient may be considered when there has been unequivocal clinical improvement. This usually occurs after 5 to 10 days of antibiotic therapy and is indicated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The patient has been afebrile for 48 to 72 hours",
"     </li>",
"     <li>",
"      Local signs and symptoms of infection are reduced considerably",
"     </li>",
"     <li>",
"      White blood cell (WBC) count has normalized",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate (ESR) has decreased by at least 20 percent, or there has been a 50 percent decrease in the concentration of C-reactive protein (CRP)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once",
"    <strong>",
"     all",
"    </strong>",
"    of these conditions have been met, outpatient therapy may be initiated. A percutaneously inserted central catheter (PICC) is frequently employed for a prolonged course of parenteral antibiotics and can be used for home therapy.",
"   </p>",
"   <p>",
"    Oral antibiotics also may be used to complete therapy in children with hematogenous osteomyelitis and avoid the well-documented risks associated with prolonged use of indwelling vascular catheters (discussed further below). With careful selection of appropriate patients and meticulous monitoring, outcomes are equivalent when treatment is completed with either oral or intravenous therapy. There is no minimum duration of initial intravenous therapy needed for successful treatment of osteomyelitis. Treatment with intravenous antibiotics for periods of seven days or less, followed by oral therapy, appears to be as successful as longer initial parenteral courses [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Sequential antibiotic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Children who are being treated as outpatients with either intravenous or oral antibiotics should be seen at one- to two-week intervals and monitored for continued clinical improvement, as well as for complications related to high-dose antibiotic therapy, such as cytopenia, antibiotic-associated diarrhea, and pseudomembranous enterocolitis.",
"   </p>",
"   <p>",
"    We obtain an ESR, complete blood count, and biochemical profile, including liver function tests, at each visit. In addition, we obtain drug levels for those children receiving oral therapy, although other authorities do not. A radiograph should be repeated at the end of therapy. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Drug monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SEQUENTIAL ANTIBIOTIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on numerous retrospective and prospective studies and clinical experience over many years, the sequential use of intravenous and oral routes of antibiotic administration is efficacious for the treatment of uncomplicated acute hematogenous osteomyelitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/5,29,34-39\">",
"     5,29,34-39",
"    </a>",
"    ]. Completing treatment with oral therapy avoids the hazards of long-term intravenous antibiotic administration, which may be significant.",
"   </p>",
"   <p>",
"    We are able to use sequential therapy in about two-thirds of our patients with osteomyelitis; some centers report nearly uniform use of sequential therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/38\">",
"     38",
"    </a>",
"    ]. In a multicenter retrospective cohort of 1021 children who received prolonged intravenous therapy for osteomyelitis, 3.4 percent required readmission to the hospital for a central venous catheter (CVC)-associated complication [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/38\">",
"     38",
"    </a>",
"    ]. &nbsp;Complications not requiring hospitalization are more frequent. In another retrospective series of 75 children who received antibiotics via CVC for more than two weeks, 41 percent experienced one or more CVC-associated complication [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The transition to oral antimicrobial therapy is usually made after about 7 to 10 days of intravenous therapy when there is evidence of clear improvement in the child's clinical condition. The safety and effectiveness of such an early change to oral therapy was best demonstrated in a 2002 systematic review of 12 prospective cohort studies that compared outcomes in children who began oral therapy after less than one week of parenteral antibiotics with others who had had parenteral antibiotics for one week or more prior to the transition [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/5\">",
"     5",
"    </a>",
"    ]. There was no difference in the overall cure rate at six months between the short and long course of parenteral therapy (95 and 99 percent cure rate, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children being considered for sequential therapy are generally immunocompetent and fully immunized. For these patients, the etiology of the infection and the expected therapeutic response are predictable. Oral therapy should not be used unless there is reason to anticipate adherence to the prescribed treatment regimen (both the dose and frequency of antimicrobial medication). Patient",
"    <span class=\"nowrap\">",
"     (and/or",
"    </span>",
"    parent) education and a continuing time commitment to follow-up by a health care provider are essential for oral treatment to be successful.",
"   </p>",
"   <p>",
"    If the treating clinician believes adherence to an outpatient regimen appears likely, switching from parenteral to oral therapy is an acceptable option under the following additional circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There has been a clear clinical response to parenteral antibiotics, as defined by the presence of each of the following features [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/30,32,40\">",
"       30,32,40",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The patient has been afebrile for 48 to 72 hours",
"     </li>",
"     <li>",
"      Local signs and symptoms of infection are reduced considerably",
"     </li>",
"     <li>",
"      Peripheral leukocyte count has normalized",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate (ESR) has decreased by at least 20 percent or there has been a 50 percent decrease in the concentration of C-reactive protein (CRP)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient has the ability to swallow, retain, and absorb an appropriate oral medication",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A plain film should be repeated prior to the initiation of oral therapy when the total duration of hospitalization exceeds 7 to 10 days, to ensure that there has been no progression of bone disease.",
"   </p>",
"   <p>",
"    The child with worsening radiographic findings should continue with parenteral antibiotic therapy and be reevaluated for lesions that may require surgical treatment, such as abscesses, sinus tracts, and sequestra. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Indications for surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Choice and dose of oral agent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of oral antibiotic should be based on susceptibility testing of the organism (when a pathogen is identified), response to parenteral antibiotic therapy, bioavailability of the oral medication, and palatability of the oral preparation.",
"   </p>",
"   <p>",
"    Antibiotics administered orally for hematogenous osteomyelitis must be given in higher doses than those used for treatment of other infections and recommended in package inserts. Specific antibiotics and the recommended starting doses are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/1,41,42\">",
"     1,41,42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"       Amoxicillin",
"      </a>",
"      (25",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 6 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/5/30804?source=see_link\">",
"       Cephalexin",
"      </a>",
"      (37.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 6 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       Clindamycin",
"      </a>",
"      (13",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 8 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/45/31446?source=see_link\">",
"       Cloxacillin",
"      </a>",
"      (31",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 6 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"       Dicloxacillin",
"      </a>",
"      (25",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 6 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/52/15172?source=see_link\">",
"       Penicillin V",
"      </a>",
"      (22",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 4 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22345?source=see_link\">",
"       Linezolid",
"      </a>",
"      (600 mg per dose administered every 12 hours for children &ge;12 years of age; 10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 8 hours for children &lt;12 years of age (maximum 600 mg per dose))",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To achieve adequate serum levels, doses of beta-lactams often can be increased to 200",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day without serious adverse side effects. Diarrhea, a frequent complication of high-dose oral beta-lactam therapy, can be mitigated by using the lower doses indicated above and adding",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/7/11382?source=see_link\">",
"     probenecid",
"    </a>",
"    (40",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in four divided doses, maximum of 2 grams per day).",
"   </p>",
"   <p>",
"    We do not generally use oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    for community-associated methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    (CA-MRSA) osteomyelitis in children because it has not been prospectively studied for this indication. However, there is some retrospective data that it may be effective [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Drug monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Expert opinion differs regarding the routine use of drug monitoring for patients on oral therapy for osteomyelitis. Although eschewed by some, we suggest monitoring because rare patients will have inadequate antibiotic levels in serum despite high oral antibiotic doses, and the consequences of inadequate treatment of osteomyelitis can be severe [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Methods to monitor drug levels include assays for specific antibiotics and the determination of serum bactericidal titers (although many hospital laboratories no longer perform this test).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Antibiotic levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assays that measure levels of specific antibiotics also can be used for drug monitoring. Adequate serum antibiotic levels in patients taking oral medications indicate the child can absorb the medication enterally. Assays are available for antibiotics that are used routinely, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/5/30804?source=see_link\">",
"     cephalexin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    This method is used to monitor patients who have not had an organism isolated. In addition, during the transition to oral therapy, adequate parenteral treatment can be continued while the dose of the oral agent is being adjusted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Serum bactericidal titer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum bactericidal titer (SBT) is the highest dilution of the patient's serum that will, after 18 hours of incubation, kill 99.9 percent of an inoculum of the infecting organism. Samples for SBT should be drawn one to two hours after a dose of antibiotic has been administered. A titer &ge;1:8 is considered adequate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SBT measurements are seldom used to monitor therapy in children with osteomyelitis. Measurement of SBT requires isolation of the organism. In addition, the SBT can be difficult to interpret when the patient is receiving more than one antibiotic. This could occur, for example, during the transition from intravenous to oral therapy at the point where the patient is receiving intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"     nafcillin",
"    </a>",
"    and oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    . The SBT would reflect the effect of both antibiotics. It would not provide specific information regarding the efficacy of the oral agent. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Management of oral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest therapeutic drug monitoring for children being transitioned to oral antibiotics. We generally use antibiotic levels, independent of the isolation of the pathogenic organism, because they are routinely available at our institution. Once adequate levels have been documented, we generally do not repeat them unless there is concern about the child&rsquo;s condition.",
"   </p>",
"   <p>",
"    Patients and families who can comply with the oral regimen and close follow-up may be discharged from the hospital and managed as outpatients. Children are seen at one- to two-week intervals and monitored for continued clinical improvement and for complications related to high-dose antibiotic therapy, such as cytopenia and pseudomembranous enterocolitis. An ESR, complete blood count, and biochemical profile, including liver function tests, are obtained at each visit. A radiograph is performed at the end of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DURATION AND EFFICACY OF THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment failure and complications from hematogenous osteomyelitis have been repeatedly linked to short duration of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/2,44-46\">",
"     2,44-46",
"    </a>",
"    ]. Treatment failures are sometimes seen when the total length of treatment is shorter than 20 to 21 days, whereas failures are uncommon (approximately 3 percent) when therapy is four weeks or more [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/5\">",
"     5",
"    </a>",
"    ]. In one retrospective report, for example, a failure rate of 19 percent was noted among children treated for less than three weeks, as compared with a 2 percent failure rate in those treated for 21 to 50 days [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/2\">",
"     2",
"    </a>",
"    ]. In a randomized trial, children with culture-proven osteomyelitis recovered completely whether they were treated for 20 or 30 days, provided that they had a good clinical response and rapid normalization of C-reactive protein [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/46\">",
"     46",
"    </a>",
"    ]. These results must be interpreted with caution because 89 percent of cases were due to methicillin-susceptible",
"    <em>",
"     S. aureus",
"    </em>",
"    (MSSA), the patients required minimal surgery, and infection-related complications were minimal.",
"   </p>",
"   <p>",
"    We therefore suggest that children with uncomplicated osteomyelitis be treated for a minimum of four weeks. The total duration for each patient should be based on the clinical response to therapy and the resolution of markers of inflammation. C-reactive protein (CRP) drops rapidly after the initiation of antimicrobial therapy and is usually normal after two weeks. In contrast, the erythrocyte sedimentation rate (ESR) may take three or more weeks to normalize.",
"   </p>",
"   <p>",
"    We administer antibiotics until the erythrocyte sedimentation rate is within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/1,3,8,43\">",
"     1,3,8,43",
"    </a>",
"    ] or for four weeks, whichever is longer. Once this has occurred, a plain radiograph should be performed to look for evidence of new bone lesions, even if there is no clinical evidence of treatment failure. Therapy can be safely stopped if the ESR and CRP are normal and the radiograph shows no evidence of sequestra or new lytic bone lesions. This individualized approach will lead to durations of therapy of four weeks in most cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     TREATMENT OF CULTURE-NEGATIVE OSTEOMYELITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with clinical and radiologic findings consistent with osteomyelitis often do not have a pathogen isolated from microbiologic specimens. A bacteriologic diagnosis is not confirmed in 20 to 50 percent of cases but does not preclude successful treatment or the use of sequential IV and oral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/2-4,47\">",
"     2-4,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The decision to continue empiric antibiotic therapy for patients in whom cultures are negative must be carefully considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H18#H18\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Diagnostic approach'",
"    </a>",
"    .) An important factor is the initial response to such therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In those who improve rapidly on a single antibiotic, empiric initial therapy should be continued. As in those with a positive culture and an uncomplicated clinical course, sequential therapy may be considered. Nevertheless, the differential diagnosis for osteomyelitis should again be reviewed and likely alternative diagnoses excluded before the child is committed to a long course of antibiotic therapy. This is particularly important for children whose imaging studies remain negative. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H18#H18\">",
"       \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Diagnostic approach'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with findings consistent with osteomyelitis whose initial cultures are negative and who do not respond to empiric antibiotic treatment as expected, an aggressive attempt must be made to isolate unusual pathogens or fastidious organisms, such as",
"      <em>",
"       K. kingae",
"      </em>",
"      . The yield of",
"      <em>",
"       K. kingae",
"      </em>",
"      is enhanced by inoculating aspirates into blood culture bottles [",
"      <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/48\">",
"       48",
"      </a>",
"      ]. An aspirate of any involved soft tissue or bone biopsy also should be obtained for histopathologic staining and culture for bacteria. In addition, appropriate serologic testing or tuberculin skin testing should be performed when exposure to",
"      <em>",
"       Coccidioides",
"      </em>",
"      or",
"      <em>",
"       Brucella",
"      </em>",
"      species, or to",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      , is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H15#H15\">",
"       \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As previously mentioned, patients with culture-negative osteomyelitis who have responded to empiric therapy with a single antibiotic and have had an uncomplicated clinical course may be treated with sequential therapy focused on likely common pathogens (",
"    <em>",
"     S. aureus",
"    </em>",
"    ,",
"    <em>",
"     Streptococcus pyogenes",
"    </em>",
"    ). These children also should be immunocompetent and fully immunized in most circumstances. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Empiric antimicrobial therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The efficacy of this approach was illustrated in a retrospective review of 85 patients, of whom 40 were culture negative [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/49\">",
"     49",
"    </a>",
"    ]. There was no significant difference between the groups of culture-positive and culture-negative patients, but it is important to note that most of the patients in this series were seen before CA-MRSA infections became common in the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF ASSOCIATED VENOUS THROMBOEMBOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with associated venous thromboembolism are usually managed in conjunction with a hematologist. Management typically involves anticoagulation until the thrombus has resolved on Doppler imaging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14234?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children\", section on 'Antithrombotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical therapy is an important adjunct to the antimicrobial regimen and may be required upon presentation or during therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/8,29,50\">",
"     8,29,50",
"    </a>",
"    ]. The following conditions require surgical management:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Subperiosteal and soft tissue abscesses and intramedullary purulence should be drained",
"     </li>",
"     <li>",
"      Sequestra should be removed",
"     </li>",
"     <li>",
"      Contiguous infectious foci should be debrided adequately and treated with effective antimicrobial therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These lesions are diagnosed using various imaging techniques, principally plain radiography and magnetic resonance imaging. CT scans also may reveal evidence of sequestra or involucra and are sometimes useful to plan a surgical intervention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, children who are not improving on antibiotic therapy may require surgical procedures to drain persistent collections of pus or debride necrotic bone. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Monitoring response to therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     CHRONIC OSTEOMYELITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic osteomyelitis, although uncommon, has been described most often with inadequate duration of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/2\">",
"     2",
"    </a>",
"    ]. In one series of 398 patients, 14 (3.5 percent) developed chronic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/3\">",
"     3",
"    </a>",
"    ]. Infection is generally considered chronic when signs and symptoms of bone inflammation have been present for at least two weeks, with radiographic evidence of devitalized bone.",
"   </p>",
"   <p>",
"    Treatment of chronic osteomyelitis involves removing devitalized bone and long-term administration of antibiotics. The choice of antimicrobial agents and the duration of therapy have not been carefully evaluated, largely because of the rarity of the disease and the fact that cases tend to have patient-specific etiologic and anatomic factors. Antibiotic regimens that have been successful in small studies include oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/45/31446?source=see_link\">",
"     cloxacillin",
"    </a>",
"    plus",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/7/11382?source=see_link\">",
"     probenecid",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"     nafcillin",
"    </a>",
"    plus oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/51-53\">",
"     51-53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on these limited data, we suggest the combination of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    and a beta-lactam for the treatment of chronic staphylococcal osteomyelitis that is methicillin susceptible. Adjunctive measures, such as local irrigation with antimicrobial solutions with or without detergents and surgical implantation of beads impregnated with antibiotics, have not been conclusively shown to affect outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/54-57\">",
"     54-57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of chronic osteomyelitis often requires repeated surgical debridement, bone grafting, and very prolonged antimicrobial therapy. Associated complications include joint stiffness, limb shortening, and pathologic fractures. Therefore, fastidious treatment of acute hematogenous osteomyelitis and careful follow-up throughout treatment are essential to avoid this complication.",
"   </p>",
"   <p>",
"    Pitfalls in the treatment of chronic osteomyelitis include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Underdosing of antimicrobial agents",
"     </li>",
"     <li>",
"      Inadequate surgical debridement",
"     </li>",
"     <li>",
"      Treatment for inadequate periods of time",
"     </li>",
"     <li>",
"      Failures in adherence to the antimicrobial therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most newborns, infants, and children who receive prompt, appropriate antimicrobial therapy before extensive bone necrosis develops have excellent outcomes. However, despite adequate therapy, a few children have significant complications such as pathologic fracture or, when infection has involved the growth plate, abnormal growth in the affected bone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/58\">",
"     58",
"    </a>",
"    ]. The abnormal growth can result in an angular deformity, shortening of the bone, and even overgrowth of the affected bone. In neonates in particular, the location of the infection and the causative organism may influence outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among neonates with osteomyelitis, sequelae result from the extension of infection into the subperiosteal space and soft tissue, involvement of the growth plate, and the spread of infection into the adjacent joint space. These patterns occur, in part, as a result of features of the newborn skeleton. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neonatal infection can therefore result in direct destruction of the growth plate and subsequent growth disturbance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Other sequelae that have been observed include avascular necrosis of the femoral head and bony deformities. Among newborns with vertebral osteomyelitis, collapse or complete destruction of one or more vertebral bodies may occur, with kyphosis or spinal cord compression (and resultant paralysis) as late complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis also is affected by the infecting organism. Recovery from group B streptococcal infection is much better in comparison with staphylococcal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Infants and children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term sequelae are uncommon in infants and children. However, multifocal disease, pathologic fractures, abnormal bone growth, chronic osteomyelitis, and the need for repeated surgical intervention have been reported frequently among patients with community-associated methicillin-resistant staphylococcal infection, which is occurring with increasing frequency in many communities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'Community-onset'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a case series of patients with",
"    <em>",
"     S. aureus",
"    </em>",
"    osteomyelitis from a single institution, 17 (4.7 percent) developed pathologic long-bone fractures; 15 of the 17 had methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/9/24730/abstract/58\">",
"     58",
"    </a>",
"    ]. Risk factors for pathologic fracture included prolonged hospital stay, multiple surgical procedures, large circumferential subperiosteal abscess, sharp zone of diminished marrow enhancement on magnetic resonance imaging, and USA300-0114 pulsotype. We suggest that children known to have these risk factors be managed with protected weight-bearing and activity restriction until inflammatory markers have returned to normal, the involved bone appears normal on radiographs, and the child is pain-free.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;With current antimicrobial regimens and surgical approaches, successful treatment is now achieved in nearly all children with hematogenous osteomyelitis. The increase in reports of",
"    <em>",
"     Kingella",
"    </em>",
"    and community-associated methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    (CA-MRSA) provide an impetus for consistent efforts to obtain cultures of blood and skeletal foci of infection. Treatment is typically initiated empirically, before the diagnosis is confirmed by imaging or culture. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Empiric antimicrobial therapy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H18#H18\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Diagnostic approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most children can be treated with sequential therapy, consisting of first parenteral and then oral therapy. This minimizes the amount of time spent in the hospital, as well as complications from prolonged vascular access. Outcomes for most children are excellent, although complication rates are increased in those with CA-MRSA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Empiric therapy &ndash; We recommend initiating empiric antimicrobial therapy for most children with presumed acute osteomyelitis (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Indications'",
"      </a>",
"      above.) Epidemiologic factors largely determine the choice of antibiotic therapy. These principally include the child's age, severity of illness, underlying medical condition, and organisms that are prevalent in the community. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Choice of agents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For neonates and young infants (&lt;3 months), we use an empiric regimen consisting of a third-generation cephalosporin, such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      , plus an antistaphylococcal agent (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      or",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"        nafcillin",
"       </a>",
"       /",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"        oxacillin",
"       </a>",
"       ).",
"      </span>",
"      Neonates who have been in an intensive care unit for more than one week should receive vancomycin, rather than",
"      <span class=\"nowrap\">",
"       nafcillin/oxacillin.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Neonates and young infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For older infants (&ge;3 months) and children, we use one of the following agents:",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"       cefazolin",
"      </a>",
"      , an antistaphylococcal penicillin",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"        nafcillin",
"       </a>",
"       /oxicillin),",
"      </span>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      . The specific choice of antistaphylococcal agent depends on the local prevalence of CA-MRSA and the susceptibility of these isolates to clindamycin. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Older infants and children'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For children between 3 and 36 months of age who require vancomycin or clindamycin (for empiric coverage of CA-MRSA), cefazolin may be added to provide empiric coverage of",
"      <em>",
"       K. kingae",
"      </em>",
"      . Alternatively, if CA-MRSA is not identified by cultures of blood, bone, or tissue aspirates, vancomycin or clindamycin may be replaced by cefazolin. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Older infants and children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children and adolescents with sickle cell disease, recent gastrointestinal or urologic surgery, and intravenous drug use are at higher risk for the development of osteomyelitis compared with other patients. Gram negative infections are more common among these patients. Patients with chronic granulomatous disease often develop infection with unusual organisms, including gram negative bacteria and fungi, and require highly individualized evaluation and therapy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Specific predisposing factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Monitoring response to therapy &ndash; Monitoring the history and physical examination, erythrocyte sedimentation rate (ESR)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C-reactive protein (CRP) levels, and plain radiographs will help identify patients who may be treated as outpatients or who are not improving as expected. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Monitoring tools'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Most children respond to therapy, as evidenced by reduction in fever and pain, within three to seven days. Often by the end of the first week, ESR has decreased by about 20 percent, and CRP by 50 percent. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Uncomplicated clinical course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who have not improved after five to seven days of treatment must be carefully evaluated for complications. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Complicated clinical course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Continued treatment as an outpatient may be considered when there has been unequivocal clinical improvement. This usually occurs after 5 to 10 days of antibiotic therapy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Outpatient therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sequential therapy &ndash; We recommend sequential therapy (parenteral antibiotic therapy, followed by oral therapy) for children with uncomplicated acute hematogenous osteomyelitis who meet the following indications (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Sequential antibiotic therapy'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There has been a clear clinical response to parenteral antibiotics",
"     </li>",
"     <li>",
"      Patient and family can adhere to oral regimen and close follow-up",
"     </li>",
"     <li>",
"      Patient can swallow, retain, and absorb an appropriate oral medication",
"      <br/>",
"      <br/>",
"      Antibiotics administered orally for hematogenous osteomyelitis must be given in higher doses than those recommended in package inserts and those used for treatment of other infections. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Choice and dose of oral agent'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      We suggest monitoring drug levels during oral therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although patients rarely have low antibiotic levels, the consequences of inadequate treatment of osteomyelitis can be severe. Children should be evaluated at one- to two-week intervals for clinical improvement and complications related to antibiotic therapy. In addition, a radiograph should be performed at the end of treatment. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Management of oral therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Duration of therapy &ndash; Observational studies consistently report that treatment failure occurs more frequently when the duration of therapy is less than 20 to 21 days. We suggest that children be treated for a minimum of four weeks (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The exact duration of therapy should be based on clinical response and resolution of markers of inflammation. We generally continue antibiotics until the ESR has normalized or for four weeks, whichever is longer. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Duration and efficacy of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Culture-negative osteomyelitis &ndash; A bacteriologic diagnosis is not confirmed in 20 to 50 percent of cases of presumed osteomyelitis in children. The decision to continue empiric antibiotic therapy is based upon the initial clinical suspicion and response to empiric therapy. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Treatment of culture-negative osteomyelitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical therapy &ndash; Surgical therapy is an important adjunct to the antimicrobial regimen and may be required upon presentation or during therapy. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Indications for surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic osteomyelitis &ndash; Chronic osteomyelitis occurs rarely in children and has been described most often with inadequate duration of therapy. The treatment of chronic osteomyelitis often requires repeated surgical debridement, bone grafting, and very prolonged antimicrobial therapy. We use the combination of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"       rifampin",
"      </a>",
"      and a beta-lactam for the treatment of chronic staphylococcal osteomyelitis for methicillin-susceptible isolates. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Chronic osteomyelitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications &ndash; Most newborns, infants, and children who receive prompt, appropriate antimicrobial therapy before extensive bone necrosis develops have excellent outcomes. However, despite adequate therapy, a few children develop significant complications. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/1\">",
"      Nelson JD, Bucholz RW, Kusmiesz H, Shelton S. Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections. J Pediatr Orthop 1982; 2:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/2\">",
"      Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children. A review of 163 cases. Am J Dis Child 1975; 129:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/3\">",
"      Nelson JD. Acute osteomyelitis in children. Infect Dis Clin North Am 1990; 4:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/4\">",
"      Karwowska A, Davies HD, Jadavji T. Epidemiology and outcome of osteomyelitis in the era of sequential intravenous-oral therapy. Pediatr Infect Dis J 1998; 17:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/5\">",
"      Le Saux N, Howard A, Barrowman NJ, et al. Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review. BMC Infect Dis 2002; 2:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/6\">",
"      Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 2005; 9:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/7\">",
"      Peltola H, P&auml;&auml;kk&ouml;nen M, Kallio P, et al. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial. Clin Microbiol Infect 2012; 18:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/8\">",
"      Kaplan SL. Osteomyelitis in children. Infect Dis Clin North Am 2005; 19:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/9\">",
"      Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/10\">",
"      Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/11\">",
"      Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/12\">",
"      Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/13\">",
"      Chen CJ, Chiu CH, Lin TY, et al. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J 2007; 26:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/14\">",
"      Messina AF, Namtu K, Guild M, et al. Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis. Pediatr Infect Dis J 2011; 30:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/15\">",
"      de Groot R, Glover D, Clausen C, et al. Bone and joint infections caused by Kingella kingae: six cases and review of the literature. Rev Infect Dis 1988; 10:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/16\">",
"      Goutzmanis JJ, Gonis G, Gilbert GL. Kingella kingae infection in children: ten cases and a review of the literature. Pediatr Infect Dis J 1991; 10:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/17\">",
"      Yagupsky P, Howard CB, Einhorn M, Dagan R. Kingella kingae osteomyelitis of the calcaneus in young children. Pediatr Infect Dis J 1993; 12:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/18\">",
"      Kiang KM, Ogunmodede F, Juni BA, et al. Outbreak of osteomyelitis/septic arthritis caused by Kingella kingae among child care center attendees. Pediatrics 2005; 116:e206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/19\">",
"      Yagupsky P. Antibiotic susceptibility of Kingella kingae isolates from children with skeletal system infections. Pediatr Infect Dis J 2012; 31:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/20\">",
"      Yagupsky P, Porsch E, St Geme JW 3rd. Kingella kingae: an emerging pathogen in young children. Pediatrics 2011; 127:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/21\">",
"      Dubnov-Raz G, Ephros M, Garty BZ, et al. Invasive pediatric Kingella kingae Infections: a nationwide collaborative study. Pediatr Infect Dis J 2010; 29:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/22\">",
"      Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/23\">",
"      Mouas H, Lutsar I, Dupont B, et al. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 2005; 40:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/24\">",
"      Rayner CR, Baddour LM, Birmingham MC, et al. Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 2004; 32:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/25\">",
"      Drew RH, Perfect JR, Srinath L, et al. Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. J Antimicrob Chemother 2000; 46:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/26\">",
"      Christ W, Lehnert T, Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10 Suppl 1:S141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/27\">",
"      Mayer DG. Overview of toxicological studies. Drugs 1987; 34 Suppl 1:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/28\">",
"      Bradley JS, Jackson MA, Committee on Infectious Diseases, American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics 2011; 128:e1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/29\">",
"      Syrogiannopoulos GA, Nelson JD. Duration of antimicrobial therapy for acute suppurative osteoarticular infections. Lancet 1988; 1:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/30\">",
"      Unkila-Kallio L, Kallio MJ, Eskola J, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics 1994; 93:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/31\">",
"      Peltola H, Unkila-Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics 1997; 99:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/32\">",
"      Roine I, Faingezicht I, Arguedas A, et al. Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children. Pediatr Infect Dis J 1995; 14:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/33\">",
"      Courtney PM, Flynn JM, Jaramillo D, et al. Clinical indications for repeat MRI in children with acute hematogenous osteomyelitis. J Pediatr Orthop 2010; 30:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/34\">",
"      Tetzlaff TR, McCracken GH Jr, Nelson JD. Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr 1978; 92:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/35\">",
"      Prober CG, Yeager AS. Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis. J Pediatr 1979; 95:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/36\">",
"      Kolyvas E, Ahronheim G, Marks MI, et al. Oral antibiotic therapy of skeletal infections in children. Pediatrics 1980; 65:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/37\">",
"      Kaplan SL, Mason EO Jr, Feigin RD. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J 1982; 75:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/38\">",
"      Zaoutis T, Localio AR, Leckerman K, et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics 2009; 123:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/39\">",
"      Ruebner R, Keren R, Coffin S, et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics 2006; 117:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/40\">",
"      Arnold JC, Cannavino CR, Ross MK, et al. Acute bacterial osteoarticular infections: eight-year analysis of C-reactive protein for oral step-down therapy. Pediatrics 2012; 130:e821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/41\">",
"      Bryson YJ, Connor JD, LeClerc M, Giammona ST. High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr 1979; 94:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/42\">",
"      Mart&iacute;nez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003; 22:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/43\">",
"      Nelson JD. Toward simple but safe management of osteomyelitis. Pediatrics 1997; 99:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/44\">",
"      HARRIS NH. Some problems in the diagnosis and treatment of acute osteomyelitis. J Bone Joint Surg Br 1960; 42-B:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/45\">",
"      Blockey NJ, Watson JT. Acute osteomyelitis in children. J Bone Joint Surg Br 1970; 52:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/46\">",
"      Peltola H, P&auml;&auml;kk&ouml;nen M, Kallio P, et al. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Pediatr Infect Dis J 2010; 29:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/47\">",
"      Bonhoeffer J, Haeberle B, Schaad UB, Heininger U. Diagnosis of acute haematogenous osteomyelitis and septic arthritis: 20 years experience at the University Children's Hospital Basel. Swiss Med Wkly 2001; 131:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/48\">",
"      Yagupsky P. Kingella kingae: from medical rarity to an emerging paediatric pathogen. Lancet Infect Dis 2004; 4:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/49\">",
"      Floyed RL, Steele RW. Culture-negative osteomyelitis. Pediatr Infect Dis J 2003; 22:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/50\">",
"      Scott RJ, Christofersen MR, Robertson WW Jr, et al. Acute osteomyelitis in children: a review of 116 cases. J Pediatr Orthop 1990; 10:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/51\">",
"      Ramos OM. Chronic osteomyelitis in children. Pediatr Infect Dis J 2002; 21:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/52\">",
"      Bell SM. Further observations on the value of oral penicillins in chronic staphylococcal osteomyelitis. Med J Aust 1976; 2:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/53\">",
"      Norden CW, Bryant R, Palmer D, et al. Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J 1986; 79:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/54\">",
"      Makin M, Geller R, Jacobs J, Sacks T. Non-toxic detergent irrigation of chronic infections. An experimental evaluation. Clin Orthop Relat Res 1973; :320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/55\">",
"      Anderson LD, Horn LG. Irrigation-suction technic in the treatment of acute hematogenous osteomyelitis, chronic osteomyelitis, and acute and chronic joint infections. South Med J 1970; 63:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/56\">",
"      Blaha JD, Calhoun JH, Nelson CL, et al. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res 1993; :8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/57\">",
"      Walenkamp GH, Kleijn LL, de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand 1998; 69:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/58\">",
"      Belthur MV, Birchansky SB, Verdugo AA, et al. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am 2012; 94:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/59\">",
"      Peters W, Irving J, Letts M. Long-term effects of neonatal bone and joint infection on adjacent growth plates. J Pediatr Orthop 1992; 12:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/60\">",
"      Williamson JB, Galasko CS, Robinson MJ. Outcome after acute osteomyelitis in preterm infants. Arch Dis Child 1990; 65:1060.",
"     </a>",
"    </li>",
"    <li>",
"     Overturf, GD. Bacterial infections of the bone and joints. In: Infectious Diseases of the Fetus and Newborn, 7th ed, Remington, JS, Klein, JO, Wilson, CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.296.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/62\">",
"      Edwards MS, Baker CJ, Wagner ML, et al. An etiologic shift in infantile osteomyelitis: the emergence of the group B streptococcus. J Pediatr 1978; 93:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/9/24730/abstract/63\">",
"      Memon IA, Jacobs NM, Yeh TF, Lilien LD. Group B streptococcal osteomyelitis and septic arthritis. Its occurrence in infants less than 2 months old. Am J Dis Child 1979; 133:921.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5958 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-820E8C5BBF-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24730=[""].join("\n");
var outline_f24_9_24730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW OF TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EMPIRIC ANTIMICROBIAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Choice of agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Older infants and children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1088553161\">",
"      S. aureus and group A streptococcus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1088553168\">",
"      K. kingae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1088553175\">",
"      Haemophilus influenzae type b",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Specific predisposing factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ISSUES WITH SPECIFIC ANTIMICROBIAL AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MONITORING RESPONSE TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Monitoring tools",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Uncomplicated clinical course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Complicated clinical course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      OUTPATIENT THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SEQUENTIAL ANTIBIOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Choice and dose of oral agent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Drug monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Antibiotic levels",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Serum bactericidal titer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Management of oral therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DURATION AND EFFICACY OF THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      TREATMENT OF CULTURE-NEGATIVE OSTEOMYELITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MANAGEMENT OF ASSOCIATED VENOUS THROMBOEMBOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      INDICATIONS FOR SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      CHRONIC OSTEOMYELITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Neonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11465?source=related_link\">",
"      Chronic granulomatous disease: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=related_link\">",
"      Clinical features of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14234?source=related_link\">",
"      Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=related_link\">",
"      Evaluation and diagnosis of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=related_link\">",
"      Fluoroquinolones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=related_link\">",
"      Overview of antibacterial susceptibility testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39946?source=related_link\">",
"      Overview of the management of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43142?source=related_link\">",
"      Pseudomonas aeruginosa skin, soft tissue, and bone infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39528?source=related_link\">",
"      Treatment of Pseudomonas aeruginosa infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37159?source=related_link\">",
"      Treatment of Staphylococcus aureus bacteremia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_9_24731="Manifestations of PBC";
var content_f24_9_24731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Manifestations of primary biliary cirrhosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Specific to PBC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Portal hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic bone disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Xanthomata",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fat soluble vitamin malabsorption",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinary tract infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Associated disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyroid dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sicca syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CREST",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celiac disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the American Association for the Study of Liver Diseases. Heathcote EJ, Hepatology 2000; 31:1005.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24731=[""].join("\n");
var outline_f24_9_24731=null;
var title_f24_9_24732="PAINAD";
var content_f24_9_24732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F59509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F59509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    PAINAD - Pain Assessment in Advanced Dementia scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Items*",
"       </td>",
"       <td class=\"subtitle1\">",
"        0",
"       </td>",
"       <td class=\"subtitle1\">",
"        1",
"       </td>",
"       <td class=\"subtitle1\">",
"        2",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breathing independent of vocalization",
"       </td>",
"       <td>",
"        Normal.",
"       </td>",
"       <td>",
"        Occasional labored breathing. Short period of hyperventilation.",
"       </td>",
"       <td>",
"        Noisy labored breathing. Long period of hyperventilation. Cheyne-Stokes respirations.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Negative vocalization",
"       </td>",
"       <td>",
"        None.",
"       </td>",
"       <td>",
"        Occasional moan or groan. Low-level speech with a negative or disapproving quality.",
"       </td>",
"       <td>",
"        Repeated troubled calling out. Loud moaning or groaning. Crying.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Facial expression",
"       </td>",
"       <td>",
"        Smiling or inexpressive.",
"       </td>",
"       <td>",
"        Sad. Frightened. Frown.",
"       </td>",
"       <td>",
"        Facial grimacing.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Body language",
"       </td>",
"       <td>",
"        Relaxed.",
"       </td>",
"       <td>",
"        Tense. Distressed pacing. Fidgeting.",
"       </td>",
"       <td>",
"        Rigid. Fists clenched. Knees pulled up. Pulling or pushing away. Striking out.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Consolability",
"       </td>",
"       <td>",
"        No need to console.",
"       </td>",
"       <td>",
"        Distracted or reassured by voice or touch.",
"       </td>",
"       <td>",
"        Unable to console, distract or reassure.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"4\" style=\"text-align: right;\">",
"        <strong>",
"         Total:",
"        </strong>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    This pain assessment score can be used to assess pain in demented patients. Patients should be observed for five minutes prior to performing the assessment. Total scores range from 0 to 10, with 10 representing severe pain.",
"    <div class=\"footnotes\">",
"     * Five-item observational tool.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Total scores range from 0 to 10 (based on a scale of 0 to 2 for five items), with a higher score indicating more severe pain (0 = \"no pain\" to 10 = \"severe pain\").",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the pain assessment in advanced dementia (PAINAD) scale. J Am Med Dir Assoc 2003; 4:9. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24732=[""].join("\n");
var outline_f24_9_24732=null;
var title_f24_9_24733="Supportive abortive Rx CVS";
var content_f24_9_24733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78562&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78562&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Supportive and abortive treatment approaches in CVS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Supportive care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Fluid, electrolyte and nutritional management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infuse 10% dextrose, 0.45% (half normal) saline solution and potassium chloride as appropriate at 1.5 times maintenance fluid rates OR through a Y-connector 10% dextrose infusion at one times maintenance and normal saline at 0.5 times maintenance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        If no enteral intake for 3-5 days, initiate peripheral parenteral nutrition with 1.5 g of amino acids/kg/day and energy units above the catabolic threshold of 55-70 kcal/kg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Antiemetic (5HT",
"        <sub>",
"         3",
"        </sub>",
"        antagonist) agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ondansetron 0.3-0.4 mg/kg/dose intravenously every 4-6 hours (maximum 20 mg per dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Side effects: constipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alternatives: granisetron",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Sedatives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diphenhydramine 1-1.25 mg/kg/dose intravenously every 6 hours (maximum 50 mg per dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lorazepam 0.05-0.1 mg/kg/dose intravenously every 6 hours (maximum 2 mg per dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Side effects: respiratory depression, hallucinations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Chlorpromazine 0.5-1 mg/kg/dose intravenously every 6 hours + diphenhydramine (see above) intravenously:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &lt;5 years or &lt;23 kg maximum 10 mg per dose, 40 mg per 24 hours chlorpromazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;5 years or &ge;23 kg maximum 18 mg per dose, 75 mg per 24 hours chlorpromazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Side effects: dystonic reactions with chlorpromazine alone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Analgesics (nonsteroidal and narcotic) agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ketorolac 0.4-1 mg/kg intravenously every 6 hours x 48 hours (maximum 30 mg per dose, maximum 120 mg per 24 hours); avoid in renal insufficiency or dehydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Side effects: gastrointestinal hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alternatives: narcotics, intravenous morphine or fentanyl by bolus or by patient-control infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Treatment of specific signs and symptoms: epigastric pain, diarrhea, and hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Epigastric pain: acid suppression by H",
"        <sub>",
"         2",
"        </sub>",
"        RAs or PPIs, (eg, intravenous ranitidine, pantoprazole)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diarrhea: antidiarrheals (eg, loperamide)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypertension: short-acting ACE inhibitors (eg, captopril)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Treatment of specific complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dehydration and electrolyte deficit: replace calculated deficits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Metabolic acidosis: determine cause and treat accordingly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        SIADH: restrict free water intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hematemesis: intravenous H",
"        <sub>",
"         2",
"        </sub>",
"        RAs or PPIs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Weight loss: nasogastric or parenteral nutrition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Abortive care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Antimigraine (triptan) agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sumatriptan: 20 mg once intranasally as early as possible at episode onset for children 12 years and older (maximum 40 mg/24 hours)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Side effects: neck pain/burning, coronary vasospasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Contraindications: basilar artery migraine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recovery and refeeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Feed ad libitum when child declares episode is over",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     H",
"     <sub>",
"      2",
"     </sub>",
"     RAs: histamine-2 receptor antagonists; PPIs: proton pump inhibitors; ACE: angiotensive converting enzyme; SIADH: syndrome of inappropriate antidiuretic hormone; %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Li BU, Lefevre F, Chelimsky GG, et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2008; 47:379. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24733=[""].join("\n");
var outline_f24_9_24733=null;
var title_f24_9_24734="Contents: Mental health";
var content_f24_9_24734=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?18/22/18798\">",
"       Patient Information",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Mental health",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Mental health",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Anxiety disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/32/32257\">",
"           Patient information: Generalized anxiety disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/10/13473\">",
"           Patient information: Panic disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/45/8914\">",
"           Patient information: Post-traumatic stress disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/42/20129\">",
"           Patient information: Social anxiety disorder (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bipolar disorder",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/5/4178\">",
"           Patient information: Bipolar disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/55/39796\">",
"           Patient information: Bipolar disorder (manic depression) (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Depression",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/57/12179\">",
"           Patient information: Depression (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/6/13413\">",
"           Patient information: Depression in adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/41/20116\">",
"           Patient information: Depression in adults (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/21/29013\">",
"           Patient information: Depression treatment options for adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/24/21894\">",
"           Patient information: Depression treatment options for adults (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/50/37664\">",
"           Patient information: Electroconvulsive therapy (ECT) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/15/37106\">",
"           Patient information: Electroconvulsive therapy (ECT) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/6/24675\">",
"           Patient information: Medicines for depression (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/9/41105\">",
"           Patient information: Postpartum depression (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/12/13510\">",
"           Patient information: Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/10/42146\">",
"           Patient information: Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/51/2866\">",
"           Patient information: Seasonal affective disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/18/11554\">",
"           Patient information: When you have depression and another health problem (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Eating disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/16/25858\">",
"           Patient information: Anorexia nervosa (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/37/26194\">",
"           Patient information: Bulimia nervosa (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Personality disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/30/33249\">",
"           Patient information: Antisocial personality disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/10/16546\">",
"           Patient information: Borderline personality disorder (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Schizophrenia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/37/44625\">",
"           Patient information: Schizophrenia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/10/1186\">",
"           Patient information: Tardive dyskinesia (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Substance abuse and addiction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/17/37137\">",
"           Patient information: Alcohol poisoning (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/21/44371\">",
"           Patient information: Alcohol use ��������� when is drinking a problem? (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/28/39361\">",
"           Patient information: Alcohol use ��������� when is drinking a problem? (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/3/44081\">",
"           Patient information: Alcohol withdrawal (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/39/31346\">",
"           Patient information: Cocaine use disorder (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38529\">",
"           Patient information: Fetal alcohol syndrome (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/54/18274\">",
"           Patient information: Marijuana use and addiction (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/6/11363\">",
"           Patient information: Narcotic pain medicines (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/21/7506\">",
"           Patient information: Prescription drug abuse (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/23/4468\">",
"           Patient information: Risks and benefits of alcohol (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tourette syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/28/16833\">",
"           Patient information: Tourette syndrome (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-3B08F21E09-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f24_9_24734=[""].join("\n");
var outline_f24_9_24734=null;
var title_f24_9_24735="Bat bite";
var content_f24_9_24735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Bat bite (arrows) on the finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 280px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo used by permission of the Texas AgriLife Extension Service, Janet Hurley, Extension Program Specialist II&ndash;School IPM, and the Bats in Schools website, file://agrilife.org/batsinschools/.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_9_24735=[""].join("\n");
var outline_f24_9_24735=null;
